00978000000000397000450099100020000070000020000270600020000470100020000609100090
00081300042000171510024000590350010000834800059000930300021001529300005001731170
00600178085000300184935001000187031000200197032000200199036000600201042000200207
20000020020906500090021112200030022004800140022304800140023704800240025104900330
0275049003300308049002500341049003100366043006100397043006100458043006100519#1#0
#i#1#20110304#Revista Brasileira de Medicina do Esporte#Rev. bras. med. esporte#
1517-8692#Sociedade Brasileira de Medicina do Exercício e do Esporte#Rev Bras Me
d Esporte#RBME#other#nd#1517-8692#6#3#20003#1#0#20000600#07#^les^hSumario#^lpt^h
Sumário#^len^hTable of Contents#^lpt^cRBME090^tArtigo de Opinião#^lpt^cRBME120^t
Artigo de Revisão#^lpt^cRBME150^tEditorial#^lpt^cRBME180^tArtigo Original#^les^t
Rev Bras Med Esporte^vvol.6^nno.3^cNiterói^mjun.^a2000#^lpt^tRev Bras Med Esport
e^vvol.6^nno.3^cNiterói^mjun.^a2000#^len^tRev Bras Med Esporte^vvol.6^nno.3^cNit
erói^mJune^a2000##
00267000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640910009000660920007000750020012000827030
00300094#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a01.htm#S#o#1#1#text#1#20110
406#124135#v6n3a01.htm#21##
00520000000000337000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000300084121000300087049000800090158000300098030002100101
03100020012203200020012406500090012601400090013503500100014412300020015401200140
0156002001200170#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a01.htm#S#h#2#1#text
#1#oa#pt#br1.1#1#4.0#ND#01#RBME150#nd#Rev Bras Med Esporte#6#3#20000600#^f73^l73
#1517-8692#2#Editorial^lpt#v6n3a01.htm##
00527000000000337000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000300084121000300087049000800090158000300098030002100101
03100020012203200020012406500090012601400090013503500100014412300020015401200210
0156002001200177#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a01.htm#S#f#3#1#text
#1#oa#pt#br1.1#1#4.0#ND#01#RBME150#nd#Rev Bras Med Esporte#6#3#20000600#^f73^l73
#1517-8692#2#<b>Editorial</b>^lpt#v6n3a01.htm##
00634000000000349000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640640013000660710003000790400003000820010
00600085042000200091120000400093121000300097049000800100158000300108030002400111
03100020013503200020013706500090013901400090014803500100015712300020016701200140
0169002001200183008008900195#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a01.htm#
S#l#4#1#text#1#^mjun.^a2000#oa#pt#br1.1#1#4.0#01#RBME150#nd#Rev. bras. med. espo
rte#6#3#20000600#^f73^l73#1517-8692#2#Editorial^lpt#v6n3a01.htm#Internet^ihttp:/
/www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-86922000000300001##
00309000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704008400067002001200151#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#5#1#text#17#<p align="right"><font face=
"Verdana" size="2"><b>EDITORIAL</b> </font></p>     ^cY#v6n3a01.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#6#2#text#17#<p>&nbsp;</p>     ^cY#v6n3a0
1.htm##
00294000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704006900067002001200136#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#7#3#text#17#<p><font size="4" face="Verd
ana"><b>Editorial</b></font></p>     ^cY#v6n3a01.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#8#4#text#17#<p>&nbsp;</p>     ^cY#v6n3a0
1.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#9#5#text#17#<p>&nbsp;</p>     ^cY#v6n3a0
1.htm##
00617000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704039100068002001200459#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#10#6#text#17#<p><font face="Verdana" siz
e="2">Continuando o processo de qualifica&ccedil;&atilde;o    e valoriza&ccedil;
&atilde;o da nossa <I>Revista Brasileira de Medicina do Esporte</I>,    temos pr
ovidenciado aspectos operacionais importantes, como a obten&ccedil;&atilde;o    
do ISSN e o protocolo da solicita&ccedil;&atilde;o de indexa&ccedil;&atilde;o   
 junto &agrave; BIREME. </font></p>     ^cY#v6n3a01.htm##
00854000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704062800068002001200696#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#11#7#text#17#<p><font face="Verdana" siz
e="2">A sigla ISSN, que significa <I>International    Standard Serial Number</I>
, ou <I>N&uacute;mero Internacional Padronizado para    Publica&ccedil;&otilde;e
s Seriadas</I>, &eacute; o identificador internacionalmente    utilizado para in
dividualizar o t&iacute;tulo de uma publica&ccedil;&atilde;o    seriada, tornand
o-o &uacute;nico e definitivo. O seu uso &eacute; definido pela    norma t&eacut
e;cnica internacional da International Standards Organization (ISO    3297) e pe
la norma brasileira da Associa&ccedil;&atilde;o Brasileira de Normas    T&eacute
;cnicas (NBR 10525). </font></p>     ^cY#v6n3a01.htm##
01034000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704080800068002001200876#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#12#8#text#17#<p><font face="Verdana" siz
e="2">A Rede ISSN &eacute; uma organiza&ccedil;&atilde;o    intergovernamental p
resente em mais de 60 pa&iacute;ses, coordenada pelo Centro    Internacional do 
ISSN, em Paris. Foi criada em 1971, durante a reuni&atilde;o    do Unisist - Sis
tema Mundial de Informa&ccedil;&atilde;o Cient&iacute;fica,    da Unesco. Implan
tada em 1974, tem como objetivo apoiar o controle bibliogr&aacute;fico    mundia
l de publica&ccedil;&otilde;es seriadas, facilitando o acesso aos seus    regist
ros e controlando a atribui&ccedil;&atilde;o do ISSN. H&aacute; mais de    800.0
00 publica&ccedil;&otilde;es seriadas registradas. Essa abrang&ecirc;ncia    a c
oloca no patamar de &uacute;nica fonte de informa&ccedil;&atilde;o sobre    publ
ica&ccedil;&otilde;es seriadas no mundo. </font></p>     ^cY#v6n3a01.htm##
00770000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704054400068002001200612#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#13#9#text#17#<p><font face="Verdana" siz
e="2">O ISSN &eacute; um dos requisitos de qualidade    editorial de apresenta&c
cedil;&atilde;o de publica&ccedil;&otilde;es seriadas    t&eacute;cnico-cient&ia
cute;ficas, de acordo com as normas t&eacute;cnicas internacionais    da ISO 8, 
da ISO 3297 e da ABNT. O ISSN &eacute; an&aacute;logo ao ISBN (<I>International 
   Standard Book Number</I>), que identifica livros. O nosso ISSN 1517-8692 pass
ar&aacute;    a ser a impress&atilde;o digital da <I>RBME</I> no mundo dos peri&
oacute;dicos.    </font></p>     ^cY#v6n3a01.htm##
00797000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704057000069002001200639#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#14#10#text#17#<p><font face="Verdana" si
ze="2">Entregamos pessoalmente no dia 14 de abril do    corrente, na BIREME em S
&atilde;o Paulo-SP, a solicita&ccedil;&atilde;o de indexa&ccedil;&atilde;o    da
 <I>RBME</I> na base de dados LILACS (Literatura Latino-Americana e do Caribe   
 em Ci&ecirc;ncias da Sa&uacute;de) e aguardamos o resultado do julgamento, que 
   se baseia em alguns crit&eacute;rios de sele&ccedil;&atilde;o de t&iacute;tul
os    que levam em considera&ccedil;&atilde;o validade, import&acirc;ncia e orig
inalidade    do tema dos peri&oacute;dicos. </font></p>     ^cY#v6n3a01.htm##
00862000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704063500069002001200704#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#15#11#text#17#<p><font face="Verdana" si
ze="2">A base de dados LILACS &eacute; coordenada pela    BIREME e compreende to
da a literatura relativa &agrave;s Ci&ecirc;ncias da Sa&uacute;de,    produzida 
por autores latino-americanos e do Caribe, publicada nos pa&iacute;ses    da Reg
i&atilde;o da Am&eacute;rica Latina e Caribe, a partir de 1982. LILACS    &eacut
e; um esfor&ccedil;o cooperativo regional, do qual participam Centros    Coorden
adores Nacionais de cada pa&iacute;s e Centros Coordenadores Especializados,    
que por sua vez coordenam Centros Cooperantes, que processam e ingressam literat
ura    para a base de dados. </font></p>     ^cY#v6n3a01.htm##
00570000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704034300069002001200412#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#16#12#text#17#<p><font face="Verdana" si
ze="2">Realizamos a solicita&ccedil;&atilde;o de indexa&ccedil;&atilde;o    por 
observarmos que a <I>RBME</I> atende plenamente aos Crit&eacute;rios de    Sele&
ccedil;&atilde;o de Peri&oacute;dicos para a Base de Dados LILACS, e desta    fo
rma estamos confiantes em um resultado favor&aacute;vel. </font></p>     ^cY#v6n
3a01.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#17#13#text#17#<p>&nbsp;</p>     ^cY#v6n3
a01.htm##
00328000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704010100069002001200170#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#18#14#text#17#<p align="center"><font fa
ce="Verdana" size="2"><B><i>Jos&eacute; Kawazoe Lazzoli</i>    </B>    ^cY#v6n3a
01.htm##
00271000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704004400069002001200113#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#19#15#text#17#<br> <i>Editor-Chefe</i></
font></p>     ^cY#v6n3a01.htm##
00340000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704011300069002001200182#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#20#16#text#17#<p align="center"><font fa
ce="Verdana" size="2"><b><i>Antonio Claudio Lucas da    N&oacute;brega</i></b>  
   ^cY#v6n3a01.htm##
00277000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704005000069002001200119#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a01.htm#S#p#21#17#text#17#<br>   <i>Editor Associado
</i></font></p>     ^cY#v6n3a01.htm##
00267000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640910009000660920007000750020012000827030
00300094#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#o#1#1#text#1#20110
314#125741#v6n3a02.htm#76##
01084000000000481000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000400084121000300088049000800091158000300099030002100102
03100020012303200020012506500090012701400090013603500100014512300020015501200970
01570100025002540100040002790100028003190100032003470100023003790100034004020100
04100436010003200477010003600509010003600545117000600581072000300587002001200590
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#h#2#1#text#1#oa#en#br1.1#1
#4.0#TAB#02#RBME150#nd#Rev Bras Med Esporte#6#3#20000600#^f74^l76#1517-8692#1#Po
sition statement of the Brazilian Society of Sports Medicine: physical activity 
and health^len#^rND^nTales de^sCarvalho#^rND^nAntonio Claudio Lucas da^sNóbrega#
^rND^nJosé Kawazoe^sLazzoli#^rND^nJoão Ricardo Turra^sMagni#^rND^nLuciano^sRezen
de#^rND^nFélix Albuquerque^sDrummond#^rND^nMarcos Aurélio Brazão de^sOliveira#^r
ND^nEduardo Henrique De^sRose#^rND^nClaudio Gil Soares de^sAraújo#^rND^nJosé Ant
ônio Caldas^sTeixeira#other#09#v6n3a02.htm##
01098000000000481000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000400084121000300088049000800091158000300099030002100102
03100020012303200020012506500090012701400090013603500100014512300020015501201110
01570100025002680100040002930100028003330100032003610100023003930100034004160100
04100450010003200491010003600523010003600559117000600595072000300601002001200604
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#f#3#1#text#1#oa#en#br1.1#1
#4.0#TAB#02#RBME150#nd#Rev Bras Med Esporte#6#3#20000600#^f74^l76#1517-8692#1#<b
>Position statement of the Brazilian Society of Sports Medicine</b>: <b>physical
 activity and health</b>^len#^rND^nTales de^sCarvalho#^rND^nAntonio Claudio Luca
s da^sNóbrega#^rND^nJosé Kawazoe^sLazzoli#^rND^nJoão Ricardo Turra^sMagni#^rND^n
Luciano^sRezende#^rND^nFélix Albuquerque^sDrummond#^rND^nMarcos Aurélio Brazão d
e^sOliveira#^rND^nEduardo Henrique De^sRose#^rND^nClaudio Gil Soares de^sAraújo#
^rND^nJosé Antônio Caldas^sTeixeira#other#09#v6n3a02.htm##
01213000000000505000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640640013000660710003000790400003000820010
00600085042000200091120000400093038000400097121000300101049000800104158000300112
03000240011503100020013903200020014106500090014301400090015203500100016112300020
01710120097001730100025002700100040002950100028003350100032003630100023003950100
03400418010004100452010003200493010003600525010003600561117000600597072000300603
002001200606008008900618#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#l#
4#1#text#1#^mJune^a2000#oa#en#br1.1#1#4.0#tab#02#RBME150#nd#Rev. bras. med. espo
rte#6#3#20000600#^f74^l76#1517-8692#1#Position statement of the Brazilian Societ
y of Sports Medicine: physical activity and health^len#^rND^nTales de^sCarvalho#
^rND^nAntonio Claudio Lucas da^sNóbrega#^rND^nJosé Kawazoe^sLazzoli#^rND^nJoão R
icardo Turra^sMagni#^rND^nLuciano^sRezende#^rND^nFélix Albuquerque^sDrummond#^rN
D^nMarcos Aurélio Brazão de^sOliveira#^rND^nEduardo Henrique De^sRose#^rND^nClau
dio Gil Soares de^sAraújo#^rND^nJosé Antônio Caldas^sTeixeira#other#09#v6n3a02.h
tm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-869220
00000300002##
00381000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704015600067002001200223#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#5#1#text#63#<p><font size="4" face="Verd
ana"><b>Position statement of the Brazilian Society    of Sports Medicine: physi
cal activity and health </b></font></p>     ^cY#v6n3a02.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#6#2#text#63#<p>&nbsp;</p>     ^cY#v6n3a0
2.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002300067002001200090#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#7#3#text#63#<p>&nbsp; </p>     ^cY#v6n3a
02.htm##
00626000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704040100067002001200468#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#8#4#text#63#<p><font face="Verdana" size
="2"><b>Tales de Carvalho; Antonio Claudio Lucas da    N&oacute;brega; Jos&eacut
e; Kawazoe Lazzoli; Jo&atilde;o Ricardo Turra Magni;    Luciano Rezende; F&eacut
e;lix Albuquerque Drummond; Marcos Aur&eacute;lio Braz&atilde;o    de Oliveira; 
Eduardo Henrique De Rose; Claudio Gil Soares de Ara&uacute;jo;    Jos&eacute; An
t&ocirc;nio Caldas Teixeira </b></font> </p>     ^cY#v6n3a02.htm##
00247000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000300064704002200067002001200089#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#9#5#text#63#<p>&nbsp;</p>     ^cY#v6n3a0
2.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704002300068002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#10#6#text#63#<p>&nbsp; </p>     ^cY#v6n3
a02.htm##
00299000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704007300068002001200141#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#11#7#text#63#<p><font face="Verdana" siz
e="3"><B>INTRODUCTION</B> </font></p>     ^cY#v6n3a02.htm##
00945000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704071900068002001200787#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#12#8#text#63#<p><font face="Verdana" siz
e="2">Health and quality of life can be preserved and    improved by practicing 
regular physical activity. Physical inactivity is an    undesirable condition an
d represents a risk to health. This document, elaborated    by exercise and spor
ts medicine physicians, is based on scientific concepts    and experience in cli
nical practice, focusing on apparently healthy individuals.    It is not the aim
 of this document to discuss aspects related to the clinical    use of exercise 
in the management of illnesses, or to aspects about activities    of competitive
 level. The purpose of this text is to guide health professionals    in the effi
cient use of physical activity.</font> </p>     ^cY#v6n3a02.htm##
00248000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000300065704002200068002001200090#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#13#9#text#63#<p>&nbsp;</p>     ^cY#v6n3a
02.htm##
00383000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704015600069002001200225#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#14#10#text#63#<p><font face="Verdana, Ar
ial, Helvetica, sans-serif" size="3"><b>EFFECT OF REGULAR    PHYSICAL ACTIVITY O
N MORBIDITY AND MORTALITY</b></font> </p>     ^cY#v6n3a02.htm##
01392000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704116500069002001201234#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#15#11#text#63#<p><font face="Verdana, Ar
ial, Helvetica, sans-serif" size="2">Epidemiological    studies have been demons
trating a close relationship between an active life-style,    lower death probab
ility and better quality of life. The deleterious effects    of sedentary life s
urpass by far the eventual complications resulting from physical    exercise pra
ctice, which, therefore, presents a very interesting risk/benefit    ratio. Cons
idering the high prevalence, allied to the significant risk of sedentary    life
 to the development of chronic-degenerative diseases, augmenting population&#146
;s    physical activity represents a definitely contribution for public health, 
with    a strong impact in the reduction of treatment costs, including hospitali
zation,    one of the reasons for its considerable social benefits. Researches h
ave been    demonstrating that physically fit and/or trained individuals tend to
 present    the majority of the chronic-degenerative illnesses in a minimal inci
dence (<a href="#tab1">table    1</a>), which can be explained by many physiolog
ic and psychological benefits,    achieved through regular physical activity. </
font> </p>     ^cY#v6n3a02.htm##
00263000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704003600069002001200105#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#16#12#text#63#<p><a name="tab1"></a> </p
>     ^cY#v6n3a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#17#13#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00306000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007900069002001200148#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#18#14#text#63#<p align="center"> <img sr
c="/img/revistas/rbme/v6n3/a02t01.gif"> </p>     ^cY#v6n3a02.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704003800069002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#19#15#text#63#<p align="center">&nbsp; <
/p>     ^cY#v6n3a02.htm##
00316000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704008900069002001200158#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#20#16#text#63#<p><font face="Verdana" si
ze="3"><b>PRE-PARTICIPATION EVALUATION</b></font> </p>     ^cY#v6n3a02.htm##
01445000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704121800069002001201287#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#21#17#text#63#<p><font face="Verdana" si
ze="2">The health risks, particularly cardiovascular    risks, consequent to mod
erate-intensity physical exercise are extremely low    and can become even more 
reduced by a criterious pre-participation evaluation    that allows for oriented
 exercise practice. Depending on the evaluated population,    the objectives of 
the physical activity and the availability of facilities and    qualified staff,
 the complexity of the evaluation can vary from the simple application    of que
stionnaires, until sophisticated medical and functional examinations.    Symptom
atic individuals and/or with important risk factors for cardiovascular,    metab
olic, pulmonary, and locomotive illnessesa, that could be aggravated by    physi
cal activity, demand specialized medical evaluation, for objective definition   
 of eventual restrictions and the correct exercise prescription. The PAR-Q (acro
nym    for Physical Activity Readiness Questionnaire) (<a href="#tab2">table 2</
a>)    has been suggested as the minimum standard pre-participation evaluation, 
because    it can identify, when there is a positive answer, the ones who need t
o be submitted    to a previous medical evaluation.</font> </p>     ^cY#v6n3a02.
htm##
00301000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007400069002001200143#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#22#18#text#63#<p><font face="Verdana" si
ze="2"> <a name="tab2"></a></font> </p>     ^cY#v6n3a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#23#19#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00305000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007800069002001200147#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#24#20#text#63#<p align="center"><img src
="/img/revistas/rbme/v6n3/a02t02.gif"> </p>     ^cY#v6n3a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#25#21#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00320000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704009300069002001200162#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#26#22#text#63#<p><font face="Verdana" si
ze="3"><B>PHYSICAL EXERCISE PRESCRIPTION</B> </font>  </p>     ^cY#v6n3a02.htm##
00905000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704067800069002001200747#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#27#23#text#63#<p><font face="Verdana" si
ze="2">There is a strong dose-dependent relationship    between the fitness leve
l and its protective effect, with risk to acquire illness    diminishing as the 
activity level augments. Significant health benefits can    be achieved with rel
atively low intensity activities, common in daily life,    as walking, climbing 
up stairs, riding a bicycle and dancing. Therefore, not    only formal physical 
exercise programs, but also informal activities that develop    fitness, are int
eresting. Both possibilities must be considered, since the combined    effect of
 them facilitates to achieve a certain amount of physical activity.    </font> <
/p>     ^cY#v6n3a02.htm##
00929000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704070200069002001200771#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#28#24#text#63#<p><font face="Verdana" si
ze="2">A regular physical exercise program must include    at least three compon
ents: aerobic, muscular resistance and flexibility, with    emphasis on each one
 depending on the clinical condition and objectives for    each individual. The 
adequate physical activity prescription must include variables    such as: mode,
 duration, intensity, and weekly frequency. Innumerable combinations    of these
 variables can provide positive results. The combination of some activities    m
ust be considered, as the ones in <a href="#tab3">table 3</a>, in order to    pr
ovide a caloric weekly expenditure of at least 2,000 kcal, considered a satisfac
tory    level. </font> </p>     ^cY#v6n3a02.htm##
00263000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704003600069002001200105#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#29#25#text#63#<p><a name="tab3"></a> </p
>     ^cY#v6n3a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#30#26#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00305000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007800069002001200147#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#31#27#text#63#<p align="center"><img src
="/img/revistas/rbme/v6n3/a02t03.gif"> </p>     ^cY#v6n3a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#32#28#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00649000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704042200069002001200491#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#33#29#text#63#<p><font face="Verdana" si
ze="2">Both the beginning and restarting of activities    must be gradual, espec
ially for the elderly individuals. Initially, the duration    is increased up to
 the minimum time accepted. Then, the intensity can be increased.    The activit
y should not induce fatigue in each session of exercise, but it can    be percei
ved as tiring, taking less than one hour to disappear. </font> </p>     ^cY#v6n3
a02.htm##
00816000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704058900069002001200658#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#34#30#text#63#<p><font face="Verdana" si
ze="2">The aerobic part of the exercise should be practiced,    if possible, eve
ry day, with a minimum duration of 30-40 minutes. A practical    and very common
 form for controlling the intensity of aerobic exercise is the    measurement of
 the heart rate. The information collected during a more detailed    functional 
and medical evaluation, obtaining the direct measure of the maximum    oxygen co
nsumption and the identification of anaerobic threshold, contribute    for an in
dividualized prescription concerning the exercise intensity. </font>  </p>     ^
cY#v6n3a02.htm##
01126000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704089900069002001200968#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#35#31#text#63#<p><font face="Verdana" si
ze="2">Exercises for improving muscular function and    flexibility are even mor
e important after 40 years of age. They must be repeated    at least two to thre
e times per week, including the main muscular groups and    joints. Recent data 
suggest that a set of six to eight exercises carried through    during only one 
series with ten to 12 repetitions or, alternatively, two series    with five to 
six repetitions and a small interval between them are enough for    maintenance 
and improvement of muscular and bone mass and demand little time,    what contri
butes to a better adherence to the resistance training. The flexibility    train
ing must involve the main body movements, carried through slowly, until    causi
ng slight discomfort, and, then, being kept by 10-20 seconds, and should    be p
erformed before and/or after the aerobic component. </font> </p>     ^cY#v6n3a02
.htm##
00463000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704023600069002001200305#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#36#32#text#63#<p><font face="Verdana" si
ze="2">There must always be conciliation between the    maximum benefit with a m
inimum risk of injuries or complications, in order to    establish an interestin
g risk/benefit relationship. </font> </p>     ^cY#v6n3a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#37#33#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00333000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704010600069002001200175#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#38#34#text#63#<p><font face="Verdana, Ar
ial, Helvetica, sans-serif" size="3"><b>CONCLUSIONS</b></font>     </p>     ^cY#
v6n3a02.htm##
00300000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007300069002001200142#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#39#35#text#63#<p><font face="Verdana" si
ze="2">We recommend that: </font> </p>     ^cY#v6n3a02.htm##
00585000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704035800069002001200427#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#40#36#text#63#<p><font face="Verdana" si
ze="2">1. Health professionals should combat sedentary    life-style, including 
in their interview specific questions about regular physical    activity, compet
itive or not, making people aware about this subject and encouraging    the incr
ement of physical activity, through informal and formal activities;    </font> <
/p>     ^cY#v6n3a02.htm##
00468000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704024100069002001200310#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#41#37#text#63#<p><font face="Verdana" si
ze="2">2.The government, at all levels, should consider    physical activity as 
a basic public health question, spreading related information    and implementin
g programs for oriented practice; </font> </p>     ^cY#v6n3a02.htm##
00485000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704025800069002001200327#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#42#38#text#63#<p><font face="Verdana" si
ze="2">3.The professional and scientific organizations,    the media, and the so
ciety in general, should contribute to reduce the prevalence    of sedentarism a
nd to provide oriented physical exercise practice. </font> </p>     ^cY#v6n3a02.
htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#43#39#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00299000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704007200069002001200141#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#44#40#text#63#<p><font face="Verdana" si
ze="3"><B>REFERENCES</B> </font> </p>     ^cY#v6n3a02.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704020300071002001200274#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#45#41#text#63#1#<p><font fac
e="Verdana" size="2">1. American College of Sports Medicine. ACSM's    Guideline
s for Exercise Testing and Prescription, 5<SUP>th</SUP> ed. Baltimore:    Willia
ms &amp; Wilkins, 1995.    ^cY#v6n3a02.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#46#42#text#63# </font> </p>     ^cY#v6n3
a02.htm##
00521000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704028000071002001200351#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#47#43#text#63#2#<p><font fac
e="Verdana" size="2">2. Bijnen FCH, Caspersen CJ, Mosterd WL. Physical    inacti
vity as a risk factor for coronary heart disease: a WHO and International    Soc
iety and Federation of Cardiology position statement. Bull World Health Organiza
tion    1994;72:1-4.    ^cY#v6n3a02.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#48#44#text#63# </font> </p>     ^cY#v6n3
a02.htm##
00665000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704042400071002001200495#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#49#45#text#63#3#<p><font fac
e="Verdana" size="2">3. Fletcher GF, Balady G, Blair SN, Blumenthal    J, Casper
sen C, Chaitman B, et al. Statement on exercise: benefits and recommendation    
for physical activity programs for all Americans - A statement for health profes
sionals    by the Committee on Exercise and Cardiac Rehabilitation of the Counci
l on Clinical    Cardiology, American Heart Association. Circulation 1996;94:857
-62.    ^cY#v6n3a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#50#46#text#63# </font>  </p>     ^cY#v6n
3a02.htm##
00414000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704017300071002001200244#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#51#47#text#63#4#<p><font fac
e="Verdana" size="2">4. Paffenbarger Jr RS, Lee I-M. Physical activity    and fi
tness for health and longevity. Res Q Exerc Sport 1996;67(Suppl 3):11-28.    ^cY
#v6n3a02.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002500069002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#52#48#text#63#    </font> </p>     ^cY#v
6n3a02.htm##
00536000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704029500071002001200366#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#53#49#text#63#5#<p><font fac
e="Verdana" size="2">5. Pate RR, Pratt M, Blair SN, Haskell WL, Macera    CA, Bo
uchard C, et al. Physical activity and public health - A recommendation    from 
the Centers for Disease Control and Prevention and the American College    of Sp
orts Medicine. JAMA 1995;273:402-7.    ^cY#v6n3a02.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#54#50#text#63# </font> </p>     ^cY#v6n3
a02.htm##
00421000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704018000071002001200251#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#55#51#text#63#6#<p><font fac
e="Verdana" size="2">6. Thomas S, Reading J, Shephard RJ. Revision    of the Phy
sical Activity Readiness Questionnaire (PAR-Q). Can J Sports Sci 1992;17:338-45.
    ^cY#v6n3a02.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002500069002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#56#52#text#63#    </font> </p>     ^cY#v
6n3a02.htm##
00439000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704019800071002001200269#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#57#53#text#63#7#<p><font fac
e="Verdana" size="2">7. U.S. Department of Health and Human Services.    Physica
l Activity and Health - A report of the Surgeon General, U.S. Government    Prin
ting Office, 1996.    ^cY#v6n3a02.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#58#54#text#63# </font> </p>     ^cY#v6n3
a02.htm##
00406000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704016500071002001200236#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#59#55#text#63#8#<p><font fac
e="Verdana" size="2">8. WHO/FIMS Committee on Physical Activity for    Health. E
xercise for health. Bull World Health Organization 1995;73:135-6.    ^cY#v6n3a02
.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#60#56#text#63# </font>  </p>     ^cY#v6n
3a02.htm##
00471000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066888000200069704023000071002001200301#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#p#61#57#text#63#9#<p><font fac
e="Verdana" size="2">9. Williams PT. Relationship of distance run    per week to
 coronary heart disease risk factors in 8283 male runners - The National    Runn
ers' Health Study. Arch Intern Med 1997;157:191-8.    ^cY#v6n3a02.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002200069002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#62#58#text#63# </font> </p>     ^cY#v6n3
a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#63#59#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#64#60#text#63#<p>&nbsp; </p>     ^cY#v6n
3a02.htm##
00437000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704021000069002001200279#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#65#61#text#63#<p><font face="Verdana" si
ze="2">1. This document was approved by the Board of    Directors of the Brazili
an Society of Sports Medicine in a meeting held in Rio    de Janeiro, RJ, Brazil
, on March 1996.    ^cY#v6n3a02.htm##
00334000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704010700069002001200176#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#66#62#text#63#<br>   2. Originally publi
shed in <I>Revista Brasileira de Medicina do Esporte 1996;    2(4):79-81.    ^cY
#v6n3a02.htm##
00422000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000300066704019500069002001200264#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a02.htm#S#p#67#63#text#63#<br>   </I>3. This documen
t can be reproduced as long as it is clearly identified as    an official positi
on statement of the Brazilian Society of Sports Medicine -    1996. </font> </p>
     ^cY#v6n3a02.htm##
00473000000000241000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670170036000690180060001050630
00200165066001000167062001900177065000900196064000500205865000900210002001200219
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#c#68#1#text#9#1#American C
ollege of Sports Medicine#ACSM's Guidelines for Exercise Testing and Prescriptio
n^len#5#Baltimore#Williams & Wilkins#19950000#1995#20000600#v6n3a02.htm##
00628000000000277000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670100018000690100020000870100
01900107012014900126030003100275710000200306065000900308064000500317031000300322
014000400325865000900329002001200338#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a02.htm#S#c#69#2#text#9#2#^rND^sBijnen^nFCH#^rND^sCaspersen^nCJ#^rND^sMosterd^nW
L.#Physical inactivity as a risk factor for coronary heart disease: a WHO and In
ternational Society and Federation of Cardiology position statement^len#Bull Wor
ld Health Organization#2#19940000#1994#72#1-4#20000600#v6n3a02.htm##
00866000000000337000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670100019000690100016000880100
01600104010002000120010001900140010001800159810000700177012026500184030001200449
06500090046106400050047003100030047501400070047886500090048500200120049403500100
0506801001200516#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#c#70#3#tex
t#9#3#^rND^sFletcher^nGF#^rND^sBalady^nG#^rND^sBlair^nSN#^rND^sBlumenthal^nJ#^rN
D^sCaspersen^nC#^rND^sChaitman^nB#et al.#Statement on exercise: benefits and rec
ommendation for physical activity programs for all Americans - A statement for h
ealth professionals by the Committee on Exercise and Cardiac Rehabilitation of t
he Council on Clinical Cardiology, American Heart Association^len#Circulation#19
960000#1996#94#857-62#20000600#v6n3a02.htm#0009-7322#Circulation##
00554000000000289000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670100026000690100016000950120
05900111030001800170065000900188064000500197031000300202032000400205014000600209
865000900215002001200224035001000236801001800246#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a02.htm#S#c#71#4#text#9#4#^rND^sPaffenbarger Jr^nRS#^rND^sLee^nI-M.#
Physical activity and fitness for health and longevity^len#Res Q Exerc Sport#199
60000#1996#67#^s3#11-28#20000600#v6n3a02.htm#0270-1367#Res Q Exerc Sport##
00733000000000337000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670100015000690100015000840100
01600099010001800115010001700133010001800150810000700168012015500175030000500330
06500090033506400050034403100040034901400060035386500090035900200120036803500100
0380801000500390#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#c#72#5#tex
t#9#5#^rND^sPate^nRR#^rND^sPratt^nM#^rND^sBlair^nSN#^rND^sHaskell^nWL#^rND^sMace
ra^nCA#^rND^sBouchard^nC#et al.#Physical activity and public health - A recommen
dation from the Centers for Disease Control and Prevention and the American Coll
ege of Sports Medicine^len#JAMA#19950000#1995#273#402-7#20000600#v6n3a02.htm#009
8-7484#JAMA##
00534000000000277000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670100016000690100017000850100
02000102012007000122030001700192710000200209065000900211064000500220031000300225
014000700228865000900235002001200244#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a02.htm#S#c#73#6#text#9#6#^rND^sThomas^nS#^rND^sReading^nJ#^rND^sShephard^nRJ.#R
evision of the Physical Activity Readiness Questionnaire (PAR-Q)^len#Can J Sport
s Sci#2#19920000#1992#17#338-45#20000600#v6n3a02.htm##
00479000000000229000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670170046000690180067001150670
00500182062002700187065000900214064000500223865000900228002001200237#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#c#74#7#text#9#7#U.S.^dDepartment of He
alth and Human Services#Physical Activity and Health - A report of the Surgeon G
eneral^len#U.S.#Government Printing Office#19960000#1996#20000600#v6n3a02.htm##
00477000000000253000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670110010000690120067000790300
03100146710000200177065000900179064000500188031000300193014000600196865000900202
002001200211#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#c#75#8#text#9#
8#WHO^dFIMS#Committee on Physical Activity for Health. Exercise for health^len#B
ull World Health Organization#2#19950000#1995#73#135-6#20000600#v6n3a02.htm##
00580000000000265000450000400050000070200460000570500020005170600020005370000030
00557010002000587090005000607080002000651180002000670100019000690120139000880300
01600227065000900243064000500252031000400257014000600261865000900267002001200276
035001000288801001600298#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a02.htm#S#c#
76#9#text#9#9#^rND^sWilliams^nPT#Relationship of distance run per week to corona
ry heart disease risk factors in 8283 male runners - The National Runners' Healt
h Study^len#Arch Intern Med#19970000#1997#157#191-8#20000600#v6n3a02.htm#0003-99
26#Arch Intern Med##
00268000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640910009000660920007000750020012000827030
00400094#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#o#1#1#text#1#20110
314#125745#v6n3a03.htm#164##
00782000000000385000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000400084121000300088049000800091158000300099030002100102
03100020012303200020012506500090012701400090013603500100014512300020015501201170
0157010004100274070006000315117000600375072000300381002001200384#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#h#2#1#text#1#ra#pt#br1.1#1#4.0#TAB#03#RBME
090#nd#Rev Bras Med Esporte#6#3#20000600#^f77^l84#1517-8692#1#Teste de exercício
: terminologia e algumas considerações sobre passado, presente e futuro baseadas
 em evidências^lpt#^rND^1A01^nClaudio Gil Soares de^sAraújo#UGF^iA01^1Departamen
to de Fisiologia da UFF^cRio de Janeiro#other#33#v6n3a03.htm##
00796000000000385000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000400084121000300088049000800091158000300099030002100102
03100020012303200020012506500090012701400090013603500100014512300020015501201310
0157010004100288070006000329117000600389072000300395002001200398#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#f#3#1#text#1#ra#pt#br1.1#1#4.0#TAB#03#RBME
090#nd#Rev Bras Med Esporte#6#3#20000600#^f77^l84#1517-8692#1#<b>Teste de exercí
cio</b>: <b>terminologia e algumas considerações sobre passado, presente e futur
o baseadas em evidências</b>^lpt#^rND^1A01^nClaudio Gil Soares de^sAraújo#UGF^iA
01^1Departamento de Fisiologia da UFF^cRio de Janeiro#other#33#v6n3a03.htm##
00913000000000409000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640640013000660710003000790400003000820010
00600085042000200091120000400093038000400097121000300101049000800104158000300112
03000240011503100020013903200020014106500090014301400090015203500100016112300020
01710120117001730100041002900700062003311170006003930720003003990020012004020080
08900414#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#l#4#1#text#1#^mjun
.^a2000#ra#pt#br1.1#1#4.0#tab#03#RBME090#nd#Rev. bras. med. esporte#6#3#20000600
#^f77^l84#1517-8692#1#Teste de exercício: terminologia e algumas considerações s
obre passado, presente e futuro baseadas em evidências^lpt#^rND^1A01^nClaudio Gi
l Soares de^sAraújo#^iA01^1UGF^2Departamento de Fisiologia da UFF^cRio de Janeir
o#other#33#v6n3a03.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_artt
ext&pid=S1517-86922000000300003##
00329000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704010300068002001200171#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#5#1#text#127#<p align="right"><font face
="Verdana" size="2"><b>ARTIGO DE OPINI&Atilde;O</b>    </font> </p>     ^cY#v6n3
a03.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704002300068002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#6#2#text#127#<p>&nbsp; </p>     ^cY#v6n3
a03.htm##
00464000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704023800068002001200306#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#7#3#text#127#<p><font face="Verdana" siz
e="4"><b><a name="topo"></a>Teste de exerc&iacute;cio:    terminologia e algumas
 considera&ccedil;&otilde;es sobre passado, presente e    futuro baseadas em evi
d&ecirc;ncias<SUP>*</SUP> </b></font> </p>     ^cY#v6n3a03.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704002300068002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#8#4#text#127#<p>&nbsp; </p>     ^cY#v6n3
a03.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704002300068002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#9#5#text#127#<p>&nbsp; </p>     ^cY#v6n3
a03.htm##
00325000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000400065704009800069002001200167#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#10#6#text#127#<p><font face="Verdana" si
ze="2"><b>Claudio Gil Soares de Ara&uacute;jo</b> </font>  </p>     ^cY#v6n3a03.
htm##
00566000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000400065704033900069002001200408#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#11#7#text#127#<p><font face="Verdana" si
ze="2">Professor do Programa de P&oacute;s-Gradua&ccedil;&atilde;o    em Educa&c
cedil;&atilde;o F&iacute;sica da UGF; Professor Adjunto do Departamento    de Fi
siologia da UFF; Diretor M&eacute;dico da Cl&iacute;nica de Medicina do    Exerc
&iacute;cio &#91;CLINIMEX&#93; - Rio de Janeiro, RJM</font> </p>     ^cY#v6n3a03
.htm##
00343000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000400065704011600069002001200185#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#12#8#text#127#<p><font face="Verdana" si
ze="2"><a href="#end">Endere&ccedil;o para correspond&ecirc;ncia</a></font>  </p
>     ^cY#v6n3a03.htm##
00271000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000400065704004400069002001200113#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#13#9#text#127#<p>&nbsp; </p> <hr size="1
"noshade>     ^cY#v6n3a03.htm##
00424000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704019600070002001200266#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#14#10#text#127#<p><font face="Verdana" s
ize="2"><B>Palavras-chave:</B> Ergometria. Teste ergom&eacute;trico.    Teste de
 esfor&ccedil;o cardiopulmonar. Ergoespirometria. </font></p> <hr size="1"noshad
e>     ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#15#11#text#127#<p>&nbsp;</p>     ^cY#v6n
3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#16#12#text#127#<p>&nbsp;</p>     ^cY#v6n
3a03.htm##
00673000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704044500070002001200515#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#17#13#text#127#<p><font face="Verdana" s
ize="2">O teste ergom&eacute;trico, tal como &eacute;    mais conhecido em nosso
 meio, constitui-se em um dos exames complementares mais    solicitados em Medic
ina. Estat&iacute;sticas americanas mostram que, em 8,2%    das consultas cardio
l&oacute;gicas e em 0,55% do total de consultas m&eacute;dicas    em geral, &eac
ute; solicitado ao paciente que se submeta a esse procedimento<SUP>1</SUP>.    <
/font> </p>     ^cY#v6n3a03.htm##
01888000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704166000070002001201730#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#18#14#text#127#<p><font face="Verdana" s
ize="2">Estimativas emp&iacute;ricas de fornecedores    de equipamentos e esta&c
cedil;&otilde;es destinadas &agrave; realiza&ccedil;&atilde;o    desse exame com
plementar sugerem que h&aacute; mais de dois mil locais capazes    de realizar t
este ergom&eacute;trico em nosso pa&iacute;s. Considerando esses    n&uacute;mer
os como v&aacute;lidos e tendo em vista o conjunto dos brasileiros    com mais d
e 35 anos de idade e admitindo uma capacidade operacional m&eacute;dia    de mil
 exames/ano por unidade (certamente subestimada para as maiores institui&ccedil;
&otilde;es),    temos que algo pr&oacute;ximo da metade da popula&ccedil;&atilde
;o pode ser    atendida e submetida a testes ergom&eacute;tricos no per&iacute;o
do de dez anos.    O Departamento de Ergometria e Reabilita&ccedil;&atilde;o Car
d&iacute;aca da    Sociedade Brasileira de Cardiologia j&aacute; conta com bem m
ais de mil membros,    constituindo-se em um departamento com um n&uacute;mero d
e colegas superior    ao de algumas especialidades m&eacute;dicas. Sabendo-se qu
e muito poucos atuam    em reabilita&ccedil;&atilde;o card&iacute;aca no Brasil,
 pode-se seguramente    estimar que a quase totalidade desses membros trabalha c
om ergometria. Adicionando-se    a esses cardiologistas aqueles m&eacute;dicos q
ue possuem forma&ccedil;&otilde;es    e/ou treinamento em &aacute;reas afins, co
mo Medicina do Exerc&iacute;cio e    do Esporte, Pneumologia, Fisiatria e Cl&iac
ute;nica M&eacute;dica, podemos supor    que um n&uacute;mero ainda maior de m&e
acute;dicos trabalha ou pode trabalhar    na supervis&atilde;o de testes ergom&e
acute;tricos. </font> </p>     ^cY#v6n3a03.htm##
01985000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704175700070002001201827#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#19#15#text#127#<p><font face="Verdana" s
ize="2">Sua indica&ccedil;&atilde;o mais freq&uuml;ente    em Cardiologia &eacut
e; na busca de informa&ccedil;&atilde;o diagn&oacute;stica    em pacientes adult
os sem altera&ccedil;&otilde;es significativas do eletrocardiograma    de repous
o e que possuam uma probabilidade intermedi&aacute;ria de doen&ccedil;a    coron
ariana significativa. Pacientes que procuram um m&eacute;dico com queixa    de d
or tor&aacute;cica possuem uma <I>chance</I> 20 vezes maior de ser solicitados  
  a realizar esse exame<SUP>1</SUP>. Dados n&atilde;o-publicados e baseados em  
  levantamentos internos de grandes laborat&oacute;rios prestadores de servi&cce
dil;os    nessa &aacute;rea sugerem que a sua maior utiliza&ccedil;&atilde;o em 
nosso    meio, representada pela grande maioria dos exames, &eacute; na avalia&c
cedil;&atilde;o    de indiv&iacute;duos assintom&aacute;ticos. Com isso, temos u
m percentual aproximado    de apenas 5% dos testes ergom&eacute;tricos considera
dos como anormais, do ponto    de vista eletrocardiogr&aacute;fico. N&atilde;o o
bstante, o cardiologista depara    com v&aacute;rias terminologias na hora de so
licitar o exame. As express&otilde;es    "teste ergom&eacute;trico", "teste de e
sfor&ccedil;o", "teste de estresse",    "ergometria", "prova de esfor&ccedil;o",
 "eletrocardiograma de esfor&ccedil;o"    e muitas outras t&ecirc;m sido emprega
das para identificar esse exame. Fica    claro assim que existem muitos termos p
ara descrever um &uacute;nico procedimento.    Considerando a experi&ecirc;ncia 
com o tema<SUP>2-12</SUP> e a partir de outros    dados levantados na literatura
, s&atilde;o tecidas algumas considera&ccedil;&otilde;es    atuais e pertinentes
 baseadas em evid&ecirc;ncias. </font> </p>     ^cY#v6n3a03.htm##
00980000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704075200070002001200822#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#20#16#text#127#<p><font face="Verdana" s
ize="2">Os objetivos deste artigo, a partir da evolu&ccedil;&atilde;o    do conh
ecimento na &aacute;rea, s&atilde;o: a) discutir aspectos terminol&oacute;gicos 
   da &aacute;rea; b) refletir sobre algumas quest&otilde;es metodol&oacute;gica
s    relacionadas ao procedimento em nosso meio; e c) tentar projetar as perspec
tivas    futuras deste m&eacute;todo de exame complementar. Este artigo de opini
&atilde;o    n&atilde;o pretende esgotar o assunto, mas apenas colocar o procedi
mento dentro    de sua devida perspectiva. Diversas fontes nacionais e estrangei
ras est&atilde;o    dispon&iacute;veis para um maior aprofundamento das quest&ot
ilde;es t&eacute;cnicas    do tema<SUP>2,3,6,8,10,11,13-24</SUP>. </font> </p>  
   ^cY#v6n3a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#21#17#text#127#<p>&nbsp; </p>     ^cY#v6
n3a03.htm##
00330000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704010200070002001200172#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#22#18#text#127#<p><font face="Verdana" s
ize="3"><B>QUEST&Otilde;ES TERMINOL&Oacute;GICAS</B>    </font> </p>     ^cY#v6n
3a03.htm##
00539000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704031100070002001200381#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#23#19#text#127#<p><font face="Verdana" s
ize="2">H&aacute; uma s&eacute;rie de aspectos terminol&oacute;gicos    relacion
ados ao t&oacute;pico de teste ergom&eacute;trico, que ser&atilde;o    aqui revi
sados e comentados de forma cr&iacute;tic<font face="Verdana, Arial, Helvetica, 
sans-serif">a</font>.    </font> </p>     ^cY#v6n3a03.htm##
02395000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704216700070002001202237#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#24#20#text#127#<p><font face="Verdana" s
ize="2">Podemos come&ccedil;ar pela express&atilde;o    "ergometria", que tal co
mo pode ser deduzido pela simples divis&atilde;o da    palavra - do grego <I>&ea
cute;rgon </I>e <I>m&eacute;tron </I>- significando    medida de trabalho, no ca
so espec&iacute;fico, trabalho f&iacute;sico. Ergometria    n&atilde;o deve ser 
confundida com teste de esfor&ccedil;o, nem todo teste de    esfor&ccedil;o &eac
ute; uma ergometria. Por exemplo, o teste de Cooper - dist&acirc;ncia    m&aacut
e;xima percorrida em 12 minutos - representa um verdadeiro teste de esfor&ccedil
;o    m&aacute;ximo que independe de ergometria. Na realidade, praticamente todo
s    os testes de campo - inclusive o da caminhada de seis minutos - n&atilde;o 
se    prop&otilde;em a medir trabalho nem requerem erg&ocirc;metros (instrumento
s    capazes de realizarem ergometria). No sentido inverso, a mesma quest&atilde
;o    surge, j&aacute; que nem toda ergometria corresponde a um teste de esfor&c
cedil;o    no sentido objetivo e cl&iacute;nico dessa express&atilde;o. Por exem
plo, pode-se    realizar uma medida de gasto energ&eacute;tico de um indiv&iacut
e;duo durante    uma determinada atividade f&iacute;sica ou laborativa, sem que 
se almeje realizar    um verdadeiro teste de esfor&ccedil;o. Desse modo, &eacute
; certamente pitoresco    e denota pouca intimidade com a tem&aacute;tica o cole
ga m&eacute;dico que solicita    uma ergometria para um paciente que apresenta d
or tor&aacute;cica de etiologia    a esclarecer. &Eacute; particularmente intere
ssante notar que a Cardiologia    brasileira adotou o termo "ergometria" como si
n&ocirc;nimo de teste de esfor&ccedil;o    nas denomina&ccedil;&otilde;es das se
ss&otilde;es cient&iacute;ficas dos seus    eventos e na denomina&ccedil;&atilde
;o do seu departamento com maior quantidade    de membros - Departamento de Ergo
metria e Reabilita&ccedil;&atilde;o Card&iacute;aca.    Em adendo, v&aacute;rios
 setores, servi&ccedil;os e unidades em hospitais e    cl&iacute;nicas incluem o
 termo "ergometria" em suas denomina&ccedil;&otilde;es,    quando talvez pretend
am se referir a teste de esfor&ccedil;o. </font> </p>     ^cY#v6n3a03.htm##
00969000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704074100070002001200811#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#25#21#text#127#<p><font face="Verdana" s
ize="2">Se a express&atilde;o ergometria para representar    o procedimento &eac
ute; critic&aacute;vel, ainda mais amb&iacute;gua e inapropriada    &eacute; a e
xpress&atilde;o teste ergom&eacute;trico. Novamente, atrav&eacute;s    da decomp
osi&ccedil;&atilde;o das duas palavras, temos algo como medida de trabalho    em
 teste ou durante teste ou, quem sabe ainda, teste de medida de trabalho.    Mui
to embora essa express&atilde;o seja utilizada nas p&aacute;ginas relativas    &
agrave; Cardiologia das tabelas da Associa&ccedil;&atilde;o M&eacute;dica Brasil
eira,    &eacute; f&aacute;cil concluir que esse termo ou express&atilde;o n&ati
lde;o    apresenta l&oacute;gica ou consist&ecirc;ncia. </font></p>     ^cY#v6n3
a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#26#22#text#127#<p>&nbsp;</p>     ^cY#v6n
3a03.htm##
00356000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704012800070002001200198#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#27#23#text#127#<p align="center"><font f
ace="Verdana" size="2"><a href="/img/revistas/rbme/v6n3/a03t01.gif">Tabela    1<
/a></font></p>     ^cY#v6n3a03.htm##
00264000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704003600070002001200106#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#28#24#text#127#<p align="left">&nbsp; </
p>     ^cY#v6n3a03.htm##
03210000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704298200070002001203052#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#29#25#text#127#<p><font face="Verdana" s
ize="2">Mais recentemente, a express&atilde;o ergoespirometria    tem aparecido 
em nossas programa&ccedil;&otilde;es e publica&ccedil;&otilde;es    cient&iacute
;ficas<SUP>8,10,11,13,17-19</SUP>. Esse termo n&atilde;o &eacute;    t&atilde;o 
novo, como talvez possa parecer para alguns colegas rec&eacute;m-chegados    &ag
rave; &aacute;rea. Em uma interessante revis&atilde;o hist&oacute;rica dos    us
os da ergoespirometria<SUP>25</SUP>, o Prof. Wildor Hollman, de Col&ocirc;nia,  
  na Alemanha, observou que o termo foi introduzido pela primeira vez em 1929,  
  muito embora a calorimetria indireta com a medida do consumo de oxig&ecirc;nio
    durante o exerc&iacute;cio j&aacute; fosse feita desde a &eacute;poca de Lav
oisier.    Em nosso meio, o Prof. Dr. Maur&iacute;cio Leal Rocha foi, certamente
, um dos    que mais enfaticamente usaram essa express&atilde;o, muito comum nas
 escolas    alem&atilde; e escandinava, com as quais ele mantinha estreitas liga
&ccedil;&otilde;es.    A decomposi&ccedil;&atilde;o da palavra inclui, al&eacute
;m da medida de trabalho,    a quest&atilde;o da respira&ccedil;&atilde;o ou dos
 volumes pulmonares. Todos    os seus seguidores e colaboradores a adotaram e o 
termo foi bastante prevalente    no nosso meio durante muitos anos. Por causa da
 maior &ecirc;nfase desse professor    na avalia&ccedil;&atilde;o de atletas, es
se procedimento foi quase que automaticamente    associado &agrave; avalia&ccedi
l;&atilde;o funcional de atletas, raramente sendo    empregado dentro de um cont
exto mais cl&iacute;nico. Talvez o Prof. Norman Jones,    da McMaster University
, no Canad&aacute;, tenha sido um dos primeiros a cunhar    e divulgar as expres
s&otilde;es teste de esfor&ccedil;o cl&iacute;nico e Medicina    do Exerc&iacute
;cio<SUP>15</SUP>. A express&atilde;o teste de esfor&ccedil;o    cardiopulmonar 
tornou-se mais conhecida com o livro de Weber e Janicki<SUP>23</SUP>,    corresp
ondendo &agrave; inclus&atilde;o de medidas ventilat&oacute;rias durante    o te
ste de esfor&ccedil;o convencional de laborat&oacute;rio. Mais recentemente,    
observamos duas express&otilde;es semelhantes, apresentadas como: teste de esfor
&ccedil;o    com an&aacute;lise de gases expirados ou ainda teste de esfor&ccedi
l;o utilizando    an&aacute;lise de gases ventilat&oacute;rios (tradu&ccedil;&at
ilde;o literal    de <I>exercise testing using ventilatory gas analysis</I>). Mu
ito embora essa    &uacute;ltima express&atilde;o pare&ccedil;a algo estranha, n
a realidade ela    &eacute; uma forma abreviada de an&aacute;lise das trocas gas
osas ventilat&oacute;rias    e tender&aacute; a se firmar na literatura especial
izada, pelo simples fato    de ter sido utilizada na denomina&ccedil;&atilde;o d
e um cap&iacute;tulo do    importante e recente <I>Guidelines for Exercise Testi
ng</I>, publicado conjuntamente    pela <I>American Heart Association </I>e pelo
 <I>American College of Cardiology</I><SUP>26</SUP>.    </font> </p>     ^cY#v6n
3a03.htm##
03987000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704375900070002001203829#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#30#26#text#127#<p><font face="Verdana" s
ize="2">A <a href="/img/revistas/rbme/v6n3/a03t02.gif">tabela    2</a> apresenta
 os resultados de diferentes estrat&eacute;gias de busca de refer&ecirc;ncias   
 no MEDLINE ao longo dos anos. O MEDLINE consiste em um banco de dados com pouco
    mais de dez milh&otilde;es de refer&ecirc;ncias cient&iacute;ficas preparado
    pela <I>National Library of Medicine </I>dos Estados Unidos, incluindo as pr
incipais    revistas cient&iacute;ficas do mundo, priorizando aquelas publicadas
 no idioma    ingl&ecirc;s, mas sem se restringir a esse idioma. Por exemplo, a 
revista cient&iacute;fica    oficial da Sociedade Brasileira de Cardiologia - "A
rquivos Brasileiros de Cardiologia"    - est&aacute; indexada nesse sistema. Com
 o passar dos anos, tem sido cada vez    maior o n&uacute;mero de revistas index
adas. Para uma an&aacute;lise primariamente    quantitativa, isso poderia acarre
tar algum vi&eacute;s, caso alguma &aacute;rea    ou especialidade passasse a se
r mais representada. Com o intuito de validar    a abordagem metodol&oacute;gica
 empregada, analisamos termos relacionados ao    exame complementar em tela, ass
im como tamb&eacute;m outras quatro estrat&eacute;gias    de busca dirigidas a t
ermos ou express&otilde;es que, propositadamente, deveriam    possuir comportame
ntos distintos no decorrer dos diferentes per&iacute;odos    de busca. Para todo
s os efeitos pr&aacute;ticos, a categoria sem limite de tempo    inclui todo o b
anco de dados do MEDLINE e corresponde a aproximadamente 20 anos.    Para reflet
ir as cita&ccedil;&otilde;es m&eacute;dias em Cardiologia, escolhemos    emprega
r a express&atilde;o <I>acute myocardial infarction</I>, que, especulamos,    n&
atilde;o teria sofrido uma grande varia&ccedil;&atilde;o de cita&ccedil;&otilde;
es    e/ou refer&ecirc;ncias ao longo dos anos. Para verificar se a escolha dos 
diferentes    intervalos de tempo era apropriada, utilizamos tr&ecirc;s outras e
xpress&otilde;es    ou combina&ccedil;&otilde;es de termos usando operadores boo
leanos, sendo uma    delas uma doen&ccedil;a mais comum nos &uacute;ltimos 15 an
os - SIDA -, uma    outra que relacionava apenas nos &uacute;ltimos 10 anos um m
icroorganismo a    uma doen&ccedil;a comum - <I>Helicobacter pylori</I> e &uacut
e;lcera - e, finalmente,    um procedimento relativamente novo em Cardiologia in
tervencionista, que &eacute;    a utiliza&ccedil;&atilde;o da angioplastia coron
&aacute;ria com coloca&ccedil;&atilde;o    de <I>stent </I>na vig&ecirc;ncia de 
infarto agudo do mioc&aacute;rdio. Considerando    que a inclus&atilde;o de nova
s refer&ecirc;ncias &eacute; um procedimento cont&iacute;nuo    no MEDLINE, tive
mos ainda o cuidado de realizar toda a nossa estrat&eacute;gia    de busca de um
a &uacute;nica vez, no decorrer de algumas poucas horas, minimizando    assim a 
<I>chance</I> de modifica&ccedil;&otilde;es expressivas na base de dados    que 
pudessem influenciar ou distorcer os nossos resultados comparativos. Uma    an&a
acute;lise cuidadosa dos resultados obtidos em fun&ccedil;&atilde;o do per&iacut
e;odo    de tempo nas estrat&eacute;gias de busca para essas &uacute;ltimas quat
ro express&otilde;es    confirma nossas expectativas e valida, de certo modo, a 
abordagem empregada    para a an&aacute;lise da literatura dispon&iacute;vel (p 
&lt 0,05). Finalmente,    foram ainda realizadas an&aacute;lises detalhadas e al
eat&oacute;rias do resultado    das v&aacute;rias estrat&eacute;gias de busca, v
isando evitar que "lixo", isto    &eacute;, artigos n&atilde;o pertinentes, foss
em inclu&iacute;dos. Utilizou-se    um n&iacute;vel inferior a 5% de refer&ecirc
;ncias n&atilde;o-pertinentes como    crit&eacute;rio de aceitabilidade da estra
t&eacute;gia de busca proposta. </font>  </p>     ^cY#v6n3a03.htm##
01617000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704138900070002001201459#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#31#27#text#127#<p><font face="Verdana" s
ize="2">Na pr&oacute;pria literatura em l&iacute;ngua    inglesa existem v&aacut
e;rios termos correlatos, por&eacute;m distintos, para    descrever esse procedi
mento, tais como <I>exercise testing </I>e <I>stress testing</I>.    Uma tentati
va de busca de refer&ecirc;ncias no MEDLINE mostra que as express&otilde;es    i
nglesas equivalentes, <I>exercise testing </I>(&agrave;s vezes &eacute; utilizad
o    <I>stress testing</I>, como o Prof. Ellestad preferia, ao inv&eacute;s de <
I>exercise    testing</I>, mas isso induz a problemas de localiza&ccedil;&atilde
;o, j&aacute;    que muitos procedimentos associados &agrave; cintigrafia e outr
os com estresse    farmacol&oacute;gico sem exerc&iacute;cio t&ecirc;m adotado r
ecentemente essa    express&atilde;o), <I>cardiopulmonary exercise testing</I>, 
<I>ergospirometry</I>    e <I>ergometry</I> produzem resultados muito diferentes
 e que se modificam ao    longo dos anos (<a href="/img/revistas/rbme/v6n3/a03t0
2.gif">Tabelas 2</a> e    <a href="#tab03">3</a>). Parece claro que essa quest&a
tilde;o varia bastante    entre a Europa e a Am&eacute;rica do Norte e dentre di
versos autores do mesmo    continente, como fica claro dos t&iacute;tulos dos li
vros dos Profs. Victor    Froelicher<SUP>14</SUP>, Norman Jones<SUP>15</SUP>, Jo
nathan Myers<SUP>16</SUP>    e Karlman Wasserman<SUP>22</SUP>. </font> </p>     
^cY#v6n3a03.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704003700070002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#32#28#text#127#<p><a name="tab03"></a> <
/p>     ^cY#v6n3a03.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704003700070002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#33#29#text#127#<p align="center">&nbsp;<
/p>     ^cY#v6n3a03.htm##
00306000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704007800070002001200148#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#34#30#text#127#<p align="center"><img sr
c="/img/revistas/rbme/v6n3/a03t03.gif"> </p>     ^cY#v6n3a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#35#31#text#127#<p>&nbsp; </p>     ^cY#v6
n3a03.htm##
01216000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704098800070002001201058#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#36#32#text#127#<p><font face="Verdana" s
ize="2">Os dados da <a href="/img/revistas/rbme/v6n3/a03t02.gif">tabela    2</a>
 permitem algumas considera&ccedil;&otilde;es. A express&atilde;o "teste    ergo
m&eacute;trico" &eacute; cerca de 30 vezes menos freq&uuml;entemente empregada  
  do que teste de esfor&ccedil;o e utilizada primariamente em publica&ccedil;&ot
ilde;es    que n&atilde;o s&atilde;o originalmente escritas em ingl&ecirc;s, inc
luindo    as brasileiras. J&aacute; "teste de estresse" fica em patamares interm
edi&aacute;rios.    Por outro lado, a "ergoespirometria" ou "espiroergometria" &
eacute; cerca de    dez vezes menos comum do que aquelas express&otilde;es que a
ssociam teste de    esfor&ccedil;o com medidas ventilat&oacute;rias e/ou cardiop
ulmonares. Interessantemente,    a soma dos resultados do teste de esfor&ccedil;
o e de sua vers&atilde;o com    an&aacute;lise de gases expirados fornece mais r
efer&ecirc;ncias do que infarto    agudo do mioc&aacute;rdio. </font> </p>     ^
cY#v6n3a03.htm##
02193000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704196500070002001202035#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#37#33#text#127#<p><font face="Verdana" s
ize="2">A <a href="#tab03">tabela 3</a>, ao apresentar    o n&uacute;mero de ref
er&ecirc;ncias anuais m&eacute;dias para cada estrat&eacute;gia    de busca, per
mite uma compara&ccedil;&atilde;o evolutiva, ao longo dos anos,    do uso das di
ferentes express&otilde;es. Ao longo do tempo, n&atilde;o h&aacute;    varia&cce
dil;&atilde;o importante no n&uacute;mero de cita&ccedil;&otilde;es    obtidas p
ara "teste de esfor&ccedil;o" (p = 0,21) ou para "ergoespirometria"    (p = 0,97
), enquanto existe uma tend&ecirc;ncia n&atilde;o-significativa de    cita&ccedi
l;&otilde;es menos freq&uuml;entes nos &uacute;ltimos anos para teste    ergom&e
acute;trico (p = 0,08). Como seria de esperar, fruto da conota&ccedil;&atilde;o 
   mais atual da express&atilde;o "teste de estresse", observamos uma n&iacute;t
ida    e significativa tend&ecirc;ncia para maior n&uacute;mero de cita&ccedil;&
otilde;es    recentes (p &lt 0,001). Vale destacar que o teste de esfor&ccedil;o
 cardiopulmonar    e suas sinon&iacute;mias, incluindo os termos ventilat&oacute
;rio e/ou troca    gasosa, tem surgido cada vez mais freq&uuml;entemente nos &ua
cute;ltimos anos    (p = 0,01), crescendo em mais de 50%, passando de um n&uacut
e;mero m&eacute;dio    de 143 para um patamar est&aacute;vel de cerca de 220 cit
a&ccedil;&otilde;es    anuais nos &uacute;ltimos cinco anos. Interessantemente, 
o termo "exerc&iacute;cio"    aparece em cerca de 1% das refer&ecirc;ncias do ba
nco de dados do MEDLINE, com    uma tend&ecirc;ncia de crescimento constante de 
aproximadamente 1% ao ano nos    &uacute;ltimos anos. Isso &eacute; ainda confir
mado por uma publica&ccedil;&atilde;o    recente da pr&oacute;pria <I>National L
ibrary of Medicine, </I>na qual s&atilde;o    listados mais de 1.500 artigos rec
entes relacionados apenas &agrave; atividade    f&iacute;sica e sa&uacute;de car
diovascular, em um per&iacute;odo de pouco mais    de cinco anos<SUP>27</SUP>. <
/font> </p>     ^cY#v6n3a03.htm##
02319000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704209100070002001202161#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#38#34#text#127#<p><font face="Verdana" s
ize="2">Na realidade, a discuss&atilde;o terminol&oacute;gica,    tal como estam
os desenvolvendo, assume que teste de esfor&ccedil;o &eacute;    a tradu&ccedil;
&atilde;o mais apropriada para <I>exercise testing</I>; contudo,    isso pode se
r uma premissa falsa. O cl&aacute;ssico <I>Webster's Dictionary</I>,    em uma d
e suas edi&ccedil;&otilde;es originais<SUP>28</SUP>, n&atilde;o relaciona    dir
etamente <I>effort </I>e <I>exercise</I>. Uma rela&ccedil;&atilde;o indireta    
entre os dois termos pode ser buscada atrav&eacute;s do termo <I>exertion</I>,  
  que ali&aacute;s &eacute; um dos originais cabe&ccedil;alhos de t&oacute;picos
    m&eacute;dicos para busca de refer&ecirc;ncias nos sistemas da <I>National L
ibrary    of Medicine</I>. O uso das express&otilde;es <I>effort</I> ou ainda <I
>effort    test* </I>fornece resultados de busca bastante decepcionantes, a maio
r parte    desses n&atilde;o relacionados &agrave; atividade f&iacute;sica ou ao
 exerc&iacute;cio    propriamente ditos, indicando que essa express&atilde;o em 
ingl&ecirc;s n&atilde;o    possui a conota&ccedil;&atilde;o eventualmente adotad
a em nosso idioma. &Eacute;    poss&iacute;vel que o uso do termo esfor&ccedil;o
 nesse contexto em nosso meio    tenha tido alguma influ&ecirc;ncia da l&iacute;
ngua francesa, tal como aconteceu    em alguns lugares e institui&ccedil;&otilde
;es, com a quest&atilde;o dos tapetes    rolantes (<I>tapis roulant</I>) ao inv&
eacute;s de esteiras rolantes, que &eacute;,    hoje em dia, a express&atilde;o 
certamente mais comum. Considerando o uso corriqueiro    e consagrado, parece co
nveniente aceitarmos exerc&iacute;cio e esfor&ccedil;o    como sin&ocirc;nimos p
ara a quest&atilde;o da caracteriza&ccedil;&atilde;o desse    exame complementar
, ainda que exerc&iacute;cio pare&ccedil;a ser o termo mais    apropriado, j&aac
ute; que muitas vezes usamos na linguagem corrente a express&atilde;o    esfor&c
cedil;o ou o verbo esfor&ccedil;ar-se com outros significados que n&atilde;o    
somente o de exerc&iacute;cio f&iacute;sico. </font> </p>     ^cY#v6n3a03.htm##
01858000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704163000070002001201700#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#39#35#text#127#<p><font face="Verdana" s
ize="2">Dessa forma, baseado na busca de refer&ecirc;ncias    no MEDLINE, parece
 claro que a express&atilde;o mais freq&uuml;ente na literatura    m&eacute;dica
 para esse exame complementar &eacute; teste de esfor&ccedil;o    ou teste de es
for&ccedil;o cardiopulmonar, quando associado &agrave;s medidas    de gases expi
rados, em detrimento das express&otilde;es ergometria, teste ergom&eacute;trico 
   ou ainda ergoespirometria. Contudo, tendo em vista a presente discuss&atilde;
o,    propomos, consoante com a lista de procedimentos m&eacute;dicos da Associa
&ccedil;&atilde;o    M&eacute;dica Brasileira (parte de Tisiologia/Pneumologia),
 que os procedimentos    sejam doravante denominados de: teste de exerc&iacute;c
io e teste cardiopulmonar    de exerc&iacute;cio, este &uacute;ltimo quando impl
icar medida e an&aacute;lise    de gases expirados (<a href="#tab03">tabela 3</a
>). As denomina&ccedil;&otilde;es    de teste de esfor&ccedil;o e de teste cardi
opulmonar de esfor&ccedil;o, devido    ao seu j&aacute; tradicional uso em nosso
 meio, seriam aceit&aacute;veis durante    um certo per&iacute;odo de transi&cce
dil;&atilde;o. Recomenda-se ainda a inclus&atilde;o    dos termos subm&aacute;xi
mo ou m&aacute;ximo para melhor caracterizar a natureza    do procedimento que s
e pretende realizar. Retornando assim ao caso cl&iacute;nico    hipot&eacute;tic
o do in&iacute;cio do artigo, temos que o colega dever&aacute;    solicitar um t
este cardiopulmonar de exerc&iacute;cio m&aacute;ximo ou, na impossibilidade    
da medida de gases, um teste de exerc&iacute;cio m&aacute;ximo. </font> </p>    
 ^cY#v6n3a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#40#36#text#127#<p>&nbsp; </p>     ^cY#v6
n3a03.htm##
00327000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704009900070002001200169#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#41#37#text#127#<p><font face="Verdana" s
ize="3"><B>QUEST&Otilde;ES METODOL&Oacute;GICAS</B> </font>  </p>     ^cY#v6n3a0
3.htm##
01247000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704101900070002001201089#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#42#38#text#127#<p><font face="Verdana" s
ize="2">Definido o nome do exame complementar, talvez    o colega precise ainda 
refletir sobre a escolha do erg&ocirc;metro. &Eacute;    poss&iacute;vel que o c
olega leitor esteja pensando: como assim? N&atilde;o    est&aacute; mais do que 
claro atualmente que a esteira rolante &eacute; o erg&ocirc;metro    de escolha,
 resguardando-se os demais erg&ocirc;metros para as situa&ccedil;&otilde;es    e
xcepcionais ou, at&eacute; melhor, substituindo o teste de exerc&iacute;cio    p
elo ecocardiograma de estresse? Sem d&uacute;vida alguma, na pr&aacute;tica,    
somente esteiras rolantes t&ecirc;m sido utilizadas na quase totalidade dos    l
aborat&oacute;rios e cl&iacute;nicas brasileiras que realizam teste de exerc&iac
ute;cio    com finalidade de diagn&oacute;stico cl&iacute;nico. Existe ainda uma
 ampla    prefer&ecirc;ncia pelo protocolo de Bruce. Esta parte deste artigo de 
ponto    de vista pretende rever agora e de forma critica algumas dessas quest&o
tilde;es.    </font> </p>     ^cY#v6n3a03.htm##
01527000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704129900070002001201369#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#43#39#text#127#<p><font face="Verdana" s
ize="2">O cicloerg&ocirc;metro (evitar denominar de bicicleta,    j&aacute; que 
nenhum deles possui duas rodas ou ciclos) foi introduzido no Brasil    no in&iac
ute;cio dos anos 60<SUP>18</SUP>, tendo o uso da esteira rolante come&ccedil;ado
    muito depois. Os argumentos pr&oacute;-esteira passam obrigatoriamente pela 
   propalada falta de pr&aacute;tica de ciclismo pela popula&ccedil;&atilde;o br
asileira    t&iacute;pica, atribuindo-se um sentido mais natural ao andar. Sem o
bviamente    questionar que &eacute; mais f&aacute;cil e natural caminhar do que
 pedalar,    a quest&atilde;o precisa ser, todavia, analisada dentro de uma &oac
ute;tica    mais abrangente. Em primeiro lugar, as dificuldades de pedalar s&ati
lde;o substancialmente    reduzidas quando se empregam pedaleiras, que praticame
nte prendem os p&eacute;s    no pedal, facilitando sobremaneira a mec&acirc;nica
 do pedalar, at&eacute; mesmo    para aqueles que nunca o fizeram ao longo da vi
da. Em rela&ccedil;&atilde;o    &agrave; esteira rolante, h&aacute; uma s&eacute
;rie de problemas de ordem f&iacute;sica,    operacional e pr&aacute;tica, que f
azem com que o exerc&iacute;cio feito na    esteira n&atilde;o seja t&atilde;o n
atural como pode parecer &agrave; primeira    vista. </font> </p>     ^cY#v6n3a0
3.htm##
03600000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704337200070002001203442#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#44#40#text#127#<p><font face="Verdana" s
ize="2">Do ponto de vista da f&iacute;sica, trabalho    &eacute; o resultado do 
produto da for&ccedil;a pelo deslocamento. Ao caminharmos    em uma esteira rola
nte, temos um vetor deslocamento igual a zero, isto &eacute;,    n&atilde;o sa&i
acute;mos do lugar! Isto n&atilde;o significa dizer que inexiste    qualquer tra
balho em andar na esteira rolante, mas apenas reconhecer que o trabalho    consi
ste simplesmente em subir e descer o centro de gravidade durante a caminhada    
simulada. Sendo assim, o gasto energ&eacute;tico efetivo dessa atividade tem    
muito pouco a ver com aquele efetivamente despendido em uma caminhada. Como    u
m sistema de composi&ccedil;&atilde;o de for&ccedil;as de natureza vetorial,    
qualquer contato do corpo do indiv&iacute;duo com um apoio ou com outro indiv&ia
cute;duo    gera um outro componente, que pode reduzir significativamente o gast
o energ&eacute;tico,    como &eacute; o caso do apoio das m&atilde;os sobre uma 
barra frontal ou lateral,    especialmente quando a esteira est&aacute; inclinad
a, ou ainda um simples contato    f&iacute;sico entre o paciente e o m&eacute;di
co que est&aacute; medindo a press&atilde;o    arterial. T&atilde;o ou mais impo
rtante ainda &eacute; a quest&atilde;o da inclina&ccedil;&atilde;o    da esteira
. Muito embora as conven&ccedil;&otilde;es habituais indiquem que    a inclina&c
cedil;&atilde;o deve ser quantificada como um &acirc;ngulo, normalmente    em gr
aus, &eacute; pr&aacute;tica habitual medi-la em percentuais para as esteiras   
 rolantes. Dessa forma, 10% de inclina&ccedil;&atilde;o positiva equivale dizer 
   que para cada 100 metros "percorridos" na horizontal temos uma subida de 10  
  metros. Ora, devemos reconhecer que o homem comum n&atilde;o est&aacute; nada 
   habituado a andar em ladeiras e, em alguns casos, como os indiv&iacute;duos  
  com claudica&ccedil;&atilde;o intermitente e/ou com grande intoler&acirc;ncia 
   ao esfor&ccedil;o, chega a evit&aacute;-las propositadamente. O protocolo mai
s    comumente utilizado para teste de exerc&iacute;cio em esteira rolante &eacu
te;    o de Bruce, no qual o primeiro est&aacute;gio se inicia com 10% de inclin
a&ccedil;&atilde;o    e a cada tr&ecirc;s minutos s&atilde;o adicionados mais 2%
. Fazendo uma compara&ccedil;&atilde;o    pr&aacute;tica, a subida do morro do C
orcovado na cidade do Rio de Janeiro,    da base at&eacute; o topo, possui uma i
nclina&ccedil;&atilde;o m&eacute;dia    de 10%, isto corresponde a aproximadamen
te 7km de percurso com 700 metros de    ascens&atilde;o, o que deixa &oacute;bvi
o que n&atilde;o se trata de algo habitual    para a maioria das pessoas. Esta e
strat&eacute;gia leva a que os pacientes se    ap&oacute;iem na esteira, diminui
ndo consideravelmente o gasto energ&eacute;tico    e, muitas vezes, interrompend
o o teste por fadiga de musculatura das regi&otilde;es    da panturrilha e da lo
mbar, desacostumadas a esse tipo de esfor&ccedil;o. Finalmente,    quando nos de
slocamos ao andar enfrentamos a resist&ecirc;ncia do ar, o que    n&atilde;o oco
rre na esteira rolante. Quanto maior a velocidade, proporcionalmente    mais f&a
acute;cil &eacute; andar/correr na esteira do que em condi&ccedil;&otilde;es    
reais, o que torna &agrave;s vezes complicado extrapolar dados de um teste em   
 esteira para condi&ccedil;&otilde;es de rua. </font> </p>     ^cY#v6n3a03.htm##
01473000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704124500070002001201315#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#45#41#text#127#<p><font face="Verdana" s
ize="2">As respostas fisiol&oacute;gicas tendem a ser    um pouco distintas em t
estes realizados nos dois erg&ocirc;metros. Uma freq&uuml;&ecirc;ncia    card&ia
cute;aca m&aacute;xima mais alta na esteira &eacute; contrabalan&ccedil;ada    p
or valores tensionais sist&oacute;licos mais elevados no cicloerg&ocirc;metro,  
  gerando duplos produtos m&aacute;ximos e altera&ccedil;&otilde;es eletrocardio
gr&aacute;ficas    semelhantes no esfor&ccedil;o m&aacute;ximo nos dois erg&ocir
c;metros<SUP>29</SUP>.    Se, por um lado, valores m&aacute;ximos de consumo de 
oxig&ecirc;nio mais altos    s&atilde;o normalmente obtidos em testes feitos em 
esteiras, especialmente para    indiv&iacute;duos jovens, sadios e fisicamente t
reinados, a qualidade da medida    de press&atilde;o arterial &eacute; muito mel
hor quando o teste &eacute; feito    em cicloerg&ocirc;metro, o que pode ser ext
remamente interessante, quando se    reconhece atualmente que um valor exagerado
 possui significado cl&iacute;nico    importante em termos de desenvolvimento fu
turo de hipertens&atilde;o arterial    sist&ecirc;mica<SUP>15,30,31</SUP>, prova
velmente decorrente de uma disfun&ccedil;&atilde;o    endotelial<SUP>32</SUP>. <
/font> </p>     ^cY#v6n3a03.htm##
00899000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704067100070002001200741#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#46#42#text#127#<p><font face="Verdana" s
ize="2">&Eacute; poss&iacute;vel que a prefer&ecirc;ncia    nacional atual pelas
 esteiras rolantes tenha outras raz&otilde;es, inclusive    de ordem de custos e
 de remunera&ccedil;&atilde;o pelos conv&ecirc;nios. Visando    analisar o compo
rtamento desta quest&atilde;o ao n&iacute;vel da literatura    m&eacute;dica de 
excel&ecirc;ncia, revisamos o MEDLINE em busca de cita&ccedil;&otilde;es    dos 
principais tipos de erg&ocirc;metros - esteira rolante, cicloerg&ocirc;metro    
de perna, cicloerg&ocirc;metro de bra&ccedil;o e remoerg&ocirc;metro -, tal    c
omo foi feito anteriormente para a terminologia do procedimento. </font> </p>   
  ^cY#v6n3a03.htm##
02017000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704178900070002001201859#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#47#43#text#127#<p><font face="Verdana" s
ize="2">Os resultados apontam para um uso bem mais freq&uuml;ente    das esteira
s rolantes do que para os cicloerg&ocirc;metros, quando o banco de    dados &eac
ute; analisado sem limite de tempo. Por outro lado, enquanto o n&uacute;mero    
de cita&ccedil;&otilde;es anuais de uso das esteiras rolantes em teste de exerc&
iacute;cio    tem se mantido constante nos &uacute;ltimos dez anos (p = 0,424) (
<a href="/img/revistas/rbme/v6n3/a03t05.gif">tabela    5</a>), os cicloerg&ocirc
;metros t&ecirc;m sido mais freq&uuml;entemente utilizados,    especialmente no 
&uacute;ltimo ano (p = 0,016), chegando a n&iacute;veis bastante    pr&oacute;xi
mos da quantidade de cita&ccedil;&otilde;es das esteiras rolantes.    Ent&atilde
;o, ao contr&aacute;rio do que provavelmente julga o senso comum,    pelo menos 
para trabalhos cient&iacute;ficos, os cicloerg&ocirc;metros est&atilde;o    send
o cada vez mais utilizados e j&aacute; rivalizam de perto com as esteiras    rol
antes. &Eacute; poss&iacute;vel que isto se deva ao crescente uso dos procedimen
tos    com coleta de gases expirados e ao maior interesse na determina&ccedil;&a
tilde;o    do limiar anaer&oacute;bico, que tendem a ser mais f&aacute;ceis de r
ealizar    em cicloerg&ocirc;metros, especialmente quando se opta por protocolos
 com raz&atilde;o    constante de incremento de cargas, denominado de protocolo 
de rampa. Os cicloerg&ocirc;metros    de bra&ccedil;o e os remoerg&ocirc;metros 
t&ecirc;m sido relativamente pouco    utilizados, por&eacute;m sem varia&ccedil;
&atilde;o apreci&aacute;vel ao longo    do tempo, sendo o uso desses equipamento
s provavelmente resguardado para situa&ccedil;&otilde;es    mais espec&iacute;fi
cas de pesquisa e/ou de avalia&ccedil;&atilde;o de atletas.    </font> </p>     
^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#48#44#text#127#<p>&nbsp;</p>     ^cY#v6n
3a03.htm##
00387000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704015900070002001200229#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#49#45#text#127#<p align="center"><a href
="/img/revistas/rbme/v6n3/a03t04.gif"><font face="Verdana, Arial, Helvetica, san
s-serif" size="2">Tabela    4</font></a> </p>     ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#50#46#text#127#<p>&nbsp;</p>     ^cY#v6n
3a03.htm##
00387000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704015900070002001200229#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#51#47#text#127#<p align="center"><a href
="/img/revistas/rbme/v6n3/a03t05.gif"><font face="Verdana, Arial, Helvetica, san
s-serif" size="2">Tabela    5</font></a> </p>     ^cY#v6n3a03.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704003700070002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#52#48#text#127#<p align="center">&nbsp;<
/p>     ^cY#v6n3a03.htm##
01846000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704161800070002001201688#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#53#49#text#127#<p align="left"><font fac
e="Verdana" size="2">Finalmente, cabe uma breve men&ccedil;&atilde;o    sobre os
 protocolos de teste. Conforme j&aacute; foi mencionado anteriormente    no text
o, o protocolo de Bruce &eacute; o mais freq&uuml;entemente utilizado    no noss
o meio. &Eacute; poss&iacute;vel que esse protocolo seja mais usado no    Brasil
 do que em qualquer outra parte do mundo. N&atilde;o &eacute; apropriado    pesq
uisar o uso desse protocolo atrav&eacute;s de cita&ccedil;&otilde;es no    MEDLI
NE, pelo fato de que muitos resumos n&atilde;o citam o protocolo de exerc&iacute
;cio    utilizado, o que poderia levar a subestimativas importantes da efetiva u
tiliza&ccedil;&atilde;o.    Independente das limita&ccedil;&otilde;es inerentes 
a esse protocolo, a tend&ecirc;ncia    atual &eacute; para a realiza&ccedil;&ati
lde;o dos denominados protocolos de    rampa, individualizando a raz&atilde;o de
 incremento de acordo com o paciente,    de modo que a dura&ccedil;&atilde;o do 
teste fique entre oito e 12 minutos<SUP>6,16,22</SUP>,    seja o exame de um mar
atonista ou de uma senhora idosa e debilitada. Dessa forma,    fica muito mais f
&aacute;cil analisar o comportamento das vari&aacute;veis hemodin&acirc;micas   
 e ventilat&oacute;rias ao esfor&ccedil;o, pois v&aacute;rios valores s&atilde;o
    obtidos e as curvas plotadas. Esses protocolos podem ser feitos em qualquer 
   tipo de erg&ocirc;metro e a maioria dos erg&ocirc;metros modernos j&aacute;  
  permite a sua realiza&ccedil;&atilde;o. A nossa pr&aacute;tica tem sido decidi
r    o protocolo de acordo com o objetivo do teste. </font> </p>     ^cY#v6n3a03
.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#54#50#text#127#<p>&nbsp; </p>     ^cY#v6
n3a03.htm##
00306000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704007800070002001200148#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#55#51#text#127#<p><font face="Verdana" s
ize="3"><B>TEND&Ecirc;NCIAS</B> </font> </p>     ^cY#v6n3a03.htm##
02171000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704194300070002001202013#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#56#52#text#127#<p><font face="Verdana" s
ize="2">Depois de v&aacute;rios anos de relativa estagna&ccedil;&atilde;o,    pa
rece que o teste de exerc&iacute;cio vem sendo novamente valorizado, sendo    um
 exemplo claro desta tend&ecirc;ncia a publica&ccedil;&atilde;o recente das    d
iretrizes de teste de exerc&iacute;cio pelo Col&eacute;gio Americano de Cardiolo
gia    e pela Associa&ccedil;&atilde;o Americana de Cora&ccedil;&atilde;o<SUP>26
</SUP>.    Algumas quest&otilde;es terminol&oacute;gicas e metodol&oacute;gicas 
foram apresentadas    neste artigo. Precisamos rever a denomina&ccedil;&atilde;o
 do procedimento,    as raz&otilde;es para sua solicita&ccedil;&atilde;o, a sua 
forma de realiza&ccedil;&atilde;o    e a escolha do erg&ocirc;metro e do protoco
lo. A inclus&atilde;o mais freq&uuml;ente    das medidas ventilat&oacute;rias re
presenta um significativo avan&ccedil;o com    importantes repercuss&otilde;es p
ara a avalia&ccedil;&atilde;o inotr&oacute;pica    card&iacute;aca n&atilde;o-in
vasiva, para a determina&ccedil;&atilde;o das capacidades    funcionais m&aacute
;xima e para esfor&ccedil;os prolongados e para a an&aacute;lise    integrada do
s sistemas cardiovascular e respirat&oacute;rio<SUP>8,17,19,20,21,23,24,33</SUP>
.    &Eacute; poss&iacute;vel que avancemos para um n&uacute;mero cada vez maior
    de testes cardiopulmonares de exerc&iacute;cio m&aacute;ximo, realizados em 
   cicloerg&ocirc;metros, utilizando protocolos individualizados de rampa. Um re
direcionamento    e uma reciclagem dos m&eacute;dicos brasileiros s&atilde;o nec
ess&aacute;rios    para que essas tend&ecirc;ncias possam ser efetivamente incor
poradas e para    que os m&eacute;dicos, e conseq&uuml;entemente seus pacientes,
 possam se beneficiar    de um exame complementar mais eficaz e mais &uacute;til
. A Sociedade Brasileira    de Cardiologia, seus departamentos e suas regionais 
podem desempenhar um papel    importante nesse contexto. </font> </p>     ^cY#v6
n3a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#57#53#text#127#<p>&nbsp; </p>     ^cY#v6
n3a03.htm##
00304000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704007600070002001200146#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#58#54#text#127#<p><font face="Verdana" s
ize="3"><B>AGRADECIMENTOS</B> </font> </p>     ^cY#v6n3a03.htm##
00401000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704017300070002001200243#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#59#55#text#127#<p><font face="Verdana" s
ize="2">O autor expressa o seu agradecimento ao Dr. F&aacute;bio    Villasboas p
elas cr&iacute;ticas feitas ao texto original. </font> </p>     ^cY#v6n3a03.htm#
#
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#60#56#text#127#<p>&nbsp; </p>     ^cY#v6
n3a03.htm##
00307000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704007900070002001200149#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#61#57#text#127#<p><font face="Verdana" s
ize="3"><B>REFER&Ecirc;NCIAS</B> </font> </p>     ^cY#v6n3a03.htm##
00418000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704017600072002001200248#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#62#58#text#127#1#<p><font fa
ce="Verdana" size="2">1. Cohen MC, Sttaford RS, Misra B. Stress testing:    nati
onal patterns and predictors of test ordering. Am Heart J 1999;138:1019-1024.   
 ^cY#v6n3a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002500070002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#63#59#text#127#    </font> </p>     ^cY#
v6n3a03.htm##
00382000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704014000072002001200212#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#64#60#text#127#2#<p><font fa
ce="Verdana" size="2">2. Ara&uacute;jo CGS. Manual de Teste de Esfor&ccedil;o.  
  1&#170; ed. Bras&iacute;lia: MEC, 1981.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#65#61#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00460000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704021800072002001200290#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#66#62#text#127#3#<p><font fa
ce="Verdana" size="2">3. Ara&uacute;jo CGS. A pr&aacute;tica e a metodologia    
dos testes ergom&eacute;tricos. Revista Brasileira de Educa&ccedil;&atilde;o    
F&iacute;sica e Desportos 1982;50:55-8.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#67#63#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00486000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704024400072002001200316#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#68#64#text#127#4#<p><font fa
ce="Verdana" size="2">4. Ara&uacute;jo CGS. Existem diferen&ccedil;as    nas res
postas cardiorrespirat&oacute;rias na marcha com ou sem apoio frontal    das m&a
tilde;os no tapete rolante? Arq Bras Cardiol 1982;36(Suppl 1):37.    ^cY#v6n3a03
.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#69#65#text#127# </font>  </p>     ^cY#v6
n3a03.htm##
00428000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704018600072002001200258#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#70#66#text#127#5#<p><font fa
ce="Verdana" size="2">5. Ara&uacute;jo CGS. Respostas cardiorrespirat&oacute;ria
s    a um exerc&iacute;cio subm&aacute;ximo prolongado. Arq Bras Cardiol 1983;41
:37-45.    ^cY#v6n3a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002500070002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#71#67#text#127#    </font> </p>     ^cY#
v6n3a03.htm##
00401000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704015900072002001200231#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#72#68#text#127#6#<p><font fa
ce="Verdana" size="2">6. Ara&uacute;jo CGS. Manual de Teste de Esfor&ccedil;o.  
  2&#170; ed. Rio de Janeiro: Ao Livro T&eacute;cnico, 1984.    ^cY#v6n3a03.htm#
#
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#73#69#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704020200072002001200274#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#74#70#text#127#7#<p><font fa
ce="Verdana" size="2">7. Ara&uacute;jo CGS. Fisiologia do exerc&iacute;cio.    I
n: Ara&uacute;jo WB (coord.). Ergometria e Cardiologia Desportiva. Rio de Janeir
o:    MEDSI, 1986:1-57.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#75#71#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00411000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704016900072002001200241#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#76#72#text#127#8#<p><font fa
ce="Verdana" size="2">8. Ara&uacute;jo CGS. A ergoespirometria oferece    algo a
 mais do que a ergometria? Boletim de Ergometria - DERC/SBC1996;2:6-8.    ^cY#v6
n3a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002500070002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#77#73#text#127#    </font> </p>     ^cY#
v6n3a03.htm##
00528000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704028600072002001200358#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#78#74#text#127#9#<p><font fa
ce="Verdana" size="2">9. Ara&uacute;jo CGS. Breve coment&aacute;rio    sobre o p
osicionamento conjunto sobre teste de esfor&ccedil;o de julho de 1997    da Amer
ican Heart Association e do American College of Cardiology. Boletim de    Ergome
tria - DERC/SBC1997;3:7-10.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#79#75#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00473000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704023000073002001200303#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#80#76#text#127#10#<p><font f
ace="Verdana" size="2">10. Ara&uacute;jo CGS. Ergoespirometria - um    procedime
nto em Medicina do Exerc&iacute;cio: necessidade, op&ccedil;&atilde;o    ou luxo
. Jornal de Medicina do Exerc&iacute;cio1998;20:2-4.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#81#77#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00442000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704019900073002001200272#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#82#78#text#127#11#<p><font f
ace="Verdana" size="2">11. Ara&uacute;jo CGS. Import&acirc;ncia da ergoespiromet
ria    na prescri&ccedil;&atilde;o de exerc&iacute;cio ao cardiopata. Revista da
 SOCERJ1998;11:38-47.    ^cY#v6n3a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002500070002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#83#79#text#127#    </font> </p>     ^cY#
v6n3a03.htm##
00497000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704025400073002001200327#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#84#80#text#127#12#<p><font f
ace="Verdana" size="2">12. Ara&uacute;jo CGS, Bastos MAPM, Pinto NLS,    Camara 
RS. A freq&uuml;&ecirc;ncia card&iacute;aca m&aacute;xima em nove diferentes    
protocolos de teste m&aacute;ximo. Rev Bras Ci&ecirc;n Esporte 1980;2:20-31.    
^cY#v6n3a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002500070002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#85#81#text#127#    </font> </p>     ^cY#
v6n3a03.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704020100073002001200274#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#86#82#text#127#13#<p><font f
ace="Verdana" size="2">13. Costa RVC. Considera&ccedil;&otilde;es sobre    o pro
tocolo de rampa aplicado no teste ergom&eacute;trico. Boletim de Ergometria    -
 DERC/SBC1999;18:16-17.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#87#83#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00409000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704016600073002001200239#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#88#84#text#127#14#<p><font f
ace="Verdana" size="2">14. Froelicher VF, Myers J, Follansbee WP, Labovitz    AJ
. Exercise and the Heart. 3<SUP>rd</SUP> ed. St. Louis: Mosby, 1993.    ^cY#v6n3
a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#89#85#text#127# </font>  </p>     ^cY#v6
n3a03.htm##
00379000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704013600073002001200209#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#90#86#text#127#15#<p><font f
ace="Verdana" size="2">15. Jones NL. Clinical Exercise Testing. 4<SUP>th</SUP>  
  ed. Philadelphia: WB Saunders, 1997.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#91#87#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00380000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704013700073002001200210#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#92#88#text#127#16#<p><font f
ace="Verdana" size="2">16. Myers J. Essentials of Cardiopulmonary Exercise    Te
sting. Champaign: Human Kinetics, 1996.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#93#89#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00446000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704020300073002001200276#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#94#90#text#127#17#<p><font f
ace="Verdana" size="2">17. Ribeiro JP, Ara&uacute;jo CGS. Ergoespirometria    no
 diagn&oacute;stico diferencial de dispn&eacute;ia. Rev Soc Cardiologia Rio    G
rande do Sul1998;7:85-90.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#95#91#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00383000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704014000073002001200213#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#96#92#text#127#18#<p><font f
ace="Verdana" size="2">18. Serra S. Considera&ccedil;&otilde;es sobre    ergoesp
irometria. Arq Bras Cardiol1997; 68:301-4.    ^cY#v6n3a03.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#97#93#text#127# </font> </p>     ^cY#v6n
3a03.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704018300073002001200256#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#98#94#text#127#19#<p><font f
ace="Verdana" size="2">19. Sociedade Brasileira de Cardiologia - Consenso    nac
ional de reabilita&ccedil;&atilde;o card&iacute;aca. Arq Bras Cardiol 1997;69:26
7-93.    ^cY#v6n3a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002500070002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#99#95#text#127#    </font> </p>     ^cY#
v6n3a03.htm##
00408000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000500062708000400067888000300071704016400074002001200238#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#100#96#text#127#20#<p><font 
face="Verdana" size="2">20. Wasserman K. Diagnosing cardiovascular and    lung p
athophysiology from exercise gas exchange. Chest 1997;112:1091-101.    ^cY#v6n3a
03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000500062708000400067704002300071002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#101#97#text#127# </font>  </p>     ^cY#v
6n3a03.htm##
00389000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000500062708000400067888000300071704014500074002001200219#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#102#98#text#127#21#<p><font 
face="Verdana" size="2">21. Wasserman K, Whipp BJ. Exercise physiology    in hea
lth and disease. Am Rev Resp Dis1975;112:219-49.    ^cY#v6n3a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000500062708000400067704002200071002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#103#99#text#127# </font> </p>     ^cY#v6
n3a03.htm##
00446000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704020100075002001200276#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#104#100#text#127#22#<p><font
 face="Verdana" size="2">22. Wasserman K, Hansen JE, Sue DY, Whipp BJ.    Princi
ples of Exercise Testing and Interpretation. 3<SUP>rd</SUP> ed. Philadelphia:   
 Lea &amp; Febiger, 1999.    ^cY#v6n3a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#105#101#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00435000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704019000075002001200265#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#106#102#text#127#23#<p><font
 face="Verdana" size="2">23. Weber KT, Janicki JS. Cardiopulmonary Exercise    T
esting - Physiologic Principles and Clinical Applications. Philadelphia: WB    S
aunders, 1986.    ^cY#v6n3a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#107#103#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00420000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704017500075002001200250#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#108#104#text#127#24#<p><font
 face="Verdana" size="2">24. Yazbeck P. Import&acirc;ncia na avalia&ccedil;&atil
de;o    do pulso de oxig&ecirc;nio. Boletim de Ergometria - DERC/SBC1999;18:18. 
   ^cY#v6n3a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#109#105#text#127# </font>  </p>     ^cY#
v6n3a03.htm##
00374000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704012900075002001200204#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#110#106#text#127#25#<p><font
 face="Verdana" size="2">25. Hollmann W, Prinz JP. Ergoespirometry and    its hi
story. Sports Med 1997;23:93-105.    ^cY#v6n3a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#111#107#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00406000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704016100075002001200236#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#112#108#text#127#26#<p><font
 face="Verdana" size="2">26. ACC/AHA Committee on Exercise Testing. ACC/AHA    G
uidelines for Exercise Testing. J Am Coll Cardiol1997;30:260-315.    ^cY#v6n3a03
.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#113#109#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00464000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704021900075002001200294#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#114#110#text#127#27#<p><font
 face="Verdana" size="2">27. National Institutes of Health. Current Bibliographi
es    in Medicine - No. 95-7: Physical Activity and Cardiovascular Health. Bethe
sda:    National Library of Medicine, 1995.    ^cY#v6n3a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#115#111#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00401000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704015600075002001200231#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#116#112#text#127#28#<p><font
 face="Verdana" size="2">28. Guralnik DB, editor. Webster's New World    Diction
ary. 2<SUP>nd</SUP> ed. Cleveland: Collins Publishers, 1981.    ^cY#v6n3a03.htm#
#
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#117#113#text#127# </font>  </p>     ^cY#
v6n3a03.htm##
00480000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704023500075002001200310#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#118#114#text#127#29#<p><font
 face="Verdana" size="2">29. Wicks JR, Sutton JR, Jones NL, et al. Comparison   
 of the electrocardiographic changes induced by maximum exercise testing with   
 treadmill and cycle ergometer. Circulation1978;57:1066-70.    ^cY#v6n3a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#119#115#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00474000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704022900075002001200304#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#120#116#text#127#30#<p><font
 face="Verdana" size="2">30. Allison TG, Cordeiro MA, Miller TD, Daida    H, Squ
ires RW, Gau GT. Prognostic significance of exercise-induced systemic    hyperte
nsion in healthy subjects. Am J Cardiol1999;83:371-5.    ^cY#v6n3a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#121#117#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00485000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704024000075002001200315#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#122#118#text#127#31#<p><font
 face="Verdana" size="2">31. Singh JP, Larson MG, Manollo TA, et al. Blood    pr
essure response during treadmill testing as a risk factor for new-onset hyperten
sion    - The Framingham heart study. Circulation1999;99:1831-6.    ^cY#v6n3a03.
htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#123#119#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00509000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704026400075002001200339#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#124#120#text#127#32#<p><font
 face="Verdana" size="2">32. Biggi A, Carra N, Zilotti M, Azzarone M,    Manca C
, Novarini A. Impaired endothelial function in patients with exaggerated    bloo
d pressure response to dynamic exercise. J Hypertens1999;17(Suppl 3):S161    (ab
stract).    ^cY#v6n3a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#125#121#text#127# </font> </p>     ^cY#v
6n3a03.htm##
00437000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704019200075002001200267#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#p#126#122#text#127#33#<p><font
 face="Verdana" size="2">33. Wasserman K, Whipp BJ, Koyal SN, Beaver WL.    Anae
robic threshold and respiratory gas exchange during exercise. J Appl Physiol    
1973; 35:236-43.    ^cY#v6n3a03.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002100072002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#127#123#text#127# </font></p>     ^cY#v6
n3a03.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#128#124#text#127#<p>&nbsp;</p>     ^cY#v
6n3a03.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#129#125#text#127#<p>&nbsp; </p>     ^cY#
v6n3a03.htm##
00417000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704018700072002001200259#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#130#126#text#127#<p><font face="Verdana"
 size="2"><B><a name="end"></a><a href="#topo"><img src="/img/revistas/rbme/v6n3
/seta.gif" border="0"></a>    Endere&ccedil;o para correspond&ecirc;ncia</B>    
^cY#v6n3a03.htm##
00327000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704009700072002001200169#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a03.htm#S#p#131#127#text#127#<BR>   E-mail: <a href=
"mailto:cgaraujo@iis.com.br">cgaraujo@iis.com.br</a></font>  </p>     ^cY#v6n3a0
3.htm##
00563000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100016000710100019000870100
01600106012007000122030001100192065000900203064000500212031000400217014001000221
865000900231002001200240035001000252801001100262#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a03.htm#S#c#132#1#text#33#1#^rND^sCohen^nMC#^rND^sSttaford^nRS#^rND^
sMisra^nB.#Stress testing: national patterns and predictors of test ordering^len
#Am Heart J#19990000#1999#138#1019-1024#20000600#v6n3a03.htm#0002-8703#Am Heart 
J##
00412000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690160018000710180031000890630
00200120066000900122062000400131065000900135064000500144865000900149002001200158
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#133#2#text#33#2#^rND^sAr
aújo^nCGS#Manual de Teste de Esforço^lpt#1#Brasília#MEC#19810000#1981#20000600#v
6n3a03.htm##
00492000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100018000710120054000890300
05000143710000200193065000900195064000500204031000300209014000500212865000900217
002001200226#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#134#3#text#3
3#3#^rND^sAraújo^nCGS#A prática e a metodologia dos testes ergométricos^lpt#Revi
sta Brasileira de Educação Física e Desportos#2#19820000#1982#50#55-8#20000600#v
6n3a03.htm##
00578000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100019000710120121000900300
01700211065000900228064000500237031000300242032000400245020000300249865000900252
002001200261035001000273801001700283#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a03.htm#S#c#135#4#text#33#4#^rND^sAraújo^nCGS.#Existem diferenças nas respostas 
cardiorrespiratórias na marcha com ou sem apoio frontal das mãos no tapete rolan
te?^lpt#Arq Bras Cardiol#19820000#1982#36#^s1#37#20000600#v6n3a03.htm#0066-782X#
Arq Bras Cardiol##
00515000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100019000710120071000900300
01700161065000900178064000500187031000300192014000600195865000900201002001200210
035001000222801001700232#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#
136#5#text#33#5#^rND^sAraújo^nCGS.#Respostas cardiorrespiratórias a um exercício
 submáximo prolongado^lpt#Arq Bras Cardiol#19830000#1983#41#37-45#20000600#v6n3a
03.htm#0066-782X#Arq Bras Cardiol##
00431000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690160018000710180031000890630
00200120066001500122062001700137065000900154064000500163865000900168002001200177
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#137#6#text#33#6#^rND^sAr
aújo^nCGS#Manual de Teste de Esforço^lpt#2#Rio de Janeiro#Ao Livro Técnico#19840
000#1984#20000600#v6n3a03.htm##
00504000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100018000710120028000890160
02000117018004000137066001500177062000600192065000900198064000500207014000500212
865000900217002001200226#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#
138#7#text#33#7#^rND^sAraújo^nCGS#Fisiologia do exercício^lpt#^rCOORD^sAraújo^nW
B#Ergometria e Cardiologia Desportiva^lpt#Rio de Janeiro#MEDSI#19860000#1986#1-5
7#20000600#v6n3a03.htm##
00468000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690160019000710180086000900620
00900176065000900185064000500194031000200199014000400201865000900205002001200214
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#139#8#text#33#8#^rND^sAr
aújo^nCGS.#A ergoespirometria oferece algo a mais do que a ergometria? Boletim d
e Ergometria^lpt#DERC/SBC#19960000#1996#2#6-8#20000600#v6n3a03.htm##
00564000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690160018000710180182000890620
00900271065000900280064000500289031000200294014000500296865000900301002001200310
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#140#9#text#33#9#^rND^sAr
aújo^nCGS#Breve comentário sobre o posicionamento conjunto sobre teste de esforç
o de julho de 1997 da American Heart Association e do American College of Cardio
logy. Boletim de Ergometria^lpt#DERC/SBC#19970000#1997#3#7-10#20000600#v6n3a03.h
tm##
00513000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730120092000910300
03200183710000200215065000900217064000500226031000300231014000400234865000900238
002001200247#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#141#10#text#
33#10#^rND^sAraújo^nCGS#Ergoespirometria - um procedimento em Medicina do Exercí
cio: necessidade, opção ou luxo^lpt#Jornal de Medicina do Exercício#2#19980000#1
998#20#2-4#20000600#v6n3a03.htm##
00525000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730120077000920300
01800169065000900187064000500196031000300201014000600204865000900210002001200219
035001000231801001800241#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#
142#11#text#33#11#^rND^sAraújo^nCGS.#Importância da ergoespirometria na prescriç
ão de exercício ao cardiopata^lpt#Revista da SOCERJ#19980000#1998#11#38-47#20000
600#v6n3a03.htm#0104-0758#Revista da SOCERJ##
00581000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100019000910100
01700110010001800127012007900145030002200224710000200246065000900248064000500257
031000200262014000600264865000900270002001200279#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a03.htm#S#c#143#12#text#33#12#^rND^sAraújo^nCGS#^rND^sBastos^nMAPM#^
rND^sPinto^nNLS#^rND^sCamara^nRS.#A freqüência cardíaca máxima em nove diferente
s protocolos de teste máximo^lpt#Rev Bras Ciên Esporte#2#19800000#1980#2#20-31#2
0000600#v6n3a03.htm##
00483000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160017000730180098000900620
00900188065000900197064000500206031000300211014000600214865000900220002001200229
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#144#13#text#33#13#^rND^s
Costa^nRVC#Considerações sobre o protocolo de rampa aplicado no teste ergométric
o. Boletim de Ergometria^lpt#DERC/SBC#19990000#1999#18#16-17#20000600#v6n3a03.ht
m##
00507000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160021000730160015000940160
02100109016001900130018002700149063000200176066001000178062000600188065000900194
064000500203865000900208002001200217#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a03.htm#S#c#145#14#text#33#14#^rND^sFroelicher^nVF#^rND^sMyers^nJ#^rND^sFollansb
ee^nWP#^rND^sLabovitz^nAJ#Exercise and the Heart^len#3#St. Louis#Mosby#19930000#
1993#20000600#v6n3a03.htm##
00424000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160017000730180030000900630
00200120066001300122062001200135065000900147064000500156865000900161002001200170
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#146#15#text#33#15#^rND^s
Jones^nNL.#Clinical Exercise Testing^len#4#Philadelphia#WB Saunders#19970000#199
7#20000600#v6n3a03.htm##
00430000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160016000730180051000890660
01000140062001500150065000900165064000500174865000900179002001200188#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#147#16#text#33#16#^rND^sMyers^nJ.#Es
sentials of Cardiopulmonary Exercise Testing^len#Champaign#Human Kinetics#199600
00#1996#20000600#v6n3a03.htm##
00519000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100019000910120
06000110030003800170710000200208065000900210064000500219031000200224014000600226
865000900232002001200241#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#
148#17#text#33#17#^rND^sRibeiro^nJP#^rND^sAraújo^nCGS.#Ergoespirometria no diagn
óstico diferencial de dispnéia^lpt#Rev Soc Cardiologia Rio Grande do Sul#2#19980
000#1998#7#85-90#20000600#v6n3a03.htm##
00484000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730120041000890300
01700130065000900147064000500156031000300161014000600164865000900170002001200179
035001000191801001700201#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#
149#18#text#33#18#^rND^sSerra^nS.#Considerações sobre ergoespirometria^lpt#Arq B
ras Cardiol#19970000#1997#68#301-4#20000600#v6n3a03.htm#0066-782X#Arq Bras Cardi
ol##
00511000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700110036000730120047001090300
01700156065000900173064000500182031000300187014000700190865000900197002001200206
035001000218801001700228#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#
150#19#text#33#19#Sociedade Brasileira de Cardiologia#Consenso nacional de reabi
litação cardíaca^lpt#Arq Bras Cardiol#19970000#1997#69#267-93#20000600#v6n3a03.h
tm#0066-782X#Arq Bras Cardiol##
00511000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100020000730120082000930300
00600175065000900181064000500190031000400195014000900199865000900208002001200217
035001000229801000600239#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#
151#20#text#33#20#^rND^sWasserman^nK.#Diagnosing cardiovascular and lung pathoph
ysiology from exercise gas exchange^len#Chest#19970000#1997#112#1091-101#2000060
0#v6n3a03.htm#0012-3692#Chest##
00521000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730100017000920120
04600109030001600155065000900171064000500180031000400185014000700189865000900196
002001200205035001000217801001600227#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a03.htm#S#c#152#21#text#33#21#^rND^sWasserman^nK#^rND^sWhipp^nBJ.#Exercise physi
ology in health and disease^len#Am Rev Resp Dis#19750000#1975#112#219-49#2000060
0#v6n3a03.htm#0003-0805#Am Rev Resp Dis##
00535000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160019000730160017000920160
01400109016001600123018005400139063000200193066001300195062001400208065000900222
064000500231865000900236002001200245#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a03.htm#S#c#153#22#text#33#22#^rND^sWasserman^nK#^rND^sHansen^nJE#^rND^sSue^nDY#
^rND^sWhipp^nBJ#Principles of Exercise Testing and Interpretation^len#3#Philadel
phia#Lea & Febiger#19990000#1999#20000600#v6n3a03.htm##
00498000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160016000730160019000890180
08800108066001300196062001200209065000900221064000500230865000900235002001200244
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#154#23#text#33#23#^rND^s
Weber^nKT#^rND^sJanicki^nJS.#Cardiopulmonary Exercise Testing - Physiologic Prin
ciples and Clinical Applications^len#Philadelphia#WB Saunders#19860000#1986#2000
0600#v6n3a03.htm##
00456000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160018000730180073000910620
00900164065000900173064000500182031000300187020000300190865000900193002001200202
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#155#24#text#33#24#^rND^s
Yazbeck^nP.#Importância na avaliação do pulso de oxigênio. Boletim de Ergometria
^lpt#DERC/SBC#19990000#1999#18#18#20000600#v6n3a03.htm##
00498000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100016000910120
03600107030001100143065000900154064000500163031000300168014000700171865000900178
002001200187035001000199801001100209#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a03.htm#S#c#156#25#text#33#25#^rND^sHollmann^nW#^rND^sPrinz^nJP#Ergoespirometry 
and its history^len#Sports Med#19970000#1997#23#93-105#20000600#v6n3a03.htm#0112
-1642#Sports Med##
00513000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700110038000730120044001110300
01800155065000900173064000500182031000300187014000800190865000900198002001200207
035001000219801001800229#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#
157#26#text#33#26#ACC/AHA Committee on Exercise Testing#ACC/AHA Guidelines for E
xercise Testing^len#J Am Coll Cardiol#19970000#1997#30#260-315#20000600#v6n3a03.
htm#0735-1097#J Am Coll Cardiol##
00501000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700170030000730180095001030660
00900198062002900207065000900236064000500245865000900250002001200259#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#158#27#text#33#27#National Institute
s of Health#Current Bibliographies in Medicine - No. 95-7: Physical Activity and
 Cardiovascular Health^len#Bethesda#National Library of Medicine#19950000#1995#2
0000600#v6n3a03.htm##
00435000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160019000730180035000920630
00200127066001000129062001900139065000900158064000500167865000900172002001200181
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#159#28#text#33#28#^rED^s
Guralnik^nDB#Webster's New World Dictionary^len#2#Cleveland#Collins Publishers#1
9810000#1981#20000600#v6n3a03.htm##
00633000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100017000890100
01600106810000700122012012200129030001200251065000900263064000500272031000300277
014000800280865000900288002001200297035001000309801001200319#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a03.htm#S#c#160#29#text#33#29#^rND^sWicks^nJR#^rND^sSutt
on^nJR#^rND^sJones^nNL#et al.#Comparison of the electrocardiographic changes ind
uced by maximum exercise testing with treadmill and cycle ergometer^len#Circulat
ion#19780000#1978#57#1066-70#20000600#v6n3a03.htm#0009-7322#Circulation##
00670000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100019000910100
01700110010001500127010001800142010001400160012009000174030001300264065000900277
06400050028603100030029101400060029486500090030000200120030903500100032180100130
0331#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#S#c#161#30#text#33#30#^r
ND^sAllison^nTG#^rND^sCordeiro^nMA#^rND^sMiller^nTD#^rND^sDaida^nH#^rND^sSquires
^nRW#^rND^sGau^nGT#Prognostic significance of exercise-induced systemic hyperten
sion in healthy subjects^len#Am J Cardiol#19990000#1999#83#371-5#20000600#v6n3a0
3.htm#0002-9149#Am J Cardiol##
00637000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100017000890100
01800106810000600124012012600130030001200256065000900268064000500277031000300282
014000700285865000900292002001200301035001000313801001200323#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a03.htm#S#c#162#31#text#33#31#^rND^sSingh^nJP#^rND^sLars
on^nMG#^rND^sManollo^nTA#et al#Blood pressure response during treadmill testing 
as a risk factor for new-onset hypertension - The Framingham heart study^len#Cir
culation#19990000#1999#99#1831-6#20000600#v6n3a03.htm#0009-7322#Circulation##
00719000000000349000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100015000730100015000880100
01700103010001800120010001500138010001900153012010700172030001200279065000900291
06400050030003100030030503200040030802000050031206100090031786500090032600200120
0335035001000347801001200357#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a03.htm#
S#c#163#32#text#33#32#^rND^sBiggi^nA#^rND^sCarra^nN#^rND^sZilotti^nM#^rND^sAzzar
one^nM#^rND^sManca^nC#^rND^sNovarini^nA.#Impaired endothelial function in patien
ts with exaggerated blood pressure response to dynamic exercise^len#J Hypertens#
19990000#1999#17#^s3#S161#abstract#20000600#v6n3a03.htm#0263-6352#J Hypertens##
00598000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730100016000920100
01600108010001800124012006900142030001500211065000900226064000500235031000300240
014000700243865000900250002001200259035001000271801001500281#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a03.htm#S#c#164#33#text#33#33#^rND^sWasserman^nK#^rND^sW
hipp^nBJ#^rND^sKoyal^nSN#^rND^sBeaver^nWL.#Anaerobic threshold and respiratory g
as exchange during exercise^len#J Appl Physiol#19730000#1973#35#236-43#20000600#
v6n3a03.htm#0021-8987#J Appl Physiol##
00271000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670910009000690920007000780020012000857030
00400097#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#o#1#1#article#1#20
110314#125752#v6n3a04.htm#225##
04548000000000709000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087121000300091049000800094158000300102030002100105
03100020012603200020012806500090013001400090013903500100014801200900015801200830
02480100024003310100043003550100035003980100035004330100034004680100043005020100
03400545010004400579070007800623070008800701070003900789083135900828085000802187
08500330219508500300222808500350225808500200229308500250231308500250233808500210
23630831249023840850008036330850029036410850028036700850033036980850019037310850
02203750085002403772085002103796117000603817072000303823002001203826#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#TAB#
04#RBME180#nd#Rev Bras Med Esporte#6#3#20000600#^f85^l92#1517-8692#Estabilidade 
no prognóstico do perfil de aptidão física de jovens atletas de handebol^lpt#Sta
bility in the physical fitness profile prognosis of young handball athletes^len#
^rND^1A01^nVagner^sRaso#^rND^1A01^nCarlos Frederico dAvila^sBrito#^rND^1A01^nTi
móteo Leandro^sAraújo#^rND^1A02^nVagner Roberto^sBergamo#^rND^1A01^nDouglas Roqu
e^sAndrade#^rND^1A01^nSandra Marcela Mahecha^sMatsudo#^rND^1A03^nNanci Maria de^
sFrança#^rND^1A01^nVictor Keihan Rodrigues^sMatsudo#Centro de Estudos do Laborat
ório de Aptidão Física de São Caetano do Sul^iA01#Universidade Metodista de Pira
cicaba^iA02^1Pontifícia Universidade Católica de Campinas#Universidade Católica 
de Brasília^iA03#^lpt^aEste estudo teve como objetivo: 1) verificar a estabilida
de do perfil de aptidão física de jovens atletas de handebol durante a adolescên
cia; e 2) comparar os resultados com a seleção paulista adulta feminina. Para ta
nto, a amostra foi constituída por cinco jovens atletas de handebol feminino que
 foram seguidas semilongitudinalmente por dois anos, com média de idade e tempo 
de prática inicial e final de 14,2 ± 1,3 anos, 18,4 ± 10,7 meses e 16,2 ± 1,3 an
os, 42,8 ± 10,7 meses, respectivamente (12h/semana de treinamento). Na temporada
 de 1997 quatro atletas foram pré-selecionadas para a seleção brasileira de cade
tes. As variáveis mensuradas foram: peso corporal (P); altura total (A); impulsã
o vertical sem (IVS) e com auxílio dos membros superiores (IVC); impulsão horizo
ntal (IH); agilidade (SR); velocidade (50m) e potência anaeróbica (40seg.), segu
indo padronização CELAFISCS. Os coeficientes de Pearson e Spearman foram signifi
cativamente altos e muitos altos (p < 0,05) para P (0,88), A (0,98 e 0,99), 50m 
(0,95 e 0,90) e 40seg. (0,87 e 0,90). Estes dados permitem concluir que as joven
s atletas apresentaram alta estabilidade nas variáveis antropométricas, velocida
de e potência anaeróbica durante um período de dois anos da adolescência, favore
cendo a hipótese de que a expectativa de sucesso esportivo pode ser predita em i
dades precoces.#^dnd^i1#^tm^lpt^kDetecção de talentos^i1#^tm^lpt^kTalento esport
ivo^i1#^tm^lpt^kEstratégia Z-CELAFISCS^i1#^tm^lpt^kEsporte^i1#^tm^lpt^kEstabilid
ade^i1#^tm^lpt^kAdolescência^i1#^tm^lpt^kHandebol^i1#^len^aThe purpose of this s
tudy was 1) to verify the stability of the physical fitness profile of young han
dball athletes during adolescence, and 2) to compare these athletes to the São P
aulo state handball adult team. The sample comprised five young female handball 
athletes who were followed-up for two years, with mean age and practice time bef
ore and after of 14.2 ± 1.3 years-old, 18.4 ± 10.7 months and 16.2 ± 1.3 years-o
ld, 42.8 ± 10.7 months, respectively (12h/week training). Variables measured wer
e: body weight (W); body height (H); vertical jump without (VJWo) and with help 
of arms (VJ); long jump (LJ); agility (SR); velocity (50m) and anaerobic power (
40seg.), by CELAFISCS standardization. It was verified that with the exception o
f VJW and 50m, the young athletes showed upper values for all variables. The Pea
rson and Spearman coefficients were significantly higher and much higher (p < 0.
05) for W (0.88), H (0.98 and 0.99), 50m (0.95 and 0.90) and 40 sec (0.87 and 0.
90). Data permit to conclude that young athletes showed stability in anthropomet
ric variables, velocity, and anaerobic power during the adolescence period, thus
 supporting the hypothesis that the expectation of success in sports can be pred
icted from early age.#^dnd^i2#^tm^len^kTalent detection^i2#^tm^len^kAthletic tal
ent^i2#^tm^len^kZ-CELAFISCS strategy^i2#^tm^len^kSports^i2#^tm^len^kStability^i2
#^tm^len^kAdolescence^i2#^tm^len^kHandball^i2#other#36#v6n3a04.htm##
04568000000000709000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087121000300091049000800094158000300102030002100105
03100020012603200020012806500090013001400090013903500100014801200970015801200900
02550100024003450100043003690100035004120100035004470100034004820100043005160100
03400559010004400593070007800637070008800715070003900803083136200842085000802204
08500330221208500300224508500350227508500200231008500250233008500250235508500210
23800831252024010850008036530850029036610850028036900850033037180850019037510850
02203770085002403792085002103816117000603837072000303843002001203846#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#TAB#
04#RBME180#nd#Rev Bras Med Esporte#6#3#20000600#^f85^l92#1517-8692#<b>Estabilida
de no prognóstico do perfil de aptidão física de jovens atletas de handebol</b>^
lpt#<b>Stability in the physical fitness profile prognosis of young handball ath
letes</b>^len#^rND^1A01^nVagner^sRaso#^rND^1A01^nCarlos Frederico dAvila^sBrito
#^rND^1A01^nTimóteo Leandro^sAraújo#^rND^1A02^nVagner Roberto^sBergamo#^rND^1A01
^nDouglas Roque^sAndrade#^rND^1A01^nSandra Marcela Mahecha^sMatsudo#^rND^1A03^nN
anci Maria de^sFrança#^rND^1A01^nVictor Keihan Rodrigues^sMatsudo#Centro de Estu
dos do Laboratório de Aptidão Física de São Caetano do Sul^iA01#Universidade Met
odista de Piracicaba^iA02^1Pontifícia Universidade Católica de Campinas#Universi
dade Católica de Brasília^iA03#^lpt^aEste estudo teve como objetivo: 1) verifica
r a estabilidade do perfil de aptidão física de jovens atletas de handebol duran
te a adolescência; e 2) comparar os resultados com a seleção paulista adulta fem
inina. Para tanto, a amostra foi constituída por cinco jovens atletas de handebo
l feminino que foram seguidas semilongitudinalmente por dois anos, com média de 
idade e tempo de prática inicial e final de 14,2 ± 1,3 anos, 18,4 ± 10,7 meses e
 16,2 ± 1,3 anos, 42,8 ± 10,7 meses, respectivamente (12h/semana de treinamento)
. Na temporada de 1997 quatro atletas foram pré-selecionadas para a seleção bras
ileira de cadetes. As variáveis mensuradas foram: peso corporal (P); altura tota
l (A); impulsão vertical sem (IVS) e com auxílio dos membros superiores (IVC); i
mpulsão horizontal (IH); agilidade (SR); velocidade (50m) e potência anaeróbica 
(40seg.), seguindo padronização CELAFISCS. Os coeficientes de Pearson e Spearman
 foram significativamente altos e muitos altos (p &lt; 0,05) para P (0,88), A (0
,98 e 0,99), 50m (0,95 e 0,90) e 40seg. (0,87 e 0,90). Estes dados permitem conc
luir que as jovens atletas apresentaram alta estabilidade nas variáveis antropom
étricas, velocidade e potência anaeróbica durante um período de dois anos da ado
lescência, favorecendo a hipótese de que a expectativa de sucesso esportivo pode
 ser predita em idades precoces.#^dnd^i1#^tm^lpt^kDetecção de talentos^i1#^tm^lp
t^kTalento esportivo^i1#^tm^lpt^kEstratégia Z-CELAFISCS^i1#^tm^lpt^kEsporte^i1#^
tm^lpt^kEstabilidade^i1#^tm^lpt^kAdolescência^i1#^tm^lpt^kHandebol^i1#^len^aThe 
purpose of this study was 1) to verify the stability of the physical fitness pro
file of young handball athletes during adolescence, and 2) to compare these athl
etes to the São Paulo state handball adult team. The sample comprised five young
 female handball athletes who were followed-up for two years, with mean age and 
practice time before and after of 14.2 ± 1.3 years-old, 18.4 ± 10.7 months and 1
6.2 ± 1.3 years-old, 42.8 ± 10.7 months, respectively (12h/week training). Varia
bles measured were: body weight (W); body height (H); vertical jump without (VJW
o) and with help of arms (VJ); long jump (LJ); agility (SR); velocity (50m) and 
anaerobic power (40seg.), by CELAFISCS standardization. It was verified that wit
h the exception of VJW and 50m, the young athletes showed upper values for all v
ariables. The Pearson and Spearman coefficients were significantly higher and mu
ch higher (p &lt; 0.05) for W (0.88), H (0.98 and 0.99), 50m (0.95 and 0.90) and
 40 sec (0.87 and 0.90). Data permit to conclude that young athletes showed stab
ility in anthropometric variables, velocity, and anaerobic power during the adol
escence period, thus supporting the hypothesis that the expectation of success i
n sports can be predicted from early age.#^dnd^i2#^tm^len^kTalent detection^i2#^
tm^len^kAthletic talent^i2#^tm^len^kZ-CELAFISCS strategy^i2#^tm^len^kSports^i2#^
tm^len^kStability^i2#^tm^len^kAdolescence^i2#^tm^len^kHandball^i2#other#36#v6n3a
04.htm##
04683000000000733000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670640013000690710003000820400003000850010
00600088042000200094120000400096038000400100121000300104049000800107158000300115
03000240011803100020014203200020014406500090014601400090015503500100016401200900
01740120083002640100024003470100043003710100035004140100035004490100034004840100
04300518010003400561010004400595070008000639070009000719070004100809083135900850
08500080220908500330221708500300225008500350228008500200231508500250233508500250
23600850021023850831249024060850008036550850029036630850028036920850033037200850
01903753085002203772085002403794085002103818117000603839072000303845002001203848
008008903860#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#l#4#1#article#
1#^mjun.^a2000#oa#pt#br1.1#1#4.0#tab#04#RBME180#nd#Rev. bras. med. esporte#6#3#2
0000600#^f85^l92#1517-8692#Estabilidade no prognóstico do perfil de aptidão físi
ca de jovens atletas de handebol^lpt#Stability in the physical fitness profile p
rognosis of young handball athletes^len#^rND^1A01^nVagner^sRaso#^rND^1A01^nCarlo
s Frederico dAvila^sBrito#^rND^1A01^nTimóteo Leandro^sAraújo#^rND^1A02^nVagner 
Roberto^sBergamo#^rND^1A01^nDouglas Roque^sAndrade#^rND^1A01^nSandra Marcela Mah
echa^sMatsudo#^rND^1A03^nNanci Maria de^sFrança#^rND^1A01^nVictor Keihan Rodrigu
es^sMatsudo#^iA01^1Centro de Estudos do Laboratório de Aptidão Física de São Cae
tano do Sul#^iA02^1Universidade Metodista de Piracicaba^2Pontifícia Universidade
 Católica de Campinas#^iA03^1Universidade Católica de Brasília#^lpt^aEste estudo
 teve como objetivo: 1) verificar a estabilidade do perfil de aptidão física de 
jovens atletas de handebol durante a adolescência; e 2) comparar os resultados c
om a seleção paulista adulta feminina. Para tanto, a amostra foi constituída por
 cinco jovens atletas de handebol feminino que foram seguidas semilongitudinalme
nte por dois anos, com média de idade e tempo de prática inicial e final de 14,2
 ± 1,3 anos, 18,4 ± 10,7 meses e 16,2 ± 1,3 anos, 42,8 ± 10,7 meses, respectivam
ente (12h/semana de treinamento). Na temporada de 1997 quatro atletas foram pré-
selecionadas para a seleção brasileira de cadetes. As variáveis mensuradas foram
: peso corporal (P); altura total (A); impulsão vertical sem (IVS) e com auxílio
 dos membros superiores (IVC); impulsão horizontal (IH); agilidade (SR); velocid
ade (50m) e potência anaeróbica (40seg.), seguindo padronização CELAFISCS. Os co
eficientes de Pearson e Spearman foram significativamente altos e muitos altos (
p < 0,05) para P (0,88), A (0,98 e 0,99), 50m (0,95 e 0,90) e 40seg. (0,87 e 0,9
0). Estes dados permitem concluir que as jovens atletas apresentaram alta estabi
lidade nas variáveis antropométricas, velocidade e potência anaeróbica durante u
m período de dois anos da adolescência, favorecendo a hipótese de que a expectat
iva de sucesso esportivo pode ser predita em idades precoces.#^dnd^i1#^tm^lpt^kD
etecção de talentos^i1#^tm^lpt^kTalento esportivo^i1#^tm^lpt^kEstratégia Z-CELAF
ISCS^i1#^tm^lpt^kEsporte^i1#^tm^lpt^kEstabilidade^i1#^tm^lpt^kAdolescência^i1#^t
m^lpt^kHandebol^i1#^len^aThe purpose of this study was 1) to verify the stabilit
y of the physical fitness profile of young handball athletes during adolescence,
 and 2) to compare these athletes to the São Paulo state handball adult team. Th
e sample comprised five young female handball athletes who were followed-up for 
two years, with mean age and practice time before and after of 14.2 ± 1.3 years-
old, 18.4 ± 10.7 months and 16.2 ± 1.3 years-old, 42.8 ± 10.7 months, respective
ly (12h/week training). Variables measured were: body weight (W); body height (H
); vertical jump without (VJWo) and with help of arms (VJ); long jump (LJ); agil
ity (SR); velocity (50m) and anaerobic power (40seg.), by CELAFISCS standardizat
ion. It was verified that with the exception of VJW and 50m, the young athletes 
showed upper values for all variables. The Pearson and Spearman coefficients wer
e significantly higher and much higher (p < 0.05) for W (0.88), H (0.98 and 0.99
), 50m (0.95 and 0.90) and 40 sec (0.87 and 0.90). Data permit to conclude that 
young athletes showed stability in anthropometric variables, velocity, and anaer
obic power during the adolescence period, thus supporting the hypothesis that th
e expectation of success in sports can be predicted from early age.#^dnd^i2#^tm^
len^kTalent detection^i2#^tm^len^kAthletic talent^i2#^tm^len^kZ-CELAFISCS strate
gy^i2#^tm^len^kSports^i2#^tm^len^kStability^i2#^tm^len^kAdolescence^i2#^tm^len^k
Handball^i2#other#36#v6n3a04.htm#Internet^ihttp://www.scielo.br/scielo.php?scrip
t=sci_arttext&pid=S1517-86922000000300004##
00351000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704012200071002001200193#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#5#1#article#185#<p align="right"><font f
ace="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ARTIGO    ORIGINAL</b></
font></p>     ^cY#v6n3a04.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704003600071002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#6#2#article#185#<p align="right">&nbsp;<
/p>     ^cY#v6n3a04.htm##
00463000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704023400071002001200305#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#7#3#article#185#<p align="left"><font fa
ce="Verdana, Arial, Helvetica, sans-serif" size="4"><b><a name="topo"></a>Estabi
lidade    no progn&oacute;stico do perfil de aptid&atilde;o f&iacute;sica de jov
ens atletas    de handebol</b></font></p>     ^cY#v6n3a04.htm##
00264000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704003500071002001200106#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#8#4#article#185#<p align="left">&nbsp;</
p>     ^cY#v6n3a04.htm##
00413000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704018400071002001200255#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#9#5#article#185#<p align="left"><font fa
ce="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Stability    in the physi
cal fitness profile prognosis of young handball athletes</b></font></p>     ^cY#
v6n3a04.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704003500072002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#10#6#article#185#<p align="left">&nbsp;<
/p>     ^cY#v6n3a04.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704003500072002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#11#7#article#185#<p align="left">&nbsp;<
/p>     ^cY#v6n3a04.htm##
00672000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704044200072002001200514#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#12#8#article#185#<p align="left"><font f
ace="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Vagner    Raso<sup>I</su
p>; Carlos Frederico d&#146;Avila Brito<sup>I</sup>; Tim&oacute;teo    Leandro A
ra&uacute;jo<sup>I</sup>; Vagner Roberto Bergamo<sup>II</sup>; Douglas    Roque 
Andrade<sup>I</sup>; Sandra Marcela Mahecha Matsudo<sup>I</sup>; Nanci    Maria 
de Fran&ccedil;a<sup>III</sup>; Victor Keihan Rodrigues Matsudo<sup>I</sup></b><
/font></p>     ^cY#v6n3a04.htm##
00449000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704021900072002001200291#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#13#9#article#185#<p align="left"><font f
ace="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Centro    de Es
tudos do Laborat&oacute;rio de Aptid&atilde;o F&iacute;sica de S&atilde;o    Cae
tano do Sul &#150; CELAFISCS    ^cY#v6n3a04.htm##
00388000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704015700073002001200230#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#14#10#article#185#<br>   <sup>II</sup>Un
iversidade Metodista de Piracicaba &#150; UNIMEP e Pontif&iacute;cia    Universi
dade Cat&oacute;lica de Campinas &#150; PUCCAMP    ^cY#v6n3a04.htm##
00330000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009900073002001200172#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#15#11#article#185#<br>   <sup>III</sup>U
niversidade Cat&oacute;lica de Bras&iacute;lia &#150; UCB</font></p>     ^cY#v6n
3a04.htm##
00345000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011400073002001200187#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#16#12#article#185#<p><font face="Verdana
" size="2"><a href="#end">Endere&ccedil;o para correspond&ecirc;ncia</a></font><
/p>     ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#17#13#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004400073002001200117#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#18#14#article#185#<p>&nbsp;</p> <hr size
="1" noshade>     ^cY#v6n3a04.htm##
00327000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009600073002001200169#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#19#15#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b></font></p>     ^cY#v6n3a0
4.htm##
01931000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704170000073002001201773#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#20#16#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Este estudo teve    como objetivo: 1) v
erificar a estabilidade do perfil de aptid&atilde;o f&iacute;sica    de jovens a
tletas de handebol durante a adolesc&ecirc;ncia; e 2) comparar os    resultados 
com a sele&ccedil;&atilde;o paulista adulta feminina. Para tanto,    a amostra f
oi constitu&iacute;da por cinco jovens atletas de handebol feminino    que foram
 seguidas semilongitudinalmente por dois anos, com m&eacute;dia de    idade e te
mpo de pr&aacute;tica inicial e final de 14,2 &plusmn; 1,3 anos, 18,4    &plusmn
; 10,7 meses e 16,2 &plusmn; 1,3 anos, 42,8 &plusmn; 10,7 meses, respectivamente
    (12h/semana de treinamento). Na temporada de 1997 quatro atletas foram pr&ea
cute;-selecionadas    para a sele&ccedil;&atilde;o brasileira de cadetes. As var
i&aacute;veis mensuradas    foram: peso corporal (P); altura total (A); impuls&a
tilde;o vertical sem (IVS)    e com aux&iacute;lio dos membros superiores (IVC);
 impuls&atilde;o horizontal    (IH); agilidade (SR); velocidade (50m) e pot&ecir
c;ncia anaer&oacute;bica (40seg.),    seguindo padroniza&ccedil;&atilde;o CELAFI
SCS. Os coeficientes de Pearson e    Spearman foram significativamente altos e m
uitos altos (p &lt 0,05) para P (0,88),    A (0,98 e 0,99), 50m (0,95 e 0,90) e 
40seg. (0,87 e 0,90). Estes dados permitem    concluir que as jovens atletas apr
esentaram alta estabilidade nas vari&aacute;veis    antropom&eacute;tricas, velo
cidade e pot&ecirc;ncia anaer&oacute;bica durante    um per&iacute;odo de dois a
nos da adolesc&ecirc;ncia, favorecendo a hip&oacute;tese    de que a expectativa
 de sucesso esportivo pode ser predita em idades precoces.</font></p>     ^cY#v6
n3a04.htm##
00503000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704027200073002001200345#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#21#17#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><b>Palavras-chave:</b>    Detec&ccedil;
&atilde;o de talentos. Talento esportivo. Estrat&eacute;gia Z-CELAFISCS.    Espo
rte. Estabilidade. Adolesc&ecirc;ncia. Handebol.</font></p> <hr size="1" noshade
>     ^cY#v6n3a04.htm##
00329000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009800073002001200171#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#22#18#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p>     ^cY#v6n3
a04.htm##
01644000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704141300073002001201486#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#23#19#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">The purpose of    this study was 1) to 
verify the stability of the physical fitness profile of    young handball athlet
es during adolescence, and 2) to compare these athletes    to the S&atilde;o Pau
lo state handball adult team. The sample comprised five    young female handball
 athletes who were followed-up for two years, with mean    age and practice time
 before and after of 14.2 &plusmn; 1.3 years-old, 18.4    &plusmn; 10.7 months a
nd 16.2 &plusmn; 1.3 years-old, 42.8 &plusmn; 10.7 months,    respectively (12h/
week training). Variables measured were: body weight (W);    body height (H); ve
rtical jump without (VJWo) and with help of arms (VJ); long    jump (LJ); agilit
y (SR); velocity (50m) and anaerobic power (40seg.), by CELAFISCS    standardiza
tion. It was verified that with the exception of VJW and 50m, the    young athle
tes showed upper values for all variables. The Pearson and Spearman    coefficie
nts were significantly higher and much higher (p &lt 0.05) for W (0.88),    H (0
.98 and 0.99), 50m (0.95 and 0.90) and 40 sec (0.87 and 0.90). Data permit    to
 conclude that young athletes showed stability in anthropometric variables,    v
elocity, and anaerobic power during the adolescence period, thus supporting    t
he hypothesis that the expectation of success in sports can be predicted from   
 early age.</font></p>     ^cY#v6n3a04.htm##
00458000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704022700073002001200300#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#24#20#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><b>Key words:</b>    Talent detection. 
Athletic talent. Z-CELAFISCS strategy. Sports. Stability.    Adolescence. Handba
ll.</font></p> <hr size="1" noshade>     ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#25#21#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#26#22#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00345000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011400073002001200187#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#27#23#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><b>INTRODU&Ccedil;&Atilde;O</b></font><
/p>     ^cY#v6n3a04.htm##
00866000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704063500073002001200708#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#28#24#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">No campo da ci&ecirc;ncia    e do movim
ento o desafio em predizer o futuro tem recebido a aten&ccedil;&atilde;o    de m
uitos pesquisadores<sup>1-4</sup>. Hollmann e Hettinger<sup>5</sup> citam    que
, de 1.000 garotos na faixa et&aacute;ria de 10 anos, apenas um ir&aacute;    ap
resentar valores de <img src="/img/revistas/rbme/v6n3/a04f01.gif" width="22" hei
ght="16"><sub>2max</sub>    de 70ml.kg<sup>-1</sup>.min<sup>-1</sup>, sendo que 
o valor padr&atilde;o referencial    nacional para esta idade &eacute; 46,33ml.k
g<sup>-1</sup>.min<sup>-16</sup>.</font></p>     ^cY#v6n3a04.htm##
00892000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704066100073002001200734#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#29#25#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A hereditariedade    pode afetar a <i>p
erformance</i> de um indiv&iacute;duo durante o per&iacute;odo    de detec&ccedi
l;&atilde;o e de acompanhamento. Wilson e Poster<sup>7</sup> verificaram    que 
pares de g&ecirc;meos monozig&oacute;ticos (MZ) seguidos do primeiro ao    nono 
ano de vida apresentam valores similares para a altura (r = 0,86 a 0,95)    e pe
so corporal (r = 0,35 a 0,89). Os valores de correla&ccedil;&atilde;o da    idad
e de menarca de pares de g&ecirc;meos MZ s&atilde;o maiores (0,80) que a    de p
ares de g&ecirc;meos dizig&oacute;ticos (0,60)<sup>8</sup>.</font></p>     ^cY#v
6n3a04.htm##
00908000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704067700073002001200750#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#30#26#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">De acordo com Malinowski<sup>9</sup>,  
  a variabilidade gen&eacute;tica &eacute; respons&aacute;vel pelo desenvolvimen
to    dos indiv&iacute;duos excepcionais, como, por exemplo, aqueles que apresen
tam    caracter&iacute;sticas que os fazem muito diferentes da maioria da popula
&ccedil;&atilde;o,    al&eacute;m do resultado de um programa de treinamento (fe
n&oacute;tipo) que    n&atilde;o &eacute; dependente apenas do gen&oacute;tipo e
 do ambiente, mas    tamb&eacute;m est&aacute; relacionado com a sensibilidade c
om que o gen&oacute;tipo    responde ao ambiente (treinamento)<sup>4</sup>.</fon
t></p>     ^cY#v6n3a04.htm##
01289000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704105800073002001201131#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#31#27#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Esta caracter&iacute;stica    de hetero
geneidade na treinabilidade est&aacute; relacionada com o gen&oacute;tipo    e &
eacute; referida como intera&ccedil;&atilde;o treinamento-gen&oacute;tipo10.    
Simoneau <i>et al</i>.<sup>11</sup> observaram que aproximadamente 70% da pot&ec
irc;ncia    anaer&oacute;bica l&aacute;ctica &eacute; dependente da hereditaried
ade, enquanto    a magnitude de resposta da pot&ecirc;ncia aer&oacute;bica m&aac
ute;xima ao treinamento    de <i>endurance</i> &eacute; de 77%<sup>12</sup>. Tho
mis <i>et al</i>.<sup>10</sup>    verificaram que o ganho de for&ccedil;a muscul
ar obtido atrav&eacute;s do teste    de uma repeti&ccedil;&atilde;o m&aacute;xim
a (1-RM) ap&oacute;s 10 semanas de    um programa de treinamento de resist&ecirc
;ncia para os flexores do cotovelo    em pares de g&ecirc;meos dizig&oacute;tico
s foi metade daquele observado em    g&ecirc;meos MZ, indicando uma contribui&cc
edil;&atilde;o moderada dos fatores    gen&eacute;ticos.</font></p>     ^cY#v6n3
a04.htm##
00918000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704068700073002001200760#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#32#28#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Mas durante o processo    de detec&cced
il;&atilde;o de talentos, a sele&ccedil;&atilde;o do indiv&iacute;duo    que apr
esenta os melhores resultados em um determinado momento n&atilde;o garante    ne
cessariamente a manuten&ccedil;&atilde;o deste mesmo posto durante todo o    per
&iacute;odo da vida quando comparado com indiv&iacute;duos de faixas et&aacute;r
ias    correspondentes. Por isso, v&aacute;rios estudos t&ecirc;m sido elaborado
s nos    &uacute;ltimos anos para saber se a boa <i>performance</i> de uma crian
&ccedil;a    aos 10-12 anos de idade pode ser mantida na vida adulta<sup>13-15</
sup>.</font></p>     ^cY#v6n3a04.htm##
01410000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704117900073002001201252#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#33#29#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Brito <i>et al</i>.<sup>16</sup>    aco
mpanharam longitudinalmente um grupo de meninos dos 9,14 &plusmn; 1,86 aos    14
,0 &plusmn; 1,88 anos de idade e analisaram as caracter&iacute;sticas das    var
i&aacute;veis antropom&eacute;tricas durante esse per&iacute;odo. Puderam    obs
ervar que a maioria dos valores obtidos na adolesc&ecirc;ncia de peso corporal, 
   altura, circunfer&ecirc;ncias de bra&ccedil;o e perna, estava sendo explicada
    pelos resultados observados na inf&acirc;ncia. Ara&uacute;jo <i>et al</i>.<s
up>17</sup>    verificaram altos e significativos valores de estabilidade na tra
nsi&ccedil;&atilde;o    da inf&acirc;ncia para a adolesc&ecirc;ncia em um grupo 
de 61 garotas. Em outro    estudo, tamb&eacute;m foi observado que crian&ccedil;
as sob risco nutricional    localizadas na m&eacute;dia da popula&ccedil;&atilde
;o da mesma caracter&iacute;stica    apresentam melhores resultados de estabilid
ade para as vari&aacute;veis antropom&eacute;tricas,    agilidade e for&ccedil;a
 de membros superiores que crian&ccedil;as localizadas    nas extremidades da cu
rva<sup>18</sup>.</font></p>     ^cY#v6n3a04.htm##
01291000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704106000073002001201133#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#34#30#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Estes estudos procuram    determinar o 
<i>tracking</i> ou <i>stability</i>, que pode ser definido como    a capacidade 
que um indiv&iacute;duo possui para manter a mesma posi&ccedil;&atilde;o    pera
nte o grupo durante determinado per&iacute;odo de tempo<sup>3,19</sup>.    Eles 
se caracterizam pela monitoriza&ccedil;&atilde;o de uma determinada vari&aacute;
vel    durante um per&iacute;odo da vida, como, por exemplo, na transi&ccedil;&a
tilde;o    da inf&acirc;ncia para a adolesc&ecirc;ncia. Deste modo, t&atilde;o i
mportante    quanto selecionar &eacute; determinar a possibilidade de estabilida
de dos resultados    observados. Portanto, este estudo teve como objetivos: 1) v
erificar a estabilidade    de vari&aacute;veis de aptid&atilde;o f&iacute;sica e
 indiretamente a expectativa    de sucesso esportivo de jovens atletas de handeb
ol durante o per&iacute;odo    da adolesc&ecirc;ncia; e 2) comparar os resultado
s com a sele&ccedil;&atilde;o    paulista adulta feminina.</font></p>     ^cY#v6
n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#35#31#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00346000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011500073002001200188#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#36#32#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><b>MATERIAL E M&Eacute;TODOS</b></font>
</p>     ^cY#v6n3a04.htm##
00328000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009700073002001200170#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#37#33#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><b>Amostra</b></font></p>     ^cY#v6n3a
04.htm##
00668000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704043700073002001200510#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#38#34#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A amostra foi constitu&iacute;da    por
 cinco jovens atletas de handebol feminino que foram seguidas semilongitudinalme
nte    por dois anos. Um informe de consentimento que explicava o desenvolviment
o experimental    do estudo e permitia a utiliza&ccedil;&atilde;o dos dados cole
tados foi obtido    de cada atleta e do seu respectivo representante legal.</fon
t></p>     ^cY#v6n3a04.htm##
00830000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704059900073002001200672#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#39#35#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">No in&iacute;cio    do estudo (setembro
/1995) as m&eacute;dias de idade e de tempo de pr&aacute;tica    esportiva foram
 de 14,2 &plusmn; 1,3 anos e de 18,4 &plusmn; 10,7 meses, respectivamente.    No
 final (setembro/1997), foram de 16,2 &plusmn; 1,3 anos e de 42,8 &plusmn;    10
,7 meses, respectivamente. As atletas treinavam cerca de 12h por semana. Todas  
  as atletas no in&iacute;cio do estudo j&aacute; haviam tido o primeiro fluxo  
  menstrual, sendo a idade m&eacute;dia de menarca de 12,5 &plusmn; 0,4 anos.</f
ont></p>     ^cY#v6n3a04.htm##
00934000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704070300073002001200776#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#40#36#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Durante o per&iacute;odo    do estudo a
s atletas participaram dos Jogos Regionais da regi&atilde;o de Campinas,    em q
ue se sagraram campe&atilde;s no ano de 1997 e ficaram em s&eacute;timo    lugar
 nos Jogos Abertos do Interior do Estado de S&atilde;o Paulo ocorridos    em Bra
gan&ccedil;a Paulista no mesmo ano. Tamb&eacute;m disputaram o campeonato    pau
lista da modalidade na categoria j&uacute;nior e posicionaram-se em quarto    lu
gar. Ressalta-se que quatro das atletas participantes do presente estudo foram  
  pr&eacute;-selecionadas para a sele&ccedil;&atilde;o brasileira de cadetes na 
   temporada de 1997.</font></p>     ^cY#v6n3a04.htm##
00328000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009700073002001200170#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#41#37#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><b>Medidas</b></font></p>     ^cY#v6n3a
04.htm##
00893000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704066200073002001200735#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#42#38#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">As vari&aacute;veis    mensuradas no in
&iacute;cio e no final do estudo foram: altura total, peso corporal    e for&cce
dil;a de membros inferiores: atrav&eacute;s do teste de impuls&atilde;o    verti
cal sem (IVS) e com aux&iacute;lio dos membros superiores (IVC) e impuls&atilde;
o    horizontal (IH); agilidade: atrav&eacute;s do teste de <i>shuttle-run</i> (
SR);    velocidade: atrav&eacute;s do teste de 50 metros (50m); e pot&ecirc;ncia
 anaer&oacute;bica:    atrav&eacute;s do teste de 40 segundos (40 seg.). Todos o
s testes seguiram a    padroniza&ccedil;&atilde;o CELAFISCS.</font></p>     ^cY#
v6n3a04.htm##
00357000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704012600073002001200199#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#43#39#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><b>An&aacute;lise    estat&iacute;stica
</b></font></p>     ^cY#v6n3a04.htm##
00808000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704057700073002001200650#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#44#40#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Para interpretar    os resultados foi u
tilizada a estat&iacute;stica descritiva atrav&eacute;s da    medida de tend&eci
rc;ncia central (m&eacute;dia aritm&eacute;tica) e de dispers&atilde;o    (desvi
o padr&atilde;o). O &iacute;ndice <i>z</i> foi determinado para localizar    o p
osicionamento das jovens atletas assim como das atletas da sele&ccedil;&atilde;o
    paulista de handebol feminino na curva de Gauss, de acordo com crit&eacute;r
ios    padr&otilde;es de refer&ecirc;ncia<sup>20</sup>.</font></p>     ^cY#v6n3a
04.htm##
00386000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704015500073002001200228#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#45#41#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os valores de z    foram calculados con
forme a f&oacute;rmula que segue:</font></p>     ^cY#v6n3a04.htm##
00331000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704010000073002001200173#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#46#42#article#185#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a04f02.gif" width="61" height="39"></p>     ^cY#v6
n3a04.htm##
00853000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704062200073002001200695#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#47#43#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">onde, <i>z</i>    = dist&acirc;ncia da 
m&eacute;dia da popula&ccedil;&atilde;o ou crit&eacute;rio    padr&atilde;o de r
efer&ecirc;ncia, em unidades de desvio padr&atilde;o; X =    resultado do sujeit
o; u = m&eacute;dia da popula&ccedil;&atilde;o ou crit&eacute;rio    padr&atilde
;o de refer&ecirc;ncia para o indiv&iacute;duo da mesma idade e sexo;    <font f
ace="Symbol">s</font> = desvio padr&atilde;o da popula&ccedil;&atilde;o    ou do
 crit&eacute;rio padr&atilde;o de refer&ecirc;ncia para o indiv&iacute;duo    da
 mesma idade e sexo.</font></p>     ^cY#v6n3a04.htm##
00911000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704068000073002001200753#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#48#44#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A an&aacute;lise    dos dados da primei
ra (set/1995) com a segunda avalia&ccedil;&atilde;o (set/1997)    foi feita com 
o teste <i>t</i> de Student para amostras dependentes, al&eacute;m    do teste n
&atilde;o param&eacute;trico de Wilcoxon. E a compara&ccedil;&atilde;o    dos re
sultados das jovens atletas no 1º e 2º momento com os dados das atletas    da se
le&ccedil;&atilde;o paulista (jovens atletas set/95 x sele&ccedil;&atilde;o    p
aulista e jovens atletas set/97 x sele&ccedil;&atilde;o paulista) foi determinad
a    atrav&eacute;s do teste<i> t </i>de Student para amostras independentes. </
font></p>     ^cY#v6n3a04.htm##
00871000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704064000073002001200713#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#49#45#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A determina&ccedil;&atilde;o    do n&ia
cute;vel de associa&ccedil;&atilde;o entre as avalia&ccedil;&otilde;es    (set/1
995 x set/1997) foi feita atrav&eacute;s do coeficiente de correla&ccedil;&atild
e;o    linear de Pearson para medidas gausianas (r) acompanhada do coeficiente d
e explica&ccedil;&atilde;o    (R), para determinar quanto os resultados obtidos 
no momento final (set/1997)    estariam sendo explicados pelos valores observado
s no momento inicial (set/1995).    Tamb&eacute;m foi utilizado o coeficiente de
 correla&ccedil;&atilde;o de Spearman.</font></p>     ^cY#v6n3a04.htm##
00865000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704063400073002001200707#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#50#46#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os valores da sele&ccedil;&atilde;o    
paulista de handebol adulta feminina<sup>21</sup> foram utilizados como par&acir
c;metros    <i>gold standard</i> da aptid&atilde;o f&iacute;sica e indiretamente
 determinaram    o sucesso esportivo. Para enriquecer a discuss&atilde;o tamb&ea
cute;m foram    empregados os valores de <i>z</i> da sele&ccedil;&atilde;o brasi
leira de handebol<sup>22</sup>.    Com exce&ccedil;&atilde;o dos valores de <i>z
</i>, todos os demais tratamentos    foram calculados pelo <i>software Graph Pad
 Instat</i> (vers&atilde;o 2.0).</font></p>     ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#51#47#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00331000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704010000073002001200173#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#52#48#article#185#<p><font size="3" face
="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^cY#v6
n3a04.htm##
01285000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704105400073002001201127#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#53#49#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Atrav&eacute;s    do coeficiente de var
ia&ccedil;&atilde;o foi verificado que a distribui&ccedil;&atilde;o    dos valor
es absolutos (m&eacute;dia &plusmn; desvio padr&atilde;o) diferiu muito    pouco
 entre os dois per&iacute;odos distintos das avalia&ccedil;&otilde;es,    de 4,6
% a 18,0%. Isto indica que os resultados foram relativamente constantes    duran
te todo o per&iacute;odo do estudo. Ao contr&aacute;rio, os grandes desvios    p
adr&otilde;es em compara&ccedil;&atilde;o com as m&eacute;dias dos valores    re
lativos (z) n&atilde;o foram normalmente distribu&iacute;dos, demonstrando    va
ria&ccedil;&atilde;o percentual de 19,4% a 90,0%, sugerindo o emprego do teste  
  n&atilde;o param&eacute;trico de Wilcoxon para analisar a evolu&ccedil;&atilde
;o    dos resultados nos dois per&iacute;odos e o coeficiente de correla&ccedil;
&atilde;o    de Spearman, que determinou o n&iacute;vel de associa&ccedil;&atild
e;o entre    os resultados como os mais apropriados.</font></p>     ^cY#v6n3a04.
htm##
00554000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704032300073002001200396#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#54#50#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os valores absolutos    e relativos das
 vari&aacute;veis peso corporal e altura referentes aos dois    momentos do estu
do e a sele&ccedil;&atilde;o paulista s&atilde;o apresentados    na <a href="#ta
b01">tabela 1</a>. </font></p> <a name="tab01"></a>      ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#55#51#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#56#52#article#185#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a04t01.gif"></p>     ^cY#v6n3a04.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#57#53#article#185#<p align="center">&nbs
p;</p>     ^cY#v6n3a04.htm##
00809000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704057800073002001200651#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#58#54#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Com exce&ccedil;&atilde;o    do valor a
bsoluto da vari&aacute;vel altura, que se diferenciou significativamente    (p &
lt 0,05) entre os per&iacute;odos distintos das avalia&ccedil;&otilde;es,    n&a
tilde;o foram constatadas diferen&ccedil;as estatisticamente significativas    e
ntre os valores absolutos das demais associa&ccedil;&otilde;es entre os per&iacu
te;odos    e a sele&ccedil;&atilde;o paulista. A mesma caracter&iacute;stica tam
b&eacute;m    foi observada para os valores de <i>z</i>.</font></p>     ^cY#v6n3
a04.htm##
00864000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704063300073002001200706#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#59#55#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">As jovens atletas    apresentaram tend&
ecirc;ncia de resultados absolutos superiores aos da sele&ccedil;&atilde;o    pa
ulista na vari&aacute;vel altura (set/1995: 163,4cm e set/1997: 168,0cm) e    no
 peso corporal (somente) no final do estudo (60,1kg). Embora n&atilde;o signific
ativos,    os valores de <i>z</i> das jovens atletas demonstraram superioridade 
aos das    atletas da sele&ccedil;&atilde;o paulista, sendo que no final do estu
do (set/1997)    a diferen&ccedil;a foi maior, o que pode sugerir um processo de
 amadurecimento    mais tardio.</font></p>     ^cY#v6n3a04.htm##
00789000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704055800073002001200631#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#60#56#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Fazendo uma compara&ccedil;&atilde;o   
 entre os dados das jovens atletas com os apresentados pela sele&ccedil;&atilde;
o    brasileira de handebol adulta feminina analisada por Gon&ccedil;alves <i>et
    al</i>.<sup>22</sup>, com m&eacute;dia de idade de 24,0 &plusmn; 3,8 anos, f
oi    observada similaridade entre os valores de <i>z</i> tanto para o peso corp
oral,    que &eacute; de 1,72, como para a altura, 1,52, neste &uacute;ltimo tam
b&eacute;m    para o valor absoluto.</font></p>     ^cY#v6n3a04.htm##
00572000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704034100073002001200414#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#61#57#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Como pode ser observado    na <a href="
#tab02">tabela 2</a>, seja analisada absoluta ou relativamente,    em geral ambo
s os grupos apresentaram resultados similares nas vari&aacute;veis    de for&cce
dil;a muscular de membros inferiores.</font></p> <a name="tab02"></a>      ^cY#v
6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#62#58#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#63#59#article#185#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a04t02.gif"></p>     ^cY#v6n3a04.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#64#60#article#185#<p align="center">&nbs
p;</p>     ^cY#v6n3a04.htm##
00622000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704039100073002001200464#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#65#61#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Houve tend&ecirc;ncia    de maiores val
ores absolutos e relativos para as jovens atletas nos dois per&iacute;odos    (e
xceto para IVC, set/1995: 38,4 &plusmn; 6,6cm e set/1997: 2,12) quando comparada
s    com a sele&ccedil;&atilde;o paulista, principalmente no caso do teste de im
puls&atilde;o    horizontal. </font></p>     ^cY#v6n3a04.htm##
00977000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704074600073002001200819#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#66#62#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Embora ambos os    grupos (jovens atlet
as e sele&ccedil;&atilde;o paulista) apresentassem valores    de z inferiores ao
s da sele&ccedil;&atilde;o brasileira (3,36), as jovens atletas    tiveram no mo
mento final do estudo (set/1997) resultados absolutos (220,6 &plusmn;    13,8cm)
 similares aos da sele&ccedil;&atilde;o brasileira adulta (224,2 &plusmn;    11,
7cm). Raso e Bergamo<sup>23</sup> registraram que atletas de handebol feminino  
  na faixa et&aacute;ria de 13 a 15 anos de idade demonstraram melhor <i>perform
ance</i>    no teste de impuls&atilde;o horizontal que garotas envolvidas apenas
 em aulas    de educa&ccedil;&atilde;o f&iacute;sica curricular.</font></p>     
^cY#v6n3a04.htm##
00997000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704076600073002001200839#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#67#63#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">As atletas campe&atilde;s    mundiais d
e basquete feminino na Austr&aacute;lia em 1994 apresentaram &iacute;ndice    z 
muito superior aos deste estudo e aos das atletas da sele&ccedil;&atilde;o    pa
ulista, 2,8 para IVS, 3,8 para IVC e 3,7 para IH<sup>4</sup>. O mesmo pode    se
r observado nas atletas da sele&ccedil;&atilde;o brasileira de voleibol feminino
    com experi&ecirc;ncia em campeonatos mundiais e ol&iacute;mpicos, que tivera
m    &iacute;ndice <i>z</i> de 3,3, 4,1 e 3,9 para IVS, IVC e IH, respectivament
e<sup>24</sup>,    demonstrando que tanto as jovens atletas como as atletas da s
ele&ccedil;&atilde;o    paulista tiveram menores resultados, independente da med
ida.</font></p>     ^cY#v6n3a04.htm##
00791000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704056000073002001200633#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#68#64#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Podem ser observados    na <a href="#ta
b03">tabela 3</a> os resultados absolutos e os valores de <i>z</i>    das vari&a
acute;veis agilidade, velocidade e pot&ecirc;ncia anaer&oacute;bica    das joven
s atletas e da sele&ccedil;&atilde;o paulista. Devido os testes de    agilidade 
estarem em tempo de <i>performance</i>, quanto menor o tempo, melhor    o result
ado; e assim, lembramos que o &iacute;ndice <i>z</i> &eacute; apresentado    com
 sinal negativo.</font></p> <a name="tab03"></a>      ^cY#v6n3a04.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#69#65#article#185#<p align="center">&nbs
p;</p>     ^cY#v6n3a04.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#70#66#article#185#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a04t03.gif"></p>     ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#71#67#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00589000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704035800073002001200431#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#72#68#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Como est&aacute;    indicado na <a href
="#tab03">tabela 3</a>, as jovens atletas apresentaram valores    absolutos de p
ot&ecirc;ncia anaer&oacute;bica no in&iacute;cio do estudo (set/1995)    estatis
ticamente superiores (p &lt 0,05) aos da sele&ccedil;&atilde;o paulista.    </fo
nt></p>     ^cY#v6n3a04.htm##
00827000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704059600073002001200669#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#73#69#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Exceto o que foi    descrito anteriorme
nte, tanto os valores absolutos como os relativos das jovens    atletas para as 
vari&aacute;veis agilidade e pot&ecirc;ncia anaer&oacute;bica    demonstraram te
nd&ecirc;ncia de superioridade nos dois momentos do estudo, mas    principalment
e em set/1997, quando os resultados relativos foram praticamente    o dobro daqu
eles apresentados pela sele&ccedil;&atilde;o paulista. Quanto &agrave;    veloci
dade, praticamente nenhuma diferen&ccedil;a foi observada entre os grupos.</font
></p>     ^cY#v6n3a04.htm##
01137000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704090600073002001200979#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#74#70#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os resultados de    velocidade foram si
milares aos da sele&ccedil;&atilde;o brasileira de voleibol    feminino (&#150;1
,50). Entretanto, os valores de z das jovens atletas, sele&ccedil;&atilde;o    p
aulista, sele&ccedil;&atilde;o brasileira de voleibol feminino e da sele&ccedil;
&atilde;o    brasileira de basquete masculino (&#150;1,40 para agilidade e &#150
;1,30 para    velocidade) foram inferiores aos da sele&ccedil;&atilde;o brasilei
ra de basquete    feminino campe&atilde; mundial: &#150;2,80 para velocidade<sup
>4</sup>. No entanto,    esta e todas as outras sele&ccedil;&otilde;es anteriorm
ente citadas apresentam    valores de <i>z</i> para a agilidade muito inferiores
 aos das jovens atletas:    &#150;3,01. Assim, as jovens atletas apresentaram me
lhores resultados na agilidade,    independente da idade e sexo.</font></p>     
^cY#v6n3a04.htm##
00644000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704041300073002001200486#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#75#71#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Em rela&ccedil;&atilde;o    aos coefici
entes de correla&ccedil;&atilde;o, as vari&aacute;veis antropom&eacute;tricas   
 apresentaram valores significativos tanto no peso corporal como na altura, que 
   variaram de alto (0,70) a muito alto (0,99), como pode ser observado na <a hr
ef="#tab04">tabela    4</a>. </font></p> <a name="tab04"></a>      ^cY#v6n3a04.h
tm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#76#72#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#77#73#article#185#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a04t04.gif"></p>     ^cY#v6n3a04.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#78#74#article#185#<p align="center">&nbs
p;</p>     ^cY#v6n3a04.htm##
00570000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704033900073002001200412#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#79#75#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Isso significa    que 96% dos valores a
bsolutos (Pearson) da altura obtidos no momento final do    estudo (set/1997) po
dem ser explicados pelos valores observados na primeira    avalia&ccedil;&atilde
;o (set/1995), e em 78% para os valores de peso corporal.</font></p>     ^cY#v6n
3a04.htm##
01065000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704083400073002001200907#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#80#76#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Dados da literatura    t&ecirc;m demons
trado que as vari&aacute;veis antropom&eacute;tricas s&atilde;o    as que aprese
ntam os maiores valores de estabilidade, independente do per&iacute;odo    de ob
serva&ccedil;&atilde;o<sup>3</sup>. Brito <i>et al</i>.<sup>25</sup> verificaram
    valores de 0,84 no peso corporal e 0,91 na altura de meninos de uma regi&ati
lde;o    de baixo n&iacute;vel socioecon&ocirc;mico no per&iacute;odo de transi&
ccedil;&atilde;o    da inf&acirc;ncia para a adolesc&ecirc;ncia (9,52 &plusmn; 1
,72 anos a 14,7    &plusmn; 1,87 anos). Outros estudos como os de Parizkov&aacut
e;26, Ara&uacute;jo    <i>et al</i>.27 e Matsudo <i>et al</i>.<sup>28</sup> corr
oboram os presentes    achados, por&eacute;m por intervalos bem maiores.</font><
/p>     ^cY#v6n3a04.htm##
00946000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704071500073002001200788#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#81#77#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Nenhuma das vari&aacute;veis    de for&
ccedil;a de membros inferiores demonstrou valores estatisticamente significativo
s.    A vari&aacute;vel impuls&atilde;o vertical sem aux&iacute;lio dos membros 
superiores    (IVS) foi a &uacute;nica que n&atilde;o apresentou estabilidade en
tre os per&iacute;odos    analisados, tendo somente 36% e 0,6% (valores absoluto
s e relativos, respectivamente)    dos valores obtidos na segunda avalia&ccedil;
&atilde;o (set/1997) explicados    pelos resultados observados na primeira avali
a&ccedil;&atilde;o (set/1995),    como pode ser observado na <a href="#tab05">ta
bela 5</a>.</font></p> <a name="tab05"></a>      ^cY#v6n3a04.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#82#78#article#185#<p align="center">&nbs
p;</p>     ^cY#v6n3a04.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#83#79#article#185#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a04t05.gif"></p>     ^cY#v6n3a04.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#84#80#article#185#<p align="left">&nbsp;
</p>     ^cY#v6n3a04.htm##
00963000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704073200073002001200805#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#85#81#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Ao contr&aacute;rio,    os coeficientes
 de correla&ccedil;&atilde;o da vari&aacute;vel impuls&atilde;o    vertical com 
aux&iacute;lio dos bra&ccedil;os (IVC) variaram de moderado (Pearson:    0,65) a
 alto (Spearman: 0,70), indicando que 42% dos valores absolutos e 53%    dos val
ores relativos alcan&ccedil;ados em setembro/1997 poderiam ser explicados    pel
os valores observados na avalia&ccedil;&atilde;o de 1995 (<a href="#tab05">tabel
a    5</a>). No teste de impuls&atilde;o horizontal foi verificado 0,46 para os 
valores    absolutos e 0,38 para os relativos, enquanto para Spearman esses coef
icientes    foram de 0,10 e 0,60, respectivamente.</font></p>     ^cY#v6n3a04.ht
m##
01189000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704095800073002001201031#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#86#82#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Brito <i>et al</i>.<sup>29</sup>    ver
ificaram valores similares no coeficiente de correla&ccedil;&atilde;o linear    
de Pearson (0,65) do IVC em garotos de uma regi&atilde;o de baixo n&iacute;vel  
  socioecon&ocirc;mico na transi&ccedil;&atilde;o da inf&acirc;ncia (9,52 &plusm
n;    1,72 anos) para a adolesc&ecirc;ncia (14,7 &plusmn; 1,87 anos) e superiore
s    aos do presente estudo quando se analisou a impuls&atilde;o horizontal (0,7
3).    Outros estudos analisaram a for&ccedil;a de membros inferiores somente no
 per&iacute;odo    da adolesc&ecirc;ncia. Espenschade<sup>30</sup> acompanhou um
 grupo de garotos    na faixa et&aacute;ria de 13 a 16 anos e observou valores d
e 0,48. Beunen <i>et    al</i>.31 e Ponnet <i>et al</i>.<sup>32</sup> verificara
m correla&ccedil;&otilde;es    altas durante este per&iacute;odo da vida, sendo 
de 0,71 e 0,87, respectivamente.    </font></p>     ^cY#v6n3a04.htm##
01094000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704086300073002001200936#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#87#83#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Como pode ser observado    na <a href="
#tab06">tabela 6</a>, com exce&ccedil;&atilde;o do teste de 40seg.    que aprese
ntou correla&ccedil;&atilde;o muito alta e significativa tanto como    medido po
r Pearson (0,94) como por Spearman (0,90), o n&iacute;vel de associa&ccedil;&ati
lde;o    entre os dois momentos distintos das avalia&ccedil;&otilde;es (set/1995
 x set/1997)    foi muito alto e significativo para as vari&aacute;veis agilidad
e (SR) e velocidade    (50m), tanto para os valores absolutos como para os relat
ivos (z). Foi verificado    que 94% e 92% dos valores absolutos e relativos, res
pectivamente, obtidos para    a agilidade em setembro de 1997 podem ser explicad
os pelos valores observados    na avalia&ccedil;&atilde;o de setembro de 1995. <
/font></p> <a name="tab06"></a>      ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#88#84#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#89#85#article#185#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a04t06.gif"></p>     ^cY#v6n3a04.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#90#86#article#185#<p align="center">&nbs
p;</p>     ^cY#v6n3a04.htm##
01250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704101900073002001201092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#91#87#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os dados de agilidade    e velocidade o
btidos no presente estudo s&atilde;o superiores aos apresentados    por Branta <
i>et al</i>.<sup>33</sup>, de 0,70, Ara&uacute;jo <i>et al</i>.<sup>17</sup>,   
 de 0,28 e 0,33, respectivamente, Brito <i>et al</i>.<sup>19</sup>, de 0,50 e   
 0,55, na ordem, e tamb&eacute;m quando s&atilde;o corrigidos pelo peso corporal
    e pela altura de acordo com Andrade <i>et al</i>.<sup>15</sup>, que verifica
ram    correla&ccedil;&otilde;es de 0,84 e 0,83 e 0,77 e 0,75, respectivamente, 
ou    ainda quando s&atilde;o analisados conforme a distribui&ccedil;&atilde;o n
a    curva de Gauss, em que os valores concentrados abaixo da m&eacute;dia (&lt 
&#150;1DP)    tiveram correla&ccedil;&atilde;o de 0,37, na m&eacute;dia (&#150;1
DP <u>&lt</u>    a <u>&lt</u> +1DP) de 0,23 e acima da m&eacute;dia (&gt 1DP) ig
ual a 0,1528;    sempre lembrando que esses autores acompanharam por intervalos 
de tempo maiores.</font></p>     ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#92#88#article#185#<p>&nbsp;</p>     ^cY#
v6n3a04.htm##
00337000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704010600073002001200179#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#93#89#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><b>DISCUSS&Atilde;O</b></font></p>     
^cY#v6n3a04.htm##
01086000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704085500073002001200928#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#94#90#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Estudos pr&eacute;vios    t&ecirc;m dem
onstrado que o peso e a altura corporal<sup>3,14,16,34</sup>, a    agilidade e a
 velocidade<sup>31,33</sup>, assim como a for&ccedil;a de membros    inferiores<
sup>30,32</sup>, tendem a se estabilizar na transi&ccedil;&atilde;o    da inf&ac
irc;ncia para a adolesc&ecirc;ncia e no per&iacute;odo da adolesc&ecirc;ncia.   
 Entretanto, nenhum estudo analisou as caracter&iacute;sticas deste fen&ocirc;me
no    em atletas. Assim, o presente estudo &eacute; o primeiro a observar a esta
bilidade    das vari&aacute;veis de aptid&atilde;o f&iacute;sica em atletas com 
o intuito    de verificar se a expectativa de sucesso esportivo anteriormente pr
ognosticada<sup>35</sup>    &eacute; mantida durante o per&iacute;odo da adolesc
&ecirc;ncia. </font></p>     ^cY#v6n3a04.htm##
00685000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704045400073002001200527#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#95#91#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Embora baseado    em um intervalo de te
mpo relativamente pequeno, os nossos resultados forneceram    fortes evid&ecirc;
ncias de que a capacidade de <i>performance</i> tende a se    estabilizar durant
e o per&iacute;odo da adolesc&ecirc;ncia e ent&atilde;o pode    se pressupor que
 os progn&oacute;sticos feitos no in&iacute;cio deste per&iacute;odo    foram ma
is seguros. </font></p>     ^cY#v6n3a04.htm##
01032000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704080100073002001200874#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#96#92#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Foram observadas    correla&ccedil;&oti
lde;es de Pearson para os valores absolutos e relativos que    variaram de -0,19
 a 0,98 e de -0,10 a 0,93, respectivamente, enquanto os coeficientes    calculad
os por Spearman foram de &#150;0,20 a 0,99, tanto para os valores absolutos    c
omo para os relativos. Bloom<sup>2</sup> define uma vari&aacute;vel est&aacute;v
el    como sendo aquela que exibe correla&ccedil;&atilde;o maior que 0,50 para d
uas    medidas obtidas num per&iacute;odo m&iacute;nimo de um ano. Contudo, Mali
na<sup>3</sup>    descreve que uma correla&ccedil;&atilde;o menor que 0,30 se ca
racteriza por    uma estabilidade baixa e aquela que apresenta valores entre 0,3
0 e 0,60 seria    considerada moderada.</font></p>     ^cY#v6n3a04.htm##
01184000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704095300073002001201026#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#97#93#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">De acordo com o    crit&eacute;rio adot
ado por Malina<sup>3</sup>, presume-se que todos os valores    superiores a 0,60
 apresentem caracter&iacute;stica de estabilidade alta. Neste    caso, com exce&
ccedil;&atilde;o das vari&aacute;veis IVS, que apresentou estabilidade    baixa 
para os valores absolutos e relativos (Pearson: &#150;0,19 e 0,08; Spearman:    
&#150;0,20 e &#150;0,10, respectivamente), e IH, que foi baixa (Spearman: 0,10  
  para os valores absolutos) e moderada (Pearson: 0,46 e 0,38, respectivamente; 
   e Spearman 0,60 para z), todas as demais vari&aacute;veis foram altas e signi
ficativas.    &Eacute; interessante notar que a varia&ccedil;&atilde;o de todos 
os valores    significativos obtidos no momento final do estudo (set/1997) estar
iam sendo    explicados por 59% a 96% dos valores observados na primeira avalia&
ccedil;&atilde;o    (set/1995).</font></p>     ^cY#v6n3a04.htm##
01216000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704098500073002001201058#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#98#94#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A hereditariedade,    a variabilidade g
en&eacute;tica e os fatores ambientais podem determinar os    padr&otilde;es de 
resposta de um indiv&iacute;duo ao treinamento. Matsudo<sup>4</sup>    cita que 
um indiv&iacute;duo que apresenta resposta tardia, mas alta, pode ter    sua cap
acidade subestimada no in&iacute;cio do processo de treinamento, enquanto    out
ro que apresenta uma resposta precoce, por&eacute;m com posterior progress&atild
e;o    baixa, pode ter seu potencial de <i>performance</i> superestimado. Neste 
sentido,    os indicadores de <i>performance</i> relacionados com a detec&ccedil
;&atilde;o    de talentos s&atilde;o muito mais dependentes da idade biol&oacute
;gica (que    pode ser medida atrav&eacute;s do desenvolvimento das caracter&iac
ute;sticas    sexuais secund&aacute;rias, idade de menarca, ou ainda, pela idade
 &oacute;ssea)    que da idade cronol&oacute;gica<sup>36</sup>.</font></p>     ^
cY#v6n3a04.htm##
01297000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704106600073002001201139#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#99#95#article#185#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Foi muito significativo    o fato de qu
atro das atletas participantes do presente estudo terem sido pr&eacute;-selecion
adas    para a sele&ccedil;&atilde;o brasileira de cadetes na temporada de 1997,
 pois    confirma o alto n&iacute;vel esportivo e respalda os dados apresentados
 por    n&oacute;s em outro estudo35. Assim, os dados permitem supor que o curto
 espa&ccedil;o    de tempo de acompanhamento entre as medidas (dois anos), o per
&iacute;odo da    vida em que os sujeitos se encontravam (adolesc&ecirc;ncia), a
 condi&ccedil;&atilde;o    de todas j&aacute; terem tido a matura&ccedil;&atilde
;o biol&oacute;gica (medida    atrav&eacute;s da idade de menarca), associados a
o fato de se tratarem de atletas    que apresentam valores de aptid&atilde;o f&i
acute;sica superiores &agrave; m&eacute;dia    da popula&ccedil;&atilde;o e simi
lares aos de atletas de alto n&iacute;vel,    sejam hip&oacute;teses para explic
ar a estabilidade dos valores entre os dois    per&iacute;odos. </font></p>     
^cY#v6n3a04.htm##
01557000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704132500074002001201399#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#100#96#article#185#<p><font face="Verdan
a, Arial, Helvetica, sans-serif" size="2">Malina<sup>3</sup>    comenta que exis
te uma rela&ccedil;&atilde;o inversamente proporcional entre    o per&iacute;odo
 de observa&ccedil;&atilde;o e os valores de correla&ccedil;&atilde;o;    assim,
 quanto menor o per&iacute;odo de tempo de exposi&ccedil;&atilde;o entre    as m
edidas, maior &eacute; a correla&ccedil;&atilde;o, o que explicaria em parte    
os seus achados. Outra vari&aacute;vel que influencia os resultados &eacute;    
o posicionamento do indiv&iacute;duo em rela&ccedil;&atilde;o aos dados da popul
a&ccedil;&atilde;o,    ou seja, indiv&iacute;duos que apresentam resultados nas 
extremidades da curva    normal tendem a manter a mesma posi&ccedil;&atilde;o du
rante o per&iacute;odo    da vida, ao contr&aacute;rio daqueles com valores dist
ribu&iacute;dos mais centralmente<sup>28</sup>.    Isto quer dizer que a possibi
lidade de sucesso esportivo de uma crian&ccedil;a    que apresenta uma <i>perfor
mance</i> extremamente acima da m&eacute;dia (z &gt    2,5) aos 10-12 anos de id
ade &eacute; maior do que aquela que apresenta resultados    similares aos da m&
eacute;dia da popula&ccedil;&atilde;o (z &lt -1,5 &lt z &lt    1,5), nas vari&aa
cute;veis chaves, estando as duas no mesmo n&iacute;vel de    amadurecimento sex
ual.</font></p>     ^cY#v6n3a04.htm##
01368000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704113600074002001201210#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#101#97#article#185#<p><font face="Verdan
a, Arial, Helvetica, sans-serif" size="2">O coeficiente de    correla&ccedil;&at
ilde;o de Spearman foi utilizado principalmente pelo fato    de os valores do &i
acute;ndice <i>z</i> n&atilde;o terem sido distribu&iacute;dos    normalmente, d
emonstrando um coeficiente de varia&ccedil;&atilde;o com amplitude    de 19,4% a
 90,0%. Entretanto, mesmo quando estes valores foram analisados pelo    coeficie
nte de correla&ccedil;&atilde;o linear de Pearson, foi verificado que    ambos (
Pearson e Spearman) variaram muito pouco, o que indica que os valores    foram r
elativamente similares. Adicionalmente, isso nos faz supor que, independente    
da forma de apresenta&ccedil;&atilde;o dos valores de correla&ccedil;&atilde;o  
  (Pearson ou Spearman), parece que a capacidade de <i>performance</i> na maiori
a    das vari&aacute;veis (com exce&ccedil;&atilde;o da agilidade e da pot&ecirc
;ncia    anaer&oacute;bica) corrigidas pelo &iacute;ndice <i>z</i> n&atilde;o so
freu    efeito do ambiente (treinamento); ou que o impacto do mesmo n&atilde;o f
oi superior    ao do avan&ccedil;o cronol&oacute;gico. </font></p>     ^cY#v6n3a
04.htm##
01095000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704086300074002001200937#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#102#98#article#185#<p><font face="Verdan
a, Arial, Helvetica, sans-serif" size="2">Esta hip&oacute;tese    &eacute; respa
ldada pelos dados referentes &agrave; altura corporal das jovens    atletas que 
apresentaram incremento significativo (p &lt 0,05) nos valores absolutos    apre
sentados em setembro de 1997, quando comparados com os do momento inicial    do 
estudo (set/1995). Contudo, quando os valores absolutos foram calculados    de a
cordo com o &iacute;ndice z esta diferen&ccedil;a desapareceu, demonstrando    q
ue o incremento ocorrido na altura corporal das jovens atletas durante o per&iac
ute;odo    da adolesc&ecirc;ncia &eacute; conseq&uuml;&ecirc;ncia apenas de fato
res relacionados    ao gen&oacute;tipo (como, por exemplo, os processos de cresc
imento e desenvolvimento)    e n&atilde;o necessariamente devido aos fatores amb
ientais (treinamento).</font></p>     ^cY#v6n3a04.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002200074002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#103#99#article#185#<p>&nbsp;</p>     ^cY
#v6n3a04.htm##
00339000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704010600075002001200181#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#104#100#article#185#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="3"><b>CONCLUS&Atilde;O</b></font></p>   
  ^cY#v6n3a04.htm##
00596000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704036300075002001200438#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#105#101#article#185#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="2">Apesar de esportivamente    significa
tivo (tr&ecirc;s temporadas), o intervalo de tempo &eacute; relativamente    peq
ueno em termos biol&oacute;gicos, de modo que os presentes achados devem    serv
ir de est&iacute;mulo a an&aacute;lises futuras de per&iacute;odos mais    longo
s. </font></p>     ^cY#v6n3a04.htm##
01053000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704082000075002001200895#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#106#102#article#185#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="2">A an&aacute;lise    das vari&aacute;v
eis da aptid&atilde;o f&iacute;sica tanto em valores absolutos    como relativos
, sendo neste caso utilizado o &iacute;ndice <i>z</i>, demonstrou    que os valo
res obtidos no momento final do estudo (setembro/1997) estavam sendo    explicad
os por aqueles valores observados no momento inicial (setembro/1995).    A altur
a corporal, a agilidade, a pot&ecirc;ncia anaer&oacute;bica, o peso corporal    
e a velocidade foram as vari&aacute;veis que apresentaram correla&ccedil;&otilde
;es    muito altas e significativas, enquanto as vari&aacute;veis de for&ccedil;
a muscular    de membros inferiores (IVS, IVC e IH) demonstraram valores de corr
ela&ccedil;&atilde;o    de fracos (0,08) a moderados (0,73).</font></p>     ^cY#
v6n3a04.htm##
00772000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704053900075002001200614#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#107#103#article#185#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="2">Foi observado que    os valores de co
rrela&ccedil;&atilde;o (Pearson e Spearman) n&atilde;o sofreram    efeito do amb
iente (treinamento) quando foram corrigidos pelo &iacute;ndice    <i>z</i>. Isto
 faz supor que provavelmente a influ&ecirc;ncia do gen&oacute;tipo    sobre a ma
ioria das vari&aacute;veis da aptid&atilde;o f&iacute;sica, com exce&ccedil;&ati
lde;o    da agilidade e da pot&ecirc;ncia anaer&oacute;bica, tenha sido maior qu
e a do    ambiente.</font></p>     ^cY#v6n3a04.htm##
01229000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704099600075002001201071#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#108#104#article#185#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="2">Este trabalho &eacute;    o primeiro 
a analisar a estabilidade das vari&aacute;veis da aptid&atilde;o    f&iacute;sic
a em atletas e suporta os resultados de outros estudos realizados    com adolesc
entes n&atilde;o atletas, de que ocorre estabilidade em algumas vari&aacute;veis
    na transi&ccedil;&atilde;o da inf&acirc;ncia para a adolesc&ecirc;ncia e dur
ante    o per&iacute;odo da adolesc&ecirc;ncia. Finalmente, estes dados permitem
 concluir    que as jovens atletas apresentaram estabilidade nas vari&aacute;vei
s antropom&eacute;tricas,    agilidade, velocidade e pot&ecirc;ncia anaer&oacute
;bica durante o per&iacute;odo    da adolesc&ecirc;ncia. Por estas vari&aacute;v
eis serem de fundamental import&acirc;ncia    na pr&aacute;tica do handebol, pod
em ser estimadas com seguran&ccedil;a na adolesc&ecirc;ncia,    contribuindo par
a que a expectativa de sucesso esportivo seja predita em idades    precoces.</fo
nt></p>     ^cY#v6n3a04.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#109#105#article#185#<p>&nbsp;</p>     ^c
Y#v6n3a04.htm##
00340000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704010700075002001200182#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#110#106#article#185#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="3"><b>REFER&Ecirc;NCIAS</b></font></p>  
   ^cY#v6n3a04.htm##
00467000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704022000077002001200297#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#111#107#article#185#1#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">1. &Auml;strand    PO. 
Crian&ccedil;as e adolescentes: performance, medidas e educa&ccedil;&atilde;o.  
  Rev Bras Ci&ecirc;ncias Esporte 1993;7:11-4.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#112#108#article#185#</font></p>     ^cY#
v6n3a04.htm##
00396000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014900077002001200226#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#113#109#article#185#2#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Blomm BS. Developing
    talent in young people. Ballantine, New York, 1985.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#114#110#article#185#</font></p>     ^cY#
v6n3a04.htm##
00448000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704020100077002001200278#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#115#111#article#185#3#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Malina RR. Tracking 
   of physical activity and physical fitness across the lifespan. Res Q Exerc Sp
ort    Suppl 1996;67:48-57.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#116#112#article#185#</font></p>     ^cY#
v6n3a04.htm##
00523000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704027600077002001200353#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#117#113#article#185#4#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Matsudo VKR.    Pred
iction of future athletic excellence. The child and adolescent athlete.    In: B
ar-Or O, editor. The encyclopedia of sports medicine. International Olympic    C
ommittee, 1996:92-109.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#118#114#article#185#</font></p>     ^cY#
v6n3a04.htm##
00454000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704020700077002001200284#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#119#115#article#185#5#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Hollmann W,    Hetti
nger T. Idade e treinamento competitivo. In: Medicina do esporte, Editora    Man
ole. S&atilde;o Paulo: 555, 1989.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#120#116#article#185#</font></p>     ^cY#
v6n3a04.htm##
00708000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704046100077002001200538#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#121#117#article#185#6#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Matsudo VKR.    Crit
&eacute;rios biol&oacute;gicos para diagn&oacute;stico, prescri&ccedil;&atilde;o
    e progn&oacute;stico de aptid&atilde;o f&iacute;sica em escolares de 7 a 18 
   anos de idade. Tese apresentada ao concurso p&uacute;blico de habilita&ccedil
;&atilde;o    &agrave; livre-doc&ecirc;ncia na Universidade Gama Filho &#150; &a
acute;rea    de Medicina, Rio de Janeiro, 1992.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#122#118#article#185#</font></p>     ^cY#
v6n3a04.htm##
00448000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704020100077002001200278#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#123#119#article#185#7#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Wilson JP, Poster   
 DW, editors. Williams textbook of endocrinology, 7<sup>th</sup> ed., Philadelph
ia,    W.B. Saunders, 1985.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#124#120#article#185#</font></p>     ^cY#
v6n3a04.htm##
00410000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704016300077002001200240#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#125#121#article#185#8#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Fischbein S.    Onse
t of puberty in MS and DZ twins. Acta Gen Med Gemellot 1977;26:151-8.    ^cY#v6n
3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#126#122#article#185#</font></p>     ^cY#
v6n3a04.htm##
00549000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704030200077002001200379#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#127#123#article#185#9#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Malinowski A.    Con
ceptions of norm and normality in biology of manuals medicine. In: Wolanski    N
, Szemir M, editors. Studies in human ecology, growth and socioeconomic conditio
ns.    Polish Academy of Sciences, Warsaw, 1986.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#128#124#article#185#</font></p>     ^cY#
v6n3a04.htm##
00528000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028000078002001200358#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#129#125#article#185#10#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Thomis MAI,    Beu
nen GP, Maes HH, Blimkie CJ, Van Leempute M, Claessens AL, Marshal G, Willems   
 E, Vlietinck RF. Strength training: importance of genetic factors. Med Sci Spor
ts    Exerc 1998;30:724-31.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#130#126#article#185#</font></p>     ^cY#
v6n3a04.htm##
00548000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704030000078002001200378#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#131#127#article#185#11#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Simoneau JA,    Lo
rtie G, Boulay MR, Margotte M, Thilbault MC, Bouchard C. Inheritance of human   
 skeletal muscle and anaerobic capacity adaptation to high-intensity intermitten
t    training. Int J Sports Med 1986; 7:167-71.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#132#128#article#185#</font></p>     ^cY#
v6n3a04.htm##
00501000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025300078002001200331#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#133#129#article#185#12#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Prud&#146;homme   
 D, Bouchard C, Leblanc C, Landry F, Fontaine E. Sensitivity of maximal aerobic 
   power to training is genotype dependent. Med Sci Sports Exerc 1984;16:489-93.
    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#134#130#article#185#</font></p>     ^cY#
v6n3a04.htm##
00655000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704040700078002001200485#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#135#131#article#185#13#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Bergamo VR.    Tal
ento, treinamento e rendimento no basquetebol feminino. Disserta&ccedil;&atilde;
o    apresentada como requisito parcial para a obten&ccedil;&atilde;o do T&iacut
e;tulo    de Mestre em Educa&ccedil;&atilde;o &#150; &aacute;rea de concentra&cc
edil;&atilde;o    Educa&ccedil;&atilde;o Motora, UNIMEP, Piracicaba, 1996.    ^c
Y#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#136#132#article#185#</font></p>     ^cY#
v6n3a04.htm##
00454000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020600078002001200284#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#137#133#article#185#14#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Pate RR, Baranowsk
i    T, Dowda M, Trost SG. Tracking of physical activity in young children. Med 
Sci    Sports Exerc 1996;28:92-6.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#138#134#article#185#</font></p>     ^cY#
v6n3a04.htm##
00539000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029100078002001200369#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#139#135#article#185#15#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">15. Andrade DR,    Mat
sudo VKR, Brito CFd&#146;A, Figueira Jr. AJ, Matsudo SMM. Weight and height    i
nfluence on tracking on neuromotor variables in children and adolescents. Med   
 Sci Sports Exerc Suppl 1997; 29:S105.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#140#136#article#185#</font></p>     ^cY#
v6n3a04.htm##
00584000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704033600078002001200414#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#141#137#article#185#16#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">16. Brito CFD,    Andr
ade DR, Rocha JR, Ara&uacute;jo TL, Matsudo VKR. Estabilidade do n&iacute;vel   
 de aptid&atilde;o f&iacute;sica entre crian&ccedil;as e adolescentes. XX Simp&o
acute;sio    Internacional de Ci&ecirc;ncias do Esporte, S&atilde;o Paulo 1996;1
11.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#142#138#article#185#</font></p>     ^cY#
v6n3a04.htm##
00536000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028800078002001200366#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#143#139#article#185#17#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">17. Ara&uacute;jo    T
L, Matsudo VKR, Matsudo SMM, Andrade DR, Andrade EL. Tracking of physical fitnes
s    of girls at childhood and at adolescence in south coast of Brazil. Med Sci 
Sports    Exerc Suppl 1997;29:S106.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#144#140#article#185#</font></p>     ^cY#
v6n3a04.htm##
00532000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028400078002001200362#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#145#141#article#185#18#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">18. Bracco MM,    Andr
ade EL, Brito CFd&#146;A, Matsudo VKR. Influence of nutritional status on    sta
bility of physical fitness in boys from low socioeconomical region. Med Sci    S
ports Exerc Suppl 1997;29:S106.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#146#142#article#185#</font></p>     ^cY#
v6n3a04.htm##
00505000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025700078002001200335#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#147#143#article#185#19#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">19. Brito CFD,    Andr
ade DR, Ara&uacute;jo TL, Matsudo VKR. Tracking variability of fitness component
s    in boys from low socioeconomic region. Med Sci Sports Exerc Suppl 1998;30:S
149.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#148#144#article#185#</font></p>     ^cY#
v6n3a04.htm##
00511000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704026300078002001200341#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#149#145#article#185#20#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">20. Matsudo VKR,    Ri
vet RE, Pereira MHN. Standard score assessment on physique and performance    of
 Brazilian athletes in a six tried competitive sports model. J Sports Sci    198
7;5:49-53.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#150#146#article#185#</font></p>     ^cY#
v6n3a04.htm##
00504000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025600078002001200334#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#151#147#article#185#21#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">21. Carvalho MTC.    P
erfil de aptid&atilde;o f&iacute;sica de atletas de handebol. XVI Simp&oacute;si
o    Internacional de Ci&ecirc;ncias do Esporte, S&atilde;o Caetano do Sul 1988;
26.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#152#148#article#185#</font></p>     ^cY#
v6n3a04.htm##
00537000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028900078002001200367#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#153#149#article#185#22#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">22. Gon&ccedil;alves  
  HR, Osiecki R, Tsuneta P e Zamberlan E. Par&acirc;metros antropom&eacute;trico
s,    metab&oacute;licos e motores em handebolistas de alto n&iacute;vel. Rev Br
as    Ci&ecirc;ncia Mov 1991;5:55-9.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#154#150#article#185#</font></p>     ^cY#
v6n3a04.htm##
00669000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704042100078002001200499#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#155#151#article#185#23#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">23. Raso V, Bergamo   
 V. Estudo comparativo de aptid&atilde;o f&iacute;sica entre escolares e atletas
    do desporto handebol. Relat&oacute;rio Final do Programa Institucional de Bo
lsas    de Inicia&ccedil;&atilde;o Cient&iacute;fica (PIBIC) do Conselho Naciona
l de    Desenvolvimento Cient&iacute;fico e Tecnol&oacute;gico (CNPq), Piracicab
a, 1995.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#156#152#article#185#</font></p>     ^cY#
v6n3a04.htm##
00547000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029900078002001200377#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#157#153#article#185#24#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">24. Figueira Jr    AJ,
 Matsudo VKR. Determination of physical performance of Brazilian volleyball    p
layers through z index. In: Coudert J, van Pragh E, editors. Pediatric Work    P
hysiology Supplement, Masson, Paris 1992; 164.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#158#154#article#185#</font></p>     ^cY#
v6n3a04.htm##
00628000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704038000078002001200458#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#159#155#article#185#25#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">25. Brito CFD,    Andr
ade DR, Rocha JR, Ara&uacute;jo TL, Matsudo VKR. Estabilidade da aptid&atilde;o 
   f&iacute;sica em escolares localizados em diferentes posi&ccedil;&otilde;es  
  da curva normal. Anais do 1º Congresso Brasileiro de Atividade F&iacute;sica  
  e Sa&uacute;de, Florian&oacute;polis 1997;93.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#160#156#article#185#</font></p>     ^cY#
v6n3a04.htm##
00411000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016300078002001200241#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#161#157#article#185#26#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">26. Parizkov&aacute;  
  J. Body fat and physical fitness. Martinus Nijhoff, The Hague, 1977.    ^cY#v6
n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#162#158#article#185#</font></p>     ^cY#
v6n3a04.htm##
00558000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704031000078002001200388#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#163#159#article#185#27#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">27. Ara&uacute;jo    T
L, Matsudo VKR, Matsudo SMM, Andrade DR, Andrade EL. Estabilidade de aptid&atild
e;o    f&iacute;sica em meninas de Ilhabela. XX Simp&oacute;sio Internacional de
 Ci&ecirc;ncias    do Esporte, S&atilde;o Paulo 1996;144.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#164#160#article#185#</font></p>     ^cY#
v6n3a04.htm##
00499000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025100078002001200329#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#165#161#article#185#28#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">28. Matsudo VKR,    Ma
tsudo SMM, Andrade EL, Ara&uacute;jo TL. Central and peripheral tracking in    g
irls from low socioeconomical region. Med Sci Sports Exerc Suppl 1997;29:S105.  
  ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#166#162#article#185#</font></p>     ^cY#
v6n3a04.htm##
00508000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704026000078002001200338#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#167#163#article#185#29#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">29. Brito CFD,    Andr
ade DR, Rocha JR, Ara&uacute;jo TL, Matsudo VKR. Physical fitness stability    f
rom infancy to adolescence in Brazilian boys. Med Sci Sports Exerc Suppl 1997b;2
9:S106.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#168#164#article#185#</font></p>     ^cY#
v6n3a04.htm##
00539000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029100078002001200369#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#169#165#article#185#30#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">30. Espenschade    A. 
Motor performance in adolescence, including the study of relationships with    m
easures of physical growth and maturity. Monographs of the Society for Research 
   in Child Development 1940;5, nº 24.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#170#166#article#185#</font></p>     ^cY#
v6n3a04.htm##
00611000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704036300078002001200441#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#171#167#article#185#31#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">31. Beunen G, de    Be
ul G, Ostyn M, Renson R, Simons J, Van Gerven D. Die konstanz motorischer    lei
stungen bei 12- bis 17 j&atilde;hrigen jungen. In: Willimczik K, Grosser    M, e
ditors. Die motorische entwicklung im kindes- und jugendalter. Schorndorf:    Ve
rlag Karl Hofmann 1979;278-84.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#172#168#article#185#</font></p>     ^cY#
v6n3a04.htm##
00639000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704039100078002001200469#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#173#169#article#185#32#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">32. Ponnet P, Beunen  
  G, Claessens AL, Lefevre J, Maes H. Stability of athletic performance in untra
ined    boys age 12 to 15 years. In: Claessens A, Lefevre J, Vanden Eynde B, edi
tors.    World-wide variation in physical fitness. Leuven: Institute of Physical
 Education,    Katholieke Universiteit Leuven 1993;136-40.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#174#170#article#185#</font></p>     ^cY#
v6n3a04.htm##
00468000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022000078002001200298#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#175#171#article#185#33#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">33. Branta C, Haubenst
ricker    J, Seefeldt V. Age changes in motor skills during childhood and adoles
cence.    Exerc Sports Sci Rev 1984;12:467-520.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#176#172#article#185#</font></p>     ^cY#
v6n3a04.htm##
00538000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029000078002001200368#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#177#173#article#185#34#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">34. Inman JW, Tremblay
    MS, Deschenes ARC, Bothwell-Myers CM. Fitness variables track during a five 
   years follow-up study in children with contrasting motor abilities. Med Sci  
  Sports Exercise Suppl 1997; 29:S13.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#178#174#article#185#</font></p>     ^cY#
v6n3a04.htm##
00544000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029600078002001200374#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#179#175#article#185#35#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">35. Raso V, Matsudo   
 SMM, Matsudo VKR, Bracco MM. Successful expectation of young handball athletes 
   by z-score strategy. In: Welsman J, Armstrong N, Kirby B, editors. Children  
  and Exercise XIX (Volume II). 1997;155-9.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#180#176#article#185#</font></p>     ^cY#
v6n3a04.htm##
00547000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029900078002001200377#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#p#181#177#article#185#36#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">36. Matsudo SMM,    Pa
schoal VCP, Amancio OMS. Atividade f&iacute;sica e sua rela&ccedil;&atilde;o    
com o crescimento e a matura&ccedil;&atilde;o biol&oacute;gica de crian&ccedil;a
s.    Cad Nutri&ccedil;&atilde;o 1997;14:1-12.    ^cY#v6n3a04.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002000075002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#182#178#article#185#</font></p>     ^cY#
v6n3a04.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#183#179#article#185#<p>&nbsp;</p>     ^c
Y#v6n3a04.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#184#180#article#185#<p>&nbsp;</p>     ^c
Y#v6n3a04.htm##
00463000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704023000075002001200305#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#185#181#article#185#<p align="left"><fon
t face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><a name="end"></a><a 
href="#topo"><img src="/img/revistas/rbme/v6n3/seta.gif" border="0"></a>    Ende
re&ccedil;o para correspond&ecirc;ncia</b>    ^cY#v6n3a04.htm##
00259000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002600075002001200101#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#186#182#article#185#<br>   Vagner Raso  
  ^cY#v6n3a04.htm##
00297000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704006400075002001200139#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#187#183#article#185#<br>   Rua Marqu&eci
rc;s de Praia Grande, 540, apto. 32B    ^cY#v6n3a04.htm##
00285000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704005200075002001200127#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#188#184#article#185#<br>   03129-110 &#1
50; S&atilde;o Paulo, SP    ^cY#v6n3a04.htm##
00316000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704008300075002001200158#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a04.htm#S#p#189#185#article#185#<br>   E-mail: <a hr
ef="mailto:vraso@usa.net">vraso@usa.net</a></font></p>     ^cY#v6n3a04.htm##
00478000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100019000740120061000930300
02600154710000200180065000900182064000500191031000200196014000500198865000900203
002001200212#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#190#1#articl
e#36#1#^rND^sÄstrand^nPO.#Crianças e adolescentes: performance, medidas e educaç
ão^lpt#Rev Bras Ciências Esporte#2#19930000#1993#7#11-4#20000600#v6n3a04.htm##
00414000000000229000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160017000740180038000910620
01100129066000900140065000900149064000500158865000900163002001200172#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#191#2#article#36#2#^rND^sBlomm^nBS.#
Developing talent in young people^len#Ballantine#New York#19850000#1985#20000600
#v6n3a04.htm##
00491000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740120075000920300
02400167710000200191065000900193064000500202031000300207014000600210865000900216
002001200225#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#192#3#articl
e#36#3#^rND^sMalina^nRR.#Tracking of physical activity and physical fitness acro
ss the lifespan^len#Res Q Exerc Sport Suppl#2#19960000#1996#67#48-57#20000600#v6
n3a04.htm##
00566000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100020000740120079000940160
01600173018004000189053003500229055001200264054000800276014000700284865000900291
002001200300#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#193#4#articl
e#36#4#^rND^sMatsudo^nVKR.#Prediction of future athletic excellence. The child a
nd adolescent athlete^len#^rED^sBar-Or^nO#The encyclopedia of sports medicine^le
n#International Olympic Committee^i1#19960000^i1#1996^i1#92-109#20000600#v6n3a04
.htm##
00502000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740100020000920120
03600112018002400148062001500172066001000187031000400197065000900201064000500210
865000900215002001200224#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#
194#5#article#36#5#^rND^sHollmann^nW#^rND^sHettinger^nT.#Idade e treinamento com
petitivo^lpt#Medicina do esporte^lpt#Editora Manole#São Paulo#555#19890000#1989#
20000600#v6n3a04.htm##
00548000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160020000740180123000940510
01500217050002400232046001500256045000900271044000500280865000900285002001200294
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#195#6#article#36#6#^rND^
sMatsudo^nVKR.#Critérios biológicos para diagnóstico, prescrição e prognóstico d
e aptidão física em escolares de 7 a 18 anos de idade^lpt#livre-docência#Univers
idade Gama Filho#Rio de Janeiro#19920000#1992#20000600#v6n3a04.htm##
00465000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160017000740160017000910180
03900108063000200147066001300149062001400162065000900176064000500185865000900190
002001200199#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#196#7#articl
e#36#7#^rED^sWilson^nJP#^rED^sPoster^nDW#Williams textbook of endocrinology^len#
7#Philadelphia#W.B. Saunders#19850000#1985#20000600#v6n3a04.htm##
00456000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100020000740120040000940300
02200134710000200156065000900158064000500167031000300172014000600175865000900181
002001200190#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#197#8#articl
e#36#8#^rND^sFischbein^nS.#Onset of puberty in MS and DZ twins^len#Acta Gen Med 
Gemellot#2#19770000#1977#26#151-8#20000600#v6n3a04.htm##
00599000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100021000740120069000950160
01800164016001600182018006600198062002700264066000700291065000900298064000500307
865000900312002001200321#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#
198#9#article#36#9#^rND^sMalinowski^nA.#Conceptions of norm and normality in bio
logy of manuals medicine^len#^rND^sWolanski^nN#^rED^sSzemir^nM#Studies in human 
ecology, growth and socioeconomic conditions^len#Polish Academy of Sciences#Wars
aw#19860000#1986#20000600#v6n3a04.htm##
00752000000000361000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100017000940100
01500111010001800126010002200144010002000166010001700186010001700203010002000220
01200530024003000210029306500090031406400050032303100030032801400070033186500090
0338002001200347035001000359801002100369#v6n3#V:\SciELO\serial\rbme\v6n3\markup\
v6n3a04.htm#S#c#199#10#article#36#10#^rND^sThomis^nMAI#^rND^sBeunen^nGP#^rND^sMa
es^nHH#^rND^sBlimkie^nCJ#^rND^sVan Leempute^nM#^rND^sClaessens^nAL#^rND^sMarshal
^nG#^rND^sWillems^nE#^rND^sVlietinck^nRF#Strength training: importance of geneti
c factors^len#Med Sci Sports Exerc#19980000#1998#30#724-31#20000600#v6n3a04.htm#
0195-9131#Med Sci Sports Exerc##
00714000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100016000950100
01700111010001800128010002000146010001900166012011500185030001700300065000900317
06400050032603100020033101400070033386500090034000200120034903500100036180100170
0371#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#200#11#article#36#11
#^rND^sSimoneau^nJA#^rND^sLortie^nG#^rND^sBoulay^nMR#^rND^sMargotte^nM#^rND^sThi
lbault^nMC#^rND^sBouchard^nC.#Inheritance of human skeletal muscle and anaerobic
 capacity adaptation to high-intensity intermittent training^len#Int J Sports Me
d#19860000#1986#7#167-71#20000600#v6n3a04.htm#0172-4622#Int J sports Med##
00652000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100018000960100
01700114010001600131010001900147012007500166030002100241065000900262064000500271
031000300276014000700279865000900286002001200295035001000307801002100317#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#201#12#article#36#12#^rND^sPrud
homme^nD#^rND^sBouchard^nC#^rND^sLeblanc^nC#^rND^sLandry^nF#^rND^sFontaine^nE.#S
ensitivity of maximal aerobic power to training is genotype dependent^len#Med Sc
i Sports Exerc#19840000#1984#16#489-93#20000600#v6n3a04.htm#0195-9131#Med Sci Sp
orts Exerc##
00458000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160018000760180062000940510
00700156050000700163046001100170045000900181044000500190865000900195002001200204
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#202#13#article#36#13#^rN
D^sBergamo^nVR#Talento, treinamento e rendimento no basquetebol feminino^lpt#Mes
tre#UNIMEP#Piracicaba#19960000#1996#20000600#v6n3a04.htm##
00592000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100020000910100
01500111010001700126012005200143030002100195065000900216064000500225031000300230
014000500233865000900238002001200247035001000259801002100269#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a04.htm#S#c#203#14#article#36#14#^rND^sPate^nRR#^rND^sBa
ranowski^nT#^rND^sDowda^nM#^rND^sTrost^nSG.#Tracking of physical activity in you
ng children^len#Med Sci Sports Exerc#19960000#1996#28#92-6#20000600#v6n3a04.htm#
0195-9131#Med Sci Sports Exerc##
00644000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100019000940100
01900113010002300132010001900155012009600174030002700270710000200297065000900299
064000500308031000300313014000500316865000900321002001200330#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a04.htm#S#c#204#15#article#36#15#^rND^sAndrade^nDR#^rND^
sMatsudo^nVKR#^rND^sBrito^nCFdA#^rND^sFigueira Jr.^nAJ#^rND^sMatsudo^nSMM#Weigh
t and height influence on tracking on neuromotor variables in children and adole
scents^len#Med Sci Sports Exerc Suppl#2#19970000#1997#29#S105#20000600#v6n3a04.h
tm##
00642000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760160018000930160
01600111016001700127016002000144018007400164053005600238056001300294055001200307
054000800319020000400327865000900331002001200340#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#205#16#article#36#16#^rND^sBrito^nCFD#^rND^sAndrade^nDR#
^rND^sRocha^nJR#^rND^sAraújo^nTL#^rND^sMatsudo^nVKR.#Estabilidade do nível de ap
tidão física entre crianças e adolescentes^lpt#Simpósio Internacional de Ciência
s do Esporte^nXX^i1^i1#São Paulo^i1#19960000^i1#1996^i1#111#20000600#v6n3a04.htm
##
00641000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100019000930100
01900112010001800131010001900149012009900168030002700267710000200294065000900296
064000500305031000300310020000500313865000900318002001200327#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a04.htm#S#c#206#17#article#36#17#^rND^sAraújo^nTL#^rND^s
Matsudo^nVKR#^rND^sMatsudo^nSMM#^rND^sAndrade^nDR#^rND^sAndrade^nEL.#Tracking of
 physical fitness of girls at childhood and at adolescence in south coast of Bra
zil^len#Med Sci Sports Exerc Suppl#2#19970000#1997#29#S106#20000600#v6n3a04.htm#
#
00621000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100018000930100
01900111010002000130012010900150030002700259710000200286065000900288064000500297
031000300302020000500305865000900310002001200319#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#207#18#article#36#18#^rND^sBracco^nMM#^rND^sAndrade^nEL#
^rND^sBrito^nCFdA#^rND^sMatsudo^nVKR.#Influence of nutritional status on stabil
ity of physical fitness in boys from low socioeconomical region^len#Med Sci Spor
ts Exerc Suppl#2#19970000#1997#29#S106#20000600#v6n3a04.htm##
00595000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100018000930100
01700111010002000128012008500148030002700233710000200260065000900262064000500271
031000300276020000500279865000900284002001200293#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#208#19#article#36#19#^rND^sBrito^nCFD#^rND^sAndrade^nDR#
^rND^sAraújo^nTL#^rND^sMatsudo^nVKR.#Tracking variability of fitness components 
in boys from low socioeconomic region^len#Med Sci Sports Exerc Suppl#2#19980000#
1998#30#S149#20000600#v6n3a04.htm##
00619000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100016000950100
01900111012012000130030001300250065000900263064000500272031000200277014000600279
865000900285002001200294035001000306801001300316#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#209#20#article#36#20#^rND^sMatsudo^nVKR#^rND^sRivet^nRE#
^rND^sPereira^nMHN#Standard score assessment on physique and performance of Braz
ilian athletes in a six tried competitive sports model^len#J Sports Sci#19870000
#1987#5#49-53#20000600#v6n3a04.htm#0264-0414#J Sports Sci##
00514000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160021000760180052000970530
05700149056002200206055001200228054000800240020000300248865000900251002001200260
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#210#21#article#36#21#^rN
D^sCarvalho^nMTC.#Perfil de aptidão física de atletas de handebol^lpt#Simpósio I
nternacional de Ciências do Esporte^nXVI^i1^i1#São Caetano do Sul^i1#19880000^i1
#1988^i1#26#20000600#v6n3a04.htm##
00590000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100017000960100
01700113010002000130012008500150030002100235710000200256065000900258064000500267
031000200272014000500274865000900279002001200288#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#211#22#article#36#22#^rND^sGonçalves^nHR#^rND^sOsiecki^n
R#^rND^sTsuneta^nP#^rND^sZamberlan^nE.#Parâmetros antropométricos, metabólicos e
 motores em handebolistas de alto nível^lpt#Rev Bras Ciência Mov#2#19910000#1991
#5#55-9#20000600#v6n3a04.htm##
00629000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160014000760160018000900180
24500108066001100353065000900364064000500373865000900378002001200387#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#212#23#article#36#23#^rND^sRaso^nV#^
rND^sBergamo^nV.#Estudo comparativo de aptidão física entre escolares e atletas 
do desporto handebol. Relatório Final do Programa Institucional de Bolsas de Ini
ciação Científica (PIBIC) do Conselho Nacional de Desenvolvimento Científico e T
ecnológico (CNPq)^lpt#Piracicaba#19950000#1995#20000600#v6n3a04.htm##
00616000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100022000760100020000980120
09000118016001700208016001900225018004900244066000600293065000900299064000500308
020000400313865000900317002001200326#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a04.htm#S#c#213#24#article#36#24#^rND^sFigueira Jr^nAJ#^rND^sMatsudo^nVKR.#Deter
mination of physical performance of Brazilian volleyball players through z index
^len#^rED^sCoudert^nJ#^rED^svan Pragh^nE#Pediatric Work Physiology Supplement, M
asson^len#Paris#19920000#1992#164#20000600#v6n3a04.htm##
00673000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760160018000930160
01600111016001700127016002000144018009900164053005900263056001700322055001200339
054000800351020000300359865000900362002001200371#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#214#25#article#36#25#^rND^sBrito^nCFD#^rND^sAndrade^nDR#
^rND^sRocha^nJR#^rND^sAraújo^nTL#^rND^sMatsudo^nVKR.#Estabilidade da aptidão fís
ica em escolares localizados em diferentes posições da curva normal^lpt#Congress
o Brasileiro de Atividade Física e Saúde^n1º^i1^i1#Florianópolis^i1#19970000^i1#
1997^i1#93#20000600#v6n3a04.htm##
00410000000000217000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160019000760180034000950660
02800129065000900157064000500166865000900171002001200180#v6n3#V:\SciELO\serial\r
bme\v6n3\markup\v6n3a04.htm#S#c#215#26#article#36#26#^rND^sParizková^nJ#Body fat
 and physical fitness^len#Martinus Nijhoff^eThe Hague#19770000#1977#20000600#v6n
3a04.htm##
00630000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760160019000930160
01900112016001800131016001900149018005800168053005600226056001300282055001200295
054000800307020000400315865000900319002001200328#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#216#27#article#36#27#^rND^sAraújo^nTL#^rND^sMatsudo^nVKR
#^rND^sMatsudo^nSMM#^rND^sAndrade^nDR#^rND^sAndrade^nEL.#Estabilidade de aptidão
 física em meninas de Ilhabela^lpt#Simpósio Internacional de Ciências do Esporte
^nXX^i1^i1#São Paulo^i1#19960000^i1#1996^i1#144#20000600#v6n3a04.htm##
00589000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100019000950100
01800114010001800132012007700150030002700227710000200254065000900256064000500265
031000300270020000500273865000900278002001200287#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#217#28#article#36#28#^rND^sMatsudo^nVKR#^rND^sMatsudo^nS
MM#^rND^sAndrade^nEL#^rND^sAraújo^nTL.#Central and peripheral tracking in girls 
from low socioeconomical region^len#Med Sci Sports Exerc Suppl#2#19970000#1997#2
9#S105#20000600#v6n3a04.htm##
00615000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100018000930100
01600111010001700127010002000144012007700164030002700241710000200268065000900270
064000500279031000300284020000500287865000900292002001200301#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a04.htm#S#c#218#29#article#36#29#^rND^sBrito^nCFD#^rND^s
Andrade^nDR#^rND^sRocha^nJR#^rND^sAraújo^nTL#^rND^sMatsudo^nVKR.#Physical fitnes
s stability from infancy to adolescence in Brazilian boys^len#Med Sci Sports Exe
rc Suppl#2#19970000#1997#29#S106#20000600#v6n3a04.htm##
00550000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160022000760180182000980650
00900280064000500289031000200294061000300296865000900299002001200308#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#219#30#article#36#30#^rND^sEspenscha
de^nA.#Motor performance in adolescence, including the study of relationships wi
th measures of physical growth and maturity. Monographs of the Society for Resea
rch in Child Development^len#19400000#1940#5#24#20000600#v6n3a04.htm##
00754000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100017000920100
01500109010001600124010001600140010002100156012007100177016002000248016001700268
01800580028506600110034306200200035406500090037406400050038301400070038886500090
0395002001200404#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#220#31#a
rticle#36#31#^rND^sBeunen^nG#^rND^sde Beul^nG#^rND^sOstyn^nM#^rND^sRenson^nR#^rN
D^sSimons^nJ#^rND^sVan Gerven^nD.#Die konstanz motorischer leistungen bei 12- bi
s 17 jãhrigen jungen^len#^rED^sWillimczik^nK#^rED^sGrosser^nM#Die motorische ent
wicklung im kindes- und jugendalter^len#Schorndorf#Verlag Karl Hofmann#19790000#
1979#278-84#20000600#v6n3a04.htm##
00789000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100016000920100
02000108010001700128010001500145012007500160016001900235016001700254016002200271
01800450029306600070033806200640034506500090040906400050041801400070042386500090
0430002001200439#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a04.htm#S#c#221#32#a
rticle#36#32#^rND^sPonnet^nP#^rND^sBeunen^nG#^rND^sClaessens^nAL#^rND^sLefevre^n
J#^rND^sMaes^nH.#Stability of athletic performance in untrained boys age 12 to 1
5 years^len#^rED^sClaessens^nA#^rED^sLefevre^nJ#^rED^sVanden Eynde^nB#World-wide
 variation in physical fitness^len#Leuven#Institute of Physical Education, Katho
lieke Universiteit Leuven#19930000#1993#136-40#20000600#v6n3a04.htm##
00547000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100024000920100
01900116012006500135030002100200710000200221065000900223064000500232031000300237
014000800240865000900248002001200257#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a04.htm#S#c#222#33#article#36#33#^rND^sBranta^nC#^rND^sHaubenstricker^nJ#^rND^sS
eefeldt^nV.#Age changes in motor skills during childhood and adolescence^len#Exe
rc Sports Sci Rev#2#19840000#1984#12#467-520#20000600#v6n3a04.htm##
00631000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100019000920100
02100111010002600132012010900158030003000267710000200297065000900299064000500308
031000300313020000400316865000900320002001200329#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a04.htm#S#c#223#34#article#36#34#^rND^sInman^nJW#^rND^sTremblay^nMS#
^rND^sDeschenes^nARC#^rND^sBothwell-Myers^nCM.#Fitness variables track during a 
five years follow-up study in children with contrasting motor abilities^len#Med 
Sci Sports Exercise Suppl#2#19970000#1997#29#S13#20000600#v6n3a04.htm##
00656000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100014000760100019000900100
01900109010001800128012007400146016001700220016001900237016001500256018004200271
065000900313064000500322014000600327865000900333002001200342#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a04.htm#S#c#224#35#article#36#35#^rND^sRaso^nV#^rND^sMat
sudo^nSMM#^rND^sMatsudo^nVKR#^rND^sBracco^nMM.#Successful expectation of young h
andball athletes by z-score strategy^len#^rED^sWelsman^nJ#^rED^sArmstrong^nN#^rE
D^sKirby^nB#Children and Exercise XIX (Volume II)^len#19970000#1997#155-9#200006
00#v6n3a04.htm##
00559000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100020000950100
01900115012008900134030001300223710000200236065000900238064000500247031000300252
014000500255865000900260002001200269#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a04.htm#S#c#225#36#article#36#36#^rND^sMatsudo^nSMM#^rND^sPaschoal^nVCP#^rND^sAm
ancio^nOMS#Atividade física e sua relação com o crescimento e a maturação biológ
ica de crianças^lpt#Cad Nutrição#2#19970000#1997#14#1-12#20000600#v6n3a04.htm##
00271000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670910009000690920007000780020012000857030
00400097#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#o#1#1#article#1#20
110314#125800#v6n3a05.htm#175##
03314000000000589000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087038000400091121000300095049000800098158000300106
03000210010903100020013003200020013206500090013401400090014303500100015201201150
01620120133002770100028004100100026004380100034004640700020004980700045005180700
01200563083099600575085000801571085002001579085002401599085002001623085001901643
08309470166208500080260908500210261708500230263808500210266108500210268211700060
2703072000302709002001202712#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#
S#h#2#1#article#1#oa#pt#br1.1#1#4.0#GRA#TAB#05#RBME180#nd#Rev Bras Med Esporte#6
#3#20000600#^f93^l98#1517-8692#Avaliação muscular isocinética da musculatura abd
utora e adutora de coxa em atletas de natação do estilo peito^lpt#Isokinetic eva
luation of the abductor and adductor musculature of the thigh in swimming athlet
es performing chest swimming style^len#^rND^1A01^nFlávia R.^sIhara#^rND^1A02^nMi
rco^sCevales#^rND^1A03^nSergio de Souza^sPinto#Fisioterapeuta^iA01#Equipe de Nat
ação de São Caetano do Sul^iA02#Unicid^iA03#^lpt^aFoi realizada nesta pesquisa a
 avaliação isocinética de 12 atletas da natação do estilo peito, com idades entr
e 15 e 22 anos, submetidos a treinamento diário, encontrando-se em performance e
stadual e nacional. Todos foram avaliados pelo aparelho de avaliação muscular is
ocinético computadorizado da marca Cybex, no seu modelo Norm, na Clínica de Fisi
oterapia da Unicid. Foi avaliada a musculatura adutora e abdutora de quadril. Fo
ram utilizados os dados obtidos a 30 graus por segundo em cinco repetições. Os r
esultados transformados em percentagem para uma melhor comparação entre outros t
rabalhos, pois já está considerando o peso do paciente. Obtiveram-se a média, a 
máxima e a mínima do torque desenvolvido por esta musculatura, sendo observada a
 relação com a amplitude do movimento e a simetria entre os dois membros. Os res
ultados mostraram um torque dominante em adutores, uma assimetria entre os dois 
membros. Observou-se um torque médio em adutor de 150,05% e abdutor em 127,06%.#
^dnd^i1#^tm^lpt^kNatação^i1#^tm^lpt^kIsocinético^i1#^tm^lpt^kAbdutor^i1#^tm^lpt^
kAdutor^i1#^len^aIn this study, an isokinetic evaluation of 12 swimming athletes
 performing the chest swimming style, ages ranging from 15 to 22 years, submitte
d to daily training and participating in state and national performances was con
ducted. A Cybex isokinetic computerized device model Norm was used to evaluate a
ll athletes at the Unicid physical therapy clinic. The muscular abduction and ad
duction of the hip were evaluated. Data obtained from a series of five repetitio
ns at 30 degrees were used. Since the patient's weight had already been consider
ed, results were converted into percentage numbers to provide for a better compa
rison with other studies on the same subject. The authors obtained the average, 
maximum, and minimum torque performed by the musculature, considering its relati
on to the extension of the movement and the symmetry between the two members. An
 average torque of 150.05% for adduction and 127.06% for abduction was found.#^d
nd^i2#^tm^len^kSwimming^i2#^tm^len^kIsokinetic^i2#^tm^len^kAbductor^i2#^tm^len^k
Adductor^i2#other#23#v6n3a05.htm##
03349000000000589000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000400087038000400091121000300095049000800098158000300106
03000210010903100020013003200020013206500090013401400090014303500100015201201220
01620120140002840100028004240100026004520100034004780700020005120700045005320700
01200577083101700589085000801606085002001614085002401634085002001658085001901678
08309470169708500080264408500210265208500230267308500210269608500210271711700060
2738072000302744002001202747#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#
S#f#3#1#article#1#oa#pt#br1.1#1#4.0#GRA#TAB#05#RBME180#nd#Rev Bras Med Esporte#6
#3#20000600#^f93^l98#1517-8692#<b>Avaliação muscular isocinética da musculatura 
abdutora e adutora de coxa em atletas de natação do estilo peito</b>^lpt#<b>Isok
inetic evaluation of the abductor and adductor musculature of the thigh in swimm
ing athletes performing chest swimming style</b>^len#^rND^1A01^nFlávia R.^sIhara
#^rND^1A02^nMirco^sCevales#^rND^1A03^nSergio de Souza^sPinto#Fisioterapeuta^iA01
#Equipe de Natação de São Caetano do Sul^iA02#Unicid^iA03#^lpt^aFoi realizada ne
sta pesquisa a avaliação isocinética de 12 atletas da natação do estilo peito, c
om idades entre 15 e 22 anos, submetidos a treinamento diário, encontrando-se em
 <i>performance</i> estadual e nacional. Todos foram avaliados pelo aparelho de 
avaliação muscular isocinético computadorizado da marca <i>Cybex</i>, no seu mod
elo <i>Norm</i>, na Clínica de Fisioterapia da Unicid. Foi avaliada a musculatur
a adutora e abdutora de quadril. Foram utilizados os dados obtidos a 30 graus po
r segundo em cinco repetições. Os resultados transformados em percentagem para u
ma melhor comparação entre outros trabalhos, pois já está considerando o peso do
 paciente. Obtiveram-se a média, a máxima e a mínima do torque desenvolvido por 
esta musculatura, sendo observada a relação com a amplitude do movimento e a sim
etria entre os dois membros. Os resultados mostraram um torque dominante em adut
ores, uma assimetria entre os dois membros. Observou-se um torque médio em aduto
r de 150,05% e abdutor em 127,06%.#^dnd^i1#^tm^lpt^kNatação^i1#^tm^lpt^kIsocinét
ico^i1#^tm^lpt^kAbdutor^i1#^tm^lpt^kAdutor^i1#^len^aIn this study, an isokinetic
 evaluation of 12 swimming athletes performing the chest swimming style, ages ra
nging from 15 to 22 years, submitted to daily training and participating in stat
e and national performances was conducted. A Cybex isokinetic computerized devic
e model Norm was used to evaluate all athletes at the Unicid physical therapy cl
inic. The muscular abduction and adduction of the hip were evaluated. Data obtai
ned from a series of five repetitions at 30 degrees were used. Since the patient
's weight had already been considered, results were converted into percentage nu
mbers to provide for a better comparison with other studies on the same subject.
 The authors obtained the average, maximum, and minimum torque performed by the 
musculature, considering its relation to the extension of the movement and the s
ymmetry between the two members. An average torque of 150.05% for adduction and 
127.06% for abduction was found.#^dnd^i2#^tm^len^kSwimming^i2#^tm^len^kIsokineti
c^i2#^tm^len^kAbductor^i2#^tm^len^kAdductor^i2#other#23#v6n3a05.htm##
03480000000000613000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670640013000690710003000820400003000850010
00600088042000200094120000400096038000400100038000400104121000300108049000800111
15800030011903000240012203100020014603200020014806500090015001400090015903500100
01680120115001780120133002930100027004260100026004530100034004790700022005130700
04700535070001400582083101400596085000801610085002001618085002401638085002001662
08500190168208309610170108500080266208500210267008500230269108500210271408500210
2735117000602756072000302762002001202765008008902777#v6n3#V:\SciELO\serial\rbme\
v6n3\markup\v6n3a05.htm#S#l#4#1#article#1#^mjun.^a2000#oa#pt#br1.1#1#4.0#gra#tab
#05#RBME180#nd#Rev. bras. med. esporte#6#3#20000600#^f93^l98#1517-8692#Avaliação
 muscular isocinética da musculatura abdutora e adutora de coxa em atletas de na
tação do estilo peito^lpt#Isokinetic evaluation of the abductor and adductor mus
culature of the thigh in swimming athletes performing chest swimming style^len#^
rND^1A01^nFlávia R^sIhara#^rND^1A02^nMirco^sCevales#^rND^1A03^nSergio de Souza^s
Pinto#^iA01^1Fisioterapeuta#^iA02^1Equipe de Natação de São Caetano do Sul#^iA03
^1Unicid#^lpt^aFoi realizada nesta pesquisa a avaliação isocinética de 12 atleta
s da natação do estilo peito, com idades entre 15 e 22 anos, submetidos a treina
mento diário, encontrando-se em performance estadual e nacional. Todos foram ava
liados pelo aparelho de avaliação muscular isocinético computadorizado da marca 
Cybex, no seu modelo Norm, na Clínica de Fisioterapia da Unicid. Foi avaliada a 
musculatura adutora e abdutora de quadril. Foram utilizados os dados obtidos a 3
0 graus por segundo em cinco repetições. Os resultados transformados em percenta
gem para uma melhor comparação entre outros trabalhos, pois já está considerando
 o peso do paciente. Obtiveram-se a média, a máxima e a mínima do torque desenvo
lvido por esta musculatura, sendo observada a relação com a amplitude do movimen
to e a simetria entre os dois membros. Os resultados mostraram um torque dominan
te em adutores, uma assimetria entre os dois membros. Observou-se um torque médi
o em adutor de 150,05 por cento e abdutor em 127,06 por cento.#^dnd^i1#^tm^lpt^k
Natação^i1#^tm^lpt^kIsocinético^i1#^tm^lpt^kAbdutor^i1#^tm^lpt^kAdutor^i1#^len^a
In this study, an isokinetic evaluation of 12 swimming athletes performing the c
hest swimming style, ages ranging from 15 to 22 years, submitted to daily traini
ng and participating in state and national performances was conducted. A Cybex i
sokinetic computerized device model Norm was used to evaluate all athletes at th
e Unicid physical therapy clinic. The muscular abduction and adduction of the hi
p were evaluated. Data obtained from a series of five repetitions at 30 degrees 
were used. Since the patient's weight had already been considered, results were 
converted into percentage numbers to provide for a better comparison with other 
studies on the same subject. The authors obtained the average, maximum, and mini
mum torque performed by the musculature, considering its relation to the extensi
on of the movement and the symmetry between the two members. An average torque o
f 150.05 percent for adduction and 127.06 percent for abduction was found.#^dnd^
i2#^tm^len^kSwimming^i2#^tm^len^kIsokinetic^i2#^tm^len^kAbductor^i2#^tm^len^kAdd
uctor^i2#other#23#v6n3a05.htm#Internet^ihttp://www.scielo.br/scielo.php?script=s
ci_arttext&pid=S1517-86922000000300005##
00319000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704009000071002001200161#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#5#1#article#148#<p align="right"><font f
ace="Verdana" size="2"><b>ARTIGO ORIGINAL</b> </font></p>     ^cY#v6n3a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002200071002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#6#2#article#148#<p>&nbsp;</p>     ^cY#v6
n3a05.htm##
00460000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704023100071002001200302#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#7#3#article#148#<p><font face="Verdana" 
size="4"><b><a name="topo"></a>Avalia&ccedil;&atilde;o    muscular isocin&eacute
;tica da musculatura abdutora e adutora de coxa em atletas    de nata&ccedil;&at
ilde;o do estilo peito </b></font></p>     ^cY#v6n3a05.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002200071002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#8#4#article#148#<p>&nbsp;</p>     ^cY#v6
n3a05.htm##
00423000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704019400071002001200265#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#9#5#article#148#<p><font face="Verdana" 
size="3"><b>Isokinetic evaluation of the abductor and    adductor musculature of
 the thigh in swimming athletes performing chest swimming    style</b></font></p
>     ^cY#v6n3a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#10#6#article#148#<p>&nbsp;</p>     ^cY#v
6n3a05.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#11#7#article#148#<p>&nbsp;</p>     ^cY#v
6n3a05.htm##
00393000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704016300072002001200235#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#12#8#article#148#<p><font face="Verdana"
 size="2"><b>Fl&aacute;via R. Ihara<SUP>I</SUP>; Mirco    Cevales<SUP>II</SUP>; 
Sergio de Souza Pinto<SUP>III</SUP> </b></font></p>     ^cY#v6n3a05.htm##
00297000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704006700072002001200139#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#13#9#article#148#<p><font face="Verdana"
 size="2"><sup>I</sup>Fisioterapeuta    ^cY#v6n3a05.htm##
00545000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704031400073002001200387#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#14#10#article#148#<br>   <sup>II</sup>Pr
ofessor de Educa&ccedil;&atilde;o F&iacute;sica; T&eacute;cnico    de Nata&ccedi
l;&atilde;o; Ex-T&eacute;cnico da Sele&ccedil;&atilde;o Brasileira    Juvenil e 
de J&uacute;nior de Nata&ccedil;&atilde;o; T&eacute;cnico da Equipe    de Nata&c
cedil;&atilde;o de S&atilde;o Caetano do Sul    ^cY#v6n3a05.htm##
00629000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704039800073002001200471#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#15#11#article#148#<br>   <sup>III</sup>F
isioterapeuta; Especialista em Traumatologia Desportiva; Mestrando    em Educa&c
cedil;&atilde;o; Prof. de Fisioterapia Ortop&eacute;dica e Traumatol&oacute;gica
    (Unicid); Supervisor de Ortopedia (Unicid); Coordenador da P&oacute;s-Gradua
&ccedil;&atilde;o    em Ortopedia (Unicid); Respons&aacute;vel pela Avalia&ccedi
l;&atilde;o Isocinetica    na Unicid</font></p>     ^cY#v6n3a05.htm##
00345000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011400073002001200187#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#16#12#article#148#<p><font face="Verdana
" size="2"><a href="#end">Endere&ccedil;o para correspond&ecirc;ncia</a></font><
/p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#17#13#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004400073002001200117#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#18#14#article#148#<p>&nbsp;</p> <hr size
="1" noshade>     ^cY#v6n3a05.htm##
00298000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704006700073002001200140#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#19#15#article#148#<p><font face="Verdana
" size="2"><B>RESUMO</B> </font></p>     ^cY#v6n3a05.htm##
01491000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704126000073002001201333#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#20#16#article#148#<p><font face="Verdana
" size="2">Foi realizada nesta pesquisa a avalia&ccedil;&atilde;o    isocin&eacu
te;tica de 12 atletas da nata&ccedil;&atilde;o do estilo peito, com    idades en
tre 15 e 22 anos, submetidos a treinamento di&aacute;rio, encontrando-se    em <
I>performance</I> estadual e nacional. Todos foram avaliados pelo aparelho    de
 avalia&ccedil;&atilde;o muscular isocin&eacute;tico computadorizado da marca   
 <I>Cybex</I>, no seu modelo <I>Norm</I>, na Cl&iacute;nica de Fisioterapia da  
  Unicid. Foi avaliada a musculatura adutora e abdutora de quadril. Foram utiliz
ados    os dados obtidos a 30 graus por segundo em cinco repeti&ccedil;&otilde;e
s. Os    resultados transformados em percentagem para uma melhor compara&ccedil;
&atilde;o    entre outros trabalhos, pois j&aacute; est&aacute; considerando o p
eso do paciente.    Obtiveram-se a m&eacute;dia, a m&aacute;xima e a m&iacute;ni
ma do torque desenvolvido    por esta musculatura, sendo observada a rela&ccedil
;&atilde;o com a amplitude    do movimento e a simetria entre os dois membros. O
s resultados mostraram um    torque dominante em adutores, uma assimetria entre 
os dois membros. Observou-se    um torque m&eacute;dio em adutor de 150,05% e ab
dutor em 127,06%. </font></p>     ^cY#v6n3a05.htm##
00393000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704016200073002001200235#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#21#17#article#148#<p><font face="Verdana
" size="2"><B>Palavras-chave:</B> Nata&ccedil;&atilde;o.    Isocin&eacute;tico. 
Abdutor. Adutor. </font></p> <hr size="1" noshade>      ^cY#v6n3a05.htm##
00302000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007100073002001200144#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#22#18#article#148#<p><font face="Verdana
" size="2"><B>ABSTRACT </B></font> </p>      ^cY#v6n3a05.htm##
01261000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704103000073002001201103#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#23#19#article#148#<p><font face="Verdana
" size="2">In this study, an isokinetic evaluation of 12    swimming athletes pe
rforming the chest swimming style, ages ranging from 15    to 22 years, submitte
d to daily training and participating in state and national    performances was 
conducted. A Cybex isokinetic computerized device model Norm    was used to eval
uate all athletes at the Unicid physical therapy clinic. The    muscular abducti
on and adduction of the hip were evaluated. Data obtained from    a series of fi
ve repetitions at 30 degrees were used. Since the patient's weight    had alread
y been considered, results were converted into percentage numbers    to provide 
for a better comparison with other studies on the same subject. The    authors o
btained the average, maximum, and minimum torque performed by the musculature,  
  considering its relation to the extension of the movement and the symmetry bet
ween    the two members. An average torque of 150.05% for adduction and 127.06% 
for    abduction was found. </font></p>     ^cY#v6n3a05.htm##
00369000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704013800073002001200211#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#24#20#article#148#<p><font face="Verdana
" size="2"><B>Key words:</B> Swimming. Isokinetic. Abductor.    Adductor. </font
></p> <hr size="1" noshade>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#25#21#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#26#22#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00316000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704008500073002001200158#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#27#23#article#148#<p><font face="Verdana
" size="3"><B>INTRODU&Ccedil;&Atilde;O</B> </font></p>     ^cY#v6n3a05.htm##
00629000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704039800073002001200471#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#28#24#article#148#<p><font face="Verdana
" size="2">A nata&ccedil;&atilde;o &eacute; um esporte conhecido    desde a Gr&e
acute;cia e Roma, onde soldados o praticavam como parte de seu treinamento.    P
or&eacute;m, somente no in&iacute;cio do s&eacute;culo XX come&ccedil;ou a    se
 desenvolver como desporto, vindo a ser estudada mais aprofundadamente nos    &u
acute;ltimos 20 anos<SUP>1,2</SUP>. </font></p>     ^cY#v6n3a05.htm##
00506000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704027500073002001200348#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#29#25#article#148#<p><font face="Verdana
" size="2">Segundo Gomes<SUP>1</SUP>, nata&ccedil;&atilde;o    &eacute; toda pr&
aacute;tica humana na &aacute;gua ou na sua superf&iacute;cie,    que exclui o u
so de qualquer artif&iacute;cio para atingir total autonomia no    meio. </font>
</p>     ^cY#v6n3a05.htm##
00614000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704038300073002001200456#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#30#26#article#148#<p><font face="Verdana
" size="2">Atualmente, existem cinco estilos competitivos    praticados na nata&
ccedil;&atilde;o: o <I>crawl</I>, borboleta, costas, peito    e o nado <I>medley
</I>. Este &uacute;ltimo consiste no somat&oacute;rio dos    outros quatro estil
os, e cada vez mais vem crescendo o n&uacute;mero de competidores    nesta modal
idade<SUP>3,4</SUP>. </font></p>     ^cY#v6n3a05.htm##
01346000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704111500073002001201188#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#31#27#article#148#<p><font face="Verdana
" size="2">O estilo <I>crawl</I> &eacute; o mais r&aacute;pido    dos estilos de
 competi&ccedil;&atilde;o. A posi&ccedil;&atilde;o do nadador    consiste em uma
 prona&ccedil;&atilde;o, com a cabe&ccedil;a baixa na linha da    &aacute;gua, c
om os quadris ligeiramente mais baixos que os ombros, e as pernas    estendidas 
para tr&aacute;s. No estilo <I>borboleta</I>, a &uacute;nica diferen&ccedil;a   
 &eacute; que os bra&ccedil;os e as pernas se movem juntos num movimento ondulat
&oacute;rio.    O nado de <I>costas</I> tamb&eacute;m &eacute; conhecido como <I
>crawl</I> invertido.    Neste nado, o nadador fica na posi&ccedil;&atilde;o sup
ina, com tronco e pernas    ligeiramente estendidos e os quadris abaixo do n&iac
ute;vel da &aacute;gua.    O nado de <I>peito</I> foi o primeiro estilo de nata&
ccedil;&atilde;o a ser    desenvolvido e vai ser melhor descrito posteriormente.
 Finalmente, o quinto    estilo competitivo, que &eacute; o <I>medley</I>, consi
ste respectivamente no    somat&oacute;rio dos estilos borboleta, costas, peito 
e <I>crawl</I><SUP>3,4</SUP>.    </font></p>     ^cY#v6n3a05.htm##
00634000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040300073002001200476#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#32#28#article#148#<p><font face="Verdana
" size="2">Durante uma competi&ccedil;&atilde;o, o principal    objetivo de um n
adador &eacute; nadar a dist&acirc;ncia total de sua prova seguindo    as regras
 oficiais que regulamentam a sa&iacute;da, execu&ccedil;&atilde;o do    nado, vi
rada, chegada, no menor tempo poss&iacute;vel, e obter a m&aacute;xima    veloci
dade da qual &eacute; capaz<SUP>4</SUP>. </font></p>     ^cY#v6n3a05.htm##
00685000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704045400073002001200527#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#33#29#article#148#<p><font face="Verdana
" size="2">O desempenho do atleta de nata&ccedil;&atilde;o    depende de v&aacut
e;rios elementos, tais como: o equil&iacute;brio, a resist&ecirc;ncia,    coorde
na&ccedil;&atilde;o, for&ccedil;a, propuls&atilde;o e a respira&ccedil;&atilde;o
.    Al&eacute;m desses elementos, h&aacute; ainda o empuxo e o peso, que em con
junto    determinar&atilde;o a imers&atilde;o e a flutuabilidade do nadador<SUP>
2</SUP>.    </font></p>     ^cY#v6n3a05.htm##
00636000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704040500073002001200478#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#34#30#article#148#<p><font face="Verdana
" size="2">A pr&aacute;tica da nata&ccedil;&atilde;o exige    uma s&eacute;rie d
e movimentos repetitivos; com isso &eacute; gerado um aumento    do rendimento d
a contra&ccedil;&atilde;o muscular, que conseq&uuml;entemente    leva ao aumento
 do t&ocirc;nus, que corresponde ao estado de tens&atilde;o em    que o m&uacute
;sculo se encontra em repouso<SUP>5</SUP>. </font></p>     ^cY#v6n3a05.htm##
01217000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704098600073002001201059#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#35#31#article#148#<p><font face="Verdana
" size="2">O nado de peito foi o primeiro nado a ser desenvolvido.    Neste nado
, o atleta mais completo &eacute; o atleta mais bem sucedido. Como    o meio aqu
&aacute;tico n&atilde;o pode proporcionar a resist&ecirc;ncia necess&aacute;ria 
   para aumentar devidamente a carga no sistema muscular, o nadador volta-se par
a    a sala de muscula&ccedil;&atilde;o. Uma parte integrante do programa de tre
inamento    da nata&ccedil;&atilde;o consiste no treinamento de for&ccedil;a e r
esist&ecirc;ncia    em seco. Este nado &eacute; o &uacute;nico nado em que os me
mbros superiores    e inferiores produzem a maior parte da propuls&atilde;o. O n
ado envolve uma    movimenta&ccedil;&atilde;o articular complexa em diversas &aa
cute;reas da anatomia.    A a&ccedil;&atilde;o do bra&ccedil;o no nado de peito 
pode ser dividida em quatro    fases distintas: tomada, varredura para baixo, va
rredura para dentro e recupera&ccedil;&atilde;o<SUP>6</SUP>.    </font></p>     
^cY#v6n3a05.htm##
01200000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704096900073002001201042#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#36#32#article#148#<p><font face="Verdana
" size="2">Nesta fase o nadador inicia a fase de puxada    da bra&ccedil;ada com
 os bra&ccedil;os estendidos para a frente, paralelos &agrave;    superf&iacute;
cie da &aacute;gua. As m&atilde;os s&atilde;o voltadas para cima,    de modo que
 as palmas estejam a quase 90 graus para fora a partir da posi&ccedil;&atilde;o 
   pronada. Ocorre uma ligeira tor&ccedil;&atilde;o do punho, fazendo com que a 
   m&atilde;o do nadador tome a forma c&ocirc;ncava. Nesta posi&ccedil;&atilde;o
    o atleta est&aacute; preparado para dar in&iacute;cio &agrave; fase propulso
ra    da bra&ccedil;ada. No final da tomada, os bra&ccedil;os encontram-se ligei
ramente    mais abertos que a largura dos ombros. M&uacute;sculos como tr&iacute
;ceps braquial,    redondo maior, flexores de punho superficiais e profundos, pe
itoral, grande    dorsal, braquiorradial, braquial e b&iacute;ceps braquial v&at
ilde;o estar agindo    nesta fase<SUP>6</SUP>. </font></p>     ^cY#v6n3a05.htm##
01556000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704132500073002001201398#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#37#33#article#148#<p><font face="Verdana
" size="2">Na fase de varredura para baixo o bra&ccedil;o    come&ccedil;a a cur
var-se no cotovelo &agrave; medida que as m&atilde;os descrevem    um movimento 
circular para baixo e para fora. As palmas encontram-se voltadas    lateralmente
, embora j&aacute; tenham iniciado o giro internamente. Ao final    deste movime
nto as m&atilde;os estar&atilde;o em seu ponto mais profundo da    bra&ccedil;ad
a, com flex&atilde;o de cotovelo de quase 90 graus. Durante este    movimento o 
nadador come&ccedil;a a levantar a cabe&ccedil;a para tomar f&ocirc;lego.    Ao 
final da varredura para baixo as m&atilde;os come&ccedil;am a se acelerar,    e 
esta acelera&ccedil;&atilde;o &eacute; mantida at&eacute; a fase de varredura   
 para dentro. M&uacute;sculos como b&iacute;ceps braquial, braquial, braquiorrad
ial,    subescapular, redondo maior, peitoral maior, grande dorsal, dorsal longo
 do    pesco&ccedil;o, semi-espinhal do pesco&ccedil;o, espl&ecirc;nio da cabe&c
cedil;a,    espl&ecirc;nio do pesco&ccedil;o e eretores da coluna v&atilde;o est
ar atuando    nesta fase. Na fase de varredura para dentro o movimento das m&ati
lde;os muda    do sentido para baixo e para fora, para o sentido interno e para 
cima, continuando    o padr&atilde;o circular iniciado com a varredura para baix
o. </font></p>     ^cY#v6n3a05.htm##
00788000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704055700073002001200630#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#38#34#article#148#<p><font face="Verdana
" size="2">As m&atilde;os correm quase diretamente para    baixo dos cotovelos, 
quando se aproximam da linha central do corpo. Quando as    m&atilde;os se junta
m abaixo do queixo, os cotovelos s&atilde;o trazidos juntos    por baixo do t&oa
cute;rax. Quando o cotovelo se aproxima um do outro, o nadador    respira. M&uac
ute;sculos como b&iacute;ceps braquial, braquiorradial, braquial,    supinador, 
peitoral maior, grande dorsal, redondo maior e trap&eacute;zio v&atilde;o    est
ar atuando nesta fase<SUP>6</SUP>. </font></p>     ^cY#v6n3a05.htm##
01103000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704087200073002001200945#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#39#35#article#148#<p><font face="Verdana
" size="2">Na fase de recupera&ccedil;&atilde;o, quando    as m&atilde;os se enc
ontram sob o queixo e os cotovelos s&atilde;o aproximados,    os bra&ccedil;os s
e estendem para a frente, paralelos &agrave; superf&iacute;cie    da &aacute;gua
. A cabe&ccedil;a volta para dentro da &aacute;gua. Quando os    bra&ccedil;os a
tingem a extens&atilde;o completa, as m&atilde;os s&atilde;o    empurradas 15 a 
20cm para baixo. Isto &eacute; para evitar que o quadril caia    abaixo da super
f&iacute;cie, mantendo assim o posicionamento adequado do corpo.    M&uacute;scu
los como tr&iacute;ceps braquial, delt&oacute;ide, peitoral maior,    coracobraq
uial atuam nesta fase. A pernada do nado de peito tamb&eacute;m se    divide em 
quatro fases: tomada, varredura para baixo, varredura para dentro    e recupera&
ccedil;&atilde;o<SUP>6</SUP>. </font></p>     ^cY#v6n3a05.htm##
00895000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704066400073002001200737#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#40#36#article#148#<p><font face="Verdana
" size="2">Na fase de tomada os joelhos est&atilde;o completamente    fletidos (
mais de 90 graus). Os p&eacute;s encontram-se acima das n&aacute;degas,    junto
s. O movimento dos p&eacute;s &eacute; girado de modo que as solas fiquem    vol
tadas para tr&aacute;s e para cima, com os dedos apontando lateralmente.    As p
ernas come&ccedil;am a se estender e os p&eacute;s fazem o percurso no sentido  
  para tr&aacute;s e para fora, nas laterais. M&uacute;sculos como tibial anteri
or,    dorsiflexores, gl&uacute;teo m&eacute;dio, tensor da <I>fascia lata</I>, 
iliopsoas,    quadr&iacute;ceps atuam nesta fase<SUP>6</SUP>. </font></p>     ^c
Y#v6n3a05.htm##
00806000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704057500073002001200648#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#41#37#article#148#<p><font face="Verdana
" size="2">Na fase de varredura para baixo as pernas continuam    a extens&atild
e;o iniciada na fase anterior. Esta extens&atilde;o faz com que    os p&eacute;s
 percorram em sentido para baixo e para fora at&eacute; atingirem    o ponto mai
s aberto, quando iniciam o percurso de volta para dentro e para baixo.    O movi
mento dos p&eacute;s muda em sentido interno. M&uacute;sculos como adutor    mag
no, adutor curto, adutor longo, pect&iacute;neo e gr&aacute;cil atuam nesta    f
ase. Funcionam como propulsores do nado<SUP>6</SUP>. </font></p>     ^cY#v6n3a05
.htm##
00830000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704059900073002001200672#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#42#38#article#148#<p><font face="Verdana
" size="2">Na fase de varredura para dentro os p&eacute;s    continuam a girar p
ara dentro. As pernas terminam a extens&atilde;o e ent&atilde;o    os p&eacute;s
 s&atilde;o trazidos para perto um do outro. Quando os p&eacute;s    est&atilde;
o quase se tocando, pode ocorrer um breve deslize, pois as pernas    mant&ecirc;
m esse posicionamento de extens&atilde;o completa por uma fra&ccedil;&atilde;o  
  de segundos. M&uacute;sculos como quadr&iacute;ceps, tibial anterior, tibial  
  posterior, gastrocn&ecirc;mio, s&oacute;leo, atuam nesta fase<SUP>6</SUP>. </f
ont></p>     ^cY#v6n3a05.htm##
00718000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704048700073002001200560#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#43#39#article#148#<p><font face="Verdana
" size="2">Na fase de recupera&ccedil;&atilde;o, no final    da parte propulsora
 da pernada, os p&eacute;s se encontram juntos. Nesta posi&ccedil;&atilde;o    e
les est&atilde;o prontos para iniciar a recupera&ccedil;&atilde;o. As pernas    
recuperam quando os bra&ccedil;os geram a propuls&atilde;o. M&uacute;sculos    c
omo o b&iacute;ceps femoral, semitendinoso, semimembranoso, sart&oacute;rio    e
 gr&aacute;cil atuam nesta fase<SUP>6</SUP>. </font></p>     ^cY#v6n3a05.htm##
00735000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704050400073002001200577#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#44#40#article#148#<p><font face="Verdana
" size="2">Como foi visto, o nado de peito &eacute; muito    complexo. Para uma 
boa pernada neste nado &eacute; necess&aacute;rio ter m&uacute;sculos    adutore
s de coxa fortes, para que a propuls&atilde;o do nado seja eficiente.    S&oacut
e; que n&atilde;o &eacute; s&oacute; da for&ccedil;a que depende o desempenho   
 de um nadador; precisa-se tamb&eacute;m da efici&ecirc;ncia mec&acirc;nica,    
flexibilidade, continuidade e bom posicionamento (Lima 1996). </font></p>     ^c
Y#v6n3a05.htm##
00814000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704058300073002001200656#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#45#41#article#148#<p><font face="Verdana
" size="2">A amplitude de movimento tamb&eacute;m &eacute;    muito importante. 
Quanto mais alongado o m&uacute;sculo, maior sua capacidade    de gerar for&cced
il;a. O comprimento do m&uacute;sculo aumenta com o treinamento    do alongament
o. Quando se faz alongamento, o m&uacute;sculo resiste, mas aumenta-se    o comp
rimento do sarc&ocirc;mero (afasta os filamentos finos dos grossos). Alongando  
  a fibra, o comprimento de repouso muda, aumentando. A fibra vai estar relaxada
,    mas o comprimento de repouso vai ser maior<SUP>7</SUP>. </font></p>     ^cY
#v6n3a05.htm##
01580000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704134900073002001201422#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#46#42#article#148#<p><font face="Verdana
" size="2">Em qualquer atividade f&iacute;sica que ocorre    em tempo superior a
 alguns minutos, a energia &eacute; fornecida pelo sistema    aer&oacute;bico. O
s exerc&iacute;cios de resist&ecirc;ncia provocam adapta&ccedil;&otilde;es    mu
sculares que controlam o fornecimento de energia. As adapta&ccedil;&otilde;es   
 que ocorrem com o treinamento promovem altera&ccedil;&otilde;es no metabolismo 
   muscular, adaptando-os para aumentar as trocas entre os capilares e as c&eacu
te;lulas,    e, conseq&uuml;entemente, uma melhoria no desempenho f&iacute;sico.
 O m&uacute;sculo    quando adaptado ao treinamento utiliza melhor a reserva de 
energia. S&oacute;    que os m&uacute;sculos que n&atilde;o s&atilde;o requisita
dos no programa de    treinamento n&atilde;o se adaptam; &eacute; por isso que c
ada vez mais se faz    necess&aacute;rio o conhecimento de biomec&acirc;nica do 
movimento de acordo    com o estilo do atleta. Um programa de alongamento adequa
do pode melhorar o    desempenho de um atleta, tendo em vista que qualquer um do
s cinco estilos vai    exigir uma grande amplitude de movimento das articula&cce
dil;&otilde;es e, se    a musculatura alcan&ccedil;ar o comprimento ideal, ir&aa
cute; ajudar o atleta    no desenvolvimento de pot&ecirc;ncia e resist&ecirc;nci
a muscular<SUP>8</SUP>.    </font></p>     ^cY#v6n3a05.htm##
01100000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704086900073002001200942#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#47#43#article#148#<p><font face="Verdana
" size="2">Atualmente, a nata&ccedil;&atilde;o &eacute;    um esporte que vem cr
escendo muito nacional e internacionalmente, gra&ccedil;as    ao bom desempenho 
que os nadadores(as) v&ecirc;m apresentando nas competi&ccedil;&otilde;es.    En
tretanto, a maior e mais preocupante defici&ecirc;ncia competitiva da nata&ccedi
l;&atilde;o    est&aacute; no estilo peito, que necessita de uma pernada forte e
 de uma boa    flexibilidade no arco de movimento. Embora apresente bons nadador
es neste estilo,    a maioria utiliza a coordena&ccedil;&atilde;o de movimento e
 a for&ccedil;a    de bra&ccedil;os para sustentar o nado, n&atilde;o fazendo us
o de uma forte    e eficiente pernada, sendo necess&aacute;ria uma avalia&ccedil
;&atilde;o da    for&ccedil;a muscular de adutores/abdutores de coxa em nadadore
s de peito<SUP>9</SUP>.    </font></p>     ^cY#v6n3a05.htm##
01134000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704090300073002001200976#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#48#44#article#148#<p><font face="Verdana
" size="2">A coxa &eacute; constitu&iacute;da de tr&ecirc;s    compartimentos mu
sculares: anterior, posterior e medial. No compartimento anterior    da coxa enc
ontra-se o m&uacute;sculo quadr&iacute;ceps femoral (m&uacute;sculo    vasto lat
eral, m&uacute;sculo vasto medial, m&uacute;sculo vasto interm&eacute;dio,    m&
uacute;sculo reto femoral) e o m&uacute;sculo sart&oacute;rio (obl&iacute;quo). 
   No compartimento medial da coxa encontram-se os m&uacute;sculos que v&atilde;
o    fazer a adu&ccedil;&atilde;o da coxa, tal como o m&uacute;sculo adutor magn
o,    m&uacute;sculo adutor longo, m&uacute;sculo adutor curto, m&uacute;sculo p
ect&iacute;neo    e m&uacute;sculo gr&aacute;cil. No compartimento posterior da 
coxa encontram-se    os m&uacute;sculos b&iacute;ceps femoral, m&uacute;sculo se
mitendinoso e m&uacute;sculo    semimembranoso<SUP>10</SUP>. </font></p>     ^cY
#v6n3a05.htm##
00500000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704026900073002001200342#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#49#45#article#148#<p><font face="Verdana
" size="2">Entre os movimentos realizados pela coxa observam-se:    abdu&ccedil;
&atilde;o, adu&ccedil;&atilde;o, flex&atilde;o, extens&atilde;o,    rota&ccedil;
&atilde;o externa e rota&ccedil;&atilde;o interna<SUP>11</SUP>.    </font></p>  
   ^cY#v6n3a05.htm##
00607000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704037600073002001200449#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#50#46#article#148#<p><font face="Verdana
" size="2">Considerando-se os m&uacute;sculos como um sistema    biol&oacute;gic
o que transforma energia qu&iacute;mica em mec&acirc;nica, a    avalia&ccedil;&a
tilde;o de sua fun&ccedil;&atilde;o envolve a determina&ccedil;&atilde;o    das 
vari&aacute;veis: for&ccedil;a, trabalho, pot&ecirc;ncia e resist&ecirc;ncia<SUP
>12</SUP>.    </font></p>     ^cY#v6n3a05.htm##
00821000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704059000073002001200663#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#51#47#article#148#<p><font face="Verdana
" size="2">A for&ccedil;a pode ser definida simplesmente    como um empurr&atild
e;o ou tra&ccedil;&atilde;o. Uma equa&ccedil;&atilde;o usada    para definir a f
or&ccedil;a &eacute; <I>F</I> = <I>m</I> x <I>a</I>, onde <I>F</I>    &eacute; a
 for&ccedil;a, <I>m</I> &eacute; a massa do objeto e <I>a</I> &eacute;    a acel
era&ccedil;&atilde;o do objeto. Por defini&ccedil;&atilde;o, for&ccedil;a    &ea
cute; uma entidade que tende a produzir movimento. A for&ccedil;a produzida    p
or um m&uacute;sculo depende de v&aacute;rios fatores<SUP>13</SUP>. </font></p> 
    ^cY#v6n3a05.htm##
00698000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704046700073002001200540#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#52#48#article#148#<p><font face="Verdana
" size="2">Fazem parte desses fatores: a) sincroniza&ccedil;&atilde;o    das uni
dades motoras; b) se&ccedil;&atilde;o transversa do m&uacute;sculo, que    deriv
a da massa e di&acirc;metro das fibras musculares; c) tipo de fibra muscular    
predominante; d) disposi&ccedil;&atilde;o anat&ocirc;mica das fibras musculares;
    e) sistemas de alavancas articulares; f) fatores et&aacute;rios e end&oacute
;crinos<SUP>12</SUP>.    </font></p>     ^cY#v6n3a05.htm##
00852000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704062100073002001200694#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#53#49#article#148#<p><font face="Verdana
" size="2">Quando se mensuram as for&ccedil;as exercidas    sobre os sistemas ar
ticulares atrav&eacute;s da isocin&eacute;tica, leva-se    em considera&ccedil;&
atilde;o o momento ou torque desenvolvido pelos grupos    musculares. Torque ou 
momento &eacute; quando uma for&ccedil;a atua sobre um    corpo e tende a produz
ir um movimento angular. O movimento angular sempre ocorre    ao redor do centro
 de rota&ccedil;&atilde;o, chamado de eixo. O torque de uma    for&ccedil;a sobr
e um eixo &eacute; o produto da for&ccedil;a e do seu bra&ccedil;o    de alavanc
a<SUP>14,15</SUP>. </font></p>     ^cY#v6n3a05.htm##
01000000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704076900073002001200842#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#54#50#article#148#<p><font face="Verdana
" size="2">Isocin&eacute;tica significa const&acirc;ncia    das for&ccedil;as em
 movimento. Durante o treinamento isocin&eacute;tico, a    velocidade com que a 
carga &eacute; movimentada &eacute; mantida constante.    Isto naturalmente sign
ifica tamb&eacute;m uma velocidade constante da contra&ccedil;&atilde;o    muscu
lar. Trata-se, portanto, de uma forma de treinamento de for&ccedil;a din&acirc;m
ica.    Maquinalmente, a velocidade permanece constante e a carga fica adaptada 
ao &acirc;ngulo    de ataque e a distens&atilde;o pr&eacute;via da fibra muscula
r. Mediante o treinamento    isocin&eacute;tico, poder&aacute; ser mobilizada um
a for&ccedil;a constante    no total da trajet&oacute;ria dos movimentos<SUP>16<
/SUP>. </font></p>     ^cY#v6n3a05.htm##
00972000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704074100073002001200814#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#55#51#article#148#<p><font face="Verdana
" size="2">Um dinam&ocirc;metro isocin&eacute;tico &eacute;    um instrumento el
etromec&acirc;nico contendo um mecanismo controlador de velocidade    e que acel
era at&eacute; uma velocidade preestabelecida ao ser aplicada qualquer    for&cc
edil;a. Depois que essa velocidade constante &eacute; alcan&ccedil;ada,    o mec
anismo de carga isocin&eacute;tico se acomoda automaticamente para proporcionar 
   uma for&ccedil;a contr&aacute;ria e igual &agrave; for&ccedil;a gerada pelo  
  m&uacute;sculo. Assim sendo, uma for&ccedil;a m&aacute;xima (ou qualquer perce
ntual    de esfor&ccedil;o m&aacute;ximo) pode ser aplicada durante todas as fas
es do    movimento numa velocidade constante<SUP>17</SUP>. </font></p>     ^cY#v
6n3a05.htm##
00702000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704047100073002001200544#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#56#52#article#148#<p><font face="Verdana
" size="2">O exerc&iacute;cio isocin&eacute;tico n&atilde;o    estimula os movim
entos naturais; assim sendo, &eacute; dif&iacute;cil avaliar    o treinamento is
ocin&eacute;tico. O aparelho destinado aos testes isocin&eacute;ticos    &eacute
; muito &uacute;til para testar a for&ccedil;a din&acirc;mica m&aacute;xima.    
A velocidade de contra&ccedil;&atilde;o &eacute; decisiva para a for&ccedil;a   
 m&aacute;xima<SUP>18</SUP>. </font></p>     ^cY#v6n3a05.htm##
00623000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704039200073002001200465#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#57#53#article#148#<p><font face="Verdana
" size="2">Durante o exerc&iacute;cio isocin&eacute;tico    a press&atilde;o per
manece constante durante todo o movimento. O dinam&ocirc;metro    isocin&eacute;
tico regula a quantidade de resist&ecirc;ncia, a sua rapidez e    melhora a for&
ccedil;a muscular, tornando-se indispens&aacute;vel nos esportes    de competi&c
cedil;&atilde;o<SUP>19</SUP>. </font></p>     ^cY#v6n3a05.htm##
00861000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704063000073002001200703#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#58#54#article#148#<p><font face="Verdana
" size="2">O exerc&iacute;cio isocin&eacute;tico &eacute;    o &uacute;nico m&ea
cute;todo que pode quantificar a for&ccedil;a muscular com    precis&atilde;o, a
trav&eacute;s de equipamentos (dinam&ocirc;metros isocin&eacute;ticos)    ajust&
aacute;veis a qualquer tipo de paciente. O m&eacute;todo pode detectar    e ajud
ar na corre&ccedil;&atilde;o de desequil&iacute;brios musculares antes    que os
 sintomas apare&ccedil;am. No caso dos atletas competitivos isso &eacute;    ess
encial, pois pode-se detectar a defici&ecirc;ncia do nado caso ela seja de    or
igem muscular<SUP>20</SUP>. </font></p>     ^cY#v6n3a05.htm##
00780000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704054900073002001200622#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#59#55#article#148#<p><font face="Verdana
" size="2">Portanto, esta pesquisa qualitativo-descritiva    prop&otilde;e uma a
valia&ccedil;&atilde;o isocin&eacute;tica de abdutores e    adutores de coxa em 
nadadores de peito, a fim de avaliar a for&ccedil;a muscular    e verificar d&ea
cute;ficits de for&ccedil;a nestas musculaturas. Esta pesquisa    tem por objeti
vo comparar dados obtidos no dinam&ocirc;metro isocin&eacute;tico    e fazer uma
 rela&ccedil;&atilde;o com o grau de amplitude de movimento e a assimetria    en
tre os membros inferiores. </font></p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#60#56#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00305000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007400073002001200147#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#61#57#article#148#<p><font face="Verdana
" size="3"><B>M&Eacute;TODO</B> </font></p>     ^cY#v6n3a05.htm##
02223000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704199200073002001202065#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#62#58#article#148#<p><font face="Verdana
" size="2">Foi constru&iacute;do e aplicado um question&aacute;rio    em 12 nada
dores entre 15 e 22 anos, no intuito de avaliar os participantes da    pesquisa.
 Foram colhidos dados sobre idade, peso, atividades extras e informa&ccedil;&oti
lde;es    de treino por eles realizados. Cada atleta teve mensurada sua goniomet
ria de    quadril (flex&atilde;o, extens&atilde;o, abdu&ccedil;&atilde;o, adu&cc
edil;&atilde;o,    rota&ccedil;&atilde;o interna, rota&ccedil;&atilde;o externa)
 pelo goni&ocirc;metro    manual. Al&eacute;m do question&aacute;rio e da goniom
etria, cada atleta realizou    um teste de for&ccedil;a muscular de abdutores e 
adutores de coxa no dinam&ocirc;metro    isocin&eacute;tico, da marca <I>Cybex</
I>, modelo <I>Norm</I>, na Cl&iacute;nica    de Fisioterapia da Universidade Cid
ade de S&atilde;o Paulo. O teste foi precedido    de um aquecimento na bicicleta
 ergom&eacute;trica (15 minutos) e alongamento.    O teste inicia-se com o atlet
a deitado em dec&uacute;bito lateral na cadeira    do dinam&ocirc;metro, devidam
ente estabilizado, com a coluna reta e extens&atilde;o    de pernas. O eixo do d
inam&ocirc;metro &eacute; alinhado ao n&iacute;vel de    gl&uacute;teos. A perna
 que est&aacute; em cima &eacute; que vai ser analisada.    O protocolo usado fo
i uma s&eacute;rie de cinco repeti&ccedil;&otilde;es a 30    graus por segundo, 
em que o resultado em N/m foi transformado em percentagem    atrav&eacute;s da d
ivis&atilde;o do resultado em N/m pelo peso corporal do atleta,    multiplicado 
por 100, posteriormente. O terapeuta descreve as etapas do teste    e da execu&c
cedil;&atilde;o correta do movimento. Ap&oacute;s an&aacute;lise    de uma perna
, o atleta muda o dec&uacute;bito lateral para o outro lado e avalia-se    a out
ra perna. &Eacute; realizada uma s&eacute;rie de cinco repeti&ccedil;&otilde;es 
   de movimento com for&ccedil;a m&aacute;xima do grupo muscular escolhido (abdu
tores    e adutores de coxa). </font></p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#63#59#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00322000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009100073002001200164#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#64#60#article#148#<p><font face="Verdana
" size="3"><B>RESULTADOS E DISCUSS&Otilde;ES</B> </font></p>     ^cY#v6n3a05.htm
##
00868000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704063700073002001200710#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#65#61#article#148#<p><font face="Verdana
" size="2">O question&aacute;rio foi aplicado em 12 atletas    do sexo masculino
. Destes, 75% pertencem &agrave; faixa et&aacute;ria de 15    a 18 anos e 25% de
 19 a 22 anos. Dos atletas avaliados, 83,3% se encontram em    n&iacute;vel de <
I>performance</I> nacional e 16,8% estadual. Quanto ao per&iacute;odo    de trei
namento, 58,3% treinam mais que tr&ecirc;s horas por dia, 25% treinam    at&eacu
te; tr&ecirc;s horas e 16,8% treinam menos que tr&ecirc;s horas. Todos    os atl
etas praticam somente nata&ccedil;&atilde;o como esporte e apresentam    em m&ea
cute;dia 70,2kg e 1,76m de altura. </font></p>     ^cY#v6n3a05.htm##
01202000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704097100073002001201044#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#66#62#article#148#<p><font face="Verdana
" size="2">Conforme demonstrado na <a href="#tab01">tabela    1</a>, os atletas 
realizam preparo f&iacute;sico antes e depois do treino. Antes    do treino a ma
ioria dos atletas trabalha mais for&ccedil;a de membros superiores    com o exte
nsor e metade tamb&eacute;m complementa o preparo com muscula&ccedil;&atilde;o  
  (exerc&iacute;cios de ombro, bra&ccedil;o e de pernas). O alongamento &eacute;
    muito pouco praticado pelos atletas antes do treino. Depois do treino a maio
ria    dos atletas n&atilde;o realiza nenhuma atividade f&iacute;sica. Os atleta
s que    fazem algum preparo f&iacute;sico escolhem entre o extensor e alongamen
to ap&oacute;s    o treino. Segundo Nascimento<SUP>8</SUP>, o alongamento adequa
do pode melhorar    o desempenho do atleta, tanto em pot&ecirc;ncia como em resi
st&ecirc;ncia muscular.    Da&iacute; sua import&acirc;ncia dentro do trabalho d
e preparo f&iacute;sico.    </font></p> <a name="tab01"></a>     ^cY#v6n3a05.htm
##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#67#63#article#148#<p align="center">&nbs
p;</p>     ^cY#v6n3a05.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#68#64#article#148#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a05t01.gif"></p>     ^cY#v6n3a05.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#69#65#article#148#<p align="center">&nbs
p;</p>     ^cY#v6n3a05.htm##
00499000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704026800073002001200341#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#70#66#article#148#<p><font face="Verdana
" size="2">De acordo com dados obtidos no question&aacute;rio,    a maioria dos 
atletas considera ter uma boa e eficiente pernada no seu nado,    alguns relatam
 que a consideram m&eacute;dia e poucos a acham fraca ou ruim.    </font></p>   
  ^cY#v6n3a05.htm##
00727000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704049600073002001200569#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#71#67#article#148#<p><font face="Verdana
" size="2">Foi verificado com o aparelho de avalia&ccedil;&atilde;o    isocin&ea
cute;tico o torque m&eacute;dio, o m&aacute;ximo e o m&iacute;nimo    dos m&uacu
te;sculos abdutores e adutores de coxa em nadadores de peito, o que    pode ser 
observado no <a href="#g01">gr&aacute;fico 1</a>, e o equil&iacute;brio    da re
la&ccedil;&atilde;o agonista/antagonista de abdutores e adutores de coxa,    que
 pode ser observado na <a href="#tab02">tabela 2</a>. </font></p>     ^cY#v6n3a0
5.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#72#68#article#148#<p><a name="g01"></a> 
</p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#73#69#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#74#70#article#148#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a05g01.gif"></p>     ^cY#v6n3a05.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#75#71#article#148#<p align="center">&nbs
p;</p>     ^cY#v6n3a05.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#76#72#article#148#<p align="center">&nbs
p;</p>     ^cY#v6n3a05.htm##
00281000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704005000073002001200123#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#77#73#article#148#<p align="left"><a nam
e="tab02"></a> </p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#78#74#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#79#75#article#148#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a05t02.gif"></p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#80#76#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
01387000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704115600073002001201229#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#81#77#article#148#<p><font face="Verdana
" size="2">O <a href="#g01">gr&aacute;fico 1</a> apresenta    a m&eacute;dia, m&
iacute;nima e m&aacute;xima do torque de abdutores e adutores    de coxa direita
 e esquerda, onde observamos que a m&eacute;dia de torque abdutor    foi de 127,
6%, chegando no m&aacute;ximo de 154%. J&aacute; o adutor atingiu    uma m&eacut
e;dia de 150,05%, chegando no m&aacute;ximo a 212%. Para termos uma    no&ccedil
;&atilde;o destas caracter&iacute;sticas podemos comparar com atletas    do fute
bol, que apresentam um torque m&aacute;ximo de abdutor de 253,40%, com    uma m&
eacute;dia de 166,55%; j&aacute; o adutor apresentou um m&aacute;ximo    de 283,
30%, com uma m&eacute;dia de 167,60%. Observa-se neste caso uma rela&ccedil;&ati
lde;o    quase igual entre os dois grupos<SUP>21</SUP>. O que n&atilde;o acontec
e no    caso dos nadadores, que apresentam uma diferen&ccedil;a a favor do aduto
r, sendo    ele mais forte que o abdutor. Trabalho realizado por Dvir<SUP>22</SU
P> mostra    que pessoas comuns apresentam um torque de adutor em 172%; j&aacute
; nos abdutores,    em 146,6%; isso em popula&ccedil;&atilde;o americana. </font
></p>     ^cY#v6n3a05.htm##
00504000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704027300073002001200346#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#82#78#article#148#<p><font face="Verdana
" size="2">Na <a href="#tab02">tabela 2</a> observam-se    os d&eacute;ficits de
 for&ccedil;a muscular dos abdutores e dos adutores de    coxa, sendo considerad
o aceit&aacute;veis d&eacute;ficits de at&eacute; 10%<SUP>23</SUP>.    </font></
p>     ^cY#v6n3a05.htm##
00538000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704030700073002001200380#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#83#79#article#148#<p><font face="Verdana
" size="2">O resultado obtido mostra que todos os atletas    apresentam d&eacute
;ficit na musculatura adutora, sendo oito atletas (66,7%)    com d&eacute;ficits
 considerados acima do aceit&aacute;vel e quatro atletas    (33,3%) com d&eacute
;ficit aceit&aacute;vel. </font></p>     ^cY#v6n3a05.htm##
00519000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704028800073002001200361#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#84#80#article#148#<p><font face="Verdana
" size="2">A musculatura abdutora tamb&eacute;m apresenta    d&eacute;ficits de 
for&ccedil;a, tendo oito atletas (66,7%) com d&eacute;ficit    acima do aceit&aa
cute;vel e quatro atletas (33,3%) com d&eacute;ficit considerado    aceit&aacute
;vel. </font></p>     ^cY#v6n3a05.htm##
00532000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704030100073002001200374#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#85#81#article#148#<p><font face="Verdana
" size="2">Foi analisada individualmente a goniometria de    quadril (flex&atild
e;o, extens&atilde;o, abdu&ccedil;&atilde;o, adu&ccedil;&atilde;o,    rota&ccedi
l;&atilde;o externa e rota&ccedil;&atilde;o interna) atrav&eacute;s    do goni&o
circ;metro manual. </font></p>     ^cY#v6n3a05.htm##
00852000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704062100073002001200694#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#86#82#article#148#<p><font face="Verdana
" size="2">Comparando os dados da goniometria e a m&eacute;dia    de torque obti
da (<a href="#g02">gr&aacute;fico 2</a>), observa-se que sete    atletas (58,32%
) apresentam torque menor de adutores de coxa do lado esquerdo,    e menor grau 
de amplitude de movimento deste mesmo lado. Outros dois atletas    (16,7%) apres
entam maior torque de adutores de coxa do lado esquerdo e maior    grau de ampli
tude de movimento deste lado. E tr&ecirc;s atletas (25%) apresentam    maior tor
que de adutores de coxa do lado esquerdo, por&eacute;m menor amplitude    de mov
imento deste lado. </font></p>     ^cY#v6n3a05.htm##
00266000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003500073002001200108#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#87#83#article#148#<p><a name="g02"></a> 
</p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#88#84#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#89#85#article#148#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a05g02.gif"></p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#90#86#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00775000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704054400073002001200617#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#91#87#article#148#<p><font face="Verdana
" size="2">Dos sete atletas que apresentaram torque menor    e amplitude de movi
mento menor do lado esquerdo, apenas tr&ecirc;s (50%) realizam    alongamento an
tes do treino. Os dois atletas com torque maior de adutores e    amplitude de mo
vimento maior do lado esquerdo realizam alongamento antes do    treino e um dele
s tamb&eacute;m ap&oacute;s o treino. E dos tr&ecirc;s atletas    com torque mai
or e amplitude de movimento menor do lado esquerdo, apenas um    realiza alongam
ento antes do treino. </font></p>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#92#88#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007700073002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#93#89#article#148#<p><font face="Verdana
" size="3"><B>CONCLUS&Atilde;O</B> </font></p>     ^cY#v6n3a05.htm##
01014000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704078300073002001200856#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#94#90#article#148#<p><font face="Verdana
" size="2">Esta pesquisa qualitativo-descritiva prop&ocirc;s    uma avalia&ccedi
l;&atilde;o isocin&eacute;tica da for&ccedil;a muscular de abdutores    e adutor
es de coxa em nadadores de peito e sua rela&ccedil;&atilde;o com o grau    de am
plitude do movimento, visando comparar dados de torque da musculatura adutora   
 e abdutora de coxa com o grau de amplitude de movimento dos atletas, verificar 
   d&eacute;ficits de for&ccedil;a muscular. Esses dados foram obtidos atrav&eac
ute;s    do teste isocin&eacute;tico realizado no dinam&ocirc;metro isocin&eacut
e;tico    da marca <I>Cybex</I>, modelo <I>Norm</I> na Cl&iacute;nica de Fisiote
rapia    da Universidade Cidade de S&atilde;o Paulo, e atrav&eacute;s do goni&oc
irc;metro    manual. </font></p>     ^cY#v6n3a05.htm##
01325000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704109400073002001201167#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#95#91#article#148#<p><font face="Verdana
" size="2">Os resultados das compara&ccedil;&otilde;es entre    torque e grau de
 amplitude de movimento obtidos nesta pesquisa mostram que graus    menores de a
mplitude de movimento levam a torques menores de for&ccedil;a muscular,    e que
 graus menores tamb&eacute;m podem levar o atleta a n&atilde;o ter altera&ccedil
;&otilde;es    no torque de for&ccedil;a muscular. Mas isso ocorreu apenas em po
ucos atletas.    J&aacute; graus de amplitude maiores levam a torques maiores de
 for&ccedil;a    muscular. Esse resultado &eacute; compat&iacute;vel com a liter
atura. E mostra    que quanto mais alongado um m&uacute;sculo, maior a amplitude
 de movimento e,    portanto, maior sua capacidade de gerar for&ccedil;a, sendo 
o inverso da mesma    forma. Uma hip&oacute;tese para atletas que tiveram graus 
menores de amplitude    de movimento, mas torques maiores de for&ccedil;a muscul
ar, &eacute; que a musculatura    se adaptou a este grau de amplitude e desenvol
veram pot&ecirc;ncia, resist&ecirc;ncia    muscular e for&ccedil;a em cima desta
 estrutura. </font></p>     ^cY#v6n3a05.htm##
00663000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704043200073002001200505#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#96#92#article#148#<p><font face="Verdana
" size="2">Foi observado que, apesar de ser a nata&ccedil;&atilde;o    um esport
e sim&eacute;trico, onde os membros t&ecirc;m que estar equilibrados,    a m&eac
ute;dia de diferen&ccedil;a entre eles foi acima dos 10% previstos em    literat
ura. E a rela&ccedil;&atilde;o ag&ocirc;nico/antag&ocirc;nico est&aacute;    a f
avor dos adutores, onde eles s&atilde;o mais fortes que os abdutores. </font></p
>     ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002200073002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#97#93#article#148#<p>&nbsp;</p>     ^cY#
v6n3a05.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#98#94#article#148#<p><font face="Verdana
" size="3"><B>REFER&Ecirc;NCIAS</B> </font></p>     ^cY#v6n3a05.htm##
00355000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069888000200073704011000075002001200185#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#99#95#article#148#1#<p><font
 face="Verdana" size="2">1. Gomes WDF. Nata&ccedil;&atilde;o. Rio de Janeiro:   
 Sprint, 1997.    ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002100074002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#100#96#article#148# </font></p>     ^cY#
v6n3a05.htm##
00392000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070888000200074704014600076002001200222#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#101#97#article#148#2#<p><fon
t face="Verdana" size="2">2. Catteau R, Garoff G. O ensino da nata&ccedil;&atild
e;o.    3&#170; ed. S&atilde;o Paulo: Manole, 1988.    ^cY#v6n3a05.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002100074002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#102#98#article#148# </font></p>     ^cY#
v6n3a05.htm##
00406000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070888000200074704016000076002001200236#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#103#99#article#148#3#<p><fon
t face="Verdana" size="2">3. Coulsilman JE. An&aacute;lise das t&eacute;cnicas  
  desportivas. 2&#170; ed. Rio de Janeiro: Ibero-americana, 1988.    ^cY#v6n3a05
.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#104#100#article#148# </font></p>     ^cY
#v6n3a05.htm##
00381000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704013400077002001200211#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#105#101#article#148#4#<p><fo
nt face="Verdana" size="2">4. Maglischo EW. Nadar ainda mais r&aacute;pido.    B
arcelona: Hispano Europ&eacute;ia, 1999.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#106#102#article#148# </font></p>     ^cY
#v6n3a05.htm##
00420000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704017300077002001200250#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#107#103#article#148#5#<p><fo
nt face="Verdana" size="2">5. Guyton AC. Fisiologia do esporte. Em: Tratado    d
e fisiologia m&eacute;dica. 8&#170; ed. Rio de Janeiro: Guanabara Koogan, 1991. 
   ^cY#v6n3a05.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#108#104#article#148#    </font></p>     
^cY#v6n3a05.htm##
00393000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014600077002001200223#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#109#105#article#148#6#<p><fo
nt face="Verdana" size="2">6. Rodeo S. O nado de peito. Sprint magazine.    Rio 
de Janeiro, 1989, n. 2, p. 6-13, mar&ccedil;o/abril.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#110#106#article#148# </font></p>     ^cY
#v6n3a05.htm##
00393000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014600077002001200223#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#111#107#article#148#7#<p><fo
nt face="Verdana" size="2">7. Kapandji IA. Membros inferiores. Em: Fisiologia   
 humana. 5&#170; ed. S&atilde;o Paulo: Manole, 1990.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#112#108#article#148# </font></p>     ^cY
#v6n3a05.htm##
00452000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704020500077002001200282#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#113#109#article#148#8#<p><fo
nt face="Verdana" size="2">8. Nascimento FAG. Les&otilde;es nos quatro estilos  
  da nata&ccedil;&atilde;o. Aqu&aacute;tica Paulista, S&atilde;o Paulo, 16 de   
 janeiro de 1999, n. 75. Ano V.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#114#110#article#148# </font></p>     ^cY
#v6n3a05.htm##
00431000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704018400077002001200261#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#115#111#article#148#9#<p><fo
nt face="Verdana" size="2">9. Cruchinho C. O nado de peito. Trabalho apresentado
    no 4&#186; Encontro Ibero-Brasileiro. S&atilde;o Jos&eacute; dos Campos, ago
.    1997.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#116#112#article#148# </font></p>     ^cY
#v6n3a05.htm##
00388000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014000078002001200218#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#117#113#article#148#10#<p><f
ont face="Verdana" size="2">10. Hall S. Biomec&acirc;nica b&aacute;sica.    3&#1
70; ed. Rio de Janeiro: Guanabara Koogan, 1993.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#118#114#article#148# </font></p>     ^cY
#v6n3a05.htm##
00424000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017600078002001200254#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#119#115#article#148#11#<p><f
ont face="Verdana" size="2">11. Clarkson HM, Gilewich GB. Avalia&ccedil;&atilde;
o    m&uacute;sculo-esquel&eacute;tica. 3&#170; ed. S&atilde;o Paulo: Manole, 19
91.    ^cY#v6n3a05.htm##
00257000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002400075002001200099#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#120#116#article#148#    </font></p>     
^cY#v6n3a05.htm##
00538000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029000078002001200368#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#121#117#article#148#12#<p><f
ont face="Verdana" size="2">12. Shinzato GT, Batistella LR. Exerc&iacute;cio    
isocin&eacute;tico _ Sua utiliza&ccedil;&atilde;o para avalia&ccedil;&atilde;o  
  e reabilita&ccedil;&atilde;o m&uacute;sculo-esquel&eacute;tica. &Acirc;mbito  
  Medicina Desportiva, 1996, 1: 11-8.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#122#118#article#148# </font></p>     ^cY
#v6n3a05.htm##
00376000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012800078002001200206#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#123#119#article#148#13#<p><f
ont face="Verdana" size="2">13. Gould III JA. Fisioterapia em ortopedia e    med
icina do esporte, SP, Manole, 1993.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#124#120#article#148# </font></p>     ^cY
#v6n3a05.htm##
00377000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704012900078002001200207#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#125#121#article#148#14#<p><f
ont face="Verdana" size="2">14. Settineri LIC. Biomec&acirc;nica, no&ccedil;&oti
lde;es    gerais, RJ, Atheneu, 1998.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#126#122#article#148# </font></p>     ^cY
#v6n3a05.htm##
00399000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015100078002001200229#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#127#123#article#148#15#<p><f
ont face="Verdana" size="2">15. Hislop HJ, Perrine JJ. The isokinetic concept   
 of exercise, Physical Therapy, New York, 1967, 47: 114-7.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#128#124#article#148# </font></p>     ^cY
#v6n3a05.htm##
00360000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704011200078002001200190#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#129#125#article#148#16#<p><f
ont face="Verdana" size="2">16. Hollmann W. Medicina de esporte, S&atilde;o    P
aulo, Manole, 1990.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#130#126#article#148# </font></p>     ^cY
#v6n3a05.htm##
00367000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704011900078002001200197#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#131#127#article#148#17#<p><f
ont face="Verdana" size="2">17. McArdle WD. Fisiologia do exerc&iacute;cio,    R
J, Guanabara Koogan, 1985.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#132#128#article#148# </font></p>     ^cY
#v6n3a05.htm##
00399000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015100078002001200229#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#133#129#article#148#18#<p><f
ont face="Verdana" size="2">18. Astrand PO. Biblioteca de educa&ccedil;&atilde;o
    f&iacute;sica, 2&#170; ed., SP., Interamericana, 1980.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#134#130#article#148# </font></p>     ^cY
#v6n3a05.htm##
00351000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704010300078002001200181#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#135#131#article#148#19#<p><f
ont face="Verdana" size="2">19. Kupriam W. Fisioterapia nos esportes, SP,    Man
ole, 1984.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#136#132#article#148# </font></p>     ^cY
#v6n3a05.htm##
00390000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704014200078002001200220#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#137#133#article#148#20#<p><f
ont face="Verdana" size="2">20. L&uacute;cio AO. Estudo isocin&eacute;tico.    &
Acirc;mbito Medicina Desportiva 1997, n. 32: 6-7.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#138#134#article#148# </font></p>     ^cY
#v6n3a05.htm##
00564000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704031600078002001200394#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#139#135#article#148#21#<p><f
ont face="Verdana" size="2">21. Miranda IFS. Avalia&ccedil;&atilde;o muscular   
 isocin&eacute;tica da musculatura adutora e abdutora em jogadores de futebol   
 profissional, Monografia (trabalho de conclus&atilde;o de curso), Curso de Fisi
oterapia,    Universidade Cidade de S&atilde;o Paulo, SP, 1999.    ^cY#v6n3a05.h
tm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#140#136#article#148# </font></p>     ^cY
#v6n3a05.htm##
00408000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016000078002001200238#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#141#137#article#148#22#<p><f
ont face="Verdana" size="2">22. Dvir Z. Isokinetics: muscle testing, interpretat
ion    and clinical applications, USA, Churchill Livingstone, 1995.    ^cY#v6n3a
05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#142#138#article#148# </font></p>     ^cY
#v6n3a05.htm##
00380000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704013200078002001200210#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#p#143#139#article#148#23#<p><f
ont face="Verdana" size="2">23. Perrin DH. Isokinetic exercise and assessment,  
  USA, Human Kinetics Publishers, 1993.    ^cY#v6n3a05.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002100075002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#144#140#article#148# </font></p>     ^cY
#v6n3a05.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#145#141#article#148#<p>&nbsp;</p>     ^c
Y#v6n3a05.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#146#142#article#148#<p>&nbsp;</p>     ^c
Y#v6n3a05.htm##
00420000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704018700075002001200262#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#147#143#article#148#<p><font face="Verda
na" size="2"><a name="end"></a><a href="#topo"><img src="/img/revistas/rbme/v6n3
/seta.gif" border="0"></a>    <b>Endere&ccedil;o para correspond&ecirc;ncia</b> 
   ^cY#v6n3a05.htm##
00269000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704003600075002001200111#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#148#144#article#148#<br>   Sergio de Sou
za Pinto    ^cY#v6n3a05.htm##
00320000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704008700075002001200162#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#149#145#article#148#<br>   Rua Marqu&eci
rc;s de Tr&ecirc;s Rios, 242, ap. 45, Bl. 1 &#150; Botafogo    ^cY#v6n3a05.htm##
00277000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004400075002001200119#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#150#146#article#148#<br>   13020-030 &#1
50; Campinas, SP    ^cY#v6n3a05.htm##
00269000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704003600075002001200111#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#151#147#article#148#<br>   Tel. (0xx19) 
233-3941    ^cY#v6n3a05.htm##
00332000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704009900075002001200174#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a05.htm#S#p#152#148#article#148#<br>   E-mail: <a hr
ef="mailto:sergiocris@uol.com.br">sergiocris@uol.com.br</a></font></p>     ^cY#v
6n3a05.htm##
00390000000000229000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160017000740180012000910660
01500103062000700118065000900125064000500134865000900139002001200148#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#153#1#article#23#1#^rND^sGomes^nWDF#
Natação^lpt#Rio de Janeiro#Sprint#19970000#1997#20000600#v6n3a05.htm##
00440000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160017000740160017000910180
02400108063000200132066001000134062000700144065000900151064000500160865000900165
002001200174#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#154#2#articl
e#23#2#^rND^sCatteau^nR#^rND^sGaroff^nG.#O ensino da natação^lpt#3#São Paulo#Man
ole#19880000#1988#20000600#v6n3a05.htm##
00443000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160022000740180037000960630
00200133066001500135062001600150065000900166064000500175865000900180002001200189
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#155#3#article#23#3#^rND^
sCoulsilman^nJE.#Análise das técnicas desportivas^lpt#2#Rio de Janeiro#Ibero-ame
ricana#19880000#1988#20000600#v6n3a05.htm##
00415000000000229000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160021000740180028000950660
01000123062001700133065000900150064000500159865000900164002001200173#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#156#4#article#23#4#^rND^sMaglischo^n
EW.#Nadar ainda mais rápido^lpt#Barcelona#Hispano Européia#19990000#1999#2000060
0#v6n3a05.htm##
00474000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740120026000920180
03300118063000200151066001500153062001700168065000900185064000500194865000900199
002001200208#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#157#5#articl
e#23#5#^rND^sGuyton^nAC.#Fisiologia do esporte^lpt#Tratado de fisiologia médica^
lpt#8#Rio de Janeiro#Guanabara Koogan#19910000#1991#20000600#v6n3a05.htm##
00475000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100016000740120020000900300
01600110710000200126066001500128065000900143064000500152032000200157014000500159
061001200164865000900176002001200185#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a05.htm#S#c#158#6#article#23#6#^rND^sRodeo^nS.#O nado de peito^lpt#Sprint magazi
ne#2#Rio de Janeiro#19890000#1989#2#6-13#março/abril#20000600#v6n3a05.htm##
00447000000000253000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100020000740120023000940180
02200117063000200139066001000141062000700151065000900158064000500167865000900172
002001200181#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#159#7#articl
e#23#7#^rND^sKapandji^nIA.#Membros inferiores^lpt#Fisiologia humana^lpt#5#São Pa
ulo#Manole#19900000#1990#20000600#v6n3a05.htm##
00495000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100023000740120041000970300
01800138710000200156066001000158065000900168064002200177032000300199061000600202
865000900208002001200217#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#
160#8#article#23#8#^rND^sNascimento^nFAG.#Lesões nos quatro estilos da natação^l
pt#Aquática Paulista#2#São Paulo#19990116#16 de janeiro de 1999#75#Ano V#2000060
0#v6n3a05.htm##
00446000000000217000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160020000740180074000940660
02000168065000900188064001000197865000900207002001200216#v6n3#V:\SciELO\serial\r
bme\v6n3\markup\v6n3a05.htm#S#c#161#9#article#23#9#^rND^sCruchinho^nC.#O nado de
 peito. Trabalho apresentado no 4º Encontro Ibero-Brasileiro^lpt#São José dos Ca
mpos#19970800#ago. 1997#20000600#v6n3a05.htm##
00425000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160015000760180023000910630
00200114066001500116062001700131065000900148064000500157865000900162002001200171
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#162#10#article#23#10#^rN
D^sHall^nS.#Biomecânica básica^lpt#3#Rio de Janeiro#Guanabara Koogan#19930000#19
93#20000600#v6n3a05.htm##
00457000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160019000760160020000950180
03400115063000200149066001000151062000700161065000900168064000500177865000900182
002001200191#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#163#11#artic
le#23#11#^rND^sClarkson^nHM#^rND^sGilewich^nGB.#Avaliação músculo-esquelética^lp
t#3#São Paulo#Manole#19910000#1991#20000600#v6n3a05.htm##
00547000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100022000950120
09300117030002700210710000200237065000900239064000500248031000200253014000500255
865000900260002001200269#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#
164#12#article#23#12#^rND^sShinzato^nGT#^rND^sBatistella^nLR.#Exercício isocinét
ico _ Sua utilização para avaliação e reabilitação músculo-esquelética^lpt#Âmbit
o Medicina Desportiva#2#19960000#1996#1#11-8#20000600#v6n3a05.htm##
00423000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160020000760180052000960660
00300148062000700151065000900158064000500167865000900172002001200181#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#165#13#article#23#13#^rND^sGould^nII
I JA#Fisioterapia em ortopedia e medicina do esporte^lpt#SP#Manole#19930000#1993
#20000600#v6n3a05.htm##
00404000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160021000760180031000970660
00300128062000800131065000900139064000500148865000900153002001200162#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#166#14#article#23#14#^rND^sSettineri
^nLIC#Biomecânica, noções gerais^lpt#RJ#Atheneu#19980000#1998#20000600#v6n3a05.h
tm##
00538000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100019000930120
03900112030001700151066000900168065000900177064000500186031000300191014000600194
865000900200002001200209035001000221801001700231#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a05.htm#S#c#167#15#article#23#15#^rND^sHislop^nHJ#^rND^sPerrine^nJJ.
#The isokinetic concept of exercise^len#Physical Therapy#New York#19670000#1967#
47#114-7#20000600#v6n3a05.htm#0031-9023#Physical therapy##
00401000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160019000760180024000950660
01000119062000700129065000900136064000500145865000900150002001200159#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#168#16#article#23#16#^rND^sHollmann^
nW.#Medicina de esporte^lpt#São Paulo#Manole#19900000#1990#20000600#v6n3a05.htm#
#
00408000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160019000760180028000950660
00300123062001700126065000900143064000500152865000900157002001200166#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#169#17#article#23#17#^rND^sMcArdle^n
WD.#Fisiologia do exercício^lpt#RJ#Guanabara Koogan#19850000#1985#20000600#v6n3a
05.htm##
00426000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160019000760180034000950630
00200129066000300131062001500134065000900149064000500158865000900163002001200172
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#170#18#article#23#18#^rN
D^sAstrand^nPO.#Biblioteca de educação física^lpt#2#SP#Interamericana#19800000#1
980#20000600#v6n3a05.htm##
00399000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160018000760180030000940660
00300124062000700127065000900134064000500143865000900148002001200157#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#171#19#article#23#19#^rND^sKupriam^n
W.#Fisioterapia nos esportes^lpt#SP#Manole#19840000#1984#20000600#v6n3a05.htm##
00441000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760120023000930300
02700116710000200143065000900145064000500154032000300159014000400162865000900166
002001200175#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#172#20#artic
le#23#20#^rND^sLúcio^nAO.#Estudo isocinético^lpt#Âmbito Medicina Desportiva#2#19
970000#1997#32#6-7#20000600#v6n3a05.htm##
00526000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160020000760180106000960510
01100202050003300213046000300246045000900249044000500258865000900263002001200272
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#173#21#article#23#21#^rN
D^sMiranda^nIFS.#Avaliação muscular isocinética da musculatura adutora e abdutor
a em jogadores de futebol profissional^lpt#Monografia#Universidade Cidade de São
 Paulo#SP#19990000#1999#20000600#v6n3a05.htm##
00456000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160015000760180074000910670
00400165062002200169065000900191064000500200865000900205002001200214#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#174#22#article#23#22#^rND^sDvir^nZ.#
Isokinetics: muscle testing, interpretation and clinical applications^len#USA#Ch
urchill Livingstone#19950000#1995#20000600#v6n3a05.htm##
00427000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160017000760180039000930670
00400132062002600136065000900162064000500171865000900176002001200185#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a05.htm#S#c#175#23#article#23#23#^rND^sPerrin^nD
H#Isokinetic exercise and assessment^len#USA#Human Kinetics Publishers#19930000#
1993#20000600#v6n3a05.htm##
00271000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670910009000690920007000780020012000857030
00400097#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#o#1#1#article#1#20
110314#125811#v6n3a06.htm#340##
03547000000000601000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000500087121000300092049000800095158000300103030002100106
03100020012703200020012906500090013101400100014003500100015001200780016001200740
02380100041003120100043003530100021003960700098004170700055005150831050005700850
00801620085002201628085002501650085002201675085002301697085002101720083101701741
08500080275808500210276608500280278708500220281508500230283708500220286005800420
2882117000602924072000302930002001202933#v6n3#V:\SciELO\serial\rbme\v6n3\markup\
v6n3a06.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILUS#06#RBME120#nd#Rev Bras Med 
Esporte#6#3#20000600#^f99^l107#1517-8692#Conseqüências do exercício para o metab
olismo da glutamina e função imune^lpt#Consequences of exercise for glutamine me
tabolism and immune function^len#^rND^1A01^nJair Rodrigues^sGarcia Júnior#^rND^1
A01 A02^nTânia Cristina^sPithon-Curi#^rND^1A01^nRui^sCuri#USP^iA01^1Instituto de
 Ciências Biomédicas^2Departamento de Fisiologia e Biofísica^cSão Paulo^sSP#Univ
ersidade Camilo Castelo Branco^iA02^cSão Paulo^sSP#^lpt^aPara o atleta, o objeti
vo do treinamento é aperfeiçoar sua capacidade física para obtenção do melhor de
sempenho em competições. Isso o leva a procurar os mais novos e eficientes métod
os de treinamento. Um aspecto importante do programa de treinamento é o período 
de recuperação entre as sessões de exercícios, imprescindível para que ocorram a
s adaptações fisiológicas, como as alterações morfológicas e a supercompensação 
das reservas energéticas. A liberação de glutamina pelos músculos esqueléticos é
 aumentada durante o exercício. Como conseqüência, o conteúdo muscular de glutam
ina diminui após um exercício extenuante. Este aminoácido, entretanto, é muito i
mportante para a funcionalidade dos leucócitos (linfócitos, macrófagos e neutróf
ilos). Portanto, após um exercício intenso, a concentração plasmática de glutami
na diminui, suprimindo a função imune e tornando o indivíduo mais suscetível a i
nfecções respiratórias. Nesta revisão são discutidas as implicações do exercício
 sobre o metabolismo dos músculos esqueléticos e leucócitos.#^dnd^i1#^tm^lpt^kEx
ercício^i1#^tm^lpt^kFunção imune^i1#^tm^lpt^kGlutamina^i1#^tm^lpt^kLeucócitos^i1
#^tm^lpt^kInfecção^i1#^len^aThe purpose of training for the athletes is to impro
ve physical capacity in order to achieve the best performance in competitions. F
or this reason, they constantly look for updated training methods. One important
 aspect in a training program is the rest period between exercise sessions, whic
h is important to promote physiological adaptations such as morphological altera
tions and fuel store overcompensation. The release of glutamine by skeletal musc
les is increased during exercise activities. As a consequence, the content of gl
utamine in the muscle decreases after a strenuous exercise session. This amino a
cid, however, plays an important role in leukocyte functioning (lymphocytes, mac
rophages, and neutrophils). Therefore, after heavy and intense exercising, plasm
a glutamine levels decrease, impairing immune function and leading the subject t
o become more susceptible to respiratory infections. In this review, the implica
tions of exercise on skeletal muscles and leukocytes metabolism are discussed.#^
dnd^i2#^tm^len^kExercise^i2#^tm^len^kImmune function^i2#^tm^len^kGlutamine^i2#^t
m^len^kLeukocytes^i2#^tm^len^kInfection^i2#FAPESP, CNPq, PRONEX e Conselho Britâ
nico#other#75#v6n3a06.htm##
03561000000000601000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670710003000690400003000720010006000750420
00200081120000400083038000500087121000300092049000800095158000300103030002100106
03100020012703200020012906500090013101400100014003500100015001200850016001200810
02450100041003260100043003670100021004100700098004310700055005290831050005840850
00801634085002201642085002501664085002201689085002301711085002101734083101701755
08500080277208500210278008500280280108500220282908500230285108500220287405800420
2896117000602938072000302944002001202947#v6n3#V:\SciELO\serial\rbme\v6n3\markup\
v6n3a06.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILUS#06#RBME120#nd#Rev Bras Med 
Esporte#6#3#20000600#^f99^l107#1517-8692#<b>Conseqüências do exercício para o me
tabolismo da glutamina e função imune</b>^lpt#<b>Consequences of exercise for gl
utamine metabolism and immune function</b>^len#^rND^1A01^nJair Rodrigues^sGarcia
 Júnior#^rND^1A01 A02^nTânia Cristina^sPithon-Curi#^rND^1A01^nRui^sCuri#USP^iA01
^1Instituto de Ciências Biomédicas^2Departamento de Fisiologia e Biofísica^cSão 
Paulo^sSP#Universidade Camilo Castelo Branco^iA02^cSão Paulo^sSP#^lpt^aPara o at
leta, o objetivo do treinamento é aperfeiçoar sua capacidade física para obtençã
o do melhor desempenho em competições. Isso o leva a procurar os mais novos e ef
icientes métodos de treinamento. Um aspecto importante do programa de treinament
o é o período de recuperação entre as sessões de exercícios, imprescindível para
 que ocorram as adaptações fisiológicas, como as alterações morfológicas e a sup
ercompensação das reservas energéticas. A liberação de glutamina pelos músculos 
esqueléticos é aumentada durante o exercício. Como conseqüência, o conteúdo musc
ular de glutamina diminui após um exercício extenuante. Este aminoácido, entreta
nto, é muito importante para a funcionalidade dos leucócitos (linfócitos, macróf
agos e neutrófilos). Portanto, após um exercício intenso, a concentração plasmát
ica de glutamina diminui, suprimindo a função imune e tornando o indivíduo mais 
suscetível a infecções respiratórias. Nesta revisão são discutidas as implicaçõe
s do exercício sobre o metabolismo dos músculos esqueléticos e leucócitos.#^dnd^
i1#^tm^lpt^kExercício^i1#^tm^lpt^kFunção imune^i1#^tm^lpt^kGlutamina^i1#^tm^lpt^
kLeucócitos^i1#^tm^lpt^kInfecção^i1#^len^aThe purpose of training for the athlet
es is to improve physical capacity in order to achieve the best performance in c
ompetitions. For this reason, they constantly look for updated training methods.
 One important aspect in a training program is the rest period between exercise 
sessions, which is important to promote physiological adaptations such as morpho
logical alterations and fuel store overcompensation. The release of glutamine by
 skeletal muscles is increased during exercise activities. As a consequence, the
 content of glutamine in the muscle decreases after a strenuous exercise session
. This amino acid, however, plays an important role in leukocyte functioning (ly
mphocytes, macrophages, and neutrophils). Therefore, after heavy and intense exe
rcising, plasma glutamine levels decrease, impairing immune function and leading
 the subject to become more susceptible to respiratory infections. In this revie
w, the implications of exercise on skeletal muscles and leukocytes metabolism ar
e discussed.#^dnd^i2#^tm^len^kExercise^i2#^tm^len^kImmune function^i2#^tm^len^kG
lutamine^i2#^tm^len^kLeukocytes^i2#^tm^len^kInfection^i2#FAPESP, CNPq, PRONEX e 
Conselho Britânico#other#75#v6n3a06.htm##
03680000000000625000450000400050000070200460000570500020005170600020005370000020
00557010002000577090008000597080002000670640013000690710003000820400003000850010
00600088042000200094120000400096038000500100121000300105049000800108158000300116
03000240011903100020014303200020014506500090014701400100015603500100016601200780
01760120074002540100041003280100043003690100021004120700100004330700057005330831
05000590085000801640085002201648085002501670085002201695085002301717085002101740
08310170176108500080277808500210278608500280280708500220283508500230285708500220
2880058004202902117000602944072000302950002001202953008008902965#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#l#4#1#article#1#^mjun.^a2000#oa#pt#br1.1#1
#4.0#ilus#06#RBME120#nd#Rev. bras. med. esporte#6#3#20000600#^f99^l107#1517-8692
#Conseqüências do exercício para o metabolismo da glutamina e função imune^lpt#C
onsequences of exercise for glutamine metabolism and immune function^len#^rND^1A
01^nJair Rodrigues^sGarcia Júnior#^rND^1A01 A02^nTânia Cristina^sPithon-Curi#^rN
D^1A01^nRui^sCuri#^iA01^1USP^2Instituto de Ciências Biomédicas^3Departamento de 
Fisiologia e Biofísica^cSão Paulo^sSP#^iA02^1Universidade Camilo Castelo Branco^
cSão Paulo^sSP#^lpt^aPara o atleta, o objetivo do treinamento é aperfeiçoar sua 
capacidade física para obtenção do melhor desempenho em competições. Isso o leva
 a procurar os mais novos e eficientes métodos de treinamento. Um aspecto import
ante do programa de treinamento é o período de recuperação entre as sessões de e
xercícios, imprescindível para que ocorram as adaptações fisiológicas, como as a
lterações morfológicas e a supercompensação das reservas energéticas. A liberaçã
o de glutamina pelos músculos esqueléticos é aumentada durante o exercício. Como
 conseqüência, o conteúdo muscular de glutamina diminui após um exercício extenu
ante. Este aminoácido, entretanto, é muito importante para a funcionalidade dos 
leucócitos (linfócitos, macrófagos e neutrófilos). Portanto, após um exercício i
ntenso, a concentração plasmática de glutamina diminui, suprimindo a função imun
e e tornando o indivíduo mais suscetível a infecções respiratórias. Nesta revisã
o são discutidas as implicações do exercício sobre o metabolismo dos músculos es
queléticos e leucócitos.#^dnd^i1#^tm^lpt^kExercício^i1#^tm^lpt^kFunção imune^i1#
^tm^lpt^kGlutamina^i1#^tm^lpt^kLeucócitos^i1#^tm^lpt^kInfecção^i1#^len^aThe purp
ose of training for the athletes is to improve physical capacity in order to ach
ieve the best performance in competitions. For this reason, they constantly look
 for updated training methods. One important aspect in a training program is the
 rest period between exercise sessions, which is important to promote physiologi
cal adaptations such as morphological alterations and fuel store overcompensatio
n. The release of glutamine by skeletal muscles is increased during exercise act
ivities. As a consequence, the content of glutamine in the muscle decreases afte
r a strenuous exercise session. This amino acid, however, plays an important rol
e in leukocyte functioning (lymphocytes, macrophages, and neutrophils). Therefor
e, after heavy and intense exercising, plasma glutamine levels decrease, impairi
ng immune function and leading the subject to become more susceptible to respira
tory infections. In this review, the implications of exercise on skeletal muscle
s and leukocytes metabolism are discussed.#^dnd^i2#^tm^len^kExercise^i2#^tm^len^
kImmune function^i2#^tm^len^kGlutamine^i2#^tm^len^kLeukocytes^i2#^tm^len^kInfect
ion^i2#FAPESP, CNPq, PRONEX e Conselho Britânico#other#75#v6n3a06.htm#Internet^i
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-86922000000300006##
00360000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704013100071002001200202#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#5#1#article#261#<p align="right"><font s
ize="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO    DE REVIS&Atild
e;O</b></font></p>     ^cY#v6n3a06.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704003600071002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#6#2#article#261#<p align="right">&nbsp;<
/p>     ^cY#v6n3a06.htm##
00448000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704021900071002001200290#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#7#3#article#261#<p><font face="Verdana, 
Arial, Helvetica, sans-serif" size="4"><b><a name="topo"></a>Conseq&uuml;&ecirc;
ncias    do exerc&iacute;cio para o metabolismo da glutamina e fun&ccedil;&atild
e;o imune</b></font>  </p>     ^cY#v6n3a06.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704002300071002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#8#4#article#261#<p>&nbsp; </p>     ^cY#v
6n3a06.htm##
00392000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000800059708000400067704016300071002001200234#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#9#5#article#261#<p><font face="Verdana, 
Arial, Helvetica, sans-serif" size="3"><b>Consequences    of exercise for glutam
ine metabolism and immune function</b></font> </p>     ^cY#v6n3a06.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#10#6#article#261#<p>&nbsp; </p>     ^cY#
v6n3a06.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#11#7#article#261#<p>&nbsp; </p>     ^cY#
v6n3a06.htm##
00445000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704021500072002001200287#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#12#8#article#261#<p><font face="Verdana,
 Arial, Helvetica, sans-serif" size="2"><b>Jair Rodrigues    Garcia J&uacute;nio
r<sup>I</sup>; T&acirc;nia Cristina Pithon-Curi<sup>I,II</sup>;    Rui Curi<sup>
I</sup></b></font> </p>     ^cY#v6n3a06.htm##
00438000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000800060708000400068704020800072002001200280#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#13#9#article#261#<p><font face="Verdana,
 Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Departamento    de Fisiologi
a e Biof&iacute;sica, Instituto de Ci&ecirc;ncias Biom&eacute;dicas,    USP, S&a
tilde;o Paulo, SP    ^cY#v6n3a06.htm##
00329000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009800073002001200171#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#14#10#article#261#<br>   <sup>II</sup>Un
iversidade Camilo Castelo Branco, S&atilde;o Paulo, SP</font>  </p>     ^cY#v6n3
a06.htm##
00347000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011600073002001200189#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#15#11#article#261#<p><font face="Verdana
" size="2"><a href="#end">Endere&ccedil;o para correspond&ecirc;ncia</a></font> 
 </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#16#12#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00276000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704004500073002001200118#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#17#13#article#261#<p>&nbsp; </p> <hr siz
e="1" noshade>     ^cY#v6n3a06.htm##
00330000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704009900073002001200172#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#18#14#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><B>RESUMO</B> </font>  </p>     ^cY#v6n
3a06.htm##
01837000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704160600073002001201679#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#19#15#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Para o atleta,    o objetivo do treinam
ento &eacute; aperfei&ccedil;oar sua capacidade f&iacute;sica    para obten&cced
il;&atilde;o do melhor desempenho em competi&ccedil;&otilde;es.    Isso o leva a
 procurar os mais novos e eficientes m&eacute;todos de treinamento.    Um aspect
o importante do programa de treinamento &eacute; o per&iacute;odo de    recupera
&ccedil;&atilde;o entre as sess&otilde;es de exerc&iacute;cios, imprescind&iacut
e;vel    para que ocorram as adapta&ccedil;&otilde;es fisiol&oacute;gicas, como 
as altera&ccedil;&otilde;es    morfol&oacute;gicas e a supercompensa&ccedil;&ati
lde;o das reservas energ&eacute;ticas.    A libera&ccedil;&atilde;o de glutamina
 pelos m&uacute;sculos esquel&eacute;ticos    &eacute; aumentada durante o exerc
&iacute;cio. Como conseq&uuml;&ecirc;ncia,    o conte&uacute;do muscular de glut
amina diminui ap&oacute;s um exerc&iacute;cio    extenuante. Este amino&aacute;c
ido, entretanto, &eacute; muito importante para    a funcionalidade dos leuc&oac
ute;citos (linf&oacute;citos, macr&oacute;fagos    e neutr&oacute;filos). Portan
to, ap&oacute;s um exerc&iacute;cio intenso, a    concentra&ccedil;&atilde;o pla
sm&aacute;tica de glutamina diminui, suprimindo    a fun&ccedil;&atilde;o imune 
e tornando o indiv&iacute;duo mais suscet&iacute;vel    a infec&ccedil;&otilde;e
s respirat&oacute;rias. Nesta revis&atilde;o s&atilde;o    discutidas as implica
&ccedil;&otilde;es do exerc&iacute;cio sobre o metabolismo    dos m&uacute;sculo
s esquel&eacute;ticos e leuc&oacute;citos. </font> </p>     ^cY#v6n3a06.htm##
00466000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704023500073002001200308#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#20#16#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><B>Palavras-chave:</B>    Exerc&iacute;
cio. Fun&ccedil;&atilde;o imune. Glutamina. Leuc&oacute;citos.    Infec&ccedil;&
atilde;o. </font> </p> <hr size="1" noshade>     ^cY#v6n3a06.htm##
00332000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704010100073002001200174#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#21#17#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><B>ABSTRACT </B></font>  </p>     ^cY#v
6n3a06.htm##
01366000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704113500073002001201208#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#22#18#article#261#<p> <font face="Verdan
a, Arial, Helvetica, sans-serif" size="2">The purpose of    training for the ath
letes is to improve physical capacity in order to achieve    the best performanc
e in competitions. For this reason, they constantly look    for updated training
 methods. One important aspect in a training program is    the rest period betwe
en exercise sessions, which is important to promote physiological    adaptations
 such as morphological alterations and fuel store overcompensation.    The relea
se of glutamine by skeletal muscles is increased during exercise activities.    
As a consequence, the content of glutamine in the muscle decreases after a stren
uous    exercise session. This amino acid, however, plays an important role in l
eukocyte    functioning (lymphocytes, macrophages, and neutrophils). Therefore, 
after heavy    and intense exercising, plasma glutamine levels decrease, impairi
ng immune function    and leading the subject to become more susceptible to resp
iratory infections.    In this review, the implications of exercise on skeletal 
muscles and leukocytes    metabolism are discussed. </font> </p>     ^cY#v6n3a06
.htm##
00419000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704018800073002001200261#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#23#19#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><B>Key words:</B>    Exercise. Immune f
unction. Glutamine. Leukocytes. Infection. </font> </p> <hr size="1" noshade>   
  ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#24#20#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#25#21#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00350000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011900073002001200192#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#26#22#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><B>INTRODU&Ccedil;&Atilde;O</B>    </fo
nt> </p>     ^cY#v6n3a06.htm##
01033000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704080200073002001200875#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#27#23#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A busca constante    por um melhor dese
mpenho &eacute; o objetivo principal de todos os atletas,    independentemente d
o esporte praticado. Esse objetivo &eacute; alcan&ccedil;ado    somente com a so
ma de v&aacute;rios fatores, mas principalmente pela escolha    criteriosa dos m
&eacute;todos de treinamento. Apesar da evolu&ccedil;&atilde;o    desses m&eacut
e;todos e das pesquisas aplicadas em &aacute;reas correlatas que    contribuem s
ignificativamente para melhorar o desempenho, n&atilde;o &eacute;    poss&iacute
;vel minimizar o papel de tr&ecirc;s vari&aacute;veis que constituem    a base d
e qualquer programa de treinamento: intensidade, freq&uuml;&ecirc;ncia    e dura
&ccedil;&atilde;o do exerc&iacute;cio. </font> </p>     ^cY#v6n3a06.htm##
00739000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704050800073002001200581#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#28#24#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Essas vari&aacute;veis    s&atilde;o fu
ndamentais para o aprimoramento da capacidade f&iacute;sica, por&eacute;m    a a
nsiedade por melhor desempenho, por vezes, faz com que essas sejam utilizadas   
 em excesso. Este fato, aliado a per&iacute;odos de recupera&ccedil;&atilde;o   
 insuficientes, resultam em uma condi&ccedil;&atilde;o conhecida como s&iacute;n
drome    do excesso de treinamento (<I>overtraining</I>)<I>.</I> </font> </p>   
  ^cY#v6n3a06.htm##
00711000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704048000073002001200553#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#29#25#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Tal estado &eacute;    denominado de s&
iacute;ndrome devido &agrave;s v&aacute;rias altera&ccedil;&otilde;es    que aca
rreta, comprometendo desde a capacidade de treinamento e desempenho em    compet
i&ccedil;&otilde;es, at&eacute; aspectos fisiol&oacute;gicos e emocionais<SUP>1,
2</SUP>.    Dentre as altera&ccedil;&otilde;es fisiol&oacute;gicas, deve-se incl
uir a fun&ccedil;&atilde;o    imune. </font> </p>     ^cY#v6n3a06.htm##
00683000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704045200073002001200525#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#30#26#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">&Eacute; do comprometimento    do siste
ma de defesa relacionado com a atividade f&iacute;sica que trataremos    nesta r
evis&atilde;o. Ser&atilde;o mostrados o metabolismo e a funcionalidade    das c&
eacute;lulas do sistema imune e sua rela&ccedil;&atilde;o com o metabolismo    d
os m&uacute;sculos esquel&eacute;ticos, tendo como elo o amino&aacute;cido    gl
utamina. </font> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#31#27#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00391000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704016000073002001200233#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#32#28#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><B>C&Eacute;LULAS    DO SISTEMA IMUNE E
 DA RESPOSTA INFLAMAT&Oacute;RIA</B> </font> </p>     ^cY#v6n3a06.htm##
01781000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704155000073002001201623#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#33#29#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Linf&oacute;citos,    macr&oacute;fagos
 e neutr&oacute;filos desempenham um papel central na resposta    imune e inflam
at&oacute;ria. Linf&oacute;citos s&atilde;o c&eacute;lulas circulantes,    t&eci
rc;m sua origem nos tecidos linf&oacute;ides prim&aacute;rios (timo e medula    
&oacute;ssea), podendo migrar para os &oacute;rg&atilde;os linf&oacute;ides    s
ecund&aacute;rios (ba&ccedil;o, linfonodos e placas de Peyer). Encontram-se    e
m estado quiescente at&eacute; serem estimulados a proliferar, por exemplo,    d
urante uma infec&ccedil;&atilde;o por v&iacute;rus ou bact&eacute;rias. Os    ma
cr&oacute;fagos podem diferir em suas caracter&iacute;sticas bioqu&iacute;micas,
    estruturais e funcionais, dependendo do estado de diferencia&ccedil;&atilde;
o,    do microambiente e de sua localiza&ccedil;&atilde;o no organismo. Em fun&c
cedil;&atilde;o    de sua localiza&ccedil;&atilde;o, recebem diferentes denomina
&ccedil;&otilde;es:    do sistema nervoso central (microglia), fixos no f&iacute
;gado (c&eacute;lulas    de Kupffer), da epiderme (c&eacute;lulas de Langerhans)
, do osso (osteoblastos)    e os macr&oacute;fagos livres do espa&ccedil;o alveo
lar e cavidades serosas<SUP>3</SUP>.    Entretanto, os macr&oacute;fagos, indepe
ndentemente de sua localiza&ccedil;&atilde;o,    compartilham de algumas das pro
priedades gerais que os tornam semelhantes entre    si, como propriedades de esp
raiamento, de fagocitose e fungicida, bactericida    e tumoricida. </font> </p> 
    ^cY#v6n3a06.htm##
00864000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704063300073002001200706#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#34#30#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Neutr&oacute;filos    constituem cerca 
de 60% dos leuc&oacute;citos circulantes em seres humanos adultos    e s&atilde;
o as primeiras c&eacute;lulas de defesa na resposta inflamat&oacute;ria    aguda
. Microrganismos fagocitados, recobertos ou n&atilde;o com complemento    ou ant
icorpo espec&iacute;fico, s&atilde;o mortos por prote&iacute;nas citot&oacute;xi
cas    derivadas dos gr&acirc;nulos citoplasm&aacute;ticos e por uma combina&cce
dil;&atilde;o    de esp&eacute;cies reativas de oxig&ecirc;nio geradas pelo neut
r&oacute;filo<SUP>4</SUP>.    </font> </p>     ^cY#v6n3a06.htm##
00922000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704069100073002001200764#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#35#31#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Apesar da inquestion&aacute;vel    impo
rt&acirc;ncia dessas c&eacute;lulas na resposta imune e inflamat&oacute;ria,    
relativamente pouco se sabia sobre o metabolismo e sua implica&ccedil;&atilde;o 
   para as diferentes fun&ccedil;&otilde;es desses tipos celulares. Na d&eacute;
cada    de 80, o grupo do Prof. Eric Newsholme determinou que macr&oacute;fagos 
e linf&oacute;citos    utilizam glutamina em altas taxas<SUP>5-7</SUP> e, recent
emente, no nosso laborat&oacute;rio,    foi verificada pela primeira vez a utili
za&ccedil;&atilde;o de glutamina tamb&eacute;m    por neutr&oacute;filos<SUP>8,9
</SUP>. </font> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#36#32#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00403000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704017200073002001200245#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#37#33#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><B><font size="3">METABOLISMO    E FUNC
IONALIDADE DOS LEUC&Oacute;CITOS</font> </B></font> </p> <B>      ^cY#v6n3a06.ht
m##
00339000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704010800073002001200181#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#38#34#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Linf&oacute;citos</font>  </p> </B>    
  ^cY#v6n3a06.htm##
01723000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704149200073002001201565#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#39#35#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os linf&oacute;citos    s&atilde;o c&ea
cute;lulas circulares pequenas (6-10&#181;m de di&acirc;metro),    com alta raz&
atilde;o n&uacute;cleo/citoplasma. Estes t&ecirc;m origem nos tecidos    linf&oa
cute;ides prim&aacute;rios (timo e medula &oacute;ssea) podendo migrar    para &
oacute;rg&atilde;os linf&oacute;ides secund&aacute;rios (ba&ccedil;o,    linfono
dos, placa de Peyer). Os linf&oacute;citos teciduais est&atilde;o em    equil&ia
cute;brio din&acirc;mico com o sangue circulante. Essas c&eacute;lulas    s&atil
de;o subdivididas de acordo com os marcadores de superf&iacute;cie, rea&ccedil;&
otilde;es    a est&iacute;mulos, origem e sobrevida. De acordo com sua origem, s
&atilde;o    classificados em linf&oacute;citos T e B. O linf&oacute;cito B atin
ge a maturidade    na medula &oacute;ssea e est&aacute; relacionado com a imunid
ade humoral, apresenta    imunoglobulinas na superf&iacute;cie; quando ativado p
or ant&iacute;geno espec&iacute;fico,    prolifera por mitose e se diferencia em
 plasm&oacute;cito, secretando, assim,    grande quantidade de anticorpos. Algum
as dessas c&eacute;lulas tamb&eacute;m    originam os linf&oacute;citos B da mem
&oacute;ria imunol&oacute;gica. Essas,    por sua vez, mant&ecirc;m a mem&oacute
;ria da exposi&ccedil;&atilde;o anterior    ao ant&iacute;geno e respondem rapid
amente ap&oacute;s uma reexposi&ccedil;&atilde;o    ao mesmo ant&iacute;geno<SUP
>4</SUP>. </font></p>     ^cY#v6n3a06.htm##
00900000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704066900073002001200742#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#40#36#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os linf&oacute;citos    T s&atilde;o os
 mais numerosos do sangue. Possuem diferencia&ccedil;&atilde;o    e matura&ccedi
l;&atilde;o intrat&iacute;mica, n&atilde;o sintetizam quantidades    detect&aacu
te;veis de imunoglobulinas, mas atuam como reguladores da resposta    imunit&aac
ute;ria celular. Integra a popula&ccedil;&atilde;o de linf&oacute;citos    T uma
 s&eacute;rie de subtipos celulares com fun&ccedil;&otilde;es espec&iacute;ficas
    na resposta imunit&aacute;ria, entre esses as c&eacute;lulas citot&oacute;xi
cas    (Tc), auxiliares ou <I>helper</I> (Th) e supressoras (Ts). </font> </p>  
   ^cY#v6n3a06.htm##
00343000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011200073002001200185#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#41#37#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><B>Macr&oacute;fagos</B>    </font> </p
>     ^cY#v6n3a06.htm##
01401000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704117000073002001201243#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#42#38#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Macr&oacute;fagos    s&atilde;o c&eacut
e;lulas mononucleares que se diferenciam a partir de mon&oacute;citos.    Seu ta
manho varia entre 25 e 50&#181;m de di&acirc;metro, possuem n&uacute;cleo    irr
egular e excentricamente posicionado, com um ou dois nucl&eacute;olos e cromatin
a    dispersa. Essas c&eacute;lulas apresentam complexo de Golgi bem desenvolvid
o,    n&uacute;mero vari&aacute;vel de ves&iacute;culas de endocitose e grande n
&uacute;mero    de mitoc&ocirc;ndrias. A superf&iacute;cie da membrana apresenta
-se irregular,    com microvilos, e o citoesqueleto &eacute; bem desenvolvido, r
odeando o n&uacute;cleo    e estendendo-se at&eacute; a periferia<SUP>10</SUP>. 
Essas caracter&iacute;sticas    ultra-estruturais podem estar modificadas em dif
erentes condi&ccedil;&otilde;es    fisiol&oacute;gicas e patol&oacute;gicas. Mac
r&oacute;fagos ativados apresentam    superf&iacute;cie mais irregular, grandes 
vac&uacute;olos citoplasm&aacute;ticos    e n&uacute;mero aumentado de lisossomo
s secund&aacute;rios em rela&ccedil;&atilde;o    &agrave;s c&eacute;lulas quiesc
entes. </font> </p>     ^cY#v6n3a06.htm##
01091000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704086000073002001200933#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#43#39#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Uma vez nos tecidos,    os macr&oacute;
fagos em geral n&atilde;o retornam &agrave; circula&ccedil;&atilde;o,    podendo
 sobreviver por v&aacute;rios meses. Esses s&atilde;o chamados de macr&oacute;fa
gos    residentes<SUP>3</SUP>. Os macr&oacute;fagos residentes est&atilde;o pres
entes    em &oacute;rg&atilde;os ou tecidos n&atilde;o inflamat&oacute;rios e se
cretam    lisozima, proteinases neutras e &aacute;cidas e esp&eacute;cies reativ
as do    oxig&ecirc;nio, possuindo pequena capacidade microbicida e fungicida. U
ma vez    ativados, aumentam a secre&ccedil;&atilde;o dessas subst&acirc;ncias e
 liberam    tamb&eacute;m uma variedade de proteinases e hidrolases neutras, com
ponentes    do sistema complemento, fatores de coagula&ccedil;&atilde;o, arginas
e e lisozima.    </font> </p>     ^cY#v6n3a06.htm##
00789000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704055800073002001200631#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#44#40#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Linf&oacute;citos    e fag&oacute;citos
 mononucleares agem em conjunto para responder rapidamente    na elimina&ccedil;
&atilde;o de ant&iacute;genos estranhos, regulando a resposta    ap&oacute;s a e
limina&ccedil;&atilde;o do ant&iacute;geno. Entretanto, essas    c&eacute;lulas 
respondem rapidamente a qualquer altera&ccedil;&atilde;o do sistema    imunit&aa
cute;rio, mas para isso aumentam a demanda metab&oacute;lica e a taxa    de util
iza&ccedil;&atilde;o de glutamina. </font> </p>     ^cY#v6n3a06.htm##
00737000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704050600073002001200579#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#45#41#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os macr&oacute;fagos    apresentam taxa
s elevadas de utiliza&ccedil;&atilde;o de glicose e glutamina<SUP>3</SUP>,    &a
grave; semelhan&ccedil;a de c&eacute;lulas de divis&atilde;o r&aacute;pida,    t
ais como enter&oacute;citos, linf&oacute;citos e c&eacute;lulas tumorais. Nos   
 macr&oacute;fagos, que n&atilde;o proliferam, a glutamina desempenha papel impo
rtante    na produ&ccedil;&atilde;o de citocinas<SUP>11</SUP>. </font> </p>     
^cY#v6n3a06.htm##
00908000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704067700073002001200750#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#46#42#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Linf&oacute;citos    e macr&oacute;fago
s utilizam ativamente glicose e glutamina, por&eacute;m esses    substratos s&at
ilde;o apenas parcialmente oxidados, sendo a glicose convertida    principalment
e a lactato e a glutamina, a glutamato, aspartato e lactato<SUP>12</SUP>.    A g
licose e a glutamina, para ser oxidadas, devem ser convertidas inicialmente    a
 piruvato, que &eacute; descarboxilado no ciclo de Krebs. Dessa forma, o piruvat
o    &eacute; o metab&oacute;lito comum da oxida&ccedil;&atilde;o parcial de gli
cose    e glutamina em linf&oacute;citos e macr&oacute;fagos<SUP>7</SUP>. </font
> </p>     ^cY#v6n3a06.htm##
00953000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704072200073002001200795#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#47#43#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Sabe-se que, em    cultura, macr&oacute
;fagos utilizam ativamente amino&aacute;cidos ricos em grupamentos    nitrogenad
os, como glutamina e arginina<SUP>13</SUP>. Isto indica que o nitrog&ecirc;nio  
  necess&aacute;rio para a s&iacute;ntese de novos amino&aacute;cidos e prote&ia
cute;nas    pode vir da glutamina e arginina extracelulares. Al&eacute;m disso, 
nessas c&eacute;lulas,    a produ&ccedil;&atilde;o de interleucina-8 depende da 
presen&ccedil;a de glutamina    no meio<SUP>13</SUP>. Em linf&oacute;citos de hu
manos e de ratos, esse amino&aacute;cido    &eacute; importante para a prolifera
&ccedil;&atilde;o<SUP>12,14,15</SUP>. </font>  </p>     ^cY#v6n3a06.htm##
00344000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704011300073002001200186#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#48#44#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2"><B>Neutr&oacute;filos</B>    </font> </
p>     ^cY#v6n3a06.htm##
00666000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704043500073002001200508#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#49#45#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Cerca de 100 bilh&otilde;es    de neutr
&oacute;filos circulam diariamente em um indiv&iacute;duo de 70kg, sob    condi&
ccedil;&otilde;es fisiol&oacute;gicas, n&uacute;mero que pode aumentar    at&eac
ute; dez vezes durante uma infec&ccedil;&atilde;o aguda<SUP>16</SUP>,    chegand
o a aproximadamente 5 x 10<SUP>11</SUP> c&eacute;lulas<SUP>17</SUP>.    </font> 
</p>     ^cY#v6n3a06.htm##
01297000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704106600073002001201139#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#50#46#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Em humanos, os    neutr&oacute;filos se
 originam de c&eacute;lulas primordiais pluripotenciais    da medula &oacute;sse
a (que tamb&eacute;m d&atilde;o origem aos mon&oacute;citos,    bem como a algun
s linf&oacute;citos e plaquetas). Ap&oacute;s sua forma&ccedil;&atilde;o,    cer
ca de 90% da popula&ccedil;&atilde;o de neutr&oacute;filos mant&eacute;m-se    n
a medula &oacute;ssea. O restante encontra-se distribu&iacute;do entre a circula
&ccedil;&atilde;o    e o endot&eacute;lio vascular, onde permanece como popula&c
cedil;&atilde;o marginal.    Este compartimento compreende c&eacute;lulas retida
s pela rede capilar, exclu&iacute;das    temporariamente da circula&ccedil;&atil
de;o por vasoconstri&ccedil;&atilde;o    ou, especialmente nos pulm&otilde;es, p
or ades&atilde;o ao endot&eacute;lio    vascular. Quando liberados da medula &oa
cute;ssea, a sobrevida dos neutr&oacute;filos    &eacute; normalmente de oito ho
ras no sangue e de mais de quatro a cinco dias    nos tecidos. </font> </p>     
^cY#v6n3a06.htm##
00657000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704042600073002001200499#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#51#47#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os neutr&oacute;filos    apresentam um 
n&uacute;cleo multilobulado, com cromatina densamente compactada,    que d&aacut
e; origem ao termo polimorfonuclear, n&atilde;o apresentam nucl&eacute;olo,    o
 aparelho de Golgi &eacute; pequeno e, quando os neutr&oacute;filos est&atilde;o
    maduros, variam em tamanho de 10 a 15mm de di&acirc;metro. </font> </p>     
^cY#v6n3a06.htm##
01398000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704116700073002001201240#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#52#48#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Os neutr&oacute;filos    s&atilde;o atr
a&iacute;dos quimiotaxicamente por c&eacute;lulas secretoras (mast&oacute;citos 
   e bas&oacute;filos), bact&eacute;rias e outros corpos estranhos para as &aacu
te;reas    de inflama&ccedil;&atilde;o. Microrganismos fagocitados, recobertos o
u n&atilde;o    com complemento ou anticorpo espec&iacute;fico, s&atilde;o morto
s por prote&iacute;nas    citot&oacute;xicas derivadas dos gr&acirc;nulos citopl
asm&aacute;ticos e por    uma combina&ccedil;&atilde;o de esp&eacute;cies reativ
as de oxig&ecirc;nio<SUP>4</SUP>.    Lloyd e Oppenheim<SUP>18</SUP> demonstraram
 que essas c&eacute;lulas tamb&eacute;m    participam na s&iacute;ntese e libera
&ccedil;&atilde;o de citocinas (interleucinas-1    e 6, fator de necrose tumoral
), que modulam os efeitos de linf&oacute;citos    T e B. Portanto, os neutr&oacu
te;filos apresentam uma fun&ccedil;&atilde;o eferente    (fagocitose e desgranul
a&ccedil;&atilde;o) e outra aferente (libera&ccedil;&atilde;o    de citocinas im
unomodulat&oacute;rias) ligadas &agrave;s respostas inflamat&oacute;ria    e imu
ne. </font> </p>     ^cY#v6n3a06.htm##
00741000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704051000073002001200583#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#53#49#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">As esp&eacute;cies    reativas de oxig&
ecirc;nio geradas pelos neutr&oacute;filos, assim como nos    macr&oacute;fagos,
 desempenham um papel importante como oxidantes microbicidas,    bem como mediad
ores da inflama&ccedil;&atilde;o e da les&atilde;o tecidual.    Uma vez estimula
dos, a maior parte do oxig&ecirc;nio consumida por neutr&oacute;filos    &eacute
; convertida em &acirc;nion super&oacute;xido pela NADPH oxidase. </font>  </p> 
    ^cY#v6n3a06.htm##
00616000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704038500073002001200458#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#54#50#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">O &acirc;nion super&oacute;xido    prod
uzido sob est&iacute;mulo em neutr&oacute;filos &eacute; rapidamente convertido 
   em per&oacute;xido de hidrog&ecirc;nio e radical hidroxil<SUP>19</SUP>, que  
  contribuem para a atividade microbicida dentro do fagossomo e no meio extracel
ular<SUP>20</SUP>.    </font> </p>     ^cY#v6n3a06.htm##
00778000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704054700073002001200620#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#55#51#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">O aumento do consumo    de glicose por 
neutr&oacute;filos e macr&oacute;fagos est&aacute; relacionado    com o processo
 de endocitose e a gera&ccedil;&atilde;o de esp&eacute;cies reativas    de oxig&
ecirc;nio<SUP>4,21-24</SUP>. Contudo, a glicose n&atilde;o &eacute;    o &uacute
;nico metab&oacute;lito energ&eacute;tico utilizado por essas c&eacute;lulas,   
 pois recentemente demonstramos que neutr&oacute;filos tamb&eacute;m utilizam   
 glutamina<SUP>9</SUP>. </font> </p>     ^cY#v6n3a06.htm##
01007000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704077600073002001200849#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#56#52#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A taxa de utiliza&ccedil;&atilde;o    d
e glutamina por neutr&oacute;filos, linf&oacute;citos e macr&oacute;fagos &eacut
e;    similar ou at&eacute; mesmo maior do que a de glicose. Com base nos produt
os    finais do metabolismo e atividade m&aacute;xima das enzimas estudadas, pod
e-se    concluir que a glutamina &eacute; utilizada por vias similares, mas n&at
ilde;o    id&ecirc;nticas, em macr&oacute;fagos, linf&oacute;citos e neutr&oacut
e;filos<SUP>25,26</SUP>.    Alta taxa de utiliza&ccedil;&atilde;o de glutamina e
 oxida&ccedil;&atilde;o    somente parcial s&atilde;o tamb&eacute;m caracter&iac
ute;sticas de enter&oacute;citos,    fibroblastos e c&eacute;lulas tumorais<SUP>
27-30</SUP>. </font> </p>     ^cY#v6n3a06.htm##
01722000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704149100073002001201564#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#57#53#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Em estudos recentes,    realizados no n
osso laborat&oacute;rio<SUP>31</SUP>, verificou-se que em neutr&oacute;filos    
de ratos incubados por uma hora, a adrenalina inibe a produ&ccedil;&atilde;o    
de &acirc;nion super&oacute;xido induzida por PMA na presen&ccedil;a de glicose,
    mas esta inibi&ccedil;&atilde;o &eacute; parcial na presen&ccedil;a de gluta
mina.    O efeito inibit&oacute;rio da adrenalina sobre a gera&ccedil;&atilde;o 
de &acirc;nion    super&oacute;xido por neutr&oacute;filos pode ter ocorrido dev
ido &agrave; baixa    produ&ccedil;&atilde;o de NADPH na via das pentoses. Na pr
esen&ccedil;a de adrenalina,    os neutr&oacute;filos desviariam o fluxo de glic
ose da via das pentoses para    a produ&ccedil;&atilde;o de lactato. Por outro l
ado, a glutamina aumenta a produ&ccedil;&atilde;o    de agentes redutores (NADH 
e NADPH) no ciclo de Krebs e, neste caso, reduz o    efeito inibit&oacute;rio de
 adrenalina sobre a produ&ccedil;&atilde;o de &acirc;nion    super&oacute;xido. 
Portanto, a glutamina pode ter uma papel importante na regula&ccedil;&atilde;o  
  da produ&ccedil;&atilde;o de &acirc;nion super&oacute;xido. Assim, altas taxas
    de utiliza&ccedil;&atilde;o de glutamina proporcionariam bases metab&oacute;
licas    apropriadas para a produ&ccedil;&atilde;o das esp&eacute;cies reativas 
de oxig&ecirc;nio    por neutr&oacute;filos, mantendo sua capacidade citol&iacut
e;tica. </font> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#58#54#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00388000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704015700073002001200230#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#59#55#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><B>VIAS DE S&Iacute;NTESE    E DEGRADA&
Ccedil;&Atilde;O DA GLUTAMINA</B> </font> </p>     ^cY#v6n3a06.htm##
01029000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704079800073002001200871#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#60#56#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Mais da metade    da glutamina consumid
a na dieta e absorvida &eacute; utilizada pelas pr&oacute;prias    c&eacute;lula
s intestinais que, por se renovarem rapidamente (poucos dias),    necessitam sin
tetizar constantemente compostos estruturais, principalmente a    partir da glic
ose e desse amino&aacute;cido<SUP>32</SUP>. Dessa forma, a maior    propor&ccedi
l;&atilde;o da glutamina circulante (concentra&ccedil;&atilde;o    aproximada de
 0,6mmol/L) &eacute; proveniente dos m&uacute;sculos esquel&eacute;ticos,    que
 sintetizam e exportam glutamina e alanina para a circula&ccedil;&atilde;o,    e
m especial durante situa&ccedil;&otilde;es de catabolismo intenso, como no    je
jum prolongado e exerc&iacute;cio. </font> </p>     ^cY#v6n3a06.htm##
00748000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704051700073002001200590#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#61#57#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A s&iacute;ntese    e a hidr&oacute;lis
e de glutamina em tecidos de mam&iacute;feros foram primeiramente    descritas p
or Krebs em 1935<SUP>33</SUP>. A s&iacute;ntese de glutamina ocorre    preferenc
ialmente no m&uacute;sculo esquel&eacute;tico, f&iacute;gado, tecido    adiposo 
e c&eacute;rebro, enquanto a hidr&oacute;lise ocorre nos rins, linfonodos,    ma
cr&oacute;fagos, trato gastrintestinal e tecido adiposo<SUP>34-36</SUP>. </font>
  </p>     ^cY#v6n3a06.htm##
01029000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704079800073002001200871#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#62#58#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A via mais importante    para a s&iacut
e;ntese da glutamina utiliza a metade direita do ciclo de Krebs,    que compreen
de desde o citrato (formado a partir de acetil-CoA e oxaloacetato)    at&eacute;
 o 2-oxoglutarato (<a href="#fig01">figura 1</a>). Esse &uacute;ltimo    &eacute
; um oxo&aacute;cido e pode ser transaminado com os amino&aacute;cidos    de cad
eia ramificada, receber um grupo amina e formar glutamato. Por sua vez,    o glu
tamato pode formar glutamina ao receber outro grupo amina, seja de outro    amin
o&aacute;cido ou da rea&ccedil;&atilde;o de desamina&ccedil;&atilde;o do    mono
fosfato de adenosina (AMP) em monofosfato de inositol (IMP) na via das purinas  
  (<a href="#fig02">figura 2</a>). </font> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#63#59#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#64#60#article#261#<p><a name="fig01"></a
> </p>     ^cY#v6n3a06.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#65#61#article#261#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a06f01.gif"> </p>     ^cY#v6n3a06.htm##
00269000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003800073002001200111#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#66#62#article#261#<p align="center">&nbs
p; </p>     ^cY#v6n3a06.htm##
00269000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003800073002001200111#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#67#63#article#261#<p align="center">&nbs
p; </p>     ^cY#v6n3a06.htm##
00281000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704005000073002001200123#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#68#64#article#261#<p align="left"><a nam
e="fig02"></a> </p>     ^cY#v6n3a06.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#69#65#article#261#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a06f02.gif"> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#70#66#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
01412000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704118100073002001201254#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#71#67#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A glutamina &eacute;    o amino&aacute;
cido livre mais abundante nos m&uacute;sculos esquel&eacute;ticos,    tendo uma 
concentra&ccedil;&atilde;o normal de 20mmol/L. Exerc&iacute;cios de    intensida
de moderada (quase intensa) depletam os estoques musculares de glicog&ecirc;nio 
   e demandam elevado metabolismo dos amino&aacute;cidos de cadeia ramificada<SU
P>37</SUP>.    A concentra&ccedil;&atilde;o de glutamina muscular ent&atilde;o &
eacute; aumentada    nos primeiros momentos desse tipo de exerc&iacute;cio, por&
eacute;m volta ao    normal em seguida devido a sua exporta&ccedil;&atilde;o par
a a circula&ccedil;&atilde;o.    Nesta, a glutamina tem com principais destinos 
o f&iacute;gado e os rins, onde    &eacute; utilizada no processo de gliconeog&e
circ;nese. Alguns estudos demonstraram    que a glutamina &eacute; o principal p
recursor para a gliconeog&ecirc;nese hep&aacute;tica<SUP>38,39</SUP>.    Outros 
destinos da glutamina s&atilde;o as c&eacute;lulas intestinais e, principalmente
,    as c&eacute;lulas do sistema imune durante o exerc&iacute;cio, quando ocorr
e    leucocitose. </font> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#72#68#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00373000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704014200073002001200215#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#73#69#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><B>METABOLISMO    MUSCULAR DURANTE O EX
ERC&Iacute;CIO</B> </font> </p>     ^cY#v6n3a06.htm##
00979000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704074800073002001200821#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#74#70#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A mol&eacute;cula    de trifosfato de a
denosina (ATP), por meio da quebra das liga&ccedil;&otilde;es    de alta energia
 entre seus fosfatos, fornece energia para a contra&ccedil;&atilde;o    muscular
, por&eacute;m sua concentra&ccedil;&atilde;o nos m&uacute;sculos &eacute;    pe
quena, suficiente para poucos segundos de contra&ccedil;&otilde;es musculares   
 apenas<SUP>40</SUP>. Por isso, existem tr&ecirc;s sistemas muito eficientes    
para a ress&iacute;ntese constante das mol&eacute;culas de ATP durante o exerc&i
acute;cio.    A predomin&acirc;ncia de um ou outro sistema &eacute; determinada 
pela intensidade    e dura&ccedil;&atilde;o do exerc&iacute;cio. </font> </p>   
  ^cY#v6n3a06.htm##
00786000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704055500073002001200628#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#75#71#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">O primeiro sistema    pode ser denomina
do de creatina-fosfato (CP) devido &agrave; utiliza&ccedil;&atilde;o    da energ
ia dessa liga&ccedil;&atilde;o fosfato para a ress&iacute;ntese do ATP.    Esse 
sistema atua imediatamente ap&oacute;s a utiliza&ccedil;&atilde;o do ATP    arma
zenado, mas tamb&eacute;m &eacute; suficiente para apenas poucos segundos    adi
cionais de contra&ccedil;&otilde;es. &Eacute; acionado no in&iacute;cio de    qu
alquer atividade f&iacute;sica. </font> </p>     ^cY#v6n3a06.htm##
00988000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704075700073002001200830#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#76#72#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">O segundo sistema    &eacute; a glic&oa
cute;lise anaer&oacute;bia e decorre da quebra da glicose    at&eacute; a forma&
ccedil;&atilde;o de &aacute;cido l&aacute;tico com ress&iacute;ntese    de ATP i
ndependente de O<SUB>2</SUB>. &Eacute; um sistema muito potente, ou    seja, com
 capacidade elevada de ress&iacute;ntese de ATP em curtos per&iacute;odos;    po
r isso, &eacute; utilizado durante exerc&iacute;cios intensos com dura&ccedil;&a
tilde;o    m&aacute;xima de poucos minutos, j&aacute; que a diminui&ccedil;&atil
de;o do    pH provocada pelo &aacute;cido l&aacute;tico inibe algumas enzimas de
ssa via    e impede a continua&ccedil;&atilde;o do processo<SUP>41</SUP>. </font
> </p>     ^cY#v6n3a06.htm##
01444000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704121300073002001201286#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#77#73#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">O &uacute;ltimo    sistema &eacute; a f
osforila&ccedil;&atilde;o oxidativa. Nesse, a ress&iacute;ntese    de ATP ocorre
 durante o transporte de el&eacute;trons, sendo o O<SUB>2</SUB>    o aceitante f
inal dos mesmos. Esse &eacute; considerado o sistema mais eficiente    em quanti
dade de ATP ressintetizada, por&eacute;m consegue atender plenamente    somente 
as demandas de exerc&iacute;cios de intensidade moderada, quando a oferta    de 
oxig&ecirc;nio &eacute; suficiente. Al&eacute;m de sintetizar mais ATP que    os
 outros sistemas, essa via apresenta outra vantagem, que &eacute; a capacidade  
  de gerar energia a partir de tr&ecirc;s substratos energ&eacute;ticos: glicose
,    &aacute;cidos graxos e amino&aacute;cidos<SUP>42</SUP>. De qualquer forma, 
tanto    em exerc&iacute;cios moderados como intensos, o principal substrato ene
rg&eacute;tico    utilizado &eacute; o glicog&ecirc;nio e a dura&ccedil;&atilde;
o do exerc&iacute;cio,    at&eacute; que haja diminui&ccedil;&atilde;o do desemp
enho ou se atinja a exaust&atilde;o,    &eacute; determinada pelos seus estoques
 nos m&uacute;sculos solicitados<SUP>43</SUP>.    </font> </p>     ^cY#v6n3a06.h
tm##
01940000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704170900073002001201782#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#78#74#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">No per&iacute;odo    de recupera&ccedil
;&atilde;o ocorre um processo chamado de d&eacute;bito de    O<SUB>2</SUB>, no q
ual o metabolismo continua elevado durante v&aacute;rias    horas, por&eacute;m 
em constante decl&iacute;nio, podendo ser dividido em tr&ecirc;s    fases: 1) fa
se r&aacute;pida, com dura&ccedil;&atilde;o de poucos minutos, suficiente    par
a a reple&ccedil;&atilde;o dos fosfagenos (ATP e CP) e reoxigena&ccedil;&atilde;
o    da mioglobina e hemoglobina; 2) fase lenta, com dura&ccedil;&atilde;o de ap
roximadamente    uma hora, quando o lactato &eacute; convertido a glicose e glic
og&ecirc;nio    (gliconeog&ecirc;nese hep&aacute;tica); 3) fase ultralenta, com 
dura&ccedil;&atilde;o    de v&aacute;rias horas, em que se prop&otilde;e que a e
stimula&ccedil;&atilde;o    dos ciclos de substratos (interconvers&otilde;es de 
substratos, como prote&iacute;na    &#174; amino&aacute;cidos &#174; prote&iacut
e;na, por exemplo) seja o fator    respons&aacute;vel pelo d&eacute;bito de O<SU
B>2</SUB><SUP>41</SUP>. A utiliza&ccedil;&atilde;o    dos substratos nesse per&i
acute;odo &eacute; determinada pelo consumo de nutrientes.    Caso nada seja con
sumido al&eacute;m de &aacute;gua, o catabolismo de prote&iacute;nas    e a mobi
liza&ccedil;&atilde;o de &aacute;cidos graxos continuam, com esses &uacute;ltimo
s    sendo utilizados como principal substrato. Em havendo consumo de nutrientes
,    principalmente carboidratos, o anabolismo prot&eacute;ico e a reesterifica&
ccedil;&atilde;o    dos &aacute;cidos graxos s&atilde;o estimulados e a glicose 
passa a ser utilizada    como o principal substrato<SUP>44</SUP>. </font> </p>  
   ^cY#v6n3a06.htm##
01108000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704087700073002001200950#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#79#75#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Uma peculiaridade    dos m&uacute;sculo
s esquel&eacute;ticos em rela&ccedil;&atilde;o ao metabolismo    dos amino&aacut
e;cidos &eacute; que, ao mesmo tempo que utilizam alguns deles    (leucina, isol
eucina, valina, glutamato, aspartato e asparagina) para a oxida&ccedil;&atilde;o
    ou s&iacute;ntese de intermedi&aacute;rios do ciclo de Krebs<SUP>45</SUP>, s
intetizam    alanina e glutamina, que s&atilde;o exportados para a circula&ccedi
l;&atilde;o,    onde tomam destinos diversos<SUP>40</SUP>. Tanto a alanina quant
o a glutamina    desempenham um papel muito importante, que &eacute; o de carrea
r a am&ocirc;nia    resultante da desamina&ccedil;&atilde;o de outros amino&aacu
te;cidos para o    f&iacute;gado e rins, evitando que os m&uacute;sculos acumule
m esse composto    t&oacute;xico. </font> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#80#76#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00427000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704019600073002001200269#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#81#77#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><B>CONCENTRA&Ccedil;&Atilde;O    PLASM&
Aacute;TICA DE GLUTAMINA DURANTE E AP&Oacute;S O EXERC&Iacute;CIO</B>    </font>
 </p>     ^cY#v6n3a06.htm##
00834000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704060300073002001200676#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#82#78#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">O treinamento tem    como caracter&iacu
te;stica estimular adapta&ccedil;&otilde;es morfol&oacute;gicas    e metab&oacut
e;licas nos m&uacute;sculos esquel&eacute;ticos e alterar a mobiliza&ccedil;&ati
lde;o    e utiliza&ccedil;&atilde;o de substratos energ&eacute;ticos. Tais alter
a&ccedil;&otilde;es    geralmente trazem benef&iacute;cios para o desempenho e s
a&uacute;de do atleta;    entretanto, podem tamb&eacute;m interferir no equil&ia
cute;brio metab&oacute;lico    e end&oacute;crino e prejudicar alguns sistemas. 
</font> </p>     ^cY#v6n3a06.htm##
01145000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704091400073002001200987#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#83#79#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">O supertreinamento,    particularmente,
 constitui-se numa situa&ccedil;&atilde;o extrema para o atleta,    pois &eacute
; caracterizado pela incapacidade de recupera&ccedil;&atilde;o adequada    ap&oa
cute;s sucessivas se&ccedil;&otilde;es de treinamento. A sensa&ccedil;&atilde;o 
   de fadiga persiste mesmo ap&oacute;s os per&iacute;odos regulares de recupera
&ccedil;&atilde;o    e acarreta altera&ccedil;&otilde;es emocionais, comportamen
tais e f&iacute;sicas<SUP>1,2,46</SUP>.    Essa situa&ccedil;&atilde;o &eacute; 
prejudicial ao atleta n&atilde;o apenas    pela impossibilidade de continua&cced
il;&atilde;o do programa de treinamento    e pela queda do desempenho nas compet
i&ccedil;&otilde;es, mas tamb&eacute;m    pelas conseq&uuml;&ecirc;ncias fisiol&
oacute;gicas relacionadas &agrave; sua    pr&oacute;pria sa&uacute;de. </font> <
/p>     ^cY#v6n3a06.htm##
00756000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704052500073002001200598#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#84#80#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Estudos t&ecirc;m    relacionado o exce
sso de treinamento, treinamento intenso e tamb&eacute;m exerc&iacute;cios    de 
longa dura&ccedil;&atilde;o com a diminui&ccedil;&atilde;o da resposta imune<SUP
>47-49</SUP>.    Essa condi&ccedil;&atilde;o decorre de altera&ccedil;&otilde;es
 hormonais<SUP>50-52</SUP>    e do metabolismo dos m&uacute;sculos esquel&eacute
;ticos e das c&eacute;lulas    envolvidas no mecanismo de defesa<SUP>53-55</SUP>
. </font> </p>     ^cY#v6n3a06.htm##
00609000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704037800073002001200451#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#85#81#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A diminui&ccedil;&atilde;o    da concen
tra&ccedil;&atilde;o plasm&aacute;tica de glutamina tem sido mencionada    por d
iversos autores como o fator que reduz a funcionalidade dos leuc&oacute;citos,  
  deixando o atleta mais vulner&aacute;vel a infec&ccedil;&otilde;es<SUP>51,54,5
6,57</SUP>.    </font> </p>     ^cY#v6n3a06.htm##
01379000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704114800073002001201221#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#86#82#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Como j&aacute;    visto anteriormente, 
os m&uacute;sculos esquel&eacute;ticos s&atilde;o a principal    fonte da glutam
ina circulante, que por sua vez &eacute; imprescind&iacute;vel    para o metabol
ismo e funcionalidade dos leuc&oacute;citos. Em humanos, a capacidade    dos m&u
acute;sculos esquel&eacute;ticos de liberar glutamina &eacute; de pelo    menos 
42mmol/h<SUP>58</SUP>, enquanto que o consumo total de glutamina por todos    os
 linf&oacute;citos do organismo &eacute; de aproximadamente 24mmol/h. Esses    d
ados indicam que a demanda de glutamina pelo linf&oacute;cito pode ser suprida  
  completamente pelo m&uacute;sculo esquel&eacute;tico. Entretanto, se houver   
 aumento na taxa de consumo desse amino&aacute;cido ou at&eacute; mesmo se a    
produ&ccedil;&atilde;o e libera&ccedil;&atilde;o pelo m&uacute;sculo estiverem  
  excessivamente diminu&iacute;das, poder&aacute; haver comprometimento da fun&c
cedil;&atilde;o    imune. Nessas condi&ccedil;&otilde;es, a glutamina &eacute; c
onsiderada um amino&aacute;cido    "condicionalmente essencial". </font> </p>   
  ^cY#v6n3a06.htm##
00952000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704072100073002001200794#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#87#83#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">O efeito do exerc&iacute;cio    sobre a
 concentra&ccedil;&atilde;o plasm&aacute;tica de glutamina (ou produ&ccedil;&ati
lde;o    de glutamina pelos m&uacute;sculos esquel&eacute;ticos) varia de acordo
 com    a intensidade do esfor&ccedil;o<SUP>48</SUP>. Em exerc&iacute;cios de ba
ixa    intensidade, a concentra&ccedil;&atilde;o plasm&aacute;tica de glutamina 
n&atilde;o    se altera, enquanto em esfor&ccedil;os moderados aumenta e em ativ
idades intensas    h&aacute; diminui&ccedil;&atilde;o. Graficamente, essa varia&
ccedil;&atilde;o    pode ser representada por uma curva em forma de "J" invertid
o (<a href="#fig03">figura    3</a>). </font> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#88#84#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00268000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704003700073002001200110#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#89#85#article#261#<p><a name="fig03"></a
> </p>     ^cY#v6n3a06.htm##
00309000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704007800073002001200151#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#90#86#article#261#<p align="center"><img
 src="/img/revistas/rbme/v6n3/a06f03.gif"> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#91#87#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
01425000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704119400073002001201267#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#92#88#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Em estudos de laborat&oacute;rio    com
 exerc&iacute;cios controlados e no campo com coleta de amostras em competi&cced
il;&otilde;es    tem sido demonstrada diminui&ccedil;&atilde;o da concentra&cced
il;&atilde;o    plasm&aacute;tica de glutamina durante ou mesmo ap&oacute;s o t&
eacute;rmino    do esfor&ccedil;o. J&aacute; no in&iacute;cio dos anos 80, Renni
e <I>et al.</I><SUP>59</SUP>    determinaram a concentra&ccedil;&atilde;o plasm&
aacute;tica de diversos amino&aacute;cidos    ap&oacute;s um exerc&iacute;cio de
 225 minutos de dura&ccedil;&atilde;o a 50%    do VO<SUB>2 m&aacute;x.</SUB> e o
bservaram que a diminui&ccedil;&atilde;o da    concentra&ccedil;&atilde;o de glu
tamina circulante (de 0,557 para 0,470mmol/L)    foi a mais acentuada entre todo
s os amino&aacute;cidos analisados. Sahlin <I>et    al.</I><SUP>60</SUP> mostrar
am diminui&ccedil;&atilde;o do conte&uacute;do de    glutamina nos m&uacute;scul
os com o decorrer do exerc&iacute;cio (75% do VO<SUB>2m&aacute;x.</SUB>),    pro
vavelmente devido ao aumento de aproximadamente 125% do efluxo desse amino&aacut
e;cido    dos m&uacute;sculos. </font> </p>     ^cY#v6n3a06.htm##
01506000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704127500073002001201348#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#93#89#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Competi&ccedil;&otilde;es    tais como 
corridas de maratona, devido &agrave; dura&ccedil;&atilde;o e &agrave;    intens
idade do esfor&ccedil;o empregado pelos atletas, parecem ser especialmente    pr
op&iacute;cias em demonstrar essa rela&ccedil;&atilde;o do exerc&iacute;cio    c
om a concentra&ccedil;&atilde;o de glutamina no plasma e no m&uacute;sculo    es
quel&eacute;tico. Parry-Billings <I>et al.</I><SUP>53</SUP> estudaram corredores
    treinados ap&oacute;s o final de uma prova de maratona e observaram diminui&
ccedil;&atilde;o    significativa na concentra&ccedil;&atilde;o plasm&aacute;tic
a de glutamina (de    0,592 para 0,495mmol/L) e dos amino&aacute;cidos de cadeia
 ramificada (de 0,489    para 0,404mmol/L). Resultados semelhantes foram encontr
ados por Castell <I>et    al.</I><SUP>61</SUP> tamb&eacute;m ap&oacute;s uma pro
va de maratona. Nesse    caso, houve diminui&ccedil;&atilde;o da concentra&ccedi
l;&atilde;o de glutamina    (de 0,571 para 0,462mmol/L) e dos amino&aacute;cidos
 de cadeia ramificada (de    0,487 para 0,368mmol/L), e o restabelecimento da co
ndi&ccedil;&atilde;o pr&eacute;-esfor&ccedil;o    ocorreu somente ap&oacute;s 16
h de recupera&ccedil;&atilde;o. </font> </p>     ^cY#v6n3a06.htm##
00818000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704058700073002001200660#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#94#90#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Keast <I>et al.</I><SUP>55</SUP>    rel
acionaram a intensidade do exerc&iacute;cio com a concentra&ccedil;&atilde;o    
plasm&aacute;tica de glutamina e encontraram uma correla&ccedil;&atilde;o invers
a.    Esses autores verificaram que a concentra&ccedil;&atilde;o plasm&aacute;ti
ca    de glutamina &eacute; reduzida em atletas submetidos a um treinamento inte
nso    durante dez dias, e verificaram que esta permaneceu menor nos seis dias s
eguintes    ao t&eacute;rmino do per&iacute;odo de treinamento. </font> </p>    
 ^cY#v6n3a06.htm##
00845000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704061400073002001200687#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#95#91#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">Walsh <I>et al.</I><SUP>57</SUP>    obs
ervaram que um &uacute;nico exerc&iacute;cio intermitente e intenso (100%    do 
<img src="/img/revistas/rbme/v6n3/a06f04.gif"><SUB>2m&aacute;x.</SUB>) &eacute; 
   suficiente para provocar uma diminui&ccedil;&atilde;o significativa da concen
tra&ccedil;&atilde;o    plasm&aacute;tica de glutamina at&eacute; 5h ap&oacute;s
 o t&eacute;rmino do    esfor&ccedil;o. Sintomaticamente, neste mesmo per&iacute
;odo, havia um n&uacute;mero    significativamente maior de leuc&oacute;citos ci
rculantes. </font> </p>     ^cY#v6n3a06.htm##
02393000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704216200073002001202235#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#96#92#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A hip&oacute;tese    mais prov&aacute;v
el para explicar a diminui&ccedil;&atilde;o da concentra&ccedil;&atilde;o    pla
sm&aacute;tica de glutamina em situa&ccedil;&otilde;es de estresse metab&oacute;
lico,    como exerc&iacute;cios prolongados e treinamentos intensos, parece ser 
a de    que h&aacute; aumento significativo da capta&ccedil;&atilde;o de glutami
na pelo    f&iacute;gado, rins e intestino, principalmente nos dois primeiros &o
acute;rg&atilde;os,    para assegurar a s&iacute;ntese <I>de novo </I>de glicose
 no processo de gliconeog&ecirc;nese    e tamponamento da acidose, respectivamen
te<SUP>57,62</SUP>. Por&eacute;m, h&aacute;    a possibilidade das c&eacute;lula
s do sistema imune, devido &agrave; leucocitose    causada pelo exerc&iacute;cio
, tamb&eacute;m contribu&iacute;rem com uma capta&ccedil;&atilde;o    consider&a
acute;vel de glutamina do plasma<SUP>63</SUP>. Outro fator seria a    menor libe
ra&ccedil;&atilde;o de glutamina do m&uacute;sculo esquel&eacute;tico.    Isto s
eria conseq&uuml;&ecirc;ncia da inibi&ccedil;&atilde;o da glutamina sintetase,  
  como j&aacute; foi demonstrado em casos de exerc&iacute;cios intensos<SUP>64-6
5</SUP>.    Al&eacute;m disso, a deple&ccedil;&atilde;o do glicog&ecirc;nio musc
ular pode    ter duas conseq&uuml;&ecirc;ncias diretas sobre o processo de s&iac
ute;ntese    de glutamina. Uma conseq&uuml;&ecirc;ncia est&aacute; relacionada &
agrave; depend&ecirc;ncia    de esqueletos de carbono para a s&iacute;ntese da g
lutamina por meio de transamina&ccedil;&atilde;o    com os amino&aacute;cidos de
 cadeia ramificada (ver <a href="#fig02">figura    2</a>)<SUP>66</SUP>. A outra 
est&aacute; relacionada &agrave; diminui&ccedil;&atilde;o    da concentra&ccedil
;&atilde;o plasm&aacute;tica dos amino&aacute;cidos de cadeia    ramificada, j&a
acute; que a diminui&ccedil;&atilde;o do conte&uacute;do de glicog&ecirc;nio    
ativa o complexo enzim&aacute;tico ceto&aacute;cido de cadeia ramificada desidro
genase    (BCKADh) e leva ao aumento da capta&ccedil;&atilde;o e do consumo dess
es amino&aacute;cidos<SUP>67</SUP>.    </font> </p>     ^cY#v6n3a06.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704002300073002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#97#93#article#261#<p>&nbsp; </p>     ^cY
#v6n3a06.htm##
00366000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704013500073002001200208#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#98#94#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="3"><B>SUPLEMENTA&Ccedil;&Atilde;O    DE GL
UTAMINA</B> </font> </p>     ^cY#v6n3a06.htm##
01126000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000800061708000400069704089500073002001200968#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#99#95#article#261#<p><font face="Verdana
, Arial, Helvetica, sans-serif" size="2">A import&acirc;ncia    da suplementa&cc
edil;&atilde;o de glutamina vem sendo estudada em processos    que envolvem resp
ostas imune e inflamat&oacute;ria. A concentra&ccedil;&atilde;o    plasm&aacute;
tica de glutamina est&aacute; diminu&iacute;da em condi&ccedil;&otilde;es    de 
estresse, tais como em pacientes queimados<SUP>14</SUP>, durante a septicemia<SU
P>68,69</SUP>,    p&oacute;s-cirurgia<SUP>53,70,71</SUP>, ap&oacute;s exerc&iacu
te;cios de resist&ecirc;ncia<SUP>61,72</SUP>    e no supertreinamento<SUP>53</SU
P>. Al&eacute;m disso, indiv&iacute;duos submetidos    a um per&iacute;odo de de
z dias de treinamento intenso, com tempo insuficiente    de repouso entre as ses
s&otilde;es, apresentam redu&ccedil;&atilde;o de 50%    na concentra&ccedil;&ati
lde;o plasm&aacute;tica de glutamina<SUP>55</SUP>. </font>  </p>     ^cY#v6n3a06
.htm##
01258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704102600074002001201100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#100#96#article#261#<p><font face="Verdan
a, Arial, Helvetica, sans-serif" size="2">Koyama <I>et al.</I><SUP>15</SUP>    t
amb&eacute;m demonstraram a import&acirc;ncia da glutamina para a prolifera&cced
il;&atilde;o    de linf&oacute;citos num estudo no qual compararam o efeito do t
reinamento e    da inje&ccedil;&atilde;o de metionina sulfoximina (MS), uma drog
a inibidora    da glutamina sintetase. Como esperado, ap&oacute;s o treinamento,
 houve aumento    significativo da concentra&ccedil;&atilde;o plasm&aacute;tica 
de corticosterona    e diminui&ccedil;&atilde;o significativa da capacidade prol
iferativa dos linf&oacute;citos    bem como da concentra&ccedil;&atilde;o plasm&
aacute;tica de glutamina. Com a    administra&ccedil;&atilde;o da droga MS, houv
e o mesmo efeito de diminui&ccedil;&atilde;o    da concentra&ccedil;&atilde;o pl
asm&aacute;tica de glutamina e da prolifera&ccedil;&atilde;o    de linf&oacute;c
itos sem, no entanto, haver altera&ccedil;&atilde;o da concentra&ccedil;&atilde;
o    de corticosterona. </font> </p>     ^cY#v6n3a06.htm##
00551000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704031900074002001200393#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#101#97#article#261#<p><font face="Verdan
a, Arial, Helvetica, sans-serif" size="2">H&aacute; evid&ecirc;ncias    de que, 
em exerc&iacute;cios intensos e prolongados, a ingest&atilde;o de fluidos    con
tendo glutamina reduz a incid&ecirc;ncia de infec&ccedil;&otilde;es no trato    
respirat&oacute;rio<SUP>73,74</SUP>. </font> </p>     ^cY#v6n3a06.htm##
00714000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704048200074002001200556#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#102#98#article#261#<p><font face="Verdan
a, Arial, Helvetica, sans-serif" size="2">Outro estudo demonstrou    a efici&eci
rc;ncia de uma suplementa&ccedil;&atilde;o de glutamina em diminuir    a incid&e
circ;ncia de infec&ccedil;&otilde;es em atletas durante sete dias ap&oacute;s   
 exerc&iacute;cio prolongado. No grupo placebo, foi observada incid&ecirc;ncia  
  de infec&ccedil;&otilde;es em 51% dos atletas, enquanto no grupo suplementado 
   esta foi de apenas 19%<SUP>75</SUP>. </font> </p>     ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000800062708000400070704002300074002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#103#99#article#261#<p>&nbsp; </p>     ^c
Y#v6n3a06.htm##
00342000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704010900075002001200184#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#104#100#article#261#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="3"><B>AGRADECIMENTOS</B>    </font> </p>
     ^cY#v6n3a06.htm##
00423000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704019000075002001200265#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#105#101#article#261#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="2">Os autores s&atilde;o    gratos ao co
nstante apoio da FAPESP, CNPq, PRONEX e Conselho Brit&acirc;nico.    </font> </p
>     ^cY#v6n3a06.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002300075002001200098#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#106#102#article#261#<p>&nbsp; </p>     ^
cY#v6n3a06.htm##
00345000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704011200075002001200187#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#107#103#article#261#<p><font face="Verda
na, Arial, Helvetica, sans-serif" size="3"><B>REFER&Ecirc;NCIAS</B>    </font> <
/p>     ^cY#v6n3a06.htm##
00388000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014100077002001200218#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#108#104#article#261#1#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Budgett R. Overtrain
ing    syndrome. Br J Sports Med 1990;24:231-6.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#109#105#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00416000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704016900077002001200246#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#110#106#article#261#2#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Kuipers H. Training 
   and orvertraining: an introduction. Med Sci Sports Exerc 1998;30:1137-9.    ^
cY#v6n3a06.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002300075002001200098#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#111#107#article#261# </font>  </p>     ^
cY#v6n3a06.htm##
00387000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704014000077002001200217#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#112#108#article#261#3#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Gordon S. Biology   
 of the macrophages. J Cell Sci 1986;4:267-86.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#113#109#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00398000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704015100077002001200228#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#114#110#article#261#4#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Stites DP, Terr    A
L. Basic human immunology. New York: Prentice Hall, 1991.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#115#111#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00504000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704025700077002001200334#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#116#112#article#261#5#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Curi R, Newsholme   
 P, Newsholme EA. Intracellular distribution of some enzymes of the glutamine   
 utilisation pathway in rat lymphocytes. Biochem BiophysRes Commun 1986;138:318-
32.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#117#113#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00500000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704025300077002001200330#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#118#114#article#261#6#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Newsholme P,    Curi
 R, Blomstrand E, Gordon S, Newsholme EA. Localization and characterization    o
f glutaminase activity in the murine macrophage. Biochem Soc Trans 1987;16:536. 
   ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#119#115#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00505000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704025800077002001200335#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#120#116#article#261#7#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Curi R, Newsholme   
 P, Newsholme EA. Metabolism of pyruvate by isolated rat mesenteric lymphocytes,
    lymphocyte mitochondria and isolated mouse macrophage. Biochem J 1988;250:38
3-8.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#121#117#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00502000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704025500077002001200332#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#122#118#article#261#8#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Pithon-Curi    TC, P
ires de Melo M, de Azevedo RB, Curi R. Glutamine utilisation by rat neutrophils.
    Characterization of phosphate-dependent glutaminase. Immunology 1996;89:R184
.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#123#119#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00513000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000200075704026600077002001200343#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#124#120#article#261#9#<p><fo
nt face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Pithon-Curi    TC, P
ires de Melo M, de Azevedo R, Zorn TMT, Curi R. Glutamine utilization by    rat 
neutrophils. Presence of phosphate-dependent glutaminase. Am J Physiol 1997;273:
C1124-C1129.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#125#121#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00419000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017100078002001200249#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#126#122#article#261#10#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Dinarello CA.    T
he endogenous pyrogens in host-defense interactions. Hosp Pract 1989;24:111-5.  
  ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#127#123#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00489000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704024100078002001200319#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#128#124#article#261#11#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Yaqoob P, Calder  
  P. Cytokine production by human peripheral blood mononuclear cells: differenti
al    sensitivity to glutamine availability. Cytokine 1998;10:790-4.    ^cY#v6n3
a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#129#125#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017800078002001200256#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#130#126#article#261#12#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Ardawi MSM,    New
sholme EA. Glutamine metabolism in lymphocytes of the rat. Biochem J 1983;212:83
5-42.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#131#127#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00534000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028600078002001200364#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#132#128#article#261#13#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Murphy CJ,    News
holme P. Importance of glutamine metabolism in murine macrophages and human    m
onocytes to L-arginine biosynthesis and rates of nitrite or urea production.    
Clin Sci (Colch) 1998;95:397-407.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#133#129#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00477000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022900078002001200307#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#134#130#article#261#14#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Parry-Billings    
M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppress
ion    after major burns<I>? </I>Lancet 1990;336: 523-5.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#135#131#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00498000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025000078002001200328#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#136#132#article#261#15#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">15. Koyama K, Kaya    
M, Tsujita J, Hori S. Effects of decreased plasma glutamine concentrations on   
 peripheral lymphocytes proliferation rats. Eur J Appl Physiol 1998;77:25-31.   
 ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#137#133#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00510000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704026200078002001200340#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#138#134#article#261#16#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">16. Lee GR, Bithell   
 TC, Foerster J, Athens JW, Lukens JN. Leukocytes: the phagocytic and immunologi
c    systems. In: Wintrobe's clinical hematology, Philadelphia: Lea Febiger, 199
3:223-57.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#139#135#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00445000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019700078002001200275#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#140#136#article#261#17#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">17. Yang KD, Hill    H
R. Neutrophil function disorders: pathophysiology, prevention, and therapy.    J
 Pediatr 1991;119:43-54.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#141#137#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00496000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704024800078002001200326#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#142#138#article#261#18#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">18. Lloyd Ar, Oppenhei
m    JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil i
n    the afferent limb of the immune response. ImmunolToday 1992;13:169-72.    ^
cY#v6n3a06.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002300075002001200098#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#143#139#article#261# </font>  </p>     ^
cY#v6n3a06.htm##
00552000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704030400078002001200382#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#144#140#article#261#19#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">19. Allen RC. Biochemi
excitation:    chemiluminescence and the study of biological oxygenation reactio
ns. In: Adam    W, Cilento G, editors. Chemical and biological generation of exc
ited states.    New York: Academic Press, 1982:309.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#145#141#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00601000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704035300078002001200431#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#146#142#article#261#20#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">20. Pithon-Curi    TC,
 Pires de Melo M, Palanch AC, Miyasaka CK, Curi R. Percentage of phagocytosis,  
  production of O<SUB>2</SUB>-<SUB>, </SUB>H<SUB>2</SUB>O<SUB>2</SUB> and NO and
    antioxidant enzyme activities of rat neutrophils in culture. Cell Biochem Fu
nct    1998;16:43-9.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#147#143#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00485000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023700078002001200315#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#148#144#article#261#21#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">21. Selvaraj RJ,    Sb
arra AJ. Relationship of glycolytic and oxidative metabolism to particle entry  
  and destruction in phagocytosing cells. Nature 1966;17:1272-6.    ^cY#v6n3a06.
htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#149#145#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00483000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023500078002001200313#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#150#146#article#261#22#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">22. Lehrer RI.    Effe
cts of colchicine and chloramphenicol on the oxidative metabolism and phagocytic
    activity of human neutrophils. J Infect Dis 1973;127:40-8.    ^cY#v6n3a06.ht
m##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#151#147#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00434000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018600078002001200264#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#152#148#article#261#23#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">23. Johnston Jr.    RB
. Oxigen metabolism and the microbicidal activity of macrophages. FASEB J    197
8;37:2756-64.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#153#149#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00440000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019200078002001200270#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#154#150#article#261#24#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">24. Boregaard N,    He
rlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin    In
vest 1982;70:550-7.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#155#151#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00540000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029200078002001200370#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#156#152#article#261#25#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">25. Curi R, Newsholme 
   P, Pithon-Curi TC, Pires-de-Melo M, Garcia C, Homem-de-Bittencourt Jr. PI, et
    al. Metabolic fate of glutamine in lymphocytes, macrophages and neutrophils.
    Braz J Med Biol Res 1999;32: 15-21.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#157#153#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00535000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704028700078002001200365#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#158#154#article#261#26#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">26. Newsholme P,    Cu
ri R, Pithon-Curi TC, Murphy CJ, Garcia C, Melo MP. Glutamine metabolism by    l
ymphocytes, macrophages, and neutrophils: its importance in health and disease. 
   J Nutr Biochem 1999;10: 316-24.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#159#155#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00449000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020100078002001200279#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#160#156#article#261#27#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">27. Hume DA, Weidemann
    MJ. Role and regulation of glucose metabolism in proliferating cells. J Natl
    Cancer Inst 1979;62:3-8.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#161#157#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00505000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025700078002001200335#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#162#158#article#261#28#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">28. Parry-Billings    
M, Leighton B, Dimitriadis GD, Curi R, Bond J, Bevan S, et al. The effect of    
tumour bearing on skeletal muscle glutamine metabolism. Int J Biochem 1991;23:93
3-7.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#163#159#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00540000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029200078002001200370#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#164#160#article#261#29#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">29. Dos-Santos    MA, 
Rosa R, Curi R, Barbieri DHGP. Effect of protein malnutrition on the glycolytic 
   and glutaminolytic enzyme activity of rat thymus and mesenteric lymph nodes. 
   Braz J Med Biol Res 1997;30: 719-22.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#165#161#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00435000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018700078002001200265#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#166#162#article#261#30#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">30. Fernandes LC,    C
uri R. Reversion of Walker 256 tumor cachexia by insulin treatment. Cancer    J 
1997;4:465-74.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#167#163#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00543000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029500078002001200373#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#168#164#article#261#31#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">31. Garcia C, Pithon-C
uri    TC, Firmano ML, Pires-de-Melo M, Newsholme P, Curi R. Effect of adrenalin
e on    glucose and glutamine metabolism and superoxide production by rat neutro
phils.    Clin Sci (Colch) 1999;96:549-55.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#169#165#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00409000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016100078002001200239#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#170#166#article#261#32#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">32. Souba WW. Intestin
al    glutamine metabolism and nutrition. J Nutr Biochem 1993;4:2-9.    ^cY#v6n3
a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#171#167#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00505000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025700078002001200335#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#172#168#article#261#33#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">33. Krebs HA. Metaboli
sm    of aminoacids. The synthesis of glutamine from glutamic acid and ammonia, 
and    enzimic hydrolysis of glutamine in animal tissues. Biochem J 1935;29:1951
-69.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#173#169#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00464000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021600078002001200294#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#174#170#article#261#34#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">34. Kowalchuck    JM, 
Curi R, Newsholme EA. Glutamine metabolism in isolated incubated adipocytes    o
f the rat<I>. </I>Biochem J 1988;249:705-8.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#175#171#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00527000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704027900078002001200357#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#176#172#article#261#35#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">35. Curi R, Newsholme 
   EA. The effect of adenine nucleotides on the rate fate of glutamine utilizati
on    by incubated mitochondria isolated from rat mesenteric lymph nodes. Mol Ce
l    Biochem 1989;86:7l-6.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#177#173#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00458000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021000078002001200288#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#178#174#article#261#36#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">36. Fryan KN, Khan    
K, Coppack SW, Elia M. Amino acid metabolism in human subcutaneous adipose tissu
e    in vivo. Clin Sci 1991;80:471-4.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#179#175#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017800078002001200256#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#180#176#article#261#37#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">37. Gastmann UAL,    L
ehmann MJ. Overtraining and the BCAA hypothesis. Med Sci Sports Exerc 1998;30:11
73-8.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#181#177#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00526000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704027800078002001200356#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#182#178#article#261#38#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">38. Nurjhan N,    Bucc
i A, Perriello G, Stumvoll M, Dailey G, Bier DM, et al. Glutamine: a major    gl
uconeogenic precursor and vehicle for interorgan carbon transport in man.    J C
lin Invest 1995;95:272-7.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#183#179#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00441000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019300078002001200271#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#184#180#article#261#39#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">39. Hankard RG,    Hay
mond MW, Darmaun D. Role of glutamine as a precursor in fasting humans. Diabetes
    1997;46:1535-41.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#185#181#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00401000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015300078002001200231#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#186#182#article#261#40#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">40. Hargreaves    M, e
ditor. Exercise metabolism. Champaign: Human Kinetics, 1995.    ^cY#v6n3a06.htm#
#
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#187#183#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00430000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704018200078002001200260#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#188#184#article#261#41#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">41. Newsholme EA,    L
eech AR. Biochemistry for the medical sciences. New York: John Wiley &amp;    So
ns, 1983.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#189#185#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019600078002001200274#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#190#186#article#261#42#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">42. Henriksson    J. E
ffect of training and nutrition on the development of skeletal muscle. J    Spor
ts Sci 1995;13:S25-S30.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#191#187#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00461000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021300078002001200291#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#192#188#article#261#43#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">43. Newsholme EA,    L
eech T, Duester G. Keep on running: the science of training and performance.    
Chichester: John Wiley &amp; Sons, 1994.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#193#189#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00451000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704020300078002001200281#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#194#190#article#261#44#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">44. MacDonald IA,    W
ebber J. Feeding, fasting and starvation: factors affecting fuel utilization.   
 Proc Nutr Soc 1995;54:267-74.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#195#191#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00480000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023200078002001200310#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#196#192#article#261#45#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">45. Wagenmakers    AJ.
 Muscle amino acid metabolism at rest and during exercise: role in human    phys
iology and metabolism. Exerc Sport Sci Rev 1998;26:287-314.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#197#193#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00410000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704016200078002001200240#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#198#194#article#261#46#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">46. Eichner ER.    Ove
rtraining: consequences and prevention. J Sports Sci 1995;13:S41-S48.    ^cY#v6n
3a06.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002300075002001200098#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#199#195#article#261# </font>  </p>     ^
cY#v6n3a06.htm##
00441000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704019300078002001200271#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#200#196#article#261#47#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">47. Sharp NCC,    Kout
edakis Y. Sport and the overtraining syndrome: immunological aspects. Br    Med 
Bull 1992;48:518-33.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#201#197#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00521000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704027300078002001200351#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#202#198#article#261#48#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">48. Rowbottom DG,    K
east D, Goodman C, Morton AR. The haematological, biochemical and immunological 
   profile of athletes suffering from the overtraining syndrome. Eur J Appl Phys
iol    1995;70:5029.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#203#199#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00518000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704027000078002001200348#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#204#200#article#261#49#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">49. Gabriel HHW,    Ur
hausen A, Valet G, Heidelbach U, Kindermann W. Overtraining and immune system:  
  a prospective longitudinal study in endurance athletes. Med Sci Sports Exerc  
  1998;30:1151-7.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#205#201#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00545000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029700078002001200375#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#206#202#article#261#50#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">50. Pedersen BK.    Ac
ute, time-limited exercise stress and the immune system: role of stress hormones
.    In: Maughan RJ, Shirreffs SM, editors. Biochemistry of exercise IX, Aberdee
n,    Scotland: Human Kinetics, 1996:377-82.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#207#203#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00544000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029600078002001200374#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#208#204#article#261#51#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">51. Pedersen BK,    Br
uunsgaard H, Klokker M, Kappel M, MacLean DA, Nielsen HB, et al. Exercise-induce
d    immunomodulation _ Possible roles of neuroendocrine and metabolic factors. 
Int    J Sports Med 1997;18(Suppl 1):S2-S7.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#209#205#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704017800078002001200256#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#210#206#article#261#52#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">52. Nieman DC,    Pede
rsen BK. Exercise and immune function. Recent developments. Sports Med 1999;27:7
3-80.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#211#207#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00556000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704030800078002001200386#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#212#208#article#261#53#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">53. Parry-Billings    
M, Budgett R, Koutedakis Y, Blomstrand E, Brooks S, Williams C, et al. Plasma   
 amino acid concentrations in the overtraining syndrome: possible effects on    
the immune system. Med Sci Sports Exerc 1992;24:1353-8.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#213#209#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00473000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022500078002001200303#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#214#210#article#261#54#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">54. Newsholme EA.    B
iochemical mechanisms to explain immunosuppression in well-trained and overtrain
ed    athletes. Int J Sports Med 1994;15: S142-S147.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#215#211#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00521000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704027300078002001200351#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#216#212#article#261#55#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">55. Keast D, Arstein  
  D, Harper W, Fry RW, Morton AR. Depression of plasma glutamine concentration  
  after exercise stress and its possible influence on the immune system. Med J  
  Aus 1995;162:15-8.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#217#213#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00405000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015700078002001200235#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#218#214#article#261#56#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">56. Mackinnon LT.    I
mmunity in athletes. Int J Sports Med 1997;18(Suppl. 1):S62-S68.    ^cY#v6n3a06.
htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#219#215#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00541000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704029300078002001200371#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#220#216#article#261#57#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">57. Walsh NP, Blannin 
   AK, Clark AM, Cook L, Robson PJ, Gleeson M. The effects of high-intensity int
ermittent    exercise on the plasma concentrations of glutamine and organic acid
s. Eur J    Appl Physiol 1998;77: 434-8.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#221#217#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00474000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022600078002001200304#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#222#218#article#261#58#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">58. Schr&ouml;ck    H,
 Cha CMJ, Goldstein L. Glutamine release from hindlimb and up-take by kidney    
in the acutely acidotic rat. Biochem J 1980;188: 557.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#223#219#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00480000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023200078002001200310#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#224#220#article#261#59#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">59. Rennie MJ,    Edwa
rds RHT, Krywawych S, Davies CT, Halliday D, Waterlow JC, et al. Effect    of ex
ercise on protein turnover in man. Clin Sci 1981;61:627-39.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#225#221#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00473000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022500078002001200303#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#226#222#article#261#60#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">60. Sahlin K, Katz    
A, Broberg S. Tricarboxylic acid cycle intermediates in human muscle during    p
rolonged exercise. Am J Physiol 1990;259: C834-C841.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#227#223#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00552000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704030400078002001200382#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#228#224#article#261#61#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">61. Castell LM,    Poo
rtmans JR, Leclercq R, Brasseur M, Duchateau J, Newsholme EA. Some aspects    of
 the acute phase response after a marathon race, and the effects of glutamine   
 supplementation. Eur J Appl Physiol 1997;75:47-53.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#229#225#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00471000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022300078002001200301#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#230#226#article#261#62#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">62. Walsh NP, Blannin 
   AK, Robson PJ, Glesson M. Glutamine, exercise and immune function. Links and 
   possible mechanisms. Sports Med 1998;26:177-91.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#231#227#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00473000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022500078002001200303#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#232#228#article#261#63#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">63. Rowbottom DG,    K
east D, Morton AR. The emerging role of glutamine as an indicator of exercise   
 stress and overtraining. Sports Med 1996;21: 80-97.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#233#229#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00487000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023900078002001200317#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#234#230#article#261#64#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">64. Falduto MT,    Hic
kson RC, Young AP. Antagonism by glucocorticoids and exercise on expression    o
f glutamine synthetase in skeletal muscle. FASEB J 1989;3:2623-38.    ^cY#v6n3a0
6.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002300075002001200098#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#235#231#article#261# </font>  </p>     ^
cY#v6n3a06.htm##
00484000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704023600078002001200314#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#236#232#article#261#65#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">65. Falduto MT,    You
ng AP, Smyrniotis G, Hickson RC. Reduction of glutamine synthetase mRNA in    hy
pertrophied skeletal muscle. Am J Physiol 1992;262:R1131-R1136.    ^cY#v6n3a06.h
tm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#237#233#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00504000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025600078002001200334#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#238#234#article#261#66#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">66. Newsholme EA,    N
ewsholme P, Curi R. The role of citric acid cycle in cells of the immune system 
   and its importance in sepsis, trauma and burns. Biochem Soc Symp 1987;54:145-
61.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#239#235#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00564000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704031600078002001200394#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#240#236#article#261#67#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">67. Zanker CL,    Swai
ne IL, Castell LM, Newsholme EA. Responses of plasma glutamine, free tryptophan 
   and branched-chain amino acids to prolonged exercise after a regime designed 
   to reduce muscle glycogen. Eur J Appl Physiol 1997;75:543-8.    ^cY#v6n3a06.h
tm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#241#237#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00507000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704025900078002001200337#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#242#238#article#261#68#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">68. Milewski PJ,    Th
relfall CJ, Heath DF, Holbrook JB, Wilford K, Irving MH. Intracellular free    a
mino acids in undernourished patients with and without sepsis. Clin Sci 1982;62:
83-91.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#243#239#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00517000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704026900078002001200347#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#244#240#article#261#69#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">69. Roth E, Funovics  
  J, Muhlbacher F, Schemper M, Mauritz W, Sporn P, et al. Metabolic disorders   
 in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr 
   1982;1:25-41.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#245#241#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00514000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704026600078002001200344#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#246#242#article#261#70#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">70. Powell H, Castell 
   LM, Parry-Billings M, Desborough JP, Hall GM, Newsholme EA. Growth hormone su
ppression    and glutamine flux associated with cardiac surgery. Clin Physiol 19
94;14:569-80.    ^cY#v6n3a06.htm##
00258000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002500075002001200100#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#247#243#article#261#    </font> </p>    
 ^cY#v6n3a06.htm##
00553000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704030500078002001200383#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#248#244#article#261#71#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">71. Jensen GL,    Mill
er RH, Talabiska DG, Fish J, Gianferante L. A double blind, prospective,    rand
omized study of glutamine-enriched with standard peptide-based feeding in    cri
tically ill patients. Am J Clin Nutr 1996;64:615-21.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#249#245#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00468000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022000078002001200298#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#250#246#article#261#72#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">72. Rohde T, MacLean  
  DA, Hartkopp A, Pedersen BK. The immune system and serum glutamine during a   
 triathlon. Eur J Appl Physiol 1996; 74:428-34.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#251#247#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00476000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704022800078002001200306#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#252#248#article#261#73#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">73. Castell LM,    New
sholme EA. The effect of oral glutamine supplementation on athletes after    pro
longed, exhaustive exercise. Nutrition 1997; 13:738-42.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#253#249#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00403000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704015500078002001200233#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#254#250#article#261#74#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">74. Nieman DC.    Imun
e response to heavy exertion. J Appl Physiol 1997;82: 1385-94.    ^cY#v6n3a06.ht
m##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#255#251#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00467000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071888000300075704021900078002001200297#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#p#256#252#article#261#75#<p><f
ont face="Verdana, Arial, Helvetica, sans-serif" size="2">75. Castell LM,    Poo
rtmans JR, Newsholme EA. Does glutamine have a role in reducing infections    in
 athletes? Eur J Appl Physiol 1996;73: 488-90.    ^cY#v6n3a06.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002200075002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#257#253#article#261# </font> </p>     ^c
Y#v6n3a06.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002300075002001200098#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#258#254#article#261#<p>&nbsp; </p>     ^
cY#v6n3a06.htm##
00256000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704002300075002001200098#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#259#255#article#261#<p>&nbsp; </p>     ^
cY#v6n3a06.htm##
00419000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704018600075002001200261#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#260#256#article#261#<p><font face="Verda
na" size="2"><a name="end"></a><a href="#topo"><img src="/img/revistas/rbme/v6n3
/seta.gif" border="0"></a><B>Endere&ccedil;o    para correspond&ecirc;ncia</B>  
  ^cY#v6n3a06.htm##
00283000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704005000075002001200125#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#261#257#article#261#<BR>   Jair Rodrigue
s Garcia J&uacute;nior    ^cY#v6n3a06.htm##
00288000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704005500075002001200130#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#262#258#article#261#<BR>   Av. Prof. Lin
eu Prestes, 1.524, sala 129    ^cY#v6n3a06.htm##
00275000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704004200075002001200117#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#263#259#article#261#<BR>   Cidade Univer
sit&aacute;ria    ^cY#v6n3a06.htm##
00284000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704005100075002001200126#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#264#260#article#261#<BR>   05508-900 &#1
50 S&atilde;o Paulo, SP    ^cY#v6n3a06.htm##
00342000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000800063708000400071704010900075002001200184#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a06.htm#S#p#265#261#article#261#<BR>   E-mail: <a hr
ef="mailto:jgjunior@fisio.icb.usp.br">jgjunior@fisio.icb.usp.br</a></font>  </p>
     ^cY#v6n3a06.htm##
00470000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740120026000920300
01600118065000900134064000500143031000300148014000600151865000900157002001200166
035001000178801001600188#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
266#1#article#75#1#^rND^sBudgett^nR.#Overtraining syndrome^len#Br J Sports Med#1
9900000#1990#24#231-6#20000600#v6n3a06.htm#0306-3674#Br J Sports Med##
00503000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100018000740120048000920300
02100140065000900161064000500170031000300175014000700178865000900185002001200194
035001000206801002100216#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
267#2#article#75#2#^rND^sKuipers^nH.#Training and orvertraining: an introduction
^len#Med Sci Sports Exerc#19980000#1998#30#1137-9#20000600#v6n3a06.htm#0195-9131
#Med Sci Sports Exerc##
00464000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100017000740120031000910300
01100122065000900133064000500142031000200147014000700149865000900156002001200165
035001000177801001100187#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
268#3#article#75#3#^rND^sGordon^nS.#Biology of the macrophages^len#J Cell Sci#19
860000#1986#4#267-86#20000600#v6n3a06.htm#0021-9533#J Cell Sci##
00434000000000241000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720160017000740160016000910180
02700107066000900134062001400143065000900157064000500166865000900171002001200180
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#269#4#article#75#4#^rND^
sStites^nDP#^rND^sTerr^nAL.#Basic human immunology^len#New York#Prentice Hall#19
910000#1991#20000600#v6n3a06.htm##
00583000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100014000740100019000880100
02100107012010300128030002600231710000200257065000900259064000500268031000400273
014000700277865000900284002001200293#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#270#5#article#75#5#^rND^sCuri^nR#^rND^sNewsholme^nP#^rND^sNewsholme^
nEA.#Intracellular distribution of some enzymes of the glutamine utilisation pat
hway in rat lymphocytes^len#Biochem BiophysRes Commun#2#19860000#1986#138#318-32
#20000600#v6n3a06.htm##
00653000000000313000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100019000740100014000930100
02000107010001600127010002100143012008700164030001800251065000900269064000500278
031000300283014000400286865000900290002001200299035001000311801001800321#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#271#6#article#75#6#^rND^sNewshol
me^nP#^rND^sCuri^nR#^rND^sBlomstrand^nE#^rND^sGordon^nS#^rND^sNewsholme^nEA.#Loc
alization and characterization of glutaminase activity in the murine macrophage^
len#Biochem Soc Trans#19870000#1987#16#536#20000600#v6n3a06.htm#0300-5127#Bioche
m Soc Trans##
00614000000000289000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100014000740100019000880100
02100107012012100128030001000249065000900259064000500268031000400273014000600277
865000900283002001200292035001000304801001000314#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#272#7#article#75#7#^rND^sCuri^nR#^rND^sNewsholme^nP#^rND
^sNewsholme^nEA.#Metabolism of pyruvate by isolated rat mesenteric lymphocytes, 
lymphocyte mitochondria and isolated mouse macrophage^len#Biochem J#19880000#198
8#250#383-8#20000600#v6n3a06.htm#0264-6021#Biochem J##
00630000000000301000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100022000740100023000960100
02100119010001500140012009800155030001100253065000900264064000500273031000300278
020000500281865000900286002001200295035001000307801001100317#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#273#8#article#75#8#^rND^sPithon-Curi^nTC#^rN
D^sPires de Melo^nM#^rND^sde Azevedo^nRB#^rND^sCuri^nR.#Glutamine utilisation by
 rat neutrophils. Characterization of phosphate-dependent glutaminase^len#Immuno
logy#19960000#1996#89#R184#20000600#v6n3a06.htm#0019-2805#Immunology##
00661000000000313000450000400050000070200460000570500020005170600020005370000040
00557010002000597090008000617080003000691180002000720100022000740100023000960100
02000119010001600139010001500155012009000170030001300260065000900273064000500282
031000400287014001200291865000900303002001200312035001000324801001300334#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#274#9#article#75#9#^rND^sPithon-
Curi^nTC#^rND^sPires de Melo^nM#^rND^sde Azevedo^nR#^rND^sZorn^nTMT#^rND^sCuri^n
R.#Glutamine utilization by rat neutrophils. Presence of phosphate-dependent glu
taminase^len#Am J Physiol#19970000#1997#273#C1124-C1129#20000600#v6n3a06.htm#000
2-9513#Am J Physiol##
00496000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760120057000970300
01100154065000900165064000500174031000300179014000600182865000900188002001200197
035001000209801001100219#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
275#10#article#75#10#^rND^sDinarello^nCA.#The endogenous pyrogens in host-defens
e interactions^len#Hosp Pract#19890000#1989#24#111-5#20000600#v6n3a06.htm#0018-5
809#Hosp Pract##
00579000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100017000920120
12000109030000900229065000900238064000500247031000300252014000600255865000900261
002001200270035001000282801000900292#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#276#11#article#75#11#^rND^sYaqoob^nP#^rND^sCalder^nP.#Cytokine produ
ction by human peripheral blood mononuclear cells: differential sensitivity to g
lutamine availability^len#Cytokine#19980000#1998#10#790-4#20000600#v6n3a06.htm#1
043-4666#CYTOKINE##
00520000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100021000940120
05100115030001000166065000900176064000500185031000400190014000700194865000900201
002001200210035001000222801001000232#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#277#12#article#75#12#^rND^sArdawi^nMSM#^rND^sNewsholme^nEA.#Glutamin
e metabolism in lymphocytes of the rat^len#Biochem J#19830000#1983#212#835-42#20
000600#v6n3a06.htm#0264-6021#Biochem J##
00629000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100020000930120
14800113030001700261065000900278064000500287031000300292014000800295865000900303
002001200312035001000324801001700334#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#278#13#article#75#13#^rND^sMurphy^nCJ#^rND^sNewsholme^nP.#Importance
 of glutamine metabolism in murine macrophages and human monocytes to L-arginine
 biosynthesis and rates of nitrite or urea production^len#Clin Sci (Colch)#19980
000#1998#95#397-407#20000600#v6n3a06.htm#0143-5221#Clin Sci (Colch)##
00594000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100024000760100015001000100
01700115010002100132012007000153030000700223065000900230064000500239031000400244
014000600248865000900254002001200263035001000275801000700285#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#279#14#article#75#14#^rND^sParry-Billings^nM
#^rND^sEvans^nJ#^rND^sCalder^nPC#^rND^sNewsholme^nEA.#Does glutamine contribute 
to immunosuppression after major burns?^len#Lancet#19900000#1990#336#523-5#20000
600#v6n3a06.htm#0099-5355#Lancet##
00634000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100014000920100
01700106010001500123012010200138030001900240065000900259064000500268031000300273
014000600276865000900282002001200291035001000303801001900313#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#280#15#article#75#15#^rND^sKoyama^nK#^rND^sK
aya^nM#^rND^sTsujita^nJ#^rND^sHori^nS.#Effects of decreased plasma glutamine con
centrations on peripheral lymphocytes proliferation rats^len#Eur J Appl Physiol#
19980000#1998#77#25-31#20000600#v6n3a06.htm#0301-5548#Eur J Appl Physiol##
00620000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100014000760100018000900100
01800108010001700126010001800143012005500161018003500216066001300251062001200264
065000900276064000500285014000700290865000900297002001200306#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#281#16#article#75#16#^rND^sLee^nGR#^rND^sBit
hell^nTC#^rND^sFoerster^nJ#^rND^sAthens^nJW#^rND^sLukens^nJN.#Leukocytes: the ph
agocytic and immunologic systems^len#Wintrobe's clinical hematology^len#Philadel
phia#Lea Febiger#19930000#1993#223-57#20000600#v6n3a06.htm##
00536000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100016000910120
07600107030001000183065000900193064000500202031000400207014000600211865000900217
002001200226035001000238801001000248#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#282#17#article#75#17#^rND^sYang^nKD#^rND^sHill^nHR.#Neutrophil funct
ion disorders: pathophysiology, prevention, and therapy^len#J Pediatr#19910000#1
991#119#43-54#20000600#v6n3a06.htm#0022-3476#J Pediatr##
00557000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100021000920120
11800113030001300231710000200244065000900246064000500255031000300260014000700263
865000900270002001200279#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
283#18#article#75#18#^rND^sLloyd^nAr#^rND^sOppenheim^nJJ.#Poly's lament: the neg
lected role of the polymorphonuclear neutrophil in the afferent limb of the immu
ne response^len#ImmunolToday#2#19920000#1992#13#169-72#20000600#v6n3a06.htm##
00614000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760120092000930160
01400185016001700199018005700216066000900273062001500282065000900297064000500306
020000400311865000900315002001200324#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#284#19#article#75#19#^rND^sAllen^nRC.#Biochemiexcitation: chemilumin
escence and the study of biological oxygenation reactions^len#^rED^sAdam^nW#^rED
^sCilento^nG#Chemical and biological generation of excited states^len#New York#A
cademic Press#19820000#1982#309#20000600#v6n3a06.htm##
00705000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100022000760100023000980100
01800121010001900139010001500158012012700173030001900300065000900319064000500328
031000300333014000500336865000900341002001200350035001000362801001900372#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#285#20#article#75#20#^rND^sPitho
n-Curi^nTC#^rND^sPires de Melo^nM#^rND^sPalanch^nAC#^rND^sMiyasaka^nCK#^rND^sCur
i^nR.#Percentage of phagocytosis, production of O2-, H2O2 and NO and antioxidant
 enzyme activities of rat neutrophils in culture^len#Cell Biochem Funct#19980000
#1998#16#43-9#20000600#v6n3a06.htm#0263-6484#Cell Biochem Funct##
00573000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100018000950120
11300113030000700226065000900233064000500242031000300247014000700250865000900257
002001200266035001000278801000700288#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#286#21#article#75#21#^rND^sSelvaraj^nRJ#^rND^sSbarra^nAJ.#Relationsh
ip of glycolytic and oxidative metabolism to particle entry and destruction in p
hagocytosing cells^len#Nature#19660000#1966#17#1272-6#20000600#v6n3a06.htm#0028-
0836#Nature##
00559000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760120119000940300
01300213065000900226064000500235031000400240014000500244865000900249002001200258
035001000270801001300280#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
287#22#article#75#22#^rND^sLehrer^nRI.#Effects of colchicine and chloramphenicol
 on the oxidative metabolism and phagocytic activity of human neutrophils^len#J 
Infect Dis#19730000#1973#127#40-8#20000600#v6n3a06.htm#0022-1899#J Infect Dis##
00505000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100024000760120067001000300
00800167065000900175064000500184031000300189014000800192865000900200002001200209
035001000221801000800231#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
288#23#article#75#23#^rND^sJohnston Jr.^nRB.#Oxigen metabolism and the microbici
dal activity of macrophages^len#FASEB J#19780000#1978#37#2756-64#20000600#v6n3a0
6.htm#0892-6638#FASEB j##
00535000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100017000950120
06300112030001400175065000900189064000500198031000300203014000600206865000900212
002001200221035001000233801001400243#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#289#24#article#75#24#^rND^sBoregaard^nN#^rND^sHerlin^nT.#Energy meta
bolism of human neutrophils during phagocytosis^len#J Clin Invest#19820000#1982#
70#550-7#20000600#v6n3a06.htm#0021-9738#J Clin Invest##
00720000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100014000760100019000900100
02200109010002300131010001600154010003500170810000700205012007600212030002000288
06500090030806400050031703100030032201400060032586500090033100200120034003500100
0352801002000362#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#290#25#a
rticle#75#25#^rND^sCuri^nR#^rND^sNewsholme^nP#^rND^sPithon-Curi^nTC#^rND^sPires-
de-Melo^nM#^rND^sGarcia^nC#^rND^sHomem-de-Bittencourt Jr.^nPI#et al.#Metabolic f
ate of glutamine in lymphocytes, macrophages and neutrophils^len#Braz J Med Biol
 Res#19990000#1999#32#15-21#20000600#v6n3a06.htm#0100-879X#Braz J Med Biol Res##
00664000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100014000950100
02200109010001700131010001600148010001600164012010800180030001500288710000200303
065000900305064000500314031000300319014000700322865000900329002001200338#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#291#26#article#75#26#^rND^sNewsh
olme^nP#^rND^sCuri^nR#^rND^sPithon-Curi^nTC#^rND^sMurphy^nCJ#^rND^sGarcia^nC#^rN
D^sMelo^nMP.#Glutamine metabolism by lymphocytes, macrophages, and neutrophils: 
its importance in health and disease^len#J Nutr Biochem#2#19990000#1999#10#316-2
4#20000600#v6n3a06.htm##
00548000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100020000910120
06900111030001900180065000900199064000500208031000300213014000400216865000900220
002001200229035001000241801001900251#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#292#27#article#75#27#^rND^sHume^nDA#^rND^sWeidemann^nMJ#Role and reg
ulation of glucose metabolism in proliferating cells^len#J Natl Cancer Inst#1979
0000#1979#62#3-8#20000600#v6n3a06.htm#0027-8874#J Natl Cancer Inst##
00682000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100024000760100018001000100
02200118010001400140010001400154010001500168810000600183012007300189030001400262
06500090027606400050028503100030029001400060029386500090029900200120030803500100
0320801001400330#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#293#28#a
rticle#75#28#^rND^sParry-Billings^nM#^rND^sLeighton^nB#^rND^sDimitriadis^nGD#^rN
D^sCuri^nR#^rND^sBond^nJ#^rND^sBevan^nS#et al#The effect of tumour bearing on sk
eletal muscle glutamine metabolism^len#Int J Biochem#19910000#1991#23#933-7#2000
0600#v6n3a06.htm#0020-711X#Int J Biochem##
00673000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760100014000970100
01400111010002200125012012900147030002000276065000900296064000500305031000300310
014000700313865000900320002001200329035001000341801002000351#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#294#29#article#75#29#^rND^sDos-Santos^nMA#^r
ND^sRosa^nR#^rND^sCuri^nR#^rND^sBarbieri^nDHGP.#Effect of protein malnutrition o
n the glycolytic and glutaminolytic enzyme activity of rat thymus and mesenteric
 lymph nodes^len#Braz J Med Biol Res#19970000#1997#30#719-22#20000600#v6n3a06.ht
m#0100-879X#Braz J Med Biol Res##
00496000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100015000960120
06400111030000900175710000200184065000900186064000500195031000200200014000700202
865000900209002001200218#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
295#30#article#75#30#^rND^sFernandes^nLC#^rND^sCuri^nR.#Reversion of Walker 256 
tumor cachexia by insulin treatment^len#Cancer J#2#19970000#1997#4#465-74#200006
00#v6n3a06.htm##
00710000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100022000920100
01800114010002300132010001900155010001500174012010600189030001700295065000900312
06400050032103100030032601400070032986500090033600200120034503500100035780100170
0367#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#296#31#article#75#31
#^rND^sGarcia^nC#^rND^sPithon-Curi^nTC#^rND^sFirmano^nML#^rND^sPires-de-Melo^nM#
^rND^sNewsholme^nP#^rND^sCuri^nR.#Effect of adrenaline on glucose and glutamine 
metabolism and superoxide production by rat neutrophils^len#Clin Sci (Colch)#199
90000#1999#96#549-55#20000600#v6n3a06.htm#0143-5221#Clin Sci (Colch)##
00455000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760120050000930300
01500143710000200158065000900160064000500169031000200174014000400176865000900180
002001200189#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#297#32#artic
le#75#32#^rND^sSouba^nWW.#Intestinal glutamine metabolism and nutrition^len#J Nu
tr Biochem#2#19930000#1993#4#2-9#20000600#v6n3a06.htm##
00578000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760120143000930300
01000236065000900246064000500255031000300260014000800263865000900271002001200280
035001000292801001000302#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
298#33#article#75#33#^rND^sKrebs^nHA.#Metabolism of aminoacids. The synthesis of
 glutamine from glutamic acid and ammonia, and enzimic hydrolysis of glutamine i
n animal tissues^len#Biochem J#19350000#1935#29#1951-69#20000600#v6n3a06.htm#026
4-6021#Biochem J##
00566000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760100014000970100
02100111012006900132030001000201065000900211064000500220031000400225014000600229
865000900235002001200244035001000256801001000266#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#299#34#article#75#34#^rND^sKowalchuck^nJM#^rND^sCuri^nR#
^rND^sNewsholme^nEA.#Glutamine metabolism in isolated incubated adipocytes of th
e rat^len#Biochem J#19880000#1988#249#705-8#20000600#v6n3a06.htm#0264-6021#Bioch
em J##
00585000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100014000760100021000900120
14700111030001600258710000200274065000900276064000500285031000300290014000500293
865000900298002001200307#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
300#35#article#75#35#^rND^sCuri^nR#^rND^sNewsholme^nEA.#The effect of adenine nu
cleotides on the rate fate of glutamine utilization by incubated mitochondria is
olated from rat mesenteric lymph nodes^len#Mol Cel Biochem#2#19890000#1989#86#7l
-6#20000600#v6n3a06.htm##
00584000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100014000920100
01800106010001500124012007100139030000900210065000900219064000500228031000300233
014000600236865000900242002001200251035001000263801000900273#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#301#36#article#75#36#^rND^sFryan^nKN#^rND^sK
han^nK#^rND^sCoppack^nSW#^rND^sElia^nM.#Amino acid metabolism in human subcutane
ous adipose tissue in vivo^len#Clin Sci#19910000#1991#80#471-4#20000600#v6n3a06.
htm#0009-9287#Clin Sci##
00531000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100019000960120
04100115030002100156065000900177064000500186031000300191014000700194865000900201
002001200210035001000222801002100232#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#302#37#article#75#37#^rND^sGastmann^nUAL#^rND^sLehmann^nMJ.#Overtrai
ning and the BCAA hypothesis^len#Med Sci Sports Exerc#19980000#1998#30#1173-8#20
000600#v6n3a06.htm#0195-9131#Med Sci Sports Exerc##
00701000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100015000930100
01900108010001800127010001600145010001500161810000700176012009800183030001400281
06500090029506400050030403100030030901400060031286500090031800200120032703500100
0339801001400349#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#303#38#a
rticle#75#38#^rND^sNurjhan^nN#^rND^sBucci^nA#^rND^sPerriello^nG#^rND^sStumvoll^n
M#^rND^sDailey^nG#^rND^sBier^nDM#et al.#Glutamine: a major gluconeogenic precurs
or and vehicle for interorgan carbon transport in man^len#J Clin Invest#19950000
#1995#95#272-7#20000600#v6n3a06.htm#0021-9738#J Clin Invest##
00549000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100018000940100
01800112012005500130030000900185065000900194064000500203031000300208014000800211
865000900219002001200228035001000240801000900250#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#304#39#article#75#39#^rND^sHankard^nRG#^rND^sHaymond^nMW
#^rND^sDarmaun^nD.#Role of glutamine as a precursor in fasting humans^len#Diabet
es#19970000#1997#46#1535-41#20000600#v6n3a06.htm#0012-1797#Diabetes##
00410000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160020000760180024000960660
01000120062001500130065000900145064000500154865000900159002001200168#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#305#40#article#75#40#^rED^sHargreave
s^nM#Exercise metabolism^len#Champaign#Human Kinetics#19950000#1995#20000600#v6n
3a06.htm##
00459000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160020000760160017000960180
04200113066000900155062001800164065000900182064000500191865000900196002001200205
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#306#41#article#75#41#^rN
D^sNewsholme^nEA#^rND^sLeech^nAR.#Biochemistry for the medical sciences^len#New 
York#John Wiley & Sons#19830000#1983#20000600#v6n3a06.htm##
00520000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760120075000970300
01300172065000900185064000500194031000300199014000800202865000900210002001200219
035001000231801001300241#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
307#42#article#75#42#^rND^sHenriksson^nJ.#Effect of training and nutrition on th
e development of skeletal muscle^len#J Sports Sci#19950000#1995#13#S25-S30#20000
600#v6n3a06.htm#0264-0414#J Sports Sci##
00508000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730160020000760160015000960160
01800111018006100129066001100190062001800201065000900219064000500228865000900233
002001200242#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#308#43#artic
le#75#43#^rND^sNewsholme^nEA#^rND^sLeech^nT#^rND^sDuester^nG.#Keep on running: t
he science of training and performance^len#Chichester#John Wiley & Sons#19940000
#1994#20000600#v6n3a06.htm##
00546000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100017000960120
07200113030001400185065000900199064000500208031000300213014000700216865000900223
002001200232035001000244801001400254#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#309#44#article#75#44#^rND^sMacDonald^nIA#^rND^sWebber^nJ.#Feeding, f
asting and starvation: factors affecting fuel utilization^len#Proc Nutr Soc#1995
0000#1995#54#267-74#20000600#v6n3a06.htm#0029-6651#Proc Nutr Soc##
00563000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100023000760120102000990300
02000201065000900221064000500230031000300235014000800238865000900246002001200255
035001000267801002000277#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
310#45#article#75#45#^rND^sWagenmakers^nAJ.#Muscle amino acid metabolism at rest
 and during exercise: role in human physiology and metabolism^len#Exerc Sport Sc
i Rev#19980000#1998#26#287-314#20000600#v6n3a06.htm#0091-6331#Exerc Sport Sci Re
v##
00489000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760120046000950300
01300141065000900154064000500163031000300168014000800171865000900179002001200188
035001000200801001300210#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
311#46#article#75#46#^rND^sEichner^nER.#Overtraining: consequences and preventio
n^len#J Sports Sci#19950000#1995#13#S41-S48#20000600#v6n3a06.htm#0264-0414#J Spo
rts Sci##
00534000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100021000930120
06300114030001200177065000900189064000500198031000300203014000700206865000900213
002001200222035001000234801001200244#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#312#47#article#75#47#^rND^sSharp^nNCC#^rND^sKoutedakis^nY.#Sport and
 the overtraining syndrome: immunological aspects^len#Br Med Bull#19920000#1992#
48#518-33#20000600#v6n3a06.htm#0007-1420#Br Med Bull##
00654000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100015000960100
01700111010001800128012011500146030001900261065000900280064000500289031000300294
020000500297865000900302002001200311035001000323801001900333#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#313#48#article#75#48#^rND^sRowbottom^nDG#^rN
D^sKeast^nD#^rND^sGoodman^nC#^rND^sMorton^nAR.#The haematological, biochemical a
nd immunological profile of athletes suffering from the overtraining syndrome^le
n#Eur J Appl Physiol#19950000#1995#70#5029#20000600#v6n3a06.htm#0301-5548#Eur J 
Appl Physiol##
00671000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100018000950100
01500113010002000128010002100148012009100169030002100260065000900281064000500290
031000300295014000700298865000900305002001200314035001000326801002100336#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#314#49#article#75#49#^rND^sGabri
el^nHHW#^rND^sUrhausen^nA#^rND^sValet^nG#^rND^sHeidelbach^nU#^rND^sKindermann^nW
.#Overtraining and immune system: a prospective longitudinal study in endurance 
athletes^len#Med Sci Sports Exerc#19980000#1998#30#1151-7#20000600#v6n3a06.htm#0
195-9131#Med Sci Sports Exerc##
00606000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760120087000950160
01800182016002000200018004200220066000900262062001500271065000900286064000500295
014000700300865000900307002001200316#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#315#50#article#75#50#^rND^sPedersen^nBK#Acute, time-limited exercise
 stress and the immune system: role of stress hormones^len#^rED^sMaughan^nRJ#^rE
D^sShirreffs^nSM#Biochemistry of exercise IX, Aberdeen^len#Scotland#Human Kineti
cs#19960000#1996#377-82#20000600#v6n3a06.htm##
00727000000000349000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100021000950100
01700116010001600133010001800149010001800167810000700185012009500192030001700287
06500090030406400050031303100030031803200020032101400060032386500090032900200120
0338035001000350801001700360#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#
S#c#316#51#article#75#51#^rND^sPedersen^nBK#^rND^sBruunsgaard^nH#^rND^sKlokker^n
M#^rND^sKappel^nM#^rND^sMacLean^nDA#^rND^sNielsen^nHB#et al.#Exercise-induced im
munomodulation _ Possible roles of neuroendocrine and metabolic factors^len#Int 
J Sports Med#19970000#1997#18#1#S2-S7#20000600#v6n3a06.htm#0172-4622#Int J sport
s Med##
00521000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100020000930120
05400113030001100167065000900178064000500187031000300192014000600195865000900201
002001200210035001000222801001100232#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#317#52#article#75#52#^rND^sNieman^nDC#^rND^sPedersen^nBK.#Exercise a
nd immune function. Recent developments^len#Sports Med#19990000#1999#27#73-80#20
000600#v6n3a06.htm#0112-1642#Sports Med##
00738000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100024000760100017001000100
02000117010002000137010001600157010001800173810000700191012010500198030002100303
06500090032406400050033303100030033801400070034186500090034800200120035703500100
0369801002100379#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#318#53#a
rticle#75#53#^rND^sParry-Billings^nM#^rND^sBudgett^nR#^rND^sKoutedakis^nY#^rND^s
Blomstrand^nE#^rND^sBrooks^nS#^rND^sWilliams^nC#et al.#Plasma amino acid concent
rations in the overtraining syndrome: possible effects on the immune system^len#
Med Sci Sports Exerc#19920000#1992#24#1353-8#20000600#v6n3a06.htm#0195-9131#Med 
Sci Sports Exerc##
00552000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760120097000970300
01700194065000900211064000500220031000300225014001000228865000900238002001200247
035001000259801001700269#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
319#54#article#75#54#^rND^sNewsholme^nEA.#Biochemical mechanisms to explain immu
nosuppression in well-trained and overtrained athletes^len#Int J Sports Med#1994
0000#1994#15#S142-S147#20000600#v6n3a06.htm#0172-4622#Int J sports Med##
00633000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100017000910100
01600108010001400124010001800138012011900156030001000275710000200285065000900287
064000500296031000400301014000500305865000900310002001200319#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#320#55#article#75#55#^rND^sKeast^nD#^rND^sAr
stein^nD#^rND^sHarper^nW#^rND^sFry^nRW#^rND^sMorton^nAR.#Depression of plasma gl
utamine concentration after exercise stress and its possible influence on the im
mune system^len#Med J Aus#2#19950000#1995#162#15-8#20000600#v6n3a06.htm##
00494000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100021000760120025000970300
01700122065000900139064000500148031000300153032000400156014000800160865000900168
002001200177035001000189801001700199#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#321#56#article#75#56#^rND^sMackinnon^nLT.#Immunity in athletes^len#I
nt J Sports Med#19970000#1997#18#^s1#S62-S68#20000600#v6n3a06.htm#0172-4622#Int 
J sports Med##
00709000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100018000920100
01600110010001400126010001700140010001800157012011600175030001900291065000900310
06400050031903100030032401400060032786500090033300200120034203500100035480100190
0364#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#322#57#article#75#57
#^rND^sWalsh^nNP#^rND^sBlannin^nAK#^rND^sClark^nAM#^rND^sCook^nL#^rND^sRobson^nP
J#^rND^sGleeson^nM.#The effects of high-intensity intermittent exercise on the p
lasma concentrations of glutamine and organic acids^len#Eur J Appl Physiol#19980
000#1998#77#434-8#20000600#v6n3a06.htm#0301-5548#Eur J Appl Physiol##
00577000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100015000930100
02000108012008600128030001000214065000900224064000500233031000400238014000400242
865000900246002001200255035001000267801001000277#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#323#58#article#75#58#^rND^sSchröck^nH#^rND^sCha^nCMJ#^rN
D^sGoldstein^nL.#Glutamine release from hindlimb and up-take by kidney in the ac
utely acidotic rat^len#Biochem J#19800000#1980#188#557#20000600#v6n3a06.htm#0264
-6021#Biochem J##
00653000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100019000930100
01900112010001700131010001800148010001900166810000700185012005000192030000900242
06500090025106400050026003100030026501400070026886500090027500200120028403500100
0296801000900306#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#324#59#a
rticle#75#59#^rND^sRennie^nMJ#^rND^sEdwards^nRHT#^rND^sKrywawych^nS#^rND^sDavies
^nCT#^rND^sHalliday^nD#^rND^sWaterlow^nJC#et al.#Effect of exercise on protein t
urnover in man^len#Clin Sci#19810000#1981#61#627-39#20000600#v6n3a06.htm#0009-92
87#Clin Sci##
00584000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100014000920100
01800106012008500124030001300209065000900222064000500231031000400236014001000240
865000900250002001200259035001000271801001300281#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#325#60#article#75#60#^rND^sSahlin^nK#^rND^sKatz^nA#^rND^
sBroberg^nS.#Tricarboxylic acid cycle intermediates in human muscle during prolo
nged exercise^len#Am J Physiol#19900000#1990#259#C834-C841#20000600#v6n3a06.htm#
0002-9513#Am J Physiol##
00721000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100020000940100
01800114010001800132010001900150010002100169012011300190030001900303065000900322
06400050033103100030033601400060033986500090034500200120035403500100036680100190
0376#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#326#61#article#75#61
#^rND^sCastell^nLM#^rND^sPoortmans^nJR#^rND^sLeclercq^nR#^rND^sBrasseur^nM#^rND^
sDuchateau^nJ#^rND^sNewsholme^nEA.#Some aspects of the acute phase response afte
r a marathon race, and the effects of glutamine supplementation^len#Eur J Appl P
hysiol#19970000#1997#75#47-53#20000600#v6n3a06.htm#0301-5548#Eur J Appl Physiol#
#
00599000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100018000920100
01700110010001800127012007500145030001100220065000900231064000500240031000300245
014000700248865000900255002001200264035001000276801001100286#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#327#62#article#75#62#^rND^sWalsh^nNP#^rND^sB
lannin^nAK#^rND^sRobson^nPJ#^rND^sGlesson^nM.#Glutamine, exercise and immune fun
ction. Links and possible mechanisms^len#Sports Med#19980000#1998#26#177-91#2000
0600#v6n3a06.htm#0112-1642#Sports Med##
00582000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100015000960100
01800111012008700129030001100216065000900227064000500236031000300241014000600244
865000900250002001200259035001000271801001100281#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#328#63#article#75#63#^rND^sRowbottom^nDG#^rND^sKeast^nD#
^rND^sMorton^nAR.#The emerging role of glutamine as an indicator of exercise str
ess and overtraining^len#Sports Med#19960000#1996#21#80-97#20000600#v6n3a06.htm#
0112-1642#Sports Med##
00594000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100018000940100
01700112012010400129030000800233065000900241064000500250031000200255014000800257
865000900265002001200274035001000286801000800296#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#329#64#article#75#64#^rND^sFalduto^nMT#^rND^sHickson^nRC
#^rND^sYoung^nAP.#Antagonism by glucocorticoids and exercise on expression of gl
utamine synthetase in skeletal muscle^len#FASEB J#19890000#1989#3#2623-38#200006
00#v6n3a06.htm#0892-6638#FASEB j##
00614000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100016000940100
02000110010001900130012007600149030001300225065000900238064000500247031000400252
014001200256865000900268002001200277035001000289801001300299#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#330#65#article#75#65#^rND^sFalduto^nMT#^rND^
sYoung^nAP#^rND^sSmyrniotis^nG#^rND^sHickson^nRC.#Reduction of glutamine synthet
ase mRNA in hypertrophied skeletal muscle^len#Am J Physiol#19920000#1992#262#R11
31-R1136#20000600#v6n3a06.htm#0002-9513#Am J Physiol##
00620000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100020000760100019000960100
01500115012011100130030001700241065000900258064000500267031000300272014000700275
865000900282002001200291035001000303801001700313#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#331#66#article#75#66#^rND^sNewsholme^nEA#^rND^sNewsholme
^nP#^rND^sCuri^nR.#The role of citric acid cycle in cells of the immune system a
nd its importance in sepsis, trauma and burns^len#Biochem Soc Symp#19870000#1987
#54#145-61#20000600#v6n3a06.htm#0067-8694#Biochem Soc Symp##
00697000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100017000930100
01800110010002100128012015400149030001900303065000900322064000500331031000300336
014000600339865000900345002001200354035001000366801001900376#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#332#67#article#75#67#^rND^sZanker^nCL#^rND^s
Swaine^nIL#^rND^sCastell^nLM#^rND^sNewsholme^nEA.#Responses of plasma glutamine,
 free tryptophan and branched-chain amino acids to prolonged exercise after a re
gime designed to reduce muscle glycogen^len#Eur J Appl Physiol#19970000#1997#75#
543-8#20000600#v6n3a06.htm#0301-5548#Eur J Appl Physiol##
00669000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100019000760100020000950100
01600115010001900131010001700150010001800167012008600185030000900271065000900280
06400050028903100030029401400060029786500090030300200120031203500100032480100090
0334#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#333#68#article#75#68
#^rND^sMilewski^nPJ#^rND^sThrelfall^nCJ#^rND^sHeath^nDF#^rND^sHolbrook^nJB#^rND^
sWilford^nK#^rND^sIrving^nMH.#Intracellular free amino acids in undernourished p
atients with and without sepsis^len#Clin Sci#19820000#1982#62#83-91#20000600#v6n
3a06.htm#0009-9287#Clin Sci##
00688000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100014000760100018000900100
02000108010001800128010001700146010001500163810000700178012009200185030001000277
06500090028706400050029603100020030101400060030386500090030900200120031803500100
0330801001000340#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#334#69#a
rticle#75#69#^rND^sRoth^nE#^rND^sFunovics^nJ#^rND^sMuhlbacher^nF#^rND^sSchemper^
nM#^rND^sMauritz^nW#^rND^sSporn^nP#et al.#Metabolic disorders in severe abdomina
l sepsis: glutamine deficiency in skeletal muscle^len#Clin Nutr#19820000#1982#1#
25-41#20000600#v6n3a06.htm#0261-5614#Clin Nutr##
00680000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100016000760100018000920100
02400110010002100134010001500155010002100170012008200191030001300273065000900286
06400050029503100030030001400070030386500090031000200120031903500100033180100130
0341#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#335#70#article#75#70
#^rND^sPowell^nH#^rND^sCastell^nLM#^rND^sParry-Billings^nM#^rND^sDesborough^nJP#
^rND^sHall^nGM#^rND^sNewsholme^nEA.#Growth hormone suppression and glutamine flu
x associated with cardiac surgery^len#Clin Physiol#19940000#1994#14#569-80#20000
600#v6n3a06.htm#0144-5979#Clin Physiol##
00700000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100017000760100017000930100
02000110010001400130010002200144012013500166030001500301065000900316064000500325
031000300330014000700333865000900340002001200349035001000361801001500371#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#336#71#article#75#71#^rND^sJense
n^nGL#^rND^sMiller^nRH#^rND^sTalabiska^nDG#^rND^sFish^nJ#^rND^sGianferante^nL.#A
 double blind, prospective, randomized study of glutamine-enriched with standard
 peptide-based feeding in critically ill patients^len#Am J Clin Nutr#19960000#19
96#64#615-21#20000600#v6n3a06.htm#0002-9165#Am J Clin Nutr##
00603000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100015000760100018000910100
01800109010002000127012006100147030001900208065000900227064000500236031000300241
014000700244865000900251002001200260035001000272801001900282#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a06.htm#S#c#337#72#article#75#72#^rND^sRohde^nT#^rND^sMa
cLean^nDA#^rND^sHartkopp^nA#^rND^sPedersen^nBK.#The immune system and serum glut
amine during a triathlon^len#Eur J Appl Physiol#19960000#1996#74#428-34#20000600
#v6n3a06.htm#0301-5548#Eur J Appl Physiol##
00566000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100021000940120
09800115030001000213065000900223064000500232031000300237014000700240865000900247
002001200256035001000268801001000278#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a06.htm#S#c#338#73#article#75#73#^rND^sCastell^nLM#^rND^sNewsholme^nEA.#The effe
ct of oral glutamine supplementation on athletes after prolonged, exhaustive exe
rcise^len#Nutrition#19970000#1997#13#738-42#20000600#v6n3a06.htm#0029-6600#Nutri
tion##
00483000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760120037000940300
01500131065000900146064000500155031000300160014000800163865000900171002001200180
035001000192801001500202#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a06.htm#S#c#
339#74#article#75#74#^rND^sNieman^nDC.#Imune response to heavy exertion^len#J Ap
pl Physiol#19970000#1997#82#1385-94#20000600#v6n3a06.htm#0021-8987#J Appl Physio
l##
00585000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090008000627080003000701180003000730100018000760100020000940100
02100114012006700135030001900202065000900221064000500230031000300235014000700238
865000900245002001200254035001000266801001900276#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a06.htm#S#c#340#75#article#75#75#^rND^sCastell^nLM#^rND^sPoortmans^n
JR#^rND^sNewsholme^nEA.#Does glutamine have a role in reducing infections in ath
letes?^len#Eur J Appl Physiol#19960000#1996#73#488-90#20000600#v6n3a06.htm#0301-
5548#Eur J Appl Physiol##
00268000000000169000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640910009000660920007000750020012000827030
00400094#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#o#1#1#text#1#20110
314#125825#v6n3a07.htm#306##
00866000000000409000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000400084121000300088049000800091158000300099030002100102
03100020012303200020012506500090012701400110013603500100014712300020015701200500
01590100037002090100040002460700048002860700101003341170006004350720003004410020
01200444#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#h#2#1#text#1#ra#pt
#br1.1#1#4.0#TAB#07#RBME120#nd#Rev Bras Med Esporte#6#3#20000600#^f108^l114#1517
-8692#1#Anemia do atleta (I): fisiopatologia do ferro^lpt#^rND^1A01^nRamón José 
Nuviala^sMateo#^rND^1A02^nMaría Gloria Lapieza^sLaínez#Hospital Clínico Universi
tário de Zaragoza^iA01#Faculdade de Medicina de Zaragoza^iA02^1Departamento de F
armacologia e Fisiologia^sZaragoza^pEspanha#other#70#v6n3a07.htm##
00880000000000409000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640710003000660400003000690010006000720420
00200078120000400080038000400084121000300088049000800091158000300099030002100102
03100020012303200020012506500090012701400110013603500100014712300020015701200640
01590100037002230100040002600700048003000700101003481170006004490720003004550020
01200458#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#f#3#1#text#1#ra#pt
#br1.1#1#4.0#TAB#07#RBME120#nd#Rev Bras Med Esporte#6#3#20000600#^f108^l114#1517
-8692#1#<b>Anemia do atleta (I)</b>: <b>fisiopatologia do ferro</b>^lpt#^rND^1A0
1^nRamón José Nuviala^sMateo#^rND^1A02^nMaría Gloria Lapieza^sLaínez#Hospital Cl
ínico Universitário de Zaragoza^iA01#Faculdade de Medicina de Zaragoza^iA02^1Dep
artamento de Farmacologia e Fisiologia^sZaragoza^pEspanha#other#70#v6n3a07.htm##
00999000000000433000450000400050000070200460000570500020005170600020005370000020
00557010002000577090005000597080002000640640013000660710003000790400003000820010
00600085042000200091120000400093038000400097121000300101049000800104158000300112
03000240011503100020013903200020014106500090014301400110015203500100016312300020
01730120050001750100037002250100040002620700050003020700103003521170006004550720
00300461002001200464008008900476#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.
htm#S#l#4#1#text#1#^mjun.^a2000#ra#pt#br1.1#1#4.0#tab#07#RBME120#nd#Rev. bras. m
ed. esporte#6#3#20000600#^f108^l114#1517-8692#1#Anemia do atleta (I): fisiopatol
ogia do ferro^lpt#^rND^1A01^nRamón José Nuviala^sMateo#^rND^1A02^nMaría Gloria L
apieza^sLaínez#^iA01^1Hospital Clínico Universitário de Zaragoza#^iA02^1Faculdad
e de Medicina de Zaragoza^2Departamento de Farmacologia e Fisiologia^sZaragoza^p
Espanha#other#70#v6n3a07.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sc
i_arttext&pid=S1517-86922000000300007##
00345000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704011900068002001200187#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#5#1#text#232#<p align="right"><font size
="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO    DE REVIS&Atilde;O
</b>    ^cY#v6n3a07.htm##
00297000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704007100068002001200139#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#6#2#text#232#<br>   <b>ARCHIVOS    DE ME
DICINA DEL DEPORTE</b></font></p>       ^cY#v6n3a07.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704002300068002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#7#3#text#232#<p>&nbsp;</p>      ^cY#v6n3
a07.htm##
00384000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704015800068002001200226#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#8#4#text#232#<p><font size="4" face="Ver
dana, Arial, Helvetica, sans-serif"><b><a name="topo"></a>Anemia    do atleta (I
): fisiopatologia do ferro</b></font> </p>     ^cY#v6n3a07.htm##
00249000000000145000450000400050000070200460000570500020005170600020005370000020
0055701000200057709000500059708000400064704002300068002001200091#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#9#5#text#232#<p>&nbsp; </p>     ^cY#v6n3
a07.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000400065704002300069002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#10#6#text#232#<p>&nbsp; </p>     ^cY#v6n
3a07.htm##
00426000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000400065704019900069002001200268#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#11#7#text#232#<p><font size="2" face="Ve
rdana, Arial, Helvetica, sans-serif"><b>Ram&oacute;n    Jos&eacute; Nuviala Mate
o<sup>I</sup>; Mar&iacute;a Gloria Lapieza La&iacute;nez<sup>II</sup></b></font>
</p>     ^cY#v6n3a07.htm##
00424000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000400065704019700069002001200266#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#12#8#text#232#<p><font size="2" face="Ve
rdana, Arial, Helvetica, sans-serif"><sup>I</sup>Servi&ccedil;o    de Bioqu&iacu
te;mica Cl&iacute;nica, Hospital Cl&iacute;nico Universit&aacute;rio    de Zarag
oza    ^cY#v6n3a07.htm##
00434000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000200058709000500060708000400065704020700069002001200276#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#13#9#text#232#<br>   </font><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><sup>II</sup>Departamento    de 
Farmacologia e Fisiologia, Faculdade de Medicina de Zaragoza, Zaragoza, Espanha<
/font>  </p>     ^cY#v6n3a07.htm##
00344000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704011600070002001200186#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#14#10#text#232#<p><font face="Verdana" s
ize="2"><a href="#end">Endere&ccedil;o para correspond&ecirc;ncia</a></font>  </
p>     ^cY#v6n3a07.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#15#11#text#232#<p>&nbsp;</p>     ^cY#v6n
3a07.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#16#12#text#232#<p>&nbsp; </p>     ^cY#v6
n3a07.htm##
00369000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704014100070002001200211#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#17#13#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif"><B><font size="3">INTRODU&Ccedil;&Atilde;O
</font></B>    </font> </p>     ^cY#v6n3a07.htm##
01171000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704094300070002001201013#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#18#14#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Os estados deficit&aacute;rios    de ferro
 (Fe) representam a car&ecirc;ncia mineral mais freq&uuml;ente no ser    humano.
 Estima-se que mais de 500 milh&otilde;es de indiv&iacute;duos sejam    portador
es de anemia por defici&ecirc;ncia de Fe<SUP>1</SUP>, embora dados mais    recen
tes elevem essa estimativa at&eacute; 600 a 700 milh&otilde;es de indiv&iacute;d
uos<SUP>2</SUP>.    Esses estados carenciais n&atilde;o s&atilde;o exclusivos de
 pa&iacute;ses subdesenvolvidos    ou em desenvolvimento, j&aacute; que tamb&eac
ute;m est&atilde;o presentes embora    em menor preval&ecirc;ncia nos pa&iacute;
ses industrializados. Na Espanha, em    um estudo realizado com a popula&ccedil;
&atilde;o adulta da regi&atilde;o de    Cantabria, demonstrou-se que a preval&ec
irc;ncia de ferropenia era de 1,1% no    sexo masculino e de 20,5% no sexo femin
ino<SUP>3</SUP>. </font> </p>     ^cY#v6n3a07.htm##
00746000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704051800070002001200588#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#19#15#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">A defici&ecirc;ncia    de Fe chegou inclus
ive a ser tema de um estudo em Medicina do Trabalho, tendo    sido descritas rel
a&ccedil;&otilde;es expressivas entre os n&iacute;veis de    hemoglobina e a pro
dutividade no trabalho<SUP>4,5</SUP>. Este fato fez com que    alguns pa&iacute;
ses tomassem medidas oficiais, como a adi&ccedil;&atilde;o    de sais de Fe em a
lguns alimentos b&aacute;sicos, como a farinha de trigo<SUP>6</SUP>.    </font> 
</p>     ^cY#v6n3a07.htm##
01296000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704106800070002001201138#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#20#16#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">No atleta, este    problema adquire uma ou
tra dimens&atilde;o, j&aacute; que as perdas corporais    habituais se somam &ag
rave;s produzidas pela atividade f&iacute;sica intensa.    Dessa forma, n&atilde
;o parece estranho que com relativa freq&uuml;&ecirc;ncia    os atletas, princip
almente do sexo feminino, encaminhem-se a servi&ccedil;os    m&eacute;dicos refe
rindo quadros de astenia, dificuldade para treinar normalmente    e, em &uacute;
ltima inst&acirc;ncia, uma clara queda do rendimento desportivo<SUP>7</SUP>.    
Algumas dessas situa&ccedil;&otilde;es s&atilde;o conseq&uuml;entes a simples   
 estados deficit&aacute;rios de Fe que comprometem de modo importante as rea&cce
dil;&otilde;es    metab&oacute;licas implicadas diretamente na produ&ccedil;&ati
lde;o de energia<SUP>8,9</SUP>,    enquanto que em outros casos se observam quad
ros de franca anemia<SUP>10,11</SUP>,    processo que j&aacute; h&aacute; muito 
foi reconhecido como <I>anemia do atleta</I><SUP>12</SUP>.    </font> </p>     ^
cY#v6n3a07.htm##
00748000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704052000070002001200590#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#21#17#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">O conhecimento    por parte do m&eacute;di
co dessas situa&ccedil;&otilde;es pode nos levar &agrave;    preven&ccedil;&atil
de;o de tais quadros em atletas nos seus est&aacute;gios    mais iniciais e ao e
stabelecimento de medidas corretoras dos estados deficit&aacute;rios    de Fe, c
om especial &ecirc;nfase na quest&atilde;o nutricional. Pela import&acirc;ncia  
  do tema, pareceu-nos relevante realizar uma revis&atilde;o do assunto. </font>
  </p>     ^cY#v6n3a07.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#22#18#text#232#<p>&nbsp; </p>     ^cY#v6
n3a07.htm##
00338000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704011000070002001200180#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#23#19#text#232#<p> <font size="3" face="
Verdana, Arial, Helvetica, sans-serif"><B>O FERRO (Fe)</B></font>  </p> <B>     
 ^cY#v6n3a07.htm##
00345000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704011700070002001200187#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#24#20#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Distribui&ccedil;&atilde;o</font>  </p> </
B>      ^cY#v6n3a07.htm##
01108000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704088000070002001200950#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#25#21#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Embora seja um    metal muito abundante na
 natureza (5% da crosta terrestre), o Fe &eacute; um    micronutriente que &eacu
te; encontrado em quantidades muito pequenas no organismo    humano. O conte&uac
ute;do total de Fe em um adulto saud&aacute;vel representa    t&atilde;o somente
 3 a 5 gramas da sua massa corporal total<SUP>8</SUP>. Apesar    dessa quantidad
e m&iacute;nima, est&aacute; amplamente distribu&iacute;do pelo    organismo, au
xiliando a formar v&aacute;rios compostos que podem ser divididos    em dois gra
ndes grupos<SUP>13</SUP>: a) compostos de Fe essenciais ou funcionais    e b) Fe
 de armazenamento e prote&iacute;nas de transporte. Na <a href="#tab01">tabela  
  1</a>, figuram esses compostos com as quantidades percentuais m&eacute;dias   
 de Fe contidas em cada um deles. </font> </p>     ^cY#v6n3a07.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704003700070002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#26#22#text#232#<p><a name="tab01"></a> <
/p>     ^cY#v6n3a07.htm##
00265000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704003700070002001200107#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#27#23#text#232#<p align="center">&nbsp;<
/p>     ^cY#v6n3a07.htm##
00306000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704007800070002001200148#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#28#24#text#232#<p align="center"><img sr
c="/img/revistas/rbme/v6n3/a07t01.gif"> </p>     ^cY#v6n3a07.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#29#25#text#232#<p>&nbsp; </p>     ^cY#v6
n3a07.htm##
00529000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704030100070002001200371#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#30#26#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Devido &agrave;    sua ampla distribui&cce
dil;&atilde;o no organismo, as suas fun&ccedil;&otilde;es    s&atilde;o muito va
riadas<SUP>13,14</SUP>, podendo ser resumidas de modo esquem&aacute;tico    da s
eguinte forma: </font> </p>     ^cY#v6n3a07.htm##
00440000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704021200070002001200282#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#31#27#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">1) Transporte de    oxig&ecirc;nio: atrav&
eacute;s do sangue (hemoglobina) e no pr&oacute;prio tecido    muscular (mioglob
ina). </font> </p>     ^cY#v6n3a07.htm##
00603000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704037500070002001200445#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#32#28#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2) Interv&eacute;m    nos processos de oxi
do-redu&ccedil;&atilde;o: nas rea&ccedil;&otilde;es de transfer&ecirc;ncia    de
 el&eacute;trons da cadeia respirat&oacute;ria que possibilitam a fosforila&cced
il;&atilde;o    oxidativa do ADP a ATP (citocromos), aumentando as reservas de e
nergia. </font>  </p>     ^cY#v6n3a07.htm##
00585000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704035700070002001200427#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#33#29#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">3) Outras fun&ccedil;&otilde;es:    como f
orma&ccedil;&atilde;o e desenvolvimento de hem&aacute;cias, do sistema    nervos
o central, sistema imunol&oacute;gico, s&iacute;ntese de DNA e a&ccedil;&atilde;
o    ou regula&ccedil;&atilde;o de diversas enzimas e horm&ocirc;nios. </font> <
/p>     ^cY#v6n3a07.htm##
00334000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704010600070002001200176#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#34#30#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif"><B>Metabolismo</B>    </font> </p>     ^cY
#v6n3a07.htm##
00632000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704040400070002001200474#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#35#31#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Em condi&ccedil;&otilde;es    normais exis
te um equil&iacute;brio marcado e quase constante para o metabolismo    do Fe, s
endo compensados o seu aporte e as perdas corporais<SUP>15</SUP>. Em    m&eacute
;dia, s&oacute; se absorve em torno de 10% de todo o Fe ingerido, perdendo-se   
 o restante pelas fezes<SUP>16</SUP>. </font> </p>     ^cY#v6n3a07.htm##
01270000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704104200070002001201112#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#36#32#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">O controle principal    do equil&iacute;br
io de Fe &eacute; realizado atrav&eacute;s dos mecanismos    de absor&ccedil;&at
ilde;o intestinal, que &eacute; m&aacute;xima na borda "em    escova" das c&eacu
te;lulas da mucosa duodenal e do jejuno proximal, sendo absorvido    principalme
nte na forma ferrosa (Fe<SUP>++</SUP>) e somente uma pequena parte    na forma f
&eacute;rrica (Fe<SUP>+++</SUP>)<SUP>17</SUP>. Estas c&eacute;lulas    liberam t
ransferrina (TRF) &agrave; luz intestinal, formando com o Fe um complexo    TRF-
Fe que &eacute; absorvido pelas c&eacute;lulas intestinais em um processo    de 
endocitose mediado pelo receptor espec&iacute;fico. No citoplasma celular,    o 
complexo TRF-Fe se comporta como um transportador hidrossol&uacute;vel e libera 
   Fe, retornando o TRF &agrave; luz intestinal. O Fe &eacute; liberado pela mem
brana    basal das c&eacute;lulas intestinais por um mecanismo de transporte ati
vo pouco    conhecido<SUP>18</SUP>. </font> </p>     ^cY#v6n3a07.htm##
01038000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704081000070002001200880#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#37#33#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Parte do Fe liberado    do complexo TRF-Fe
 se une de forma irrevers&iacute;vel &agrave; apoferritina    prote&iacute;na mu
ltim&eacute;rica presente em muitos tecidos formando ferritina    e n&atilde;o p
odendo ser transportado &agrave; corrente circulat&oacute;ria,    sendo eliminad
o na luz intestinal no processo de descama&ccedil;&atilde;o das    c&eacute;lula
s intestinais, perdendo-se assim pelas fezes. O n&iacute;vel de    apoferritina 
presente nas c&eacute;lulas intestinais determina a quantidade    de Fe armazena
do de forma n&atilde;o absorv&iacute;vel; portanto, a s&iacute;ntese    de apofe
rritina (estimulada pelo Fe) protege contra a absor&ccedil;&atilde;o    de quant
idades excessivas desse metal<SUP>18</SUP>. </font> </p>     ^cY#v6n3a07.htm##
01091000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704086300070002001200933#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#38#34#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">O Fe que deve ser    transportado pelo san
gue, seja proveniente da dieta ou do catabolismo da hemoglobina,    une-se &agra
ve; TRF s&eacute;rica, de estrutura semelhante &agrave; das c&eacute;lulas    in
testinais. Essa prote&iacute;na &eacute; capaz de se ligar at&eacute; a dois    
&aacute;tomos de Fe, embora nem sempre se encontre saturada: pode n&atilde;o    
transportar Fe (apof&eacute;rrica), transportar um &aacute;tomo (monof&eacute;rr
ica)    ou dois (dif&eacute;rrica)<SUP>15</SUP>. Para determinar a satura&ccedil
;&atilde;o    da TRF, previamente se deve conhecer a capacidade total de transpo
rte de Fe    (TIBC) por um m&eacute;todo espec&iacute;fico ou se pode calcular i
ndiretamente    conhecendo a sideremia e a concentra&ccedil;&atilde;o de TRF-pro
te&iacute;na.    </font> </p>     ^cY#v6n3a07.htm##
01312000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704108400070002001201154#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#39#35#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Os principais dep&oacute;sitos    de Fe no
 organismo est&atilde;o localizados no sistema mononuclear fagoc&iacute;tico    
(f&iacute;gado, ba&ccedil;o e medula &oacute;ssea) e nas c&eacute;lulas do par&e
circ;nquima    hep&aacute;tico. A forma de armazenamento s&atilde;o os dois comp
lexos prote&iacute;na-Fe:    ferritina e hemossiderina. A ferritina &eacute; uma
 prote&iacute;na capaz de    armazenar o Fe em forma f&eacute;rrica, presente em
 quase todas as c&eacute;lulas    do organismo e em m&iacute;nimas quantidades n
o plasma sangu&iacute;neo. &Eacute;    muito sol&uacute;vel e capaz de transferi
r o Fe facilmente a outros compartimentos.    A hemossiderina &eacute; formada p
or agregados amorfos de ferritina, com baixa    solubilidade e capacidade de int
erc&acirc;mbio de Fe. Em condi&ccedil;&otilde;es    normais s&oacute; &eacute; e
ncontrada no sistema mononuclear fagoc&iacute;tico,    mas em condi&ccedil;&otil
de;es patol&oacute;gicas pode se acumular em qualquer    tecido<SUP>19</SUP>. </
font> </p>     ^cY#v6n3a07.htm##
01347000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704111900070002001201189#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#40#36#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Al&eacute;m do    Fe n&atilde;o absorvido 
e eliminado pelas fezes, o processo de descama&ccedil;&atilde;o    produz uma pe
rda adicional que oscila entre 0,45mg ao dia nas mulheres e 0,51mg    ao dia nos
 homens, aos quais se deve adicionar os 0,11mg ao dia de perdas urin&aacute;rias
    e os 0,24mg ao dia devidos &agrave; perda cut&acirc;nea, quantidades m&eacut
e;dias    aceitas tanto para homens quanto para mulheres<SUP>20</SUP>. Se a essa
s quantidades    somarmos as perdas atrav&eacute;s do suor, com amplas varia&cce
dil;&otilde;es    conforme a regi&atilde;o e a t&eacute;cnica de colheita utiliz
ada, obter&iacute;amos    perdas m&eacute;dias di&aacute;rias ao redor de 1mg ao
 dia<SUP>21</SUP>. No    caso de uma mulher f&eacute;rtil, as perdas est&atilde;
o claramente aumentadas    pelas hemorragias menstruais. Embora essas perdas sej
am objeto de discrep&acirc;ncia    entre os diferentes trabalhos, admite-se como
 mais freq&uuml;ente uma perda    aproximada de 0,5mg ao dia de Fe, ao longo do 
ciclo menstrual<SUP>22</SUP>.    </font> </p>     ^cY#v6n3a07.htm##
00348000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704012000070002001200190#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#41#37#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif"><B>Necessidades    nutricionais</B> </font
> </p>     ^cY#v6n3a07.htm##
00974000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704074600070002001200816#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#42#38#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Conforme acima    disposto e segundo as at
uais Recomenda&ccedil;&otilde;es Diet&eacute;ticas (RDA)<SUP>21</SUP>,    aconse
lha-se uma ingest&atilde;o m&iacute;nima de Fe de 12mg ao dia nos rapazes    de 
11 a 18 anos e de 10mg ao dia a partir dos 19 anos, enquanto que para as    mulh
eres o m&iacute;nimo &eacute; de 15mg ao dia dos 11 aos 50 anos, reduzindo-se   
 para 10mg ao dia a partir dessa idade. Por outro lado, deve-se destacar que    
existem situa&ccedil;&otilde;es especiais, como &eacute; o caso das crian&ccedil
;as,    adolescentes, gr&aacute;vidas e atletas, nos quais essas necessidades po
dem    estar importantemente aumentadas<SUP>21,23,24</SUP>. </font> </p>     ^cY
#v6n3a07.htm##
01246000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704101800070002001201088#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#43#39#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Al&eacute;m de    satisfazer adequadamente
 as necessidades nutricionais m&iacute;nimas de Fe,    deve-se levar em conta qu
e a sua absor&ccedil;&atilde;o n&atilde;o depende somente    da quantidade total
 ingerida mas tamb&eacute;m da biodisponibilidade de Fe nos    alimentos, com um
a absor&ccedil;&atilde;o intestinal diferente dependendo de    tratar-se de Fe h
emo ou hem&iacute;nico ou de Fe n&atilde;o hemo<SUP>25,26</SUP>.    O Fe hemo re
presenta em torno de 40% do Fe total contido nas carnes, peixes    e mariscos, e
nquanto que o Fe n&atilde;o hemo perfaz os 60% restantes desses    alimentos, al
&eacute;m de todo o ferro contido nos outros alimentos, principalmente    nos ve
getais<SUP>21</SUP>. De forma pr&aacute;tica, aconselha-se que pelo menos    10%
 do Fe total ingerido seja Fe hemo e o ideal &eacute; que os homens ingiram    p
elo menos 1,0 grama ao dia e as mulheres 1,5 grama ao dia desse tipo de Fe<SUP>2
7</SUP>.    </font> </p>     ^cY#v6n3a07.htm##
01304000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704107600070002001201146#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#44#40#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">A diferente absor&ccedil;&atilde;o    do F
e foi estudada por diversos autores, entre os quais McArdle <I>et al.</I><SUP>28
</SUP>,    que relatam que somente 2 a 10% do Fe n&atilde;o hemo &eacute; absorv
ido, enquanto    que 10 a 35% do Fe hemo o s&atilde;o. Outros autores, como Rasm
ussen <I>et al.</I><SUP>29</SUP>,    enfatizam que em m&eacute;dia 5,3% do Fe n&
atilde;o hemo e 37,3% do Fe hemo    s&atilde;o absorvidos. A explica&ccedil;&ati
lde;o dessas diferen&ccedil;as deve-se    ao fato de que a mucosa intestinal abs
orve muito melhor o Fe no estado reduzido    ou ferroso (Fe<SUP>++</SUP>), forma
 que &eacute; obtida muito mais facilmente    a partir do Fe hemo, que se origin
a diretamente da hemoglobina e mioglobina    e que forma complexos porfir&iacute
;nicos intactos. Por meio de proteases g&aacute;stricas    e intestinais &eacute
; produzida a separa&ccedil;&atilde;o do Fe da globina,    reduzindo-se a Fe<SUP
>++</SUP>, que &eacute; facilmente absorv&iacute;vel<SUP>30</SUP>.    </font> </
p>     ^cY#v6n3a07.htm##
00765000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704053700070002001200607#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#45#41#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Por outro lado,    a absor&ccedil;&atilde;
o do Fe n&atilde;o hemo &eacute; muito menor porque este    tende a se combinar 
com determinadas subst&acirc;ncias contidas nos alimentos,    formando precipita
dos de hidr&oacute;xido f&eacute;rrico muito insol&uacute;veis    e necessitando
 de um pH &aacute;cido, proporcionado pelo &aacute;cido clor&iacute;drico    do 
est&ocirc;mago, para poder ser reduzido e formar quelatos sol&uacute;veis<SUP>14
</SUP>.    </font> </p>     ^cY#v6n3a07.htm##
01641000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704141300070002001201483#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#46#42#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Existe uma s&eacute;rie    de fatores da p
r&oacute;pria dieta que podem alterar a absor&ccedil;&atilde;o    de Fe, sendo a
 de Fe n&atilde;o hemo a que pode ser mais afetada pela composi&ccedil;&atilde;o
    da mesma<SUP>25</SUP>. Assim, esta absor&ccedil;&atilde;o &eacute; favorecid
a    por uma alimenta&ccedil;&atilde;o muito pobre em Fe, o que leva a um m&aacu
te;ximo    aproveitamento do mesmo, j&aacute; que a mucosa intestinal tende a ma
nter constantes    os n&iacute;veis de Fe do organismo. H&aacute; tamb&eacute;m 
uma s&eacute;rie    de nutrientes como a vitamina C, o &aacute;cido f&oacute;lic
o, diversos amino&aacute;cidos    e a&ccedil;&uacute;cares, que facilitam essa a
bsor&ccedil;&atilde;o, favorecendo    &agrave; redu&ccedil;&atilde;o do Fe n&ati
lde;o hemo<SUP>26,31</SUP>. Pelo contr&aacute;rio,    foi demonstrado que certas
 subst&acirc;ncias e nutrientes interferem negativamente    sobre a mesma, como 
&eacute; o caso do etilenodiaminotetracloroacetato (EDTA),    conservante muito 
freq&uuml;ente em diversos alimentos, fitatos, oxalatos, fosfatos,    tanatos, c
ompostos fen&oacute;licos, carbonato c&aacute;lcico, fibra, leite    e anti&aacu
te;cidos, combinando-se com grande freq&uuml;&ecirc;ncia com o Fe    n&atilde;o 
hemo e dando lugar a complexos ou quelatos de Fe insol&uacute;veis<SUP>14,25</SU
P>.    </font> </p>     ^cY#v6n3a07.htm##
00904000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704067600070002001200746#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#47#43#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">A altera&ccedil;&atilde;o    do equil&iacu
te;brio aporte-perdas de Fe, seja por uma ingest&atilde;o insuficiente    e/ou p
or um aumento das perdas leva a uma situa&ccedil;&atilde;o deficit&aacute;ria   
 dos dep&oacute;sitos de Fe (ferropenia), com clara redu&ccedil;&atilde;o das   
 suas reservas org&acirc;nicas (ferritina baixa) e em &uacute;ltima inst&acirc;n
cia    a instaura&ccedil;&atilde;o de uma anemia manifesta (redu&ccedil;&atilde;
o da    hemoglobina), que nos indiv&iacute;duos envolvidos em atividades desport
istas    &eacute; denominada <I>anemia do atleta</I><SUP>12,32</SUP>. </font> </
p>     ^cY#v6n3a07.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#48#44#text#232#<p>&nbsp;</p>     ^cY#v6n
3a07.htm##
00376000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704014800070002001200218#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#49#45#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif"><B><font size="3">FERRO    E ATIVIDADE F&I
acute;SICA</font></B> </font> </p>     ^cY#v6n3a07.htm##
01046000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704081800070002001200888#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#50#46#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">A rela&ccedil;&atilde;o    entre o ferro n
os atletas e o seu desempenho f&iacute;sico &eacute; um tema    que desperta int
eresse tanto do ponto de vista m&eacute;dico como desportivo<SUP>8,33</SUP>.    
Levando-se em conta que o Fe desempenha um papel fundamental no transporte de   
 oxig&ecirc;nio e na produ&ccedil;&atilde;o de energia, parece necess&aacute;ria
    a manuten&ccedil;&atilde;o de um equil&iacute;brio nos atletas, j&aacute; qu
e    os estados carenciais de Fe podem comprometer de forma importante os result
ados    desportivos<SUP>11</SUP>. Por outro lado, o estudo dos efeitos do exerc&
iacute;cio    f&iacute;sico sobre o equil&iacute;brio de Fe no atleta tem sido o
 objetivo    de diversos trabalhos<SUP>34-36</SUP>. </font> </p>     ^cY#v6n3a07
.htm##
00686000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704045800070002001200528#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#51#47#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">As perdas e d&eacute;ficits    de Fe nos a
tletas podem ser conseq&uuml;&ecirc;ncia de diversos fatores, sendo    que na ma
ioria das vezes h&aacute; a sobreposi&ccedil;&atilde;o de v&aacute;rias    dessa
s causas. Estas podem ser classificadas em dois grupos: 1) as devidas a    fator
es nutricionais e 2) as ocasionadas por aumentos das necessidades e/ou    das pe
rdas de Fe. </font> </p>     ^cY#v6n3a07.htm##
00368000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704014000070002001200210#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#52#48#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">1) Entre os <B>fatores    nutricionais</B>
 se destacam: </font> </p>     ^cY#v6n3a07.htm##
00767000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704053900070002001200609#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#53#49#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">1.a) <B>Ingest&atilde;o    insuficiente de
 Fe</B>. Este &eacute; um fator bastante comum na popula&ccedil;&atilde;o    em 
geral<SUP>37</SUP>. No caso do atleta e especialmente na mulher que pratica    e
sportes nos quais a est&eacute;tica seja crit&eacute;rio de pontua&ccedil;&atild
e;o,    chega-se em algumas ocasi&otilde;es a uma importante restri&ccedil;&atil
de;o    da ingest&atilde;o cal&oacute;rica e conseq&uuml;entemente de Fe<SUP>38,
39</SUP>.    </font> </p>     ^cY#v6n3a07.htm##
01065000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704083700070002001200907#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#54#50#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">1.b)<B> Absor&ccedil;&atilde;o    intestin
al reduzida pela pr&oacute;pria composi&ccedil;&atilde;o da dieta</B>.    Confor
me foi comentado anteriormente, de acordo com a composi&ccedil;&atilde;o    da d
ieta, a absor&ccedil;&atilde;o de Fe pode ser facilitada ou inibida<SUP>25</SUP>
.    Em outras ocasi&otilde;es, como ocorre nos atletas que fazem dietas vegetar
ianas,    embora seja atingida a ingest&atilde;o m&iacute;nima recomendada de Fe
, sem    d&uacute;vida quase todo o Fe ingerido &eacute; do tipo n&atilde;o hemo
, com    a conseq&uuml;ente dificuldade para a sua absor&ccedil;&atilde;o intest
inal,    o que se traduz em n&iacute;veis s&eacute;ricos de ferritina inferiores
 aos    de outros atletas que t&ecirc;m uma dieta normal<SUP>40</SUP>. </font> <
/p>     ^cY#v6n3a07.htm##
00410000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704018200070002001200252#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#55#51#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2) Entre as causas    devidas ao <B>aument
o das necessidades e/ou perdas</B>, podemos mencionar: </font>  </p>     ^cY#v6n
3a07.htm##
00637000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704040900070002001200479#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#56#52#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2.a)<B> Aumento    da mioglobina e dos sis
temas enzim&aacute;ticos devido ao treinamento muscular</B>.    O treinamento re
gular produz modifica&ccedil;&otilde;es no organismo, com aumentos    da massa m
uscular e maiores necessidades de compostos de Fe, sendo alterado    o equil&iac
ute;brio desse micronutriente<SUP>9</SUP>. </font> </p>     ^cY#v6n3a07.htm##
01413000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704118500070002001201255#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#57#53#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2.b)<B> Hem&oacute;lise    aumentada por r
edu&ccedil;&atilde;o da meia-vida das hem&aacute;cias</B>. Os    cont&iacute;nuo
s traumatismos mec&acirc;nicos sobre as hem&aacute;cias, principalmente    nos e
sportes com golpes freq&uuml;entes palmares ou plantares (caratecas ou    corrid
as sobre superf&iacute;cies duras) provocam um enfraquecimento progressivo    da
 membrana da hem&aacute;cia que d&aacute; lugar a uma microhem&oacute;lise    ac
elerada<SUP>35</SUP>. Em outras ocasi&otilde;es, a hem&oacute;lise &eacute;    c
onseq&uuml;ente a diversas causas que ocorrem durante a atividade f&iacute;sica:
    aumento da temperatura corporal, acidose metab&oacute;lica ou aumentos das c
atecolaminas    circulantes<SUP>41,42</SUP> ou inclusive, como relata Williamson
<SUP>43</SUP>,    a exist&ecirc;ncia de um poss&iacute;vel fator hemol&iacute;ti
co de origem renal    ou espl&ecirc;nica. Todas as situa&ccedil;&otilde;es anter
iores conduziriam    a uma redu&ccedil;&atilde;o da resist&ecirc;ncia osm&oacute
;tica da hem&aacute;cia    com a conseq&uuml;ente redu&ccedil;&atilde;o da sua v
ida m&eacute;dia. </font>  </p>     ^cY#v6n3a07.htm##
01174000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704094600070002001201016#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#58#54#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">A destrui&ccedil;&atilde;o    dos eritr&oa
cute;citos d&aacute; lugar &agrave; libera&ccedil;&atilde;o da hemoglobina    qu
e se une &agrave; haptoglobina, prote&iacute;na plasm&aacute;tica de origem    h
ep&aacute;tica, formando complexos de hemoglobina-haptoglobina, que pelo seu    
tamanho n&atilde;o podem ser filtrados atrav&eacute;s dos rins e que ser&atilde;
o    transportados at&eacute; o hepat&oacute;cito, liberando-se posteriormente m
ais    uma vez a haptoglobina &agrave; corrente circulat&oacute;ria<SUP>44</SUP>
. Secundariamente,    isto acarretar&aacute; redu&ccedil;&otilde;es marcadas da 
haptoglobina s&eacute;rica,    indicativas dessa destrui&ccedil;&atilde;o<SUP>41
,45</SUP>. Quando a haptoglobina    ultrapassa a sua capacidade de satura&ccedil
;&atilde;o por parte da hemoglobina,    ser&aacute; excretada atrav&eacute;s da 
urina<SUP>44</SUP>. </font> </p>     ^cY#v6n3a07.htm##
01106000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704087800070002001200948#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#59#55#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2.c) <B>Perdas    urin&aacute;rias de Fe</
B>. Ocorre na forma de hemat&uacute;ria, hemoglobin&uacute;ria    ou mioglobin&u
acute;ria, sendo mais freq&uuml;ente nos corredores. Dessa forma,    Halvorsen <
I>et al.</I><SUP>46</SUP> descrevem este achado em 13% dos seus maratonistas    
e Siegel <I>et al.</I><SUP>47</SUP> em 18%, enquanto que Seiler <I>et al.</I><SU
P>48</SUP>    o observam em 25% dos seus corredores de longa dist&acirc;ncia. Ou
tros autores,    como Weight <I>et al.</I><SUP>49</SUP>, relatam achados semelha
ntes nos marchadores,    denominando-os <I>hemoglobin&uacute;ria da marcha atl&e
acute;tica</I>. Por &uacute;ltimo,    foram descritos tamb&eacute;m altera&ccedi
l;&otilde;es mec&acirc;nicas da parede    uretral com les&otilde;es micro e macr
osc&oacute;picas<SUP>24</SUP>. </font>  </p>     ^cY#v6n3a07.htm##
01171000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704094300070002001201013#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#60#56#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2.d)<B> Perdas    gastrointestinais de san
gue</B>. S&atilde;o descritas muito freq&uuml;entemente    em corredores de long
a dist&acirc;ncia<SUP>46</SUP>. A presen&ccedil;a de hemoglobina    fecal &eacut
e; um achado muito freq&uuml;ente e a sua causa mais comum &eacute;    creditada
 &agrave; redu&ccedil;&atilde;o da perfus&atilde;o espl&acirc;ncnica,    que dur
ante o exerc&iacute;cio f&iacute;sico chega a 80%<SUP>24</SUP>, com a    conseq&
uuml;ente hip&oacute;xia e isquemia intestinal que produzir&aacute; les&otilde;e
s    ulcerativas<SUP>50</SUP>. Tamb&eacute;m foram descritas como poss&iacute;ve
is    causas os microtraumas da parede intestinal e de estresse do pr&oacute;pri
o    exerc&iacute;cio que pode ocasionar gastrite erosiva<SUP>51</SUP> e inclusi
ve    podem ser devidas ao uso de analg&eacute;sicos e antiinflamat&oacute;rios<
SUP>24</SUP>.    </font> </p>     ^cY#v6n3a07.htm##
00751000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704052300070002001200593#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#61#57#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2.e)<B> Perdas    pelo suor</B>. Em ambien
tes quentes muito &uacute;midos, a sudorese &eacute;    profusa, com o conseq&uu
ml;ente aumento das perdas de Fe<SUP>52</SUP>. Assim,    Velar<SUP>53</SUP> rela
ta que em condi&ccedil;&otilde;es de intensa sudorese    pode-se chegar a perder
 at&eacute; 40mg de Fe por decilitro de suor; dessa forma,    com uma perda de d
ois a tr&ecirc;s litros de suor, s&atilde;o eliminadas 0,8    a 1,2mg de Fe. </f
ont> </p>     ^cY#v6n3a07.htm##
01057000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704082900070002001200899#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#62#58#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2.f) <B>Eritropoiese    ineficaz</B>. Dura
nte o exerc&iacute;cio f&iacute;sico a necessidade de oxig&ecirc;nio    por part
e dos tecidos pode atuar como um est&iacute;mulo da eritropoiese<SUP>7</SUP>.   
 Sem d&uacute;vida, o treinamento cont&iacute;nuo produz aumentos do 2,3-difosfo
glicerato    intra-eritrocit&aacute;rio e esses aumentos deslocam a curva de dis
socia&ccedil;&atilde;o    da hemoglobina para a direita, cedendo assim o oxig&ec
irc;nio mais facilmente    aos tecidos, entre eles os rins, nos quais ao n&iacut
e;vel da m&aacute;cula    densa est&aacute; reduzida a s&iacute;ntese de eritrop
oietina, reduzindo-se    conseq&uuml;entemente o est&iacute;mulo sobre a medula 
&oacute;ssea, desacelerando-se    a eritropoiese<SUP>54</SUP>. </font> </p>     
^cY#v6n3a07.htm##
00666000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704043800070002001200508#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#63#59#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2.g) <B>Menstrua&ccedil;&atilde;o</B>:    
Todas as perdas de Fe no atleta s&atilde;o maiores nas mulheres, devido &agrave;
s    perdas menstruais adicionais, conforme anteriormente comentado<SUP>20</SUP>
,    constituindo sem d&uacute;vida uma das causas desencadeantes mais important
es    dos estados ferrop&ecirc;nicos nas mulheres atletas<SUP>54</SUP>. </font> 
</p>     ^cY#v6n3a07.htm##
00987000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704075900070002001200829#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#64#60#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Por &uacute;ltimo,    sem ser uma causa de
 perda de Fe, deve-se levar em conta o aumento do volume    plasm&aacute;tico pr
ovocado pelo treinamento, o que leva a redu&ccedil;&otilde;es    relativas da co
ncentra&ccedil;&atilde;o de hemoglobina, podendo ocasionar quadros    aparentes 
de anemia<SUP>44</SUP>. Esta hemodilui&ccedil;&atilde;o &eacute; o    que se den
omina <I>pseudoanemia do atleta</I><SUP>55</SUP>. O acr&eacute;scimo    do volum
e plasm&aacute;tico poderia ser devido a um aumento da atividade renina-angioten
sina    e da vasopressina, com a conseq&uuml;ente reten&ccedil;&atilde;o pelo ri
m de    &aacute;gua e sais, principalmente s&oacute;dio<SUP>24,55</SUP>. </font>
 </p>     ^cY#v6n3a07.htm##
00739000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704051100070002001200581#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#65#61#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Embora alguns trabalhos    relatem que o a
umento do volume plasm&aacute;tico seja transit&oacute;rio e    presente unicame
nte nas primeiras semanas de treinamento<SUP>44,56</SUP>, outros,    por sua vez
, consideram que se trata de uma situa&ccedil;&atilde;o permanente    e que muit
os diagn&oacute;sticos de anemia do atleta s&atilde;o equivocados,    tratando-s
e apenas de anemias por dilui&ccedil;&atilde;o<SUP>55,57</SUP>. </font>  </p>   
  ^cY#v6n3a07.htm##
00625000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704039700070002001200467#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#66#62#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">As defici&ecirc;ncias    de Fe ocasionadas
 pelo exerc&iacute;cio f&iacute;sico n&atilde;o conduzem bruscamente    ao surgi
mento de anemia; esta se desenvolve progressivamente em tr&ecirc;s fases.    Est
as fases est&atilde;o amplamente descritas na literatura<SUP>7,8,13</SUP>    e p
odem ser assim esquematizadas: </font> </p>     ^cY#v6n3a07.htm##
01566000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704133800070002001201408#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#67#63#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">1)<B> Defici&ecirc;ncia    de ferro pr&eac
ute;-latente</B>. Come&ccedil;am a se esvaziar os dep&oacute;sitos    de Fe do s
istema mononuclear fagoc&iacute;tico, permanecendo ainda intactos    os dep&oacu
te;sitos dos macr&oacute;fagos da medula &oacute;ssea. A hemoglobina,    o hemat
&oacute;crito, a hematimetria, a concentra&ccedil;&atilde;o da hemoglobina    co
rpuscular m&eacute;dia, o Fe plasm&aacute;tico, a transferrina (TRF) e o percent
ual    de satura&ccedil;&atilde;o da TRF mostram valores normais. As redu&ccedil
;&otilde;es    do Fe de dep&oacute;sito s&atilde;o traduzidas em redu&ccedil;&ot
ilde;es paralelas    da ferritina s&eacute;rica, sendo este par&acirc;metro o me
lhor para o diagn&oacute;stico    precoce desse estado<SUP>58,59</SUP>. Os valor
es de ferritina s&eacute;rica    dados como indicadores de defici&ecirc;ncia de 
dep&oacute;sito de Fe variam    conforme os diferentes autores: Weaver e Rajaram
<SUP>7</SUP> estabelecem o limite    em 12ng/ml; Selby e Eichner<SUP>41</SUP> em
 15ng/ml e por &uacute;ltimo Roberts    e Smith<SUP>60</SUP>, Harju <I>et al.</I
><SUP>61</SUP> e Wick <I>et al.</I><SUP>62</SUP>,    o estabelecem em 20ng/ml. C
ontudo, esse ponto ser&aacute; posteriormente motivo    de uma discuss&atilde;o 
mais ampla. </font> </p>     ^cY#v6n3a07.htm##
01556000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704132800070002001201398#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#68#64#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">2) <B>Defici&ecirc;ncia    de ferro latent
e ou eritropoiese deficiente</B>. Os n&iacute;veis de ferritina    s&eacute;rica
, assim como dos macr&oacute;fagos na medula &oacute;ssea, continuam    diminuin
do, at&eacute; que os dep&oacute;sitos de Fe do organismo estejam quase    nulos
. Apesar de que continua havendo um aumento da absor&ccedil;&atilde;o intestinal
    de Fe, o Fe s&eacute;rico come&ccedil;a a reduzir alcan&ccedil;ando valores 
   inferiores a 60<font face="Symbol">m</font>g/dl, com aumentos paralelos da tr
ansferrina    s&eacute;rica e redu&ccedil;&otilde;es do seu percentual de satura
&ccedil;&atilde;o    abaixo de 16%<SUP>7,54</SUP>. Jacobs <I>et al.</I><SUP>63</
SUP> relacionam a    este estado ferritinas inferiores a 10ng/ml com satura&cced
il;&otilde;es de    TRF inferiores a 16%. Pode haver altera&ccedil;&otilde;es da
 eritropoiese, mas    os valores de hemoglobina permanecem semelhantes ainda den
tro da faixa de normalidade<SUP>16</SUP>.    Do ponto de vista cl&iacute;nico su
rgem sintomas subjetivos como: astenia, adinamia,    anorexia, cefal&eacute;ias 
e palpita&ccedil;&otilde;es que s&atilde;o possivelmente    indicativos de uma r
edu&ccedil;&atilde;o do Fe ligado aos sistemas enzim&aacute;ticos<SUP>7</SUP>.  
  </font> </p>     ^cY#v6n3a07.htm##
01635000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704140700070002001201477#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#69#65#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">3)<B> Defici&ecirc;ncia    de ferro manife
sta ou anemia ferrop&ecirc;nica</B>. Al&eacute;m de tudo que    est&aacute; desc
rito no item anterior, instala-se um quadro de anemia cl&iacute;nica,    com red
u&ccedil;&otilde;es importantes da hemoglobina. Os dep&oacute;sitos de    Fe do 
sistema mononuclear fagoc&iacute;tico est&atilde;o praticamente vazios    e nem 
os macr&oacute;fagos da medula &oacute;ssea cont&ecirc;m ferritina. A    s&eacut
e;rie vermelha do hemograma mostra altera&ccedil;&otilde;es patol&oacute;gicas  
  e desta forma o conte&uacute;do de hemoglobina dos eritr&oacute;citos cai bem 
   abaixo dos valores normais, sendo o limite inferior de 12g/dl na mulher e de 
   14g/dl no homem<SUP>11</SUP>. Tamb&eacute;m encontram-se redu&ccedil;&otilde;
es    do hemat&oacute;crito e da hematimetria, junto com uma importante redu&cce
dil;&atilde;o    do ferro s&eacute;rico e da satura&ccedil;&atilde;o da TRF<SUP>
54</SUP>. Os    sintomas que acompanham esse est&aacute;gio s&atilde;o os coment
ados anteriormente,    mas mais acentuados, al&eacute;m de c&atilde;imbras e hip
ermenorr&eacute;ia    nas mulheres. &Agrave; medida em que aumenta a gravidade d
a anemia, surgem sinais    cl&iacute;nicos como: altera&ccedil;&otilde;es epitel
iais, digestivas e da pele    e f&acirc;neros (unhas, p&ecirc;los)<SUP>15</SUP>.
 </font> </p>     ^cY#v6n3a07.htm##
01141000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704091300070002001200983#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#70#66#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Al&eacute;m dos    par&acirc;metros citado
s anteriormente, atualmente h&aacute; um grande interesse    na determina&ccedil
;&atilde;o do receptor sol&uacute;vel da transferrina (RTFS).    Comprovou-se qu
e os estados ferrodeficit&aacute;rios s&atilde;o acompanhados    por marcados au
mentos do <I>pool</I> global do receptor da transferrina (RTF)<SUP>64</SUP>.    
Por outro lado, est&aacute; em estudos o <I>Iron Responsive-Element Binding    P
rotein</I> (IRE-BP), denominado tamb&eacute;m fator regulador do ferro e prote&i
acute;na    repressora da ferritina. Nos estados nos quais se reduz o ferro intr
acelular    dispon&iacute;vel, produz-se um aumento do IRE-BP, que por sua vez p
rovoca um    aumento do receptor da transferrina e paralelamente uma redu&ccedil
;&atilde;o    da produ&ccedil;&atilde;o de ferritina<SUP>65</SUP>. </font> </p> 
    ^cY#v6n3a07.htm##
01111000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704088300070002001200953#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#71#67#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">&Eacute; evidente    que os d&eacute;ficit
s de Fe provocam altera&ccedil;&otilde;es da capacidade    de desenvolver trabal
ho f&iacute;sico; entretanto, n&atilde;o est&aacute; evidente    a partir de qua
l grau de defici&ecirc;ncia essas altera&ccedil;&otilde;es podem    se tornar im
portantes. Assim, Miller <I>et al.</I><SUP>66</SUP> postulam que,    se n&atilde
;o houver redu&ccedil;&otilde;es da concentra&ccedil;&atilde;o de    hemoglobina
, n&atilde;o estar&aacute; alterada a capacidade f&iacute;sica, enquanto    que 
Pate<SUP>11</SUP> afirma que inclusive com n&iacute;veis de hemoglobina    consi
derados como sub&oacute;timos (que em indiv&iacute;duos treinados pode    ser de
 at&eacute; 14g/dl em mulheres e 16g/dl em homens), j&aacute; pode estar    alte
rado o transporte de oxig&ecirc;nio. </font> </p>     ^cY#v6n3a07.htm##
01136000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704090800070002001200978#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#72#68#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Alguns trabalhos    consideram que os d&ea
cute;ficits de Fe sem anemia j&aacute; podem modificar    o desempenho desportiv
o, baseando-se no fato de que se pode alterar a capacidade    oxidativa muscular
, desviando-se a produ&ccedil;&atilde;o de energia para a    via anaer&oacute;bi
ca com ac&uacute;mulo de lactato, al&eacute;m de se produzir    uma redu&ccedil;
&atilde;o da concentra&ccedil;&atilde;o da hemoglobina muscular    e das enzimas
 mitocondriais, tais como a nicotinadeninadinucleot&iacute;deo    (NADH<SUP><SUP
>_</sup></SUP>), succinato desidrogenase e xantina oxidase<SUP>7,9,10</SUP>.    
Sem d&uacute;vida, Newhouse <I>et al.</I><SUP>67</SUP> indicam que, at&eacute;  
  que a ferritina s&eacute;rica se reduza abaixo de 20ng/ml, n&atilde;o parece  
  haver altera&ccedil;&otilde;es do desempenho f&iacute;sico. </font> </p>     ^
cY#v6n3a07.htm##
01161000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704093300070002001201003#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#73#69#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Estudos realizados    com ratos de laborat
&oacute;rio submetidos a treinamento f&iacute;sico e dietas    pobres em Fe, com
 o que se induziam d&eacute;ficits de Fe sem anemia, demonstraram    redu&ccedil
;&otilde;es do citocromo C com altera&ccedil;&otilde;es da fosforila&ccedil;&ati
lde;o    oxidativa no n&iacute;vel muscular, desvio do metabolismo para vias ana
er&oacute;bicas    e secundariamente redu&ccedil;&otilde;es do <img src="file://
/F|/web/htdocs/img/revistas/rbme/v6n3/a04f01.gif" width="22" height="16"><SUB>2m
&aacute;x</SUB>    ou pot&ecirc;ncia aer&oacute;bica m&aacute;xima<SUP>14,68</SU
P>. Estes mesmos    fatos foram tamb&eacute;m demonstrados em desportistas, enco
ntrando-se modifica&ccedil;&otilde;es    da capacidade de trabalho f&iacute;sico
 devidas a altera&ccedil;&otilde;es do    transporte de oxig&ecirc;nio<SUP>9,69<
/SUP>. </font> </p>     ^cY#v6n3a07.htm##
01479000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704125100070002001201321#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#74#70#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">O que parece mais    evidente s&atilde;o o
s efeitos de uma anemia franca, por defici&ecirc;ncia de    Fe, sobre o exerc&ia
cute;cio f&iacute;sico. Al&eacute;m dos sintomas que indicam    a presen&ccedil;
a de anemia<SUP>7,70</SUP>, as baixas concentra&ccedil;&otilde;es    de hemoglob
ina levam a uma redu&ccedil;&atilde;o das trocas de oxig&ecirc;nio    e di&oacut
e;xido de carbono no interior da fibra muscular, com redu&ccedil;&otilde;es    s
ecund&aacute;rias do pH<SUP>13</SUP>. Segundo destacam Parr <I>et al.</I><SUP>54
</SUP>,    concentra&ccedil;&otilde;es de hemoglobina inferiores a 12g/dl propor
cionam    uma capacidade de transporte de oxig&ecirc;nio de apenas 75% de um ind
iv&iacute;duo    com concentra&ccedil;&atilde;o de hemoglobina de 16g/dl, o que 
conduz a altera&ccedil;&otilde;es    da respira&ccedil;&atilde;o ao n&iacute;vel
 celular e aumento do metabolismo    anaer&oacute;bico e da concentra&ccedil;&at
ilde;o de lactato. Por &uacute;ltimo,    Hercberg<SUP>68</SUP> comprovou que em 
ratos an&ecirc;micos submetidos a um    exerc&iacute;cio intenso foram produzida
s altera&ccedil;&otilde;es da s&iacute;ntese    de ATP ao n&iacute;vel mitocondr
ial. </font> </p>     ^cY#v6n3a07.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#75#71#text#232#<p>&nbsp; </p>     ^cY#v6
n3a07.htm##
00359000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704013100070002001200201#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#76#72#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif"><B><font size="3">AGRADECIMENTOS</font></B
>    </font> </p>     ^cY#v6n3a07.htm##
00507000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704027900070002001200349#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#77#73#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif">Ao Dr. Enric Gimferrer    da Unidade de Fe
rropatologia do Hospital de la Santa Creu i Sant Pau de Barcelona    pela revis&
atilde;o e pelas sugest&otilde;es feitas sobre o manuscrito original.    </font>
 </p>     ^cY#v6n3a07.htm##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#78#74#text#232#<p>&nbsp; </p>     ^cY#v6
n3a07.htm##
00362000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704013400070002001200204#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#79#75#text#232#<p><font size="2" face="V
erdana, Arial, Helvetica, sans-serif"><B><font size="3">REFER&Ecirc;NCIAS</font>
</B>    </font> </p>     ^cY#v6n3a07.htm##
00402000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704016000072002001200232#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#80#76#text#232#1#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">1. Finch CA, Huebers    H. P
erspectives in iron metabolism. N Engl J Med 1982;306:1520-8.    ^cY#v6n3a07.htm
##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#81#77#text#232# </font> </p>     ^cY#v6n
3a07.htm##
00426000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704018400072002001200256#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#82#78#text#232#2#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">2. De Mayer E,    Adiels-Teg
man M. The prevalence of anaemia in the world. World Health Stat Q    1985;38:30
2-16.    ^cY#v6n3a07.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#83#79#text#232# </font> </p>     ^cY#v6n
3a07.htm##
00524000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704028200072002001200354#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#84#80#text#232#3#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">3. Hermosa V, Mazo    E, Car
ril J, Cordovilla JJ, Luce&ntilde;o A, Zubizarreta A. Estudio prospectivo    sob
re la prevalencia de ferropenia en la poblaci&oacute;n adulta de Cantabria.    M
ed Clin 1986;87:135-40.    ^cY#v6n3a07.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#85#81#text#232# </font> </p>     ^cY#v6n
3a07.htm##
00403000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704016100072002001200233#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#86#82#text#232#4#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">4. Viteri FE, Torun    B. An
aemia and physical work capacity. Clin Haematol 1974;3:609-26.    ^cY#v6n3a07.ht
m##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#87#83#text#232# </font>  </p>     ^cY#v6
n3a07.htm##
00496000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704025400072002001200326#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#88#84#text#232#5#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">5. Edgerton VR,    Gardner G
W, Ohira Y, Gunawardena KA, Senewiratne B. Iron deficiency anaemia    and its ef
fects on worker productivity and activity patterns. Br Med J 1979;2:1546-9.    ^
cY#v6n3a07.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002500070002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#89#85#text#232#    </font> </p>     ^cY#
v6n3a07.htm##
00403000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704016100072002001200233#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#90#86#text#232#6#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">6. Hallberg L.    Iron nutri
tion and food iron fortification. Semin Hematol 1982;19:31-41.    ^cY#v6n3a07.ht
m##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#91#87#text#232# </font>  </p>     ^cY#v6
n3a07.htm##
00390000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704014800072002001200220#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#92#88#text#232#7#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">7. Weaver CM, Rajaram    S. 
Exercise and iron status. J Nutr 1992;122: 782-7.    ^cY#v6n3a07.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#93#89#text#232# </font> </p>     ^cY#v6n
3a07.htm##
00402000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704016000072002001200232#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#94#90#text#232#8#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">8. Clement DB,    Sawchuk LL
. Iron status and sport performance. Sports Med 1984;1:65-74.    ^cY#v6n3a07.htm
##
00251000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002300070002001200093#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#95#91#text#232# </font>  </p>     ^cY#v6
n3a07.htm##
00451000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000200070704020900072002001200281#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#96#92#text#232#9#<p><font si
ze="2" face="Verdana, Arial, Helvetica, sans-serif">9. Swearingen JV.    Iron de
ficiency in athletes: consequence or adaption in strenous activity. J    Orthop 
Sports Phys Ther 1986;7:192-5.    ^cY#v6n3a07.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#97#93#text#232# </font> </p>     ^cY#v6n
3a07.htm##
00397000000000157000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066888000300070704015400073002001200227#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#98#94#text#232#10#<p><font s
ize="2" face="Verdana, Arial, Helvetica, sans-serif">10. Dallman PR.    Manifest
ations of iron deficiency. Semin Hematol 1982; 19:19-30.    ^cY#v6n3a07.htm##
00250000000000145000450000400050000070200460000570500020005170600020005370000030
0055701000300058709000500061708000400066704002200070002001200092#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#99#95#text#232# </font> </p>     ^cY#v6n
3a07.htm##
00422000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000500062708000400067888000300071704017800074002001200252#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#100#96#text#232#11#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Pate RR. Sports    ane
mia: a review of the current research literature. Phys Sports Med 1983;11:115-31
.    ^cY#v6n3a07.htm##
00254000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000500062708000400067704002500071002001200096#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#101#97#text#232#    </font> </p>     ^cY
#v6n3a07.htm##
00407000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000500062708000400067888000300071704016300074002001200237#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#102#98#text#232#12#<p><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Yoshimura H.    Anemia
 during physical training (sports anemia). Nutr Rev 1970;10:251-3.    ^cY#v6n3a0
7.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000300059709000500062708000400067704002300071002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#103#99#text#232# </font>  </p>     ^cY#v
6n3a07.htm##
00422000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704017700075002001200252#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#104#100#text#232#13#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Dallman PR.    Bioche
mical basis for the manifestations of iron deficiency. Ann Rev Nutr 1986;6:13-40
.    ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#105#101#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00456000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704021100075002001200286#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#106#102#text#232#14#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Linder MC.    Nutrici
&oacute;n, aspectos bioqu&iacute;micos, metab&oacute;licos y cl&iacute;nicos.   
 Pamplona: Ed. Eunsa, 1988:189-241.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#107#103#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00500000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704025500075002001200330#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#108#104#text#232#15#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Vives JL. Anemia    f
errop&eacute;nica y otros transtornos del metabolismo del hierro. In: Sans-Sabra
fen    J. Hematolog&iacute;a cl&iacute;nica. Barcelona: Ed. Doyma, 1988:177-93. 
   ^cY#v6n3a07.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#109#105#text#232# </font>  </p>     ^cY#
v6n3a07.htm##
00412000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704016700075002001200242#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#110#106#text#232#16#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Haymes EM.    Nutriti
onal concerns: need for iron. Med Sports Exerc 1987;5(Suppl):S197-S200.    ^cY#v
6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#111#107#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00480000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704023500075002001200310#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#112#108#text#232#17#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Anderson L,    Dible 
MV, Turkki PR, Mitchell HS, Rynbergen HJ. Nutrici&oacute;n y diet&eacute;tica   
 de Cooper. Mexico, D.C.: Ed. Interamericana, 1988: 75-110.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#113#109#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00455000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704021000075002001200285#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#114#110#text#232#18#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Kutchai H.    Gastroi
ntestinal system. In: Berne RM, Levy MN. Principles of physiology. Missouri:    
Ed. Mosby-Year Book, 1996:437-501.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#115#111#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00411000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704016600075002001200241#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#116#112#text#232#19#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Garc&iacute;a    JD, 
Crespo L, Guerra JM. Anemias ferrop&eacute;nicas. JANO 1990; 38:43-50.    ^cY#v6
n3a07.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#117#113#text#232# </font>  </p>     ^cY#
v6n3a07.htm##
00446000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704020100075002001200276#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#118#114#text#232#20#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Haymes EM,    Lamanca
 JJ. Iron loss in runners during exercise: implications and recommendations.    
Sports Med 1989;7:277-85.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#119#115#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00484000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704023900075002001200314#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#120#116#text#232#21#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">21. National Research    
Council Committee of Dietary Allowances. Recommended dietary allowances. 10<SUP>
th</SUP>    ed. Washington, D.C.: National Academy Press, 1989.    ^cY#v6n3a07.h
tm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#121#117#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00518000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704027300075002001200348#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#122#118#text#232#22#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Hallberg L,    Hogdah
ll AM, Nilsson L, Rybo R. Menstrual blood loss: a population study. Variation   
 at different ages and attempts to define normality. Acta Obstet Gynecol Scand  
  1966;45:320-51.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#123#119#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00532000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704028700075002001200362#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#124#120#text#232#23#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Dallman PR.    Changi
ng iron needs from birth through adolescence. In: Fomon SJ, Zlotkin S,    editor
s. Nutritional anemias. Nestl&eacute; Nutrition Workshop Series, Vol.    30. New
 York: Raven Press, 1992:29-38.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#125#121#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704019900075002001200274#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#126#122#text#232#24#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Watts E. Athletes'   
 anaemia. A review of possible causes and guidelines on investigation. Br J Spor
ts    Med 1989;23:81-3.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#127#123#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00403000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704015800075002001200233#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#128#124#text#232#25#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">25. Hallberg L.    Bioava
ilability of dietary iron in man. Ann Rev Nutr 1981; 1:123-47.    ^cY#v6n3a07.ht
m##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#129#125#text#232# </font>  </p>     ^cY#
v6n3a07.htm##
00467000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704022200075002001200297#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#130#126#text#232#26#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Monsen ER,    Hallber
g L, Layrisse M, Hegsted DM, Cook JD, Mertz W, et al. Estimation of available   
 dietary iron. Am J Clin Nutr 1978;31: 134-41.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#131#127#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00507000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704026200075002001200337#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#132#128#text#232#27#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">27. Raper NR, Rosenthal  
  JC, Woteki CE. Estimates of available iron in diets of individuals 1 year old 
   and older in the Nationwide Food Consumption Survey. J Am Diet Assoc 1984;84:
783-7.    ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#133#129#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00407000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704016200075002001200237#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#134#130#text#232#28#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">28. McArdle WD,    Katch 
FI, Kath VL. Exercise physiology. Philadelphia: Lea-Febiger, 1991.    ^cY#v6n3a0
7.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#135#131#text#232# </font>  </p>     ^cY#
v6n3a07.htm##
00553000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704030800075002001200383#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#136#132#text#232#29#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">29. Rasmussen EB,    Hall
berg L, Isaksson B, Arvidsson B. Food iron absorption in man. Applications    of
 the two-pool extrinsic tag method to measure heme and nonheme iron absorption  
  from the whole diet. J Clin Invest 1974;53:247-55.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#137#133#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00485000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704024000075002001200315#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#138#134#text#232#30#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">30. Bauer JD. Hemoglobina
,    porfiria y metabolismo del hierro. In: Kaplan LA, Pesce AJ. Qu&iacute;mica 
cl&iacute;nica.    Buenos Aires: Ed. Panamericana, 1988: 721-73.    ^cY#v6n3a07.
htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#139#135#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00557000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704031200075002001200387#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#140#136#text#232#31#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">31. Macphail P,    Bothwe
ll TH. The prevalence and causes of nutritional iron deficiency anemia.    In: F
omon SJ, Zlotkin S, editors. Nutritional anemias. Nestl&eacute; Nutrition    Wor
kshop Series, Vol. 30. New York: Raven Press, 1992:1-12.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#141#137#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00409000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704016400075002001200239#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#142#138#text#232#32#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">32. Newhouse LJ,    Cleme
nt DB. Iron status in athletes. An update. Sports Med 1988;5:337-52.    ^cY#v6n3
a07.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#143#139#text#232# </font>  </p>     ^cY#
v6n3a07.htm##
00457000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704021200075002001200287#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#144#140#text#232#33#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">33. Brotherhood    J, Bro
zovic B, Pugh LGC. Haematological status of middle- and long-distance    runners
. Clin Sci Molec Med 1975;48:139-45.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#145#141#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00457000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704021200075002001200287#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#146#142#text#232#34#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">34. Blum SM, Sherman    A
R, Boileau RA. The effects of fitness-type exercise on iron status in adult    w
omen. Am J Clin Nutr 1986;43:456-63.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#147#143#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00422000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704017700075002001200252#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#148#144#text#232#35#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">35. Hunding A,    Jordal 
R, Paulev PE. Runner's anemia and iron deficiency. Acta Med Scand 1981;209:315-8
.    ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#149#145#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00443000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704019800075002001200273#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#150#146#text#232#36#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">36. Telford RD,    Cunnin
gham RB, Deakin V, Kerr DA. Iron status and diet in athletes. Med Sci    Sports 
Exerc 1993;25:796-800.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#151#147#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00452000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704020700075002001200282#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#152#148#text#232#37#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">37. Clement DB,    Asmund
son RC. Nutritional intake and hematological parameters in endurance runners.   
 Phys Sports Med 1982;10:37-43.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#153#149#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00463000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704021800075002001200293#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#154#150#text#232#38#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">38. Moffat RJ.    Dietary
 status of elite female high school gymnasts. Inadequacy of vitamin and    miner
al intake. J Am Diet Assoc 1984;84:1361-3.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#155#151#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00494000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704024900075002001200324#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#156#152#text#232#39#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">39. Lopez MA, Nuviala    
RJ, Ab&oacute;s D, Giner A. Estado nutricional del hierro en gimnastas de r&iacu
te;tmica    y nadadoras premen&aacute;rquicas. Arch Med Dep 1989;6:47-55.    ^cY
#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#157#153#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00475000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704023000075002001200305#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#158#154#text#232#40#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">40. Snyder AC,    Dvorak 
LL, Roepke JB. Influence of dietary iron source on measures of iron status    am
ong female runners. Med Sci Sports Exerc 1989;21:7-10.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#159#155#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00444000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704019900075002001200274#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#160#156#text#232#41#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">41. Selby GB, Eichner    
ER. Endurance swimming, intravascular hemolysis, anemia, and iron depletion.    
Am J Med 1986;81:791-4.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#161#157#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00438000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704019300075002001200268#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#162#158#text#232#42#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">42. Szygula Z.    Erythro
cytic system under the influence of physical exercise and training. Sports    Me
d 1990;10:181-97.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#163#159#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00404000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704015900075002001200234#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#164#160#text#232#43#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">43. Williamson    MR. Ane
mia in runners and other athletes. Phys Sports Med 1981;9:73-9.    ^cY#v6n3a07.h
tm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#165#161#text#232# </font>  </p>     ^cY#
v6n3a07.htm##
00462000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704021700075002001200292#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#166#162#text#232#44#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">44. O'Neil F, Hynak-Hanki
nson    MT, Gorman J. Research and application of current topics in sports nutri
tion.    J Am Diet Assoc 1986;86:1007-15.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#167#163#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00539000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704029400075002001200369#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#168#164#text#232#45#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">45. Nuviala RJ,    Lapiez
a MG, Ans&oacute;n JL, Castillo MC, Giner A. Efectos de una carrera de    marat&
oacute;n sobre los par&aacute;metros hematol&oacute;gicos minerales y    element
os traza. Arch Med Dep 1993;10:413-20.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#169#165#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00442000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704019700075002001200272#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#170#166#text#232#46#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">46. Halvorsen FA,    Lyng
 J, Ritland S. Gastrointestinal bleeding in marathon runners. Scand J Gastroente
rol    1989;21:493-7.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#171#167#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00465000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704022000075002001200295#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#172#168#text#232#47#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">47. Siegel AJ,    Henneke
ns CH, Solomon HS, Boeckel BV. Exercise-related hematuria. Findings in    a grou
p of marathon runners. JAMA 1979;241: 391-2.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#173#169#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00502000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704025700075002001200332#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#174#170#text#232#48#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">48. Seiler D, Nagel    D,
 Franz H, Hellstern P, Leitzmann C, Jung K. Effects of long-distance running    
on iron metabolism and hematological parameters. Int J Sports Med 1989;10:357-62
.    ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#175#171#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00410000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704016500075002001200240#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#176#172#text#232#49#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">49. Weight LM,    Byrne M
J, Jacobs P. Haemolytic effects of exercise. Clin Sci 1991;81:147-52.    ^cY#v6n
3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#177#173#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00473000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704022800075002001200303#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#178#174#text#232#50#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">50. McCabe ME,    Peura D
A, Kadakia SC, Bocek Z, Johnson LF. Gastrointestinal blood loss associated    wi
th running a marathon. Dig Dis Sci 1986; 31:1229-32.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#179#175#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00454000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704020900075002001200284#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#180#176#text#232#51#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">51. McMahon LF,    Ryan M
J, Larson D, Fisher RL: Occult gastrointestinal blood loss in marathon    runner
s. Ann Intern Med 1984;100:846-7.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#181#177#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00585000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704034000075002001200415#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#182#178#text#232#52#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">52. Katsumura T,    Iwanf
 H, Shimomitsu T, Takanami Y, Ohya Y, Sakamoto A, et al. Change in serum    iron
 after triathlon _ an effect of small amount of iron. In: Hermans GPH, Mosterd  
  WP, editors. Sports, medicine and health. Amsterdam: Excerpta Medica, 1990:487
-91.    ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#183#179#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00411000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704016600075002001200241#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#184#180#text#232#53#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">53. Vellar OD.    Studies
 on sweat losses of nutrients. Scand J Clin Lab Invest 1968;21:157-67.    ^cY#v6
n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#185#181#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00418000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704017300075002001200248#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#186#182#text#232#54#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">54. Parr RB, Bachman    M
A, Moss RA. Iron deficiency in female athletes. Phys Sports Med 1984;12:81-6.   
 ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#187#183#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00420000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704017500075002001200250#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#188#184#text#232#55#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">55. Eichner ER.    Sports
 anemia, iron supplements and blood doping. Med Sci Sports Exerc 1992;24:315-8. 
   ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#189#185#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00483000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704023800075002001200313#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#190#186#text#232#56#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">56. Frederickson    LA, P
uhl JL, Runyan WS. Effects of training on indices of iron status of young    fem
ale cross-country runners. Med Sci Sports Exerc 1983;15:271-6.    ^cY#v6n3a07.ht
m##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#191#187#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00582000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704033700075002001200412#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#192#188#text#232#57#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">57. Weight LM,    Noakes 
TD. Physical activity and iron metabolism. In: Bouchard C, Shephard RJ,    Stepj
ens T, editors. Physical activity, fitness, and health. International Proceeding
s    and consensus statement. Champaign: Humans Kinetics Publishers, 1994:456-70
.    ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#193#189#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00479000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704023400075002001200309#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#194#190#text#232#58#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">58. Finch CA, Bellotti   
 V, Stray S, Lipschitz DA, Cook JD, Pippard MJ, et al. Plasma ferritin determina
tion    as a diagnostic tool. West J Med 1986; 145:657-63.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#195#191#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00451000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704020600075002001200281#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#196#192#text#232#59#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">59. Walters GO,    Miller
 FM, Worwood M. Serum ferritin concentration and iron stores in normal    subjec
ts. J Clin Path 1973;26:770-2.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#197#193#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00458000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704021300075002001200288#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#198#194#text#232#60#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">60. Roberts D,    Smith D
. Serum ferritin values in elite speed and synchronized swimmers and    speed sk
aters. J Lab Clin Med 1990;116:661-5.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#199#195#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00491000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704024600075002001200321#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#200#196#text#232#61#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">61. Harju E, Pakarinen   
 A, Larmi T. A comparison between serum ferritin concentration and the amount   
 of bone marrow stainable iron. Scand J Clin Lab Invest 1984;44:555-6.    ^cY#v6
n3a07.htm##
00253000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002300072002001200095#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#201#197#text#232# </font>  </p>     ^cY#
v6n3a07.htm##
00420000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704017500075002001200250#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#202#198#text#232#62#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">62. Wick M, Pinggera    W
, Lehmann P. Ferritin in iron metabolism. New York: Springer-Verlag Wien, 1991. 
   ^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#203#199#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00497000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704025200075002001200327#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#204#200#text#232#63#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">63. Jacobs A, Miller    F
, Worwood M, Beamish MR, Wardrop CA. Ferritin in the serum of normal subjects   
 and patients with iron deficiency and iron overload. Br Med J 1972;4:206-8.    
^cY#v6n3a07.htm##
00255000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002500072002001200097#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#205#201#text#232#    </font> </p>     ^c
Y#v6n3a07.htm##
00450000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704020500075002001200280#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#206#202#text#232#64#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">64. Gimferrer E.    Fisio
log&iacute;a e inter&eacute;s cl&iacute;nico del receptor de la transferrina.   
 Bio-reguladores 1994;3:8-15.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#207#203#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00440000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704019500075002001200270#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#208#204#text#232#65#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">65. Brittenham    GM. New
 advances in iron metabolism, iron deficiency and iron overload. Curr    Opin He
matol 1994;1:101-6.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#209#205#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00480000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704023500075002001200310#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#210#206#text#232#66#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">66. Miller E, Brown    B,
 Gorman D. The effects of hemoglobin supplements on maximal oxygen uptake    in 
female athletes. J Manipulative Physiol Ther 1983;6:189-95.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#211#207#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00485000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704024000075002001200315#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#212#208#text#232#67#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">67. Newhouse IJ,    Cleme
nt DB, Tauton JE, McKenzie DC. The effects of prevalent/latent iron deficiency  
  on physical work capacity. Med Sci Sports Exerc 1989;21:263-8.    ^cY#v6n3a07.
htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#213#209#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00398000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704015300075002001200228#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#214#210#text#232#68#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">68. Hercberg S.    La car
ence en fer en nutrition humaine. Paris: Ed. Inter, 1988.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#215#211#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00475000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704023000075002001200305#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#216#212#text#232#69#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">69. Buzina R, Grgic    Z,
 Jusic M, Sapunar J, Milanovic V, Brubacher G. Nutritional status and physical  
  working capacity. Hum Nutr Clin Nutr 1982;36:429-38.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#217#213#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00519000000000157000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068888000300072704027400075002001200349#v6n
3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#p#218#214#text#232#70#<p><font
 size="2" face="Verdana, Arial, Helvetica, sans-serif">70. Risser WL,    Lee EJ,
 Poindexter HBW, West MS, Pivarnik JM, Risser JMH, et al. Iron deficiency    in 
female athletes: its prevalence and impact on performance. Med Sci Sports    Exe
rc 1988;20:116-21.    ^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#219#215#text#232# </font> </p>     ^cY#v
6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#220#216#text#232#<p>&nbsp;</p>     ^cY#v
6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#221#217#text#232#<p>&nbsp;</p>     ^cY#v
6n3a07.htm##
00524000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704029400072002001200366#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#222#218#text#232#<p><font size="2" face=
"Verdana, Arial, Helvetica, sans-serif"><B><a name="end"></a></B><a href="#topo"
><img src="/img/revistas/rbme/v6n3/seta.gif" border="0"></a></font>    <font siz
e="2" face="Verdana, Arial, Helvetica, sans-serif"><B>Endere&ccedil;o    para co
rrespond&ecirc;ncia</B>    ^cY#v6n3a07.htm##
00272000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704004200072002001200114#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#223#219#text#232#<BR>   Dr. Ram&oacute;n
 J. Nuviala    ^cY#v6n3a07.htm##
00289000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704005900072002001200131#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#224#220#text#232#<BR>   Servicio de Bioq
u&iacute;mica Cl&iacute;nica    ^cY#v6n3a07.htm##
00282000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704005200072002001200124#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#225#221#text#232#<BR>   Hospital Cl&iacu
te;nico Universitario    ^cY#v6n3a07.htm##
00269000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704003900072002001200111#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#226#222#text#232#<BR>   Avda. San Juan B
osco, 15    ^cY#v6n3a07.htm##
00271000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704004100072002001200113#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#227#223#text#232#<BR>   50009 - Zaragoza
 - Espanha    ^cY#v6n3a07.htm##
00337000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704010700072002001200179#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#228#224#text#232#<BR>   E-mail: <a href=
"mailto:glapieza@posta.unizar.es">glapieza@posta.unizar.es</a></font>  </p>     
^cY#v6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#229#225#text#232#<p>&nbsp;</p>     ^cY#v
6n3a07.htm##
00252000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704002200072002001200094#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#230#226#text#232#<p>&nbsp;</p>     ^cY#v
6n3a07.htm##
00315000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704008500072002001200157#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#231#227#text#232#<p><font size="2" face=
"Verdana, Arial, Helvetica, sans-serif">Traduzido por:    ^cY#v6n3a07.htm##
00399000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704016900072002001200241#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#232#228#text#232#<br>   </font><font siz
e="2" face="Verdana, Arial, Helvetica, sans-serif">Jos&eacute;    Kawazoe Lazzol
iEditor-Chefe da Revista Brasileira de Medicina do Esporte    ^cY#v6n3a07.htm##
00384000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704015400072002001200226#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#233#229#text#232#<br>   </font><font siz
e="2" face="Verdana, Arial, Helvetica, sans-serif">Vice-Presidente    da Socieda
de de Medicina Desportiva do Rio de Janeiro    ^cY#v6n3a07.htm##
00334000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704010400072002001200176#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#234#230#text#232#<br>   Professor do Dep
to. de Morfologia e da Disciplina de Medicina do Exerc&iacute;cio    e do    ^cY
#v6n3a07.htm##
00308000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704007800072002001200150#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#235#231#text#232#<br>   Esporte, da Univ
ersidade Federal Fluminense, Niter&oacute;i, RJ    ^cY#v6n3a07.htm##
00315000000000145000450000400050000070200460000570500020005170600020005370000040
0055701000400059709000500063708000400068704008500072002001200157#v6n3#V:\SciELO\
serial\rbme\v6n3\markup\v6n3a07.htm#S#p#236#232#text#232#<br>   Diretor do ERGOC
ENTER/Cor Diagnose, Petr&oacute;polis, RJ</font> </p>     ^cY#v6n3a07.htm##
00501000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100016000710100018000870120
03600105030001300141065000900154064000500163031000400168014000700172865000900179
002001200188035001000200801001300210#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#237#1#text#70#1#^rND^sFinch^nCA#^rND^sHuebers^nH.#Perspectives in ir
on metabolism^len#N Engl J Med#19820000#1982#306#1520-8#20000600#v6n3a07.htm#002
8-4793#N Engl J Med##
00529000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100018000710100024000890120
04300113030002000156065000900176064000500185031000300190014000700193865000900200
002001200209035001000221801002000231#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#238#2#text#70#2#^rND^sDe Mayer^nE#^rND^sAdiels-Tegman^nM.#The preval
ence of anaemia in the world^len#World Health Stat Q#19850000#1985#38#302-16#200
00600#v6n3a07.htm#0379-8070#World Health Stat Q##
00642000000000313000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100017000710100014000880100
01600102010002100118010001600139010002200155012009500177030000900272710000200281
065000900283064000500292031000300297014000700300865000900307002001200316#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#239#3#text#70#3#^rND^sHermosa^nV
#^rND^sMazo^nE#^rND^sCarril^nJ#^rND^sCordovilla^nJJ#^rND^sLuceño^nA#^rND^sZubiza
rreta^nA.#Estudio prospectivo sobre la prevalencia de ferropenia en la población
 adulta de Cantabria^les#Med Clin#2#19860000#1986#87#135-40#20000600#v6n3a07.htm
##
00503000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100017000710100016000880120
03900104030001400143065000900157064000500166031000200171014000700173865000900180
002001200189035001000201801001400211#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#240#4#text#70#4#^rND^sViteri^nFE#^rND^sTorun^nB.#Anaemia and physica
l work capacity^len#Clin Haematol#19740000#1974#3#609-26#20000600#v6n3a07.htm#03
08-2261#Clin Haematol##
00623000000000301000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100019000710100018000900100
01500108010002200123010002200145012008900167030000900256065000900265064000500274
031000200279865000900281002001200290035001000302801000900312#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#241#5#text#70#5#^rND^sEdgerton^nVR#^rND^sGar
dner^nGW#^rND^sOhira^nY#^rND^sGunawardena^nKA#^rND^sSenewiratne^nB.#Iron deficie
ncy anaemia and its effects on worker productivity and activity patterns^len#Br 
Med J#19790000#1979#2#20000600#v6n3a07.htm#0007-1447#Br Med J##
00485000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100019000710120047000900300
01400137065000900151064000500160031000300165014000600168865000900174002001200183
035001000195801001400205#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
242#6#text#70#6#^rND^sHallberg^nL.#Iron nutrition and food iron fortification^le
n#Semin Hematol#19820000#1982#19#31-41#20000600#v6n3a07.htm#0037-1963#Semin Hema
tol##
00482000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100017000710100018000880120
02900106030000700135065000900142064000500151031000400156014000600160865000900166
002001200175035001000187801000700197#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#243#7#text#70#7#^rND^sWeaver^nCM#^rND^sRajaram^nS.#Exercise and iron
 status^len#J Nutr#19920000#1992#122#782-7#20000600#v6n3a07.htm#0022-3166#J Nutr
##
00499000000000277000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100018000710100019000890120
03800108030001100146065000900157064000500166031000200171014000600173865000900179
002001200188035001000200801001100210#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#244#8#text#70#8#^rND^sClement^nDB#^rND^sSawchuk^nLL.#Iron status and
 sport performance^len#Sports Med#19840000#1984#1#65-74#20000600#v6n3a07.htm#011
2-1642#Sports Med##
00542000000000265000450000400050000070200460000570500020005170600020005370000040
00557010002000597090005000617080003000661180002000690100022000710120078000930300
02600171065000900197064000500206031000200211014000600213865000900219002001200228
035001000240801002600250#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
245#9#text#70#9#^rND^sSwearingen^nJV.#Iron deficiency in athletes: consequence o
r adaption in strenous activity^len#J Orthop Sports Phys Ther#19860000#1986#7#19
2-5#20000600#v6n3a07.htm#0190-6011#J Orthop Sports Phys Ther##
00478000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730120038000920300
01400130065000900144064000500153031000300158014000600161865000900167002001200176
035001000188801001400198#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
246#10#text#70#10#^rND^sDallman^nPR.#Manifestations of iron deficiency^len#Semin
 Hematol#19820000#1982#19#19-30#20000600#v6n3a07.htm#0037-1963#Semin Hematol##
00469000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730120063000890300
01600152710000200168065000900170064000500179031000300184014000700187865000900194
002001200203#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#247#11#text#
70#11#^rND^sPate^nRR.#Sports anemia: a review of the current research literature
^len#Phys Sports Med#2#19830000#1983#11#115-31#20000600#v6n3a07.htm##
00483000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100020000730120052000930300
00900145065000900154064000500163031000300168014000600171865000900177002001200186
035001000198801000900208#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
248#12#text#70#12#^rND^sYoshimura^nH.#Anemia during physical training (sports an
emia)^len#Nutr Rev#19700000#1970#10#251-3#20000600#v6n3a07.htm#0029-6643#Nutr Re
v##
00468000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730120064000920300
01300156710000200169065000900171064000500180031000200185014000600187865000900193
002001200202#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#249#13#text#
70#13#^rND^sDallman^nPR.#Biochemical basis for the manifestations of iron defici
ency^len#Ann Rev Nutr#2#19860000#1986#6#13-40#20000600#v6n3a07.htm##
00451000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160018000730180060000910660
00900151062000600160065000900166064000500175014000800180865000900188002001200197
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#250#14#text#70#14#^rND^s
Linder^nMC.#Nutrición, aspectos bioquímicos, metabólicos y clínicos^les#Pamplona
#Eunsa#19880000#1988#189-241#20000600#v6n3a07.htm##
00536000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730120070000900160
02400160018002400184066001000208062001000218065000900228064000500237014000700242
865000900249002001200258#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
251#15#text#70#15#^rND^sVives^nJL.#Anemia ferropénica y otros transtornos del me
tabolismo del hierro^les#^rND^sSans-Sabrafen^nJ.#Hematología clínica^les#Barcelo
na#Ed. Doyma#19880000#1988#177-93#20000600#v6n3a07.htm##
00471000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730120040000910300
01700131710000200148065000900150064000500159031000200164032000800166014001000174
865000900184002001200193#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
252#16#text#70#16#^rND^sHaymes^nEM.#Nutritional concerns: need for iron^len#Med 
Sports Exerc#2#19870000#1987#5#^sSuppl#S197-S200#20000600#v6n3a07.htm##
00563000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160018000730160016000910160
01700107016001900124016002000143018003600163066001300199062001900212065000900231
064000500240014000700245865000900252002001200261#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#253#17#text#70#17#^rND^sAnderson^nL#^rND^sDible^nMV#^rND
^sTurkki^nPR#^rND^sMitchell^nHS#^rND^sRynbergen^nHJ#Nutrición y dietética de Coo
per^les#Mexico^eD.C.#Ed. Interamericana#19880000#1988#75-110#20000600#v6n3a07.ht
m##
00529000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730120028000910160
01600119016001500135018002900150066000900179062002000188065000900208064000500217
014000800222865000900230002001200239#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#254#18#text#70#18#^rND^sKutchai^nH.#Gastrointestinal system^len#^rND
^sBerne^nRM#^rND^sLevy^nMN#Principles of physiology^len#Missouri#Ed. Mosby-Year 
Book#19960000#1996#437-501#20000600#v6n3a07.htm##
00477000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100016000900100
01700106012002500123030000500148710000200153065000900155064000500164031000300169
014000600172865000900178002001200187#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#255#19#text#70#19#^rND^sGarcía^nJD#^rND^sCrespo^nL#^rND^sGuerra^nJM#
Anemias ferropénicas^lpt#JANO#2#19900000#1990#38#43-50#20000600#v6n3a07.htm##
00538000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100019000900120
07500109030001100184065000900195064000500204031000200209014000700211865000900218
002001200227035001000239801001100249#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#256#20#text#70#20#^rND^sHaymes^nEM#^rND^sLamanca^nJJ.#Iron loss in r
unners during exercise: implications and recommendations^len#Sports Med#19890000
#1989#7#277-85#20000600#v6n3a07.htm#0112-1642#Sports Med##
00478000000000241000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700170058000730180035001310630
00300166066001700169062002300186031000300209020000300212865000900215002001200224
#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#257#21#text#70#21#Nation
al Research Council Committee of Dietary Allowances#Recommended dietary allowanc
es^len#10#Washington^eD.C.#National Academy Press#19#89#20000600#v6n3a07.htm##
00658000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100019000910100
01700110010001500127012010700142030002600249065000900275064000500284031000300289
014000700292865000900299002001200308035001000320801002600330#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#258#22#text#70#22#^rND^sHallberg^nL#^rND^sHo
gdahll^nAM#^rND^sNilsson^nL#^rND^sRybo^nR.#Menstrual blood loss: a population st
udy. Variation at different ages and attempts to define normality^len#Acta Obste
t Gynecol Scand#19660000#1966#45#320-51#20000600#v6n3a07.htm#0001-6349#Acta Obst
et Gynecol Scand##
00587000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730120055000920160
01600147016001700163018006700180066000900247062001200256065000900268064000500277
014000600282865000900288002001200297#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#259#23#text#70#23#^rND^sDallman^nPR.#Changing iron needs from birth 
through adolescence^len#^rED^sFomon^nSJ#^rED^sZlotkin^nS#Nutritional anemias. Ne
stlé Nutrition Workshop Series, Vol. 30^len#New York#Raven Press#19920000#1992#2
9-38#20000600#v6n3a07.htm##
00523000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730120083000890300
01600172065000900188064000500197031000300202014000500205865000900210002001200219
035001000231801001600241#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
260#24#text#70#24#^rND^sWatts^nE.#Athletes' anaemia. A review of possible causes
 and guidelines on investigation^len#Br J Sports Med#19890000#1989#23#81-3#20000
600#v6n3a07.htm#0306-3674#Br J Sports Med##
00448000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730120043000920300
01300135710000200148065000900150064000500159031000200164014000700166865000900173
002001200182#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#261#25#text#
70#25#^rND^sHallberg^nL.#Bioavailability of dietary iron in man^len#Ann Rev Nutr
#2#19810000#1981#1#123-47#20000600#v6n3a07.htm##
00645000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100018000900100
01800108010001800126010001500144010001500159810000700174012004100181030001500222
06500090023706400050024603100030025101400070025486500090026100200120027003500100
0282801001500292#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#262#26#t
ext#70#26#^rND^sMonsen^nER#^rND^sHallberg^nL#^rND^sLayrisse^nM#^rND^sHegsted^nDM
#^rND^sCook^nJD#^rND^sMertz^nW#et al.#Estimation of available dietary iron^len#A
m J Clin Nutr#19780000#1978#31#134-41#20000600#v6n3a07.htm#0002-9165#Am J Clin N
utr##
00622000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100020000890100
01800109012011900127030001600246065000900262064000500271031000300276014000600279
865000900285002001200294035001000306801001600316#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#263#27#text#70#27#^rND^sRaper^nNR#^rND^sRosenthal^nJC#^r
ND^sWoteki^nCE.#Estimates of available iron in diets of individuals 1 year old a
nd older in the Nationwide Food Consumption Survey^len#J Am Diet Assoc#19840000#
1984#84#783-7#20000600#v6n3a07.htm#0002-8223#J Am Diet Assoc##
00461000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160018000730160016000910160
01600107018002400123066001300147062001200160065000900172064000500181865000900186
002001200195#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#264#28#text#
70#28#^rND^sMcArdle^nWD#^rND^sKatch^nFI#^rND^sKath^nVL.#Exercise physiology^len#
Philadelphia#Lea-Febiger#19910000#1991#20000600#v6n3a07.htm##
00680000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100020000730100018000930100
01800111010001900129012014700148030001400295065000900309064000500318031000300323
014000700326865000900333002001200342035001000354801001400364#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#265#29#text#70#29#^rND^sRasmussen^nEB#^rND^s
Hallberg^nL#^rND^sIsaksson^nB#^rND^sArvidsson^nB#Food iron absorption in man. Ap
plications of the two-pool extrinsic tag method to measure heme and nonheme iron
 absorption from the whole diet^len#J Clin Invest#19740000#1974#53#247-55#200006
00#v6n3a07.htm#0021-9738#J Clin Invest##
00545000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730120051000900160
01700141016001700158018002000175066001300195062001700208065000900225064000500234
014000700239865000900246002001200255#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#266#30#text#70#30#^rND^sBauer^nJD.#Hemoglobina, porfiria y metabolis
mo del hierro^les#^rND^sKaplan^nLA#^rND^sPesce^nAJ.#Química clínica^lpt#Buenos A
ires#Ed. Panamericana#19880000#1988#721-73#20000600#v6n3a07.htm##
00630000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100020000910120
06800111016001600179016001700195018006700212066000900279062001200288065000900300
064000500309014000500314865000900319002001200328#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#267#31#text#70#31#^rND^sMacphail^nP#^rND^sBothwell^nTH.#
The prevalence and causes of nutritional iron deficiency anemia^len#^rED^sFomon^
nSJ#^rED^sZlotkin^nS#Nutritional anemias. Nestlé Nutrition Workshop Series, Vol.
 30^len#New York#Raven Press#19920000#1992#1-12#20000600#v6n3a07.htm##
00504000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730100019000920120
03900111030001100150065000900161064000500170031000200175014000700177865000900184
002001200193035001000205801001100215#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#268#32#text#70#32#^rND^sNewhouse^nLJ#^rND^sClement^nDB.#Iron status 
in athletes. An update^len#Sports Med#19880000#1988#5#337-52#20000600#v6n3a07.ht
m#0112-1642#Sports Med##
00536000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100021000730100018000940100
01700112012006300129030001900192710000200211065000900213064000500222031000300227
014000700230865000900237002001200246#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#269#33#text#70#33#^rND^sBrotherhood^nJ#^rND^sBrozovic^nB#^rND^sPugh^
nLGC.#Haematological status of middle- and long-distance runners^len#Clin Sci Mo
lec Med#2#19750000#1975#48#139-45#20000600#v6n3a07.htm##
00571000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100015000730100018000880100
01900106012007100125030001500196065000900211064000500220031000300225014000700228
865000900235002001200244035001000256801001500266#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#270#34#text#70#34#^rND^sBlum^nSM#^rND^sSherman^nAR#^rND^
sBoileau^nRA.#The effects of fitness-type exercise on iron status in adult women
^len#Am J Clin Nutr#19860000#1986#43#456-63#20000600#v6n3a07.htm#0002-9165#Am J 
Clin Nutr##
00539000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100016000900100
01800106012004000124030001500164065000900179064000500188031000400193014000600197
865000900203002001200212035001000224801001500234#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#271#35#text#70#35#^rND^sHunding^nA#^rND^sJordal^nR#^rND^
sPaulev^nPE.#Runner's anemia and iron deficiency^len#Acta Med Scand#19810000#198
1#209#315-8#20000600#v6n3a07.htm#0001-6101#Acta Med Scand##
00581000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100021000910100
01600112010001600128012003700144030002100181065000900202064000500211031000300216
014000800219865000900227002001200236035001000248801002100258#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#272#36#text#70#36#^rND^sTelford^nRD#^rND^sCu
nningham^nRB#^rND^sDeakin^nV#^rND^sKerr^nDA.#Iron status and diet in athletes^le
n#Med Sci Sports Exerc#19930000#1993#25#796-800#20000600#v6n3a07.htm#0195-9131#M
ed Sci Sports Exerc##
00513000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100021000910120
07300112030001600185710000200201065000900203064000500212031000300217014000600220
865000900226002001200235#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
273#37#text#70#37#^rND^sClement^nDB#^rND^sAsmundson^nRC.#Nutritional intake and 
hematological parameters in endurance runners^len#Phys Sports Med#2#19820000#198
2#10#37-43#20000600#v6n3a07.htm##
00542000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730120098000910300
01600189065000900205064000500214031000300219014000700222865000900229002001200238
035001000250801001600260#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
274#38#text#70#38#^rND^sMoffat^nRJ.#Dietary status of elite female high school g
ymnasts. Inadequacy of vitamin and mineral intake^len#J Am Diet Assoc#19840000#1
984#84#1361-3#20000600#v6n3a07.htm#0002-8223#J Am Diet Assoc##
00538000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100018000890100
01400107010001600121012008500137030001300222710000200235065000900237064000500246
865000900251002001200260#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
275#39#text#70#39#^rND^sLopez^nMA#^rND^sNuviala^nRJ#^rND^sAbós^nD#^rND^sGiner^nA
.#Estado nutricional del hierro en gimnastas de rítmica y nadadoras premenárquic
as^les#Arch Med Dep#2#19890000#1989#20000600#v6n3a07.htm##
00595000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100017000900100
01800107012008500125030002100210065000900231064000500240031000300245014000500248
865000900253002001200262035001000274801002100284#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#276#40#text#70#40#^rND^sSnyder^nAC#^rND^sDvorak^nLL#^rND
^sRoepke^nJB.#Influence of dietary iron source on measures of iron status among 
female runners^len#Med Sci Sports Exerc#19890000#1989#21#7-10#20000600#v6n3a07.h
tm#0195-9131#Med Sci Sports Exerc##
00534000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100019000890120
07600108030000900184065000900193064000500202031000300207014000600210865000900216
002001200225035001000237801000900247#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#277#41#text#70#41#^rND^sSelby^nGB#^rND^sEichner^nER.#Endurance swimm
ing, intravascular hemolysis, anemia, and iron depletion^len#Am J Med#19860000#1
986#81#791-4#20000600#v6n3a07.htm#0002-9343#Am J Med##
00512000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730120078000910300
01100169065000900180064000500189031000300194014000700197865000900204002001200213
035001000225801001100235#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
278#42#text#70#42#^rND^sSzygula^nZ.#Erythrocytic system under the influence of p
hysical exercise and training^len#Sports Med#19900000#1990#10#181-97#20000600#v6
n3a07.htm#0112-1642#Sports Med##
00450000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100022000730120041000950300
01600136710000200152065000900154064000500163031000200168014000500170865000900175
002001200184#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#279#43#text#
70#43#^rND^sWilliamson^nMR.#Anemia in runners and other athletes^len#Phys Sports
 Med#2#19810000#1981#9#73-9#20000600#v6n3a07.htm##
00577000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100026000890100
01700115012006700132030001600199065000900215064000500224031000300229014000800232
865000900240002001200249035001000261801001600271#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#280#44#text#70#44#^rND^sO'Neil^nF#^rND^sHynak-Hankinson^
nMT#^rND^sGorman^nJ.#Research and application of current topics in sports nutrit
ion^len#J Am Diet Assoc#19860000#1986#86#1007-15#20000600#v6n3a07.htm#0002-8223#
J Am Diet Assoc##
00623000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100018000910100
01600109010001900125010001600144012010100160030001300261710000200274065000900276
064000500285031000300290014000700293865000900300002001200309#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#281#45#text#70#45#^rND^sNuviala^nRJ#^rND^sLa
pieza^nMG#^rND^sAnsón^nJL#^rND^sCastillo^nMC#^rND^sGiner^nA.#Efectos de una carr
era de maratón sobre los parámetros hematológicos minerales y elementos traza^le
s#Arch Med Dep#2#19930000#1993#10#413-20#20000600#v6n3a07.htm##
00563000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100020000730100014000930100
01800107012005000125030002200175065000900197064000500206031000300211014000600214
865000900220002001200229035001000241801002200251#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#282#46#text#70#46#^rND^sHalvorsen^nFA#^rND^sLyng^nJ#^rND
^sRitland^nS.#Gastrointestinal bleeding in marathon runners^len#Scand J Gastroen
terol#19890000#1989#21#493-7#20000600#v6n3a07.htm#0036-5521#Scand J Gastroentero
l##
00586000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100020000900100
01800110010001900128012007200147030000500219065000900224064000500233031000400238
014000600242865000900248002001200257035001000269801000500279#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#283#47#text#70#47#^rND^sSiegel^nAJ#^rND^sHen
nekens^nCH#^rND^sSolomon^nHS#^rND^sBoeckel^nBV.#Exercise-related hematuria. Find
ings in a group of marathon runners^len#JAMA#19790000#1979#241#391-2#20000600#v6
n3a07.htm#0098-7484#JAMA##
00672000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100015000890100
01500104010001900119010001900138010001500157012008500172030001700257065000900274
06400050028303100030028801400070029186500090029800200120030703500100031980100170
0329#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#284#48#text#70#48#^r
ND^sSeiler^nD#^rND^sNagel^nD#^rND^sFranz^nH#^rND^sHellstern^nP#^rND^sLeitzmann^n
C#^rND^sJung^nK.#Effects of long-distance running on iron metabolism and hematol
ogical parameters^len#Int J Sports Med#19890000#1989#10#357-62#20000600#v6n3a07.
htm#0172-4622#Int J sports Med##
00521000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100016000900100
01700106012003500123030000900158065000900167064000500176031000300181014000700184
865000900191002001200200035001000212801000900222#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#285#49#text#70#49#^rND^sWeight^nLM#^rND^sByrne^nMJ#^rND^
sJacobs^nP.#Haemolytic effects of exercise^len#Clin Sci#19910000#1991#81#147-52#
20000600#v6n3a07.htm#0009-9287#Clin Sci##
00618000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100016000900100
01800106010001500124010001800139012006700157030001200224065000900236064000500245
031000300250014000800253865000900261002001200270035001000282801001200292#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#286#50#text#70#50#^rND^sMcCabe^n
ME#^rND^sPeura^nDA#^rND^sKadakia^nSC#^rND^sBocek^nZ#^rND^sJohnson^nLF#Gastrointe
stinal blood loss associated with running a marathon^len#Dig Dis Sci#19860000#19
86#31#1229-32#20000600#v6n3a07.htm#0163-2116#Dig Dis Sci##
00585000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100015000910100
01600106010001700122012005900139030001500198065000900213064000500222031000400227
014000600231865000900237002001200246035001000258801001500268#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#287#51#text#70#51#^rND^sMcMahon^nLF#^rND^sRy
an^nMJ#^rND^sLarson^nD#^rND^sFisher^nRL#Occult gastrointestinal blood loss in ma
rathon runners^len#Ann Intern Med#19840000#1984#100#846-7#20000600#v6n3a07.htm#0
003-4819#Ann Intern Med##
00748000000000349000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730100015000920100
02000107010001800127010001400145010001800159810000700177012007700184016001900261
01600180028001800320029806600100033006200160034006500090035606400050036501400070
0370865000900377002001200386#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#
S#c#288#52#text#70#52#^rND^sKatsumura^nT#^rND^sIwanf^nH#^rND^sShimomitsu^nT#^rND
^sTakanami^nY#^rND^sOhya^nY#^rND^sSakamoto^nA#et al.#Change in serum iron after 
triathlon _ an effect of small amount of iron^len#^rED^sHermans^nGPH#^rED^sMoste
rd^nWP#Sports, medicine and health^len#Amsterdam#Excerpta Medica#19900000#1990#4
87-91#20000600#v6n3a07.htm##
00501000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730120041000910300
02400132065000900156064000500165031000300170014000700173865000900180002001200189
035001000201801002400211#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
289#53#text#70#53#^rND^sVellar^nOD.#Studies on sweat losses of nutrients^len#Sca
nd J Clin Lab Invest#19680000#1968#21#157-67#20000600#v6n3a07.htm#0036-5513#Scan
d J Clin Lab Invest##
00499000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100015000730100018000880100
01500106012003900121030001600160710000200176065000900178064000500187031000300192
014000500195865000900200002001200209#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#290#54#text#70#54#^rND^sParr^nRB#^rND^sBachman^nMA#^rND^sMoss^nRA#Ir
on deficiency in female athletes^len#Phys Sports Med#2#19840000#1984#12#81-6#200
00600#v6n3a07.htm##
00507000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730120053000920300
02100145065000900166064000500175031000300180014000600183865000900189002001200198
035001000210801002100220#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
291#55#text#70#55#^rND^sEichner^nER.#Sports anemia, iron supplements and blood d
oping^len#Med Sci Sports Exerc#19920000#1992#24#315-8#20000600#v6n3a07.htm#0195-
9131#Med Sci Sports Exerc##
00602000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100023000730100015000960100
01700111012008800128030002100216065000900237064000500246031000300251014000600254
865000900260002001200269035001000281801002100291#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#292#56#text#70#56#^rND^sFrederickson^nLA#^rND^sPuhl^nJL#
^rND^sRunyan^nWS#Effects of training on indices of iron status of young female c
ross-country runners^len#Med Sci Sports Exerc#19830000#1983#15#271-6#20000600#v6
n3a07.htm#0195-9131#Med Sci Sports Exerc##
00680000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100018000900120
04200108016001800150016001900168016001800187018009400205066001000299062002700309
065000900336064000500345014000700350865000900357002001200366#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#293#57#text#70#57#^rND^sWeight^nLM#^rND^sNoa
kes^nTD.#Physical activity and iron metabolism^len#^rED^sBouchard^nC#^rED^sSheph
ard^nRJ#^rED^sStepjens^nT#Physical activity, fitness, and health. International 
Proceedings and consensus statement^len#Champaign#Humans Kinetics Publishers#199
40000#1994#456-70#20000600#v6n3a07.htm##
00653000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100018000890100
01500107010002000122010001500142010001800157810000700175012005500182030001100237
06500090024806400050025703100040026201400070026686500090027300200120028203500100
0294801001100304#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#294#58#t
ext#70#58#^rND^sFinch^nCA#^rND^sBellotti^nV#^rND^sStray^nS#^rND^sLipschitz^nDA#^
rND^sCook^nJD#^rND^sPippard^nMJ#et al.#Plasma ferritin determination as a diagno
stic tool^len#West J Med#19860000#1986#145#657-63#20000600#v6n3a07.htm#0093-0415
#West J Med##
00530000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100018000730100017000910100
01800108012006800126030001200194710000200206065000900208064000500217031000300222
014000600225865000900231002001200240#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#295#59#text#70#59#^rND^sWalters^nGO#^rND^sMiller^nFM#^rND^sWorwood^n
M.#Serum ferritin concentration and iron stores in normal subjects^len#J Clin Pa
th#2#19730000#1973#26#770-2#20000600#v6n3a07.htm##
00554000000000277000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100016000900120
08500106030001500191065000900206064000500215031000400220014000600224865000900230
002001200239035001000251801001500261#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3
a07.htm#S#c#296#60#text#70#60#^rND^sRoberts^nD#^rND^sSmith^nD.#Serum ferritin va
lues in elite speed and synchronized swimmers and speed skaters^len#J Lab Clin M
ed#19900000#1990#116#661-5#20000600#v6n3a07.htm#0022-2143#J Lab Clin Med##
00614000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100015000730100019000880100
01600107012009900123030002400222065000900246064000500255031000300260014000600263
865000900269002001200278035001000290801002400300#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#297#61#text#70#61#^rND^sHarju^nE#^rND^sPakarinen^nA#^rND
^sLarmi^nT.#A comparison between serum ferritin concentration and the amount of 
bone marrow stainable iron^len#Scand J Clin Lab Invest#19840000#1984#44#555-6#20
000600#v6n3a07.htm#0036-5513#Scand J Clin Lab Invest##
00474000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160014000730160018000870160
01800105018003200123066000900155062002100164065000900185064000500194865000900199
002001200208#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#298#62#text#
70#62#^rND^sWick^nM#^rND^sPinggera^nW#^rND^sLehmann^nP.#Ferritin in iron metabol
ism^len#New York#Springer-Verlag Wien#19910000#1991#20000600#v6n3a07.htm##
00641000000000313000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100016000890100
01700105010001800122010001900140012009700159030000900256065000900265064000500274
031000200279014000600281865000900287002001200296035001000308801000900318#v6n3#V:
\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#299#63#text#70#63#^rND^sJacobs^n
A#^rND^sMiller^nF#^rND^sWorwood^nM#^rND^sBeamish^nMR#^rND^sWardrop^nCA.#Ferritin
 in the serum of normal subjects and patients with iron deficiency and iron over
load^len#Br Med J#19720000#1972#4#206-8#20000600#v6n3a07.htm#0007-1447#Br Med J#
#
00472000000000253000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100020000730120065000930300
01600158710000200174065000900176064000500185031000200190014000500192865000900197
002001200206#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#300#64#text#
70#64#^rND^sGimferrer^nE.#Fisiología e interés clínico del receptor de la transf
errina^les#Bio-reguladores#2#19940000#1994#3#8-15#20000600#v6n3a07.htm##
00521000000000265000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100022000730120071000950300
01800166065000900184064000500193031000200198014000600200865000900206002001200215
035001000227801001800237#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#
301#65#text#70#65#^rND^sBrittenham^nGM.#New advances in iron metabolism, iron de
ficiency and iron overload^len#Curr Opin Hematol#19940000#1994#1#101-6#20000600#
v6n3a07.htm#1065-6251#Curr Opin Hematol##
00607000000000289000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100015000890100
01700104012008600121030002800207065000900235064000500244031000200249014000700251
865000900258002001200267035001000279801002800289#v6n3#V:\SciELO\serial\rbme\v6n3
\markup\v6n3a07.htm#S#c#302#66#text#70#66#^rND^sMiller^nE#^rND^sBrown^nB#^rND^sG
orman^nD.#The effects of hemoglobin supplements on maximal oxygen uptake in fema
le athletes^len#J Manipulative Physiol Ther#19830000#1983#6#189-95#20000600#v6n3
a07.htm#0161-4754#J Manipulative Physiol Ther##
00623000000000301000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100019000730100018000920100
01700110010002000127012007800147030002100225065000900246064000500255031000300260
014000600263865000900269002001200278035001000290801002100300#v6n3#V:\SciELO\seri
al\rbme\v6n3\markup\v6n3a07.htm#S#c#303#67#text#70#67#^rND^sNewhouse^nIJ#^rND^sC
lement^nDB#^rND^sTauton^nJE#^rND^sMcKenzie^nDC.#The effects of prevalent/latent 
iron deficiency on physical work capacity^len#Med Sci Sports Exerc#19890000#1989
#21#263-8#20000600#v6n3a07.htm#0195-9131#Med Sci Sports Exerc##
00416000000000229000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700160019000730180043000920660
00600135062001000141065000900151064000500160865000900165002001200174#v6n3#V:\Sci
ELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#304#68#text#70#68#^rND^sHercberg^nS.
#La carence en fer en nutrition humaine^lfr#Paris#Ed. Inter#19880000#1988#200006
00#v6n3a07.htm##
00647000000000325000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100016000730100015000890100
01500104010001700119010001900136010002000155012005300175030001900228065000900247
06400050025603100030026101400070026486500090027100200120028003500100029280100190
0302#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#305#69#text#70#69#^r
ND^sBuzina^nR#^rND^sGrgic^nZ#^rND^sJusic^nM#^rND^sSapunar^nJ#^rND^sMilanovic^nV#
^rND^sBrubacher^nG.#Nutritional status and physical working capacity^len#Hum Nut
r Clin Nutr#19820000#1982#36#429-38#20000600#v6n3a07.htm#0263-8290#Hum Nutr Clin
 Nutr##
00701000000000337000450000400050000070200460000570500020005170600020005370000040
00557010003000597090005000627080003000671180003000700100017000730100014000900100
02200104010001500126010001900141010001800160810000700178012008100185030002100266
06500090028706400050029603100030030101400070030486500090031100200120032003500100
0332801002100342#v6n3#V:\SciELO\serial\rbme\v6n3\markup\v6n3a07.htm#S#c#306#70#t
ext#70#70#^rND^sRisser^nWL#^rND^sLee^nEJ#^rND^sPoindexter^nHBW#^rND^sWest^nMS#^r
ND^sPivarnik^nJM#^rND^sRisser^nJMH#et al.#Iron deficiency in female athletes: it
s prevalence and impact on performance^len#Med Sci Sports Exerc#19880000#1988#20
#116-21#20000600#v6n3a07.htm#0195-9131#Med Sci Sports Exerc##
